Sentence,class,file
"82 2 3277 6872: e-mail, hskim3@ewha.ac.krReceived October 16, 2012 / Last Revision November 5, 2012 / AcceptedNovember 10, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/f4/jap-4-218.PMC3517960.pdf
"82 2 2228 8713: e-mail, jfshim@yuhs.acReceived October 21, 2012 / Last Revision November 6, 2012 / AcceptedNovember 12, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.http://dx.doi.org/10.4047/jap.2012.4.4.227 ORIGINAL ARTICLE J Adv Prosthodont 2012;4:227-34 ��These authors are equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/a4/5d/jap-4-227.PMC3517961.pdf
"http://dx.doi.org/10.4047/jap.2012.4.4.235 Magnet retained intraoral-extra oral combination  prosthesis: a case report Saurav Banerjee1*, MDS, Surender Kumar2, MDS, Amit Bera3, BDS, Tapas Gupta3, MDS, Ardhendu Banerjee4, MDS 1Awadh Dental College & Hospital, Jamshedpur, India,  2IDEAS, Gwalior, Madhya Pradesh, India, 3Dr R Ahmed Dental College & Hospital, Kolkata, India, 4Kalinga Institute of Dental Sciences, Bhubaneswar, India Facial prosthesis is generally considered over surgical reconstruction to restore function and appearance in patients with faci al defects that result- ed from cancer resection.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/jap-4-235.PMC3517962.pdf
"91 9830668042: e-mail, sauravbnrj@gmail.comReceived October 25, 2011 / Last Revision March 23, 2012 / Accepted May 7, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/jap-4-235.PMC3517962.pdf
"http://dx.doi.org/10.4047/jap.2012.4.4.239 Prosthodontic management of worn dentition in  pediatric patient with complete overlay dentures:  a case report Prince Kumar1*, MDS, Jyoti Rastogi2, MDS, Chandni Jain3, MDS, Harkanwal Preet Singh4, MDS 1Department of Prosthodontics, Shree Bankey Bihari Dental College and Research Centre, Ghaziabad, Uttar Pradesh, India 2Department of Prosthodontics, Dental College, Azamgarh, Uttar Pradesh, India 3Private Practitioner, Jabalpur, Madhya Pradesh, India  4Department of Oral Pathology, Swami Devi Dyal Hospital and Dental College, Panchkula, Haryana, India Overlay complete dentures are simple, reversible and economical treatment modality for patients with congenital or acquired dis orders that severe- ly affect the tooth development.",Non-OADS,/arxiv_data1/oa_pdf/7a/1f/jap-4-239.PMC3517963.pdf
"91 9412860201: e-mail, drprincegupta20032007@gmail.comReceived November 9, 2011 / Last Revision December 29, 2011 / AcceptedJanuary 16, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/1f/jap-4-239.PMC3517963.pdf
"91 9336262202: e-mail, neerja_gogia@yahoo.comReceived January 18, 2012 / Last Revision February 6, 2012 / AcceptedFebruary 26, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.http://dx.doi.org/10.4047/jap.2012.4.4.243 CASE REPORT J Adv Prosthodont 2012;4:243-7",Non-OADS,/arxiv_data1/oa_pdf/c4/b0/jap-4-243.PMC3517964.pdf
"To understand the technique well, this articledescribes a case report of a patient who had undergone partialmaxillectomy secondary to squamous cell carcinoma rehabilitatedwith a hollow obturator prosthesis.http://dx.doi.org/10.4047/jap.2012.4.4.248 A hollow definitive obturator fabrication technique for management of partial maxillectomy Pravinkumar Gajanan Patil1*, MDS, Smita Pravinkumar Patil2, MDS 1Department of Prosthodontics, Government Dental College and Hospital, 2Department of Orthodontics and Dentofacial Orthopedics, Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital, Nagpur, Maharashtra, India Maxillary obturator prosthesis is the most frequent treatment option for management of partial or total maxillectomy.",Non-OADS,/arxiv_data1/oa_pdf/7a/d4/jap-4-248.PMC3517965.pdf
"91 9923294699: e-mail, pravinandsmita@yahoo.co.inReceived February 17, 2012 / Last Revision July 26, 2012 / Accepted August 6, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/d4/jap-4-248.PMC3517965.pdf
"82 2 2072 2664: e-mail, ksh1250@snu.ac.krReceived October 13, 2012 / Last Revision November 6, 2012 / AcceptedNovember 12, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.http://dx.doi.org/10.4047/jap.2012.4.4.254 CASE REPORT J Adv Prosthodont 2012;4:254-8",Non-OADS,/arxiv_data1/oa_pdf/85/79/jap-4-254.PMC3517966.pdf
"The intent of this conventional review is tohighlight the occupational hazards and risks associated inProsthodontic practice and to briefly discuss their managementtactics in routine practice with a view to enhance awarenessand take preventive measures to reduce the risk among the pro-fessionals.http://dx.doi.org/10.4047/jap.2012.4.4.259 Occupational health hazards in a prosthodontic practice: review of risk factors and management strategies Indumathi Sivakumar1*, MDS, Kuthalingam Subbiah Arunachalam2, MDS, EGR Solomon3, MDS 1Department of Prosthodontics, Vishnu Dental College, Bhimavaram, India 2Department of Prosthodontics, Sri Moogambikai Institute of Dental Sciences, Kulasekram, India 3Department of Prosthodontics, Satyabahma University Dental College and Hospital, Chennai, India The intent of this article was to analyze the potential hazards and risks involved in persons exposed to prosthodontic practice .",Non-OADS,/arxiv_data1/oa_pdf/95/26/jap-4-259.PMC3517967.pdf
"91 9573157197: e-mail, cherub2008@gmail.comReceived July 10, 2012 / Last Revision October 22, 2012 / Accepted November6, 2012 ⓒ2012 The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/26/jap-4-259.PMC3517967.pdf
Available at http://www.inchem.org/documents/harmproj/harmproj/harmproj1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/26/jap-4-259.PMC3517967.pdf
"Department of Labor occupational noise exposure.1983; CFR29, 1910.95. http://www.OSHA.gov/pls/oshaweb/owadisp.show_document?p_table=standars&p_id=9735.",OADS,/arxiv_data1/oa_pdf/95/26/jap-4-259.PMC3517967.pdf
Availableat http://www.osha.gov/SLTC/beryllium/index.html.,OADS,/arxiv_data1/oa_pdf/95/26/jap-4-259.PMC3517967.pdf
Available at http://www.osha.gov/about.html.,Non-OADS,/arxiv_data1/oa_pdf/95/26/jap-4-259.PMC3517967.pdf
Report of the Japanese Government to the IAEA Ministerial Conference on Nuclear Safety.Available at http://www.iaea.org/newscenter/focus/fukushima/japan-report/ (2011).,Non-OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
Available at http://radioactivity.mext.go.jp/en/ contents/1000/294/view.html (2012).,OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
Available at http://radioactivity.mext.go.jp/en/contents/6000/5268/view.html (2012).,OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
Available at http://www.kankyo- hoshano.go.jp (in Japanese) (2012).,Non-OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
Available at http://www.data.jma.go.jp (in Japanese).,OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kakiuchi, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/df/8f/srep00947.PMC3517976.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/a6/srep00945.PMC3517977.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kawamata, M. & Ochiya, T. Two distinct knockout approaches highlight a critical role for p53 in rat development.",Non-OADS,/arxiv_data1/oa_pdf/ff/a6/srep00945.PMC3517977.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/26/srep00944.PMC3517978.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wakasa, Y., Hayashi, S., Ozawa, K. & Takaiwa, F. Multiple roles of the ER stress sensor IRE1 demonstrated by gene targeting in rice.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/srep00944.PMC3517978.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interest: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/srep00951.PMC3517979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kamthan, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/9c/srep00951.PMC3517979.pdf
"InSupplementary Information H, we describe the data processing method in detail and present the results of the functional analysis (g:profiler: http://biit.cs.ut.ee/gprofiler/ and NOA: http://app.aporc.org/NOA/) 30,31of these leading networks for two complex diseases.",Non-OADS,/arxiv_data1/oa_pdf/98/93/srep00813.PMC3517980.pdf
Additional information Data and materials availability: Data are available in the National Center for Biotechnology Information Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo)under accession numbers GSE2565 and GSE6764.,Non-OADS,/arxiv_data1/oa_pdf/98/93/srep00813.PMC3517980.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/98/93/srep00813.PMC3517980.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Liu, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/98/93/srep00813.PMC3517980.pdf
"castaneum , blast (tblastn) searches were performed in the Beetlebase (http://beetlebase.org/) and in the NCBI (http://www.ncbi.nlm.nih.gov/) using known Dsx protein sequences as a query.",OADS,/arxiv_data1/oa_pdf/3e/40/srep00948.PMC3517981.pdf
"Sequence analysis .Exons and introns, of the Tcdsx were identified by aligning sequences of RT-PCR products with their corresponding genomic DNA sequences obtained from the Beetlebase (http://beetlebase.org/) and the NCBI (http:// www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/3e/40/srep00948.PMC3517981.pdf
Exon-intron boundaries were confirmed by aligning thesequences through Spidey program (http://www.ncbi.nlm.nih.gov/spidey/).,OADS,/arxiv_data1/oa_pdf/3e/40/srep00948.PMC3517981.pdf
Author contributions Both authors planned and conducted experiments and wrote manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3e/40/srep00948.PMC3517981.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Shukla, J.N.",Non-OADS,/arxiv_data1/oa_pdf/3e/40/srep00948.PMC3517981.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/61/srep00950.PMC3517982.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Bernadac, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/srep00950.PMC3517982.pdf
http://books.google.com/ngrams (date of access: 14 January 2011).,Non-OADS,/arxiv_data1/oa_pdf/b2/96/srep00943.PMC3517984.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/How to cite this article: Petersen, A.M., Tenenbaum, J.N., Havlin, S., Stanley, H.E.",Non-OADS,/arxiv_data1/oa_pdf/b2/96/srep00943.PMC3517984.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/srep00946.PMC3517985.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Gim, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/srep00946.PMC3517985.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society Biochemical Journal    www.biochemj.org © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"Data collection and processing Diffraction data for crystals of WDR5 in complex with WDR5-0102 and WDR5-0103 were collected on a Rigaku FR-E c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
Crystal diffraction data and reﬁnement statistics for the structures are shown in Supplementary Table S1 at http://www.biochemj.org/bj/449/bj4490151add.htm.,OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"Reactions were carried out in 20μl of 20 mM Tris/HCl (pH 8.0), 5 mM DTT (dithiothreitol) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
We screened a library of 16 000 diverse small molecules(see the Supplementary Online Data http://www.biochemj.,OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"WDR5-0103 occupies the binding pocket with a similar geometry to that of WDR5-0102, but the methoxy substituent induces a 2.5 Å shift of the benzamide ring in the upper shallow c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
The tetrameric complexwas signiﬁcantly more active than the trimeric complex which does not include ASH2L ( k catvalues of 27 +−0.3 compared with 3.4+−0.1 h−1; Supplementary Figure S2 and Supplementary Table S2 at http://www.biochemj.org/bj/449/bj4490151add.htm).,Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"At concentrations up to 100 μM, WDR5- 0103 showed no inhibitory effect on the human H3K4methyltransferase SETD7, or six other HMTs (G9a, EHMT1, SUV39H2, SETD8, PRMT3 and PRMT5) (Supplementary Figure S3 at http://www.biochemj.org/bj/449/bj4490151add.htm).",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"WDR5has been reported to (i) directly mediate formation of the tetra- meric core complex [15], (ii) facilitate interaction of the MLL1 catalytic subunit with the histone substrate [15,38,41], and (iii) contribute to formation of a stable complex with RbBP5 and c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"285, 32967–32976 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"Cell 43, 811–822 Received 13 August 2012/13 September 2012; accepted 19 September 2012 Published as BJ Immediate Publication 19 September 2012, doi:10.1042/BJ20121280 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"Km(μM) Protein complex S-adenosylmethionine Peptide kcat(h−1) MLL–WDR5–RbBP5 2 +−0.1 2 +−0.1 3.5 +−0.1 MLL–WDR5–RbBP5–ASH2L 2.6 +−0.1 1.1 +−0.1 27 +−0.3 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
"55, 191–205 Received 13 August 2012/13 September 2012; accepted 19 September 2012 Published as BJ Immediate Publication 19 September 2012, doi:10.1042/BJ20121280 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/46/bj4490151.PMC3517986.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/08/79/srep00949.PMC3517987.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Levy-Tzedek, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/08/79/srep00949.PMC3517987.pdf
"583Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/23/aps-39-583.PMC3517999.pdf
"585Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/e2/aps-39-585.PMC3518000.pdf
Available from:  http://www.emea.europa.eu/pdfs/human/pmf/2001-83- EC.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/e2/aps-39-585.PMC3518000.pdf
"593Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/db/aps-39-593.PMC3518001.pdf
"Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/db/aps-39-593.PMC3518001.pdf
"601Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/73/aps-39-601.PMC3518002.pdf
"606Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/b3/aps-39-606.PMC3518003.pdf
"612Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/70/aps-39-612.PMC3518004.pdf
"Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/70/aps-39-612.PMC3518004.pdf
"619Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/aps-39-619.PMC3518005.pdf
"626Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/dd/aps-39-626.PMC3518006.pdf
"631Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/82/aps-39-631.PMC3518007.pdf
"Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/82/aps-39-631.PMC3518007.pdf
"637Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/d1/aps-39-637.PMC3518008.pdf
"643Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/f8/aps-39-643.PMC3518009.pdf
"649Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/f7/aps-39-649.PMC3518010.pdf
"655Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/7a/aps-39-655.PMC3518011.pdf
"659Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/a7/aps-39-659.PMC3518012.pdf
"663Copyright © 2012  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/e2/aps-39-663.PMC3518013.pdf
"Received: 5 Sep 2012 • Revised: 1 1 Oct 2012 • Accepted: 24 Oct 2012 pISSN: 2234-6163  • eISSN: 2234-6171  http://dx.doi.org/10.5999/aps.2012.39.6.667  • Arch Plast Surg 2012;39:667-668 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/18/aps-39-667.PMC3518014.pdf
"Received: 30 Jun 2012 • Revised: 31 Jul 2012 • Accepted: 13 Aug 2012  pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.669  • Arch Plast Surg 2012;39:669-671 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/bd/aps-39-669.PMC3518015.pdf
"Received: 10 Apr 2012 • Revised: 1 Jun 2012 • Accepted: 2 Jun 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.671  • Arch Plast Surg 2012;39:671-673 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/bd/aps-39-669.PMC3518015.pdf
"Received: 10 Apr 2012 • Revised: 1 Jun 2012 • Accepted: 2 Jun 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.671  • Arch Plast Surg 2012;39:671-673 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/50/aps-39-671.PMC3518016.pdf
"Received: 31 Aug 2012 • Revised: 26 Sep 2012 • Accepted: 26 Sep 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.673  • Arch Plast Surg 2012;39:673-675 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Images Fig.",Non-OADS,/arxiv_data1/oa_pdf/83/50/aps-39-671.PMC3518016.pdf
"Received: 31 Aug 2012 • Revised: 26 Sep 2012 • Accepted: 26 Sep 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.673  • Arch Plast Surg 2012;39:673-675 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Images Fig.",Non-OADS,/arxiv_data1/oa_pdf/65/85/aps-39-673.PMC3518017.pdf
"Received: 31 May 2012 • Revised: 16 Jul 2012 • Accepted: 17 Jul 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.675  • Arch Plast Surg 2012;39:675-678 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Imagesconsiderations in a previously healthy child.",Non-OADS,/arxiv_data1/oa_pdf/65/85/aps-39-673.PMC3518017.pdf
"Received: 31 May 2012 • Revised: 16 Jul 2012 • Accepted: 17 Jul 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.675  • Arch Plast Surg 2012;39:675-678 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Imagesconsiderations in a previously healthy child.",Non-OADS,/arxiv_data1/oa_pdf/d3/78/aps-39-675.PMC3518018.pdf
"Received: 4 May 2012 • Revised: 1 1 May 2012 • Accepted: 13 May 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.678  • Arch Plast Surg 2012;39:678-680 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/78/aps-39-675.PMC3518018.pdf
"Received: 4 May 2012 • Revised: 1 1 May 2012 • Accepted: 13 May 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.678  • Arch Plast Surg 2012;39:678-680 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/ad/aps-39-678.PMC3518019.pdf
"Received: 2 May 2012 • Revised: 15 Jun 2012 • Accepted: 16 Jun 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.680  • Arch Plast Surg 2012;39:680-683 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/ad/aps-39-678.PMC3518019.pdf
"Received: 2 May 2012 • Revised: 15 Jun 2012 • Accepted: 16 Jun 2012 pISSN: 2234-6163  • eISSN: 2234-6171 http://dx.doi.org/ 10.5999/aps.2012.39.6.680  • Arch Plast Surg 2012;39:680-682 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/8b/aps-39-680.PMC3518020.pdf
"For the rest of COMMUNICATIONS The 17th Dandelion Camp:   There and Back Yewon Lee Department of Plastic and Reconstructive Surgery, Konkuk University School of  Medicine, Seoul, Korea Correspondence: Yewon Lee Department of Plastic and Reconstructive Surgery, Konkuk University School of Medicine,   120 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82-2-2030-5235, Fax: +82-2-2030-5249, E-mail: janetlee0418@gmail.com Received: 27 Aug 2012 • Revised: 28 Aug 2012 • Accepted: 29 Aug 2012 pISSN: 2234-6163  • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2012.39.6.683  • Arch Plast Surg 2012;39:683-684 Copyright  2012 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/67/aps-39-683.PMC3518021.pdf
This paper is available on line at http://www.mcponline.org 1790 Molecular & Cellular Proteomics 11.12,OADS,/arxiv_data1/oa_pdf/68/a8/zjw1790.PMC3518105.pdf
The PSSM matrices were also visualized as sequence logos using the Sequence2Logo server (http://www.cbs.dtu.dk/biotools/Seq2Logo-1.0/).,OADS,/arxiv_data1/oa_pdf/68/a8/zjw1790.PMC3518105.pdf
This paper is available on line at http://www.mcponline.org 1768 Molecular & Cellular Proteomics 11.12,OADS,/arxiv_data1/oa_pdf/65/e9/zjw1768.PMC3518106.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.12 1801,Non-OADS,/arxiv_data1/oa_pdf/2c/7c/zjw1801.PMC3518108.pdf
This paper is available on line at http://www.mcponline.org 1578 Molecular & Cellular Proteomics 11.11,Non-OADS,/arxiv_data1/oa_pdf/76/0d/zjw1578.PMC3518112.pdf
This paper is available on line at http://www.mcponline.org 1612 Molecular & Cellular Proteomics 11.12,Non-OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"However, these libraries can beused only with software running on the Microsoft Windowsoperating systems, although there has been some success ingetting them to work properly under Windows emulators (see,e.g., http://tools.proteomecenter.org/wiki/index.php?title /H11005 Msconvert_Wine).",Non-OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"During a similar time frame, theHUPO PSI independently developed the mzData format(http://psidev.info/mzdata).",OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"This file is similar to the format describedabove in that it encodes multiple MS/MS spectra in a singlefile via m/z, intensity pairs separated by headers; in the case of MGF files, the headers can contain a bit more informa-tion, including search engine instructions (see http://www.matrixscience.com/ help/data_file_help.html for additional description).",OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"In an attempt tostandardize this inevitable part of a common workflow, thePSI is developing the mzTab format (http://www.psidev.info/mztab).",OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"In order to address the problem of wildly variable header line formats, the PSI has recently defined a new format, thePSI Extended FASTA Format (PEFF; http://www.psidev.info/peff).",Non-OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"Finally, there is a related format infra-structure called AnIML (for “analytical information markuplanguage”; http://animl.sourceforge.net/) that plans to sup-port many different data types.",OADS,/arxiv_data1/oa_pdf/39/1c/zjw1612.PMC3518119.pdf
"This conceptof data sharing has gained substantial traction in the field ofMS-based proteomics, in which the PRIDE 1(PRoteomics IDEntifications) database (http://www.ebi.ac.uk/pride) at theEuropean Bioinformatics Institute (EBI, Cambridge, UK) is oneof the most prominent public data repositories (1).",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
PRIDE is also afounding member of the ProteomeXchange (PX) consortium(http://www.proteomexchange.org) (2).,Non-OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
This paper is available on line at http://www.mcponline.org 1682 Molecular & Cellular Proteomics 11.12,Non-OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"In this framework,PRIDE is the initial submission point for tandem MS data.Currently, the first pilot PX submissions (containing raw dataand processed results) have already been carried out (http://proteomecentral.proteomexchange.org) and the system isnow starting to accept regular submissions.",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
This was the philosophy that drove the development of the original PRIDE Converter ( 6) (http://pride-converter.googlecode.,Non-OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
EXPERIMENTAL PROCEDURES ThePRIDE Converter 2 tool suite is developed in Java and all the source code is available online (http://pride-converter-2.googlecode.com).,OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"For example, it is now possible tosubmit peptide mass fingerprint (PMF) data generated by Mascot(http://www.matrixscience.com).",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"Designed to be easy to parse, itcontains only the minimal information required to evaluate the resultsof a proteomics experiment (http://mztab.googlecode.com).",Non-OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
A full developer’s guide to programming cus-tom DAOs is available at http://code.google.com/p/pride-converter-2/wiki/HowToWriteADao and in the supplemental File S2 (section 2).,OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"The report file XML schema is well-defined and annotated (http://pride-converter-2.googlecode.com/svn/trunk/report-api/src/main/resources/reportfile.xsd), and a Java API hasbeen provided to generate report files, making it easy tointegrate this functionality into an existing proteomics LIMS asa first step in exporting data to PRIDE XML.",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"In practice, this has al- ready happened in the last few months, as the module sup-porting data from Proteome Discoverer .msf results files wascreated independently, outside of the core PRIDE team, usingthe existing Thermo MSF Parser library ( 14), in the context of the EU FP7 project PRIME-XS (http://www.primexs.eu).",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"This is the case for the ProteinLynx Global Server (PLGS, Waters), hEIDI (http://biodev.extra.cea.fr/docs/heidi), OmicsHub Proteomics (Integromics), PeptideShaker(http://peptide-shaker.googlecode.com), and Proteios ( 18), among others.",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
"MatrixScience (2012) Mascot Parser API, http://www.matrixscience.",OADS,/arxiv_data1/oa_pdf/e6/e6/zjw1682.PMC3518121.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.12 1965,Non-OADS,/arxiv_data1/oa_pdf/b3/05/zjw1965.PMC3518124.pdf
This paper is available on line at http://www.mcponline.org 1840 Molecular & Cellular Proteomics 11.12,Non-OADS,/arxiv_data1/oa_pdf/fd/b0/zjw1840.PMC3518125.pdf
"To compensate for those missing SILACratios, additional data interpretation was conducted using Peptide-Shaker version 0.12.0 (http://code.google.com/p/peptide-shaker/) inorder to identify missing candidate peptides based on multi-searchengine database searches, including Mascot, OMSSA ( 44), and X!Tandem ( 45), combined with a thorough FDR assessment (46).",OADS,/arxiv_data1/oa_pdf/fd/b0/zjw1840.PMC3518125.pdf
"Interestingly, a recent bioinformatic study proposedthat the human Coa6 homolog C1Orf31 is a putative assemblyfactor for cytochrome coxidase ( 76).Data Availability— All MS data are publicly available via the PRIDE repository (http://www.ebi.ac.uk/pride/) ( 77, 78), using accession numbers 24150–24184.",OADS,/arxiv_data1/oa_pdf/fd/b0/zjw1840.PMC3518125.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Original Article Eyespot display in the peacock butterfly  triggers antipredator behaviors in naïve  adult fowl Martin  Olofsson,a Hanne  Løvlie,a,b,c Jessika  Tibblin,a Sven  Jakobsson,a and Christer  Wiklunda aDepartment of Zoology, Stockholm University, SE-10691 Stockholm, Sweden, bDepartment of Ecology  and Genetics, Animal Ecology, Uppsala University, SE-75236 Uppsala, Sweden, and cDepartment of  Physics, Chemistry and Biology, Linköping University, SE-58183 Linköping, Sweden Large conspicuous eyespots have evolved in multiple taxa and presumably function to thwart predator attacks.",Non-OADS,/arxiv_data1/oa_pdf/e4/77/ars167.PMC3518204.pdf
SuPPLEMEnTAr Y MATErIAL Supplementary material can be found at http://www.beheco.,Non-OADS,/arxiv_data1/oa_pdf/e4/77/ars167.PMC3518204.pdf
Available from: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/e4/77/ars167.PMC3518204.pdf
"Published by Oxford University Press on behalf of   the International Society for Behavioral Ecology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Original Article Geometric analysis of macronutrient selection  in breeds of the domestic dog, Canis lupus  familiaris Adrian K.  Hewson-Hughes,a Victoria L.  Hewson-Hughes,a Alison  Colyer ,a Andrew T.  Miller ,a Scott  J. McGrane,a Simon R.  Hall,a Richard F.  Butterwick,a Stephen J.  Simpson,b and David  Raubenheimerc aWALTHAM® Centre for Pet Nutrition, Freeby Lane, Waltham-on-the-Wolds, Melton Mowbray,  Leicestershire LE14 4RT, UK, bSchool of Biological Sciences and the Charles Perkins Centre, University  of Sydney, New South Wales, Australia, and cInstitute of Natural Sciences, Massey University, Auckland,  New Zealand Although many herbivores and omnivores have been shown to balance their intake of macronutrients when faced with nutri- tionally variable foods, study of this ability has been relatively neglected in carnivores, largely on the assumption that prey are less variable in nutrient composition than the foods of herbivores and omnivores and such mechanisms therefore unnecessary.",Non-OADS,/arxiv_data1/oa_pdf/49/b1/ars168.PMC3518205.pdf
SuPPLEMEnTARY MATERIAL Supplementary material can be found at http://www.beheco.,Non-OADS,/arxiv_data1/oa_pdf/49/b1/ars168.PMC3518205.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi   .org/10.1016/0028-3908(95)00113- K Garner, C.C., S. Kindler, and E.D.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.5225-03.200 4 Hartmann, M., R. Heumann, and V. Lessmann.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1093/emboj/20.21.588 7 Hirokawa, N., Y. Noda, Y. Tanaka, and S. Niwa.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"10:682– 696. http://dx.doi.org/10.1038/nrm277 4 Huang, E.J., and L.F. Reichardt.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi .org/  10.1146/annurev.neuro.24.1.67 7 Jahn, R., and R.H. Scheller.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/nrm200 2 Kalla, S., M. Stern, J. Basu, F. Varoqueaux, K. Reim, C. Rosenmund, N.E.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.4330-06.200 6 Kim, T., M.C.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/   10.1016/j.neuron.2011.11.03 0 Ludwig, M., and G. Leng.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/ 10.1038/   nrn184 5 Ma, C., W. Li, Y. Xu, and J. Rizo.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/nsmb.204 7 Matsuda, N., H. Lu, Y .",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1863-09.200 9 McAllister, A.K., L.C.",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1146/ annurev.neuro.22.1.29 5 Meijer, M., P. Burkhardt, H. de Wit, R.F.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/emboj.2012.7 2 Meyer-Lindenberg, A., G. Domes, P. Kirsch, and M. Heinrichs.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/   nrn304 4 Nagai, T., K. Ibata, E.S.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/3504900 4 Ramamoorthy, P., Q. Wang, and M.D.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .2933-11.201 1 Rhee, J.S., A. Betz, S. Pyott, K. Reim, F. Varoqueaux, I. Augustin, D. Hesse, T.C.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi   .org/10.1016/S0092-8674(01)00635- 3 Richmond, J.E., R.M.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/3508558 3 Rizo, J., and T.C.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
http://dx.doi.org/   10.1016/j.conb.2003.09.01 1genotype.,OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1093/emboj/19.14.358 6 Augustin, I., C. Rosenmund, T.C.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/2276 8 Bartfai, T., K. Iverfeldt, G. Fisone, and P. Serfözö.",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1146/annurev.pa.28.040188.00144 1 Basu, J., A. Betz, N. Brose, and C. Rosenmund.",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4908-06.200 7 Deng, L., P.S.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.01.00 5 de Wit, H., A.M. Walter, I. Milosevic, A. Gulyás-Kovács, D. Riedel, J.B.  Sørensen, and M. Verhage.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1016/j.cell.2009.07.02 7 De Wit, J., F. De Winter, J. Klooster, and J. Verhaagen.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1016/j.mcn.2004.12.00 9 de Wit, J., R.F.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1111/j.1600-0854   .2006.00442. x de Wit, J., R.F.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3931-08.200 9 Galli, T., E.P.",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.04.01 3 Schlager, M.A., and C.C.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"2:25. http://dx.doi.org/   10.1186/1756-6606-2-2 5 Schmitz, S.K., J.J. Hjorth, R.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/   10.1016/j.jneumeth.2010.12.01 1 Shakiryanova, D., A. Tully, and E.S.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1038/nn171 9 Silverman, M.A., S. Johnson, D. Gurkins, M. Farmer, J.E.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4694-04.200 5 Sørensen, J.B. 2009.",Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/   10.1146/annurev.cellbio.24.110707.17523 9 Südhof, T.C.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"27:509– 547. http://dx.doi.org/10.1146/annurev.neuro.26.041002.13141 2 Südhof, T.C., and J.E.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10   .1126/science.116174 8 Toonen, R.F., and M. Verhage.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi   .org/10.1073/pnas.12262379 9 Verhage, M., and R.F.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/   10.1016/j.ceb.2007.05.00 2 Verhage, M., H.T.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1016/0896-6273(91)90054- 4 Verhage, M., A.S. Maia, J.J. Plomp, A.B.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1126/science   .287.5454.86 4 Wierda, K.D., R.F.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/10.1016/j   .neuron.2007.04.00 1 Wong, M.Y., C. Zhou, D. Shakiryanova, T.E.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.12.03 6 Xu, T., and P. Xu.",OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
33:1915– 1919. http://dx.doi.org/10.1007/s11064-008-9648- 2,Non-OADS,/arxiv_data1/oa_pdf/0d/6f/JCB_201208024.PMC3518216.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub ­ lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by ­nc­sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1093/emboj/21.5.99 5 Breyton, C., W. Haase, T.A.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1038/nature0082 7 Brundage, L., J.P. Hendrick, E. Schiebel, A.J.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90111- Q Cannon, K.S., E. Or, W.M.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1083/jcb.20041201 9 Dalal, K., C.S.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1074/jbc.M110.17563 8 Ding, H., I. Mukerji, and D. Oliver.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1021/bi035099 b Duong, F. 2003.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1038/   nature0743 9 Erlandson, K.J., E. Or, A.R.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1074/ jbc.M71035620 0 Gelis, I., A.M. Bonvin, D. Keramisanou, M. Koukaki, G. Gouridis, S. Karamanou,  A. Economou, and C.G.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1016/j.cell.2007.09.03 9 Gold, V.A., A. Robson, A.R.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1074/jbc   .M70206620 0 Gold, V.A., A. Robson, H. Bao, T. Romantsov, F. Duong, and I. Collinson.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10   .1016/j.celrep.2011.11.00 3 Hunt, J.F., S. Weinkauf, L. Henry, J.J. Fak, P. McNicholas, D.B.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201205191/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1038/sj.emboj.760172 1 Lill, R., W. Dowhan, and W. Wickner.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1016/   0092-8674(90)90742- W Or, E., A. Navon, and T.A.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1093/emboj/cdf47 1 Osborne, A.R., and T.A.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1016/j.cell.2007.02.03 6 Osborne, A.R., W.M.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1038/nature1001 4 Park, E., and T.A.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1021/ct300315 7 Piggot, T.J., R.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1021/bi201237 a Robson, A., A.E.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/   10.1016/j.jmb.2007.09.08 6 Robson, A., B. Carr, R.B.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10   .1016/j.febslet.2008.12.00 3 Robson, A., V.A.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/   10.1073/pnas.080959210 6 Tam, P.C., A.P.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1038/sj.emboj.760080 4 Van den Berg, B., W.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1038/   nature0221 8 Wolf, M.G., M. Hoefling, C. Aponte-Santamaría, H. Grubmüller, and G.  Groenhof.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1002/jcc.2150 7 Woodbury, R.L., S.J.S.",Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi   .org/10.1110/ps.409010 2 Zimmer, J., and T.A.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
"http://dx.doi.org/10.1016/j.jmb.2009.10.02 4 Zimmer, J., Y. Nam, and T.A.",OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
455:936– 943. http://dx.doi.org/10.1038/nature0733 5,Non-OADS,/arxiv_data1/oa_pdf/c4/05/JCB_201205191.PMC3518217.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/   10.1083/jcb.147.7.153 3 Bonilha, V.L., M.E.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1016/j.exer.2005.09.01 3 Bretscher, A.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/   10.1083/jcb.108.3.92 1 Burakov, A.V., O.V.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1007/s10630-005-0123- 9 Carreno, S., I. Kouranti, E.S.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"180:739– 746. http://dx.doi.org/10.1083/jcb.20070916 1 Chambers, D.N., and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10   .1021/bi048038 2 Charras, G.T., C.K.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1073/   pnas.92.16.749 5 Crepaldi, T., A. Gautreau, P.M. Comoglio, D. Louvard, and M. Arpin.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1083/jcb.138.2.42 3 Coscoy, S., F. Waharte, A. Gautreau, M. Martin, D. Louvard, P. Mangeat, M.  Arpin, and F. Amblard.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1006/   dbio.2001.019 2 Delpire, E. 2009.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1007/s00424-009-0674- y Fehon, R.G., A.I.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1038/nrm286 6 Fidalgo, M., A. Guerrero, M. Fraile, C. Iglesias, C.M.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1074/jbc.M111.32025 9 Fievet, B.T., A. Gautreau, C. Roy, L. Del Maestro, P. Mangeat, D. Louvard,  and M. Arpin.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"164:653– 659. http://dx.doi.org/10.1083/jcb.20030703 2 Finnerty, C.M., D. Chambers, J. Ingraffea, H.R.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"117:1547– 1552. http://dx.doi.org/10.1242/jcs.0103 8 Garbett, D., and A. Bretscher.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1083/jcb.20120400 8 Garbett, D., D.P.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1083/jcb.20100411 5 Gary, R., and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1083/jcb.150.1.19 3 Gisler, S.M., S. Pribanic, D. Bacic, P. Forrer, A. Gantenbein, L.A. Sabourin, A.  Tsuji, Z.S.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201207047/DC1.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1074/mcp.M700468-MCP20 0 Belkina, N.V., Y. Liu, J.J. Hao, H. Karasuyama, and S. Shaw.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1074/mcp   .M200025-MCP20 0 Pao, W., and J. Chmielecki.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1038/nrc294 7 Pao, W., V.A.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1371/   journal.pmed.002007 3 Pearson, M.A., D. Reczek, A. Bretscher, and P.A.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)80836- 3 Pietromonaco, S.F., P.C.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1074/jbc.273.13.759 4 Polesello, C., I. Delon, P. Valenti, P. Ferrer, and F. Payre.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1038/ncb85 6 Sabourin, L.A., K. Tamai, P. Seale, J. Wagner, and M.A.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1128/MCB.20.2.684-696.200 0 Shcherbina, A., A. Bretscher, D.M.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1006/bbrc.1998.982 3 Smolka, M.B., C.P.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10   .1073/pnas.070162210 4 Speck, O., S.C. Hughes, N.K.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1038/   nature0129 5 Storbeck, C.J., S. Wagner, P. O’Reilly, M. McKay, R.J.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1091/mbc.E08-07-070 7 Takeuchi, K., N. Sato, H. Kasahara, N. Funayama, A. Nagafuchi, S. Yonemura,  S. Tsukita, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1083/jcb.125.6.137 1 ten Klooster, J.P., M. Jansen, J. Yuan, V. Oorschot, H. Begthel, V. Di Giacomo,  F. Colland, J. de Koning, M.M.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1016/j.devcel.2009.01.01 6 Wagner, S., T.A.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1074/ jbc.M20589920 0 Wagner, S., C.J.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1371/journal.pone.000186 8 Xing, B., A. Jedsadayanmata, and S.C. Lam.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1074/jbc.M10858720 0 Yamamoto, N., M. Honma, and H. Suzuki.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/   10.1124/mol.110.07086 2 Yonemura, S., S. Tsukita, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
http://dx.doi.org/10.1083/jcb.145.7.149 7major scaffolder in brush borders of proximal tubular cells.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
http://dx.doi.org/10.1046/j.1523-1755.2003.00266.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1038/ncb253 7 Gorelik, J., A.I.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1073/   pnas.103050210 0 Hanono, A., D. Garbett, D. Reczek, D.N.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1083/jcb.20060404 6 Hayashi, K., S. Yonemura, T. Matsui, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1101/gad.30330 4 Hirao, M., N. Sato, T. Kondo, S. Yonemura, M. Monden, T. Sasaki, Y .",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1083/jcb.135.1.3 7 Hughes, S.C., and R.G.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1083/jcb.20060800 9 Jackson, D.I., and C. Dickson.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1242/dev.0097 6 Kinoshita, E., E. Kinoshita-Kikuta, K. Takiyama, and T. Koike.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1016/j.cub.2007.12.05 1 LaLonde, D.P., D. Garbett, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1091/mbc.E10-01-000 8 Li, Q., M.R.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1016/j.jmb.2006.10.07 5 Matsui, T., M. Maeda, Y. Doi, S. Yonemura, M. Amano, K. Kaibuchi, S.  Tsukita, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1083/jcb.140.3.64 7 Matsui, T., S. Yonemura, S. Tsukita, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi   .org/10.1016/S0960-9822(99)80508- 9 Meder, D., A. Shevchenko, K. Simons, and J. Füllekrug.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"226:650– 656. http://dx.doi.org/10.1006/bbrc.1996.141 0 Nakamura, N., N. Oshiro, Y. Fukata, M. Amano, M. Fukata, S. Kuroda, Y.  Matsuura, T. Leung, L. Lim, and K. Kaibuchi.",OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
http://dx.doi.org/10.1046/j.1365-2443.2000.00348.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
"http://dx.doi.org/10.1093/emboj/20.11.272 3 Ong, S.E., B. Blagoev, I. Kratchmarova, D.B.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/JCB_201207047.PMC3518218.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
All cDNA constructs were  verified by sequencing and detailed maps are available on the laboratory  website (http://phm.utoronto.ca/angers).,OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201206051/DC1.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1074/jbc   .M109.06994 8 Ahmed, S.M., A.M. Daulat, and S. Angers.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1007/978-1-61779-160-4_2 2 Alley, M.C., D.A.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1126/science.275.5304.130 8 Arjonen, A., R. Kaukonen, and J. Ivaska.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.4161/   cam.5.5.1772 3 Arthur, W.T., L.A. Quilliam, and J.A.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/10.1083/jcb.20040406 8ImageJ software version 1.44p.,OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1073/pnas.98.4.185 3 Freeman, S.A., S.J.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-09-341 4 Fujita, H., S. Fukuhara, A. Sakurai, A. Yamagishi, Y. Kamioka, Y. Nakaoka,  M. Masuda, and N. Mochizuki.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1074/jbc   .M40970120 0 Gardel, M.L., B. Sabass, L. Ji, G. Danuser, U.S. Schwarz, and C.M.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1083/jcb.20081006 0 Gardel, M.L., I.C.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1146/   annurev.cellbio.011209.12203 6 Geiger, B., J.P. Spatz, and A.D. Bershadsky.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1038/nrm259 3 Gérard, A., A.E.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/jcb.20060816 1 Glading, A., J. Han, R.A. Stockton, and M.H.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/jcb.20070517 5 Gruneberg, U., R. Neef, X. Li, E.H. Chan, R.B.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/   jcb.20051106 1 Hall, R.A., R.T. Premont, C.W.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1038/3345 8 Han, J., C.J.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.cub.2006.08.03 5 Hansen, C.A., A.G. Schroering, D.J.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/   jcb.126.3.81 1 Harris, B.Z., and W.A.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/nrm277 4 Houslay, M.D.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/   10.1111/j.1476-5381.2009.00359.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/onc.2011.45 0 Humbert, P., S. Russell, and H. Richardson.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1007/s10555-009-9185- 8 Itoh, M., C.M.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-06-424 6 Jeon, T.J., D.J.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/jcb.20060707 2 Jordan, M., A. Schallhorn, and F.M.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1158/0008-5472.CAN-08-426 9 Banerjee, R., R.S.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/onc.2011.14 1 Baumgartner, M., G. Radziwill, M. Lorger, A. Weiss, and K. Moelling.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1128/MCB.01024-0 7 Béraud-Dufour, S., R. Gautier, C. Albiges-Rizo, P. Chardin, and E. Faurobert.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/10.1111/j.1742-4658.2007.06068.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1083/jcb.20031109 3 Boettner, B., E.E.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.ceb.2005.02.00 9 Bos, J.L., K. de Bruyn, J. Enserink, B. Kuiperij, S. Rangarajan, H. Rehmann, J.  Riedl, J. de Rooij, F. van Mansfeld, and F. Zwartkruis.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1042/BST031008 3 Carleton, M., M. Mao, M. Biery, P. Warrener, S. Kim, C. Buser, C.G.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/jcb.133.6.140 3 Corson, T.W., and B.L.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1002/ijc.2195 4 Corson, T.W., A. Huang, M.S.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/sj.onc.120864 1 Corson, T.W., C.Q.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1158/1078-0432.CCR-07-039 3 Crooks, G.E., G. Hon, J.M.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1101/gr.84900 4 Cruet-Hennequart, S., S. Maubant, J. Luis, P. Gauduchon, C. Staedel, and S.  Dedhar.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"22:1688– 1702. http://dx.doi.org/10.1038/sj.onc.120634 7 Dao, V.T., A.G. Dupuy, O. Gavet, E. Caron, and J. de Gunzburg.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1242/jcs.04130 1 de Rooij, J., F.J. Zwartkruis, M.H.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/2488 4 Desgrosellier, J.S., and D.A.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/nrc274 8 Eng, J., A. McCormack, and J. Yates.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/   1044-0305(94)80016- 2 Fanning, A.S., and J.M.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1172/JCI650 9 Felding-Habermann, B.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1023/A:102298300035 5 Felding-Habermann, B., T.E.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1038/nrc164 7 Meerschaert, K., E. Bruyneel, O.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1007/s00109000008 8 Müller, A., B. Homey, H. Soto, N. Ge, D. Catron, M.E.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-07-305 7 Oakes, P .W., Y .",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/jcb.20110704 2 Parsons, J.T., A.R.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/nrm295 7 Patra, C.R., C.N.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1021/cb200536 r Radziwill, G., A. Weiss, J. Heinrich, M. Baumgartner, P. Boisguerin, K. Owada,  and K. Moelling.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760170 6 Rantala, J.K., J. Pouwels, T. Pellinen, S. Veltel, P. Laasola, E. Mattila, C.S.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/ncb234 0 Ross, S.H., A.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1242/jcs.07983 0 Rubinfeld, B., S. Munemitsu, R. Clark, L. Conroy, K. Watt, W.J.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"65:1033– 1042. http://dx.doi.org/10.1016/0092-8674(91)90555- D Schneider, T.D., and R.M.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1093/nar/18.20.609 7 Sebzda, E., M. Bracke, T. Tugal, N. Hogg, and D.A.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1038/ni76 5 Sheng, M., and C. Sala.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/10.1146/   annurev.neuro.24.1.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1126/science.113342 7 Smolen, G.A., B.J.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1101/   gad.156150 7 Tang, X., Z.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1074/jbc.M110.20661 5 Thériault, B.L., S. Pajovic, M.Q.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1002/ijc.2618 9 Thorsen, T.S., K.L.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1093/nar/24.4.59 6 Katagiri, K., A. Maeda, M. Shimonaka, and T. Kinashi.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1038/ni95 0 Kaverina, I.N., A.A. Minin, F.K.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1006/cbir.1997.013 6 Kaverina, I., O. Krylyshkina, and J.V.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"34:746– 761. http://dx.doi.org/10.1016/S1357-2725(01)00171- 6 Keller, A., A.I.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi   .org/10.1021/ac025747 h Kim, C., F. Ye, and M.H.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1146/annurev-   cellbio-100109-10410 4 Kim, E., and M. Sheng.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/nrn151 7 Kim, W.J., Z. Gersey, and Y. Daaka.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.canlet   .2012.01.02 2 Kinashi, T., and K. Katagiri.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.imlet.2004.02.00 8 Kinashi, T., and K. Katagiri.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/10.1111/ j.1365-2567.2005.02214.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1124/   jpet.109.16481 4 Krylyshkina, O., I. Kaverina, W. Kranewitter, W. Steffen, M.C.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1083/jcb.20010505 1 Kuwada, S.K., and X. Li.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.devcel.2004.07.02 1 Lee, H.S., C.J.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1074/jbc.M80711720 0 Li, T.T., M. Alemayehu, A.I.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/nbt1010-101 5 Lorenowicz, M.J., M. Fernandez-Borja, M.R.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.ejcb.2008.05.00 4 Ludford-Menting, M.J., J. Oliaro, F. Sacirbegovic, E.T.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.immuni   .2005.04.00 9 Lyle, K.S., J.H.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1016/j.cellsig.2008.01.01 8 Matsumoto, S., K. Fumoto, T. Okamoto, K. Kaibuchi, and A. Kikuchi.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi   .org/10.1038/emboj.2010.2 6,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1371/ journal.pbio.006023 9 Tsygankova, O.M., G.V.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"27:6647– 6658. http://dx.doi.org/10.1128/MCB.00155-0 7 Uchiyama, Y., M. Sakaguchi, T. Terabayashi, T. Inenaga, S. Inoue, C. Kobayashi,  N. Oshima, H. Kiyonari, N. Nakagata, Y. Sato, et al.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/   10.1073/pnas.091374810 7 Verhey, K.J., and J.W.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10   .1038/nrm278 2 Wang, C., R. Navab, V. Iakovlev, Y. Leng, J. Zhang, M.S.",OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/10.1158/1541-7786.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"31:1676– 1684. http://dx.doi.org/10.1093/carcin/bgq13 4 Zhang, Y., B.A.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
"http://dx.doi.org/10.1038/nchembio.15 2 Zheng, H., L. Gao, Y. Feng, L. Yuan, H. Zhao, and L.A. Cornelius.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-08-239 9,Non-OADS,/arxiv_data1/oa_pdf/75/bd/JCB_201206051.PMC3518219.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201205115/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20021104 8 Baker, D.J., K.B.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi   .org/10.1038/ng138 2 Baker, D.J., K.B.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi   .org/10.1083/jcb.20050708 1 Baker, D.J., F. Jin, K.B.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.10.02 3 Bolanos ­Garcia, V.M., T. Kiyomitsu, S. D’Arcy, D.Y.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi   .org/10.1016/j.str.2008.10.01 5 Boyarchuk, Y., A. Salic, M. Dasso, and A. Arnaoutov.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
176:919– 928. http://dx.doi.org/10.1083/jcb.20060904 4with Bub1F/F cells were performed with MEFs that were immortalized by  expression of SV40 large T antigen.,Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/   10.1126/science.118018 9 Kelly, A.E., C. Ghenoiu, J.Z.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/   10.1126/science.118950 5 Kimmins, S., C. Crosio, N. Kotaja, J. Hirayama, L. Monaco, C. Höög, M. van  Duin, J.A.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1210/me.2006­033 2 Kitajima, T.S., S. Hauf, M. Ohsugi, T. Yamamoto, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.cub.2004.12.04 4 Kitajima, T.S., T. Sakuno, K. Ishiguro, S. Iemura, T. Natsume, S.A. Kawashima,  and Y .",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1038/   nature0466 3 Kiyomitsu, T., C. Obuse, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1128/MCB.00815­1 0 Klebig, C., D. Korinth, and P. Meraldi.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20090212 8 Krenn, V ., A. Wehenkel, X. Li, S. Santaguida, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20111001 3 Kulukian, A., J.S.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi   .org/10.1016/j.devcel.2008.11.00 5 Lampson, M.A., and T.M.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1038/ncb120 8 Lara ­Gonzalez, P., M.I.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1242/jcs   .09476 3 Larsen, N.A., J. Al ­Bassam, R.R.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"10:42– 52. http://dx.doi.org/10.1038/ncb166 7 Lee, S., P. Thebault, L. Freschi, S. Beaufils, T.L.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1074/jbc   .M111.30735 5 Li, M., X. Fang, Z. Wei, J.P. York, and P. Zhang.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20090402 0 Liu, D., G. Vader, M.J. Vromans, M.A.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1126/   science.116700 0 Malureanu, L.A. 2011.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1007/978 ­1­60761 ­  974­1_1 1 McGuinness, B.E., T. Hirota, N.R.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1371/ journal.pbio.003008 6 McGuinness, B.E., M. Anger, A. Kouznetsova, A.M. Gil­Bernabé, W. Helmhart,  N.R.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/   10.1016/j.cub.2009.01.06 4Chen, R.H. 2004.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1038/sj.emboj.760030 8 Chung, E., and R.H. Chen.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/   jcb.20020809 1 Elowe, S., K. Dulla, A. Uldschmid, X. Li, Z. Dou, and E.A.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1242/jcs.05650 7 Fernández­Miranda, G., M. Trakala, J. Martín, B. Escobar, A. González,  N.B.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1242/dev.06638 1 Fernius, J., and K.G.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1371/journal.pgen.003021 3 Girdler, F., F. Sessa, S. Patercoli, F. Villa, A. Musacchio, and S. Taylor.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"15:552– 562. http://dx.doi.org/10.1016/j.chembiol.2008.04.01 3 Hamada, M., A. Haeger, K.B.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi   .org/10.1083/jcb.20110201 8 Hauf, S., R.W.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20020809 2 Holland, A.J., and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"10:478– 487. http://dx.doi.org/10.1038/nrm271 8 Huang, H., J. Feng, J. Famulski, J.B. Rattner, S.T.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20070112 2 Huang, X., C.V. Andreu­Vieyra, J.P. York, R. Hatcher, T. Lu, M.M.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1371/journal.pbio.006001 5 Indjeian, V .B., B.M.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1126/science.110136 6 Jeganathan, K., L. Malureanu, D.J.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb.20070601 5 Jin, F., M. Hamada, L. Malureanu, K.B.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1371/jour nal  .pgen.100114 7 Johnson, V.L., M.I.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.cub.2004.03.00 1 Kawashima, S.A., T. Tsukahara, M. Langegger, S. Hauf, T.S.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1101/gad.149730 7 Kawashima, S.A., Y .",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1534/genetics   .108.09087 8 Tsukahara, T., Y. Tanno, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1038/nature0939 0 van Ree, J.H., K.B.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"188:83– 100. http://dx.doi.org/10.1083/jcb.20090614 7 Wang, F., J. Dai, J.R. Daum, E. Niedzialkowska, B. Banerjee, P.T.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1126/science.118943 5 Wang, F., N.P.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.cub.2011.05.01 6 Wang, X., J.R. Babu, J.M.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1074/jbc.M10108320 0 Welburn, J.P., M. Vleugel, D. Liu, J.R. Yates III, M.A.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.02.03 4 Wong, O.K., and G. Fang.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1091/mbc   .E06­04­034 6 Xu, Z., B. Cetin, M. Anger, U.S. Cho, W. Helmhart, K. Nasmyth, and W. Xu.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.06.03 1 Yamagishi, Y., T. Honda, Y. Tanno, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1126/science.119449 8 Yasui, Y ., T. Urano, A. Kawajiri, K. Nagata, M. Tatsuka, H. Saya, K. Furukawa,  T. Takahashi, I. Izawa, and M. Inagaki.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1074/jbc   .M31112820 0Nozawa, R.S., K. Nagao, H.T.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1038/ncb207 5 O’Gorman, S., N.A.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1242/   jcs.05950 1 Perera, D., V .",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/   j.devcel.2007.08.00 8 Peters, J.M.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi   .org/10.1038/nrm198 8 Pinsky, B.A., and S. Biggins.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/   j.tcb.2005.07.00 5 Qi, W., and H. Yu.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1074/jbc   .M60937620 0 Raymond, C.S., and P. Soriano.",Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1002/dvg.2065 9 Ricke, R.M., J.H.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/j.tig.2008.07.00 2 Ricke, R.M., K.B.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/   jcb.20101203 5 Riedel, C.G., V.L.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1038/nature0466 4 Ruchaud, S., M. Carmena, and W.C. Earnshaw.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/   10.1158/0008 ­5472.CAN ­07­6330 Sharp ­Baker, H., and R.H. Chen.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1083/jcb   .20010209 3 Tang, Z., H. Shu, D. Oncel, S. Chen, and H. Yu.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/   j.molcel.2004.09.03 1 Tang, Z., Y.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/   10.1073/pnas.040860010 2 Tang, Z., H. Shu, W. Qi, N.A.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"http://dx.doi.org/10.1016/   j.devcel.2006.03.01 0 Taylor, S.S., E. Ha, and F. McKeon.",OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
http://dx.doi.org/10   .1083/jcb.142.1.,Non-OADS,/arxiv_data1/oa_pdf/6f/b6/JCB_201205115.PMC3518220.pdf
"These results reveal a postsyn - aptic signaling pathway that engages transsynaptic inter - actions to coordinate synapse development.The novel synaptogenic protein Farp1 links  postsynaptic cytoskeletal dynamics and  transsynaptic organization Lucas Cheadle and Thomas Biederer Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520 © 2012 Cheadle and Biederer  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
Online supplemental material  is available at http://www.jcb.org/cgi/content/full/jcb.201205041/DC1.,Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .2739-07.200 7 Fogel, A.I., M. Stagi, K. Perez de Arce, and T. Biederer.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1038/emboj.2011.33 6 Frost, N.A., J.M.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1016/j.conb.2010.06.00 9 Futai, K., M.J. Kim, T. Hashikawa, P. Scheiffele, M. Sheng, and Y. Hayashi.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/nn183 7 García-Mata, R., K. Wennerberg, W.T.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/   S0076-6879(06)06031- 9 Govek, E.E., S.E.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1101/gad.125640 5 Groves, J.T., and J. Kuriyan.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1038/nsmb.184 4 Hart, M.J., A. Eva, D. Zangrilli, S.A. Aaronson, T. Evans, R.A. Cerione, and  Y. Zheng.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/S0955-0674(99)00080- 0 Hotulainen, P., and C.C.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1083/jcb.20100300 8 Itoh, R.E., K. Kurokawa, Y. Ohba, H. Yoshizaki, N. Mochizuki, and M.  Matsuda.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1128/MCB.22.18.6582-6591.200 2 Jaffe, A.B., and A.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.21.020604.15072 1 Jones, D.H., and A.I.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1016/0005-2736(74)90268- 5 Kasai, H., M. Matsuzaki, J. Noguchi, N. Yasumatsu, and H. Nakahara.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/S0166-2236(03)00162- 0 Kayser, M.S., M.J. Nolt, and M.B.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1016/j.neuron.2008.05.00 7 Klein, R. 2009.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/nn.223 1 Knott, G.W., A. Holtmaat, L. Wilbrecht, E. Welker, and K. Svoboda.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/nn174 7 Koyano, Y., T. Kawamoto, M. Shen, W. Yan, M. Noshiro, K. Fujii, and Y. Kato.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1006/bbrc.1997.782 6 Lindskog, M., L. Li, R.D.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1073/pnas.101639910 7 Matus, A., M. Ackermann, G. Pehling, H.R.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/   10.1073/pnas.79.23.759 0 Missler, M., T.C.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1101/   cshperspect.a00569 4 Moeller, M.L., Y .",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1002/ajmg   .a.3052 7 Biederer, T. 2006.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/j.ygeno.2005.08.01 7 Biederer, T., and P. Scheiffele.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1038/nprot.2007.9 2 Biederer, T., Y. Sara, M. Mozhayeva, D. Atasoy, X. Liu, E.T.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1126/   science.107235 6 Bonhoeffer, T., and R. Yuste.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/   S0896-6273(02)00906- 6 Burkel, B.M., G. von Dassow, and W.M.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1002/   cm.2022 6 Chklovskii, D.B., B.W.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/   nature0301 2 Cho, K.O., C.A.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1016/0896-6273(92)90245- 9 Dávalos, A., C. Fernández-Hernando, G. Sowa, B. Derakhshan, M.I.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1074/mcp   .M110.00128 9 El-Husseini, A.E., E. Schnell, D.M.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/   j.neuron.2006.05.01 8 Ferguson, S.M., A. Raimondi, S. Paradise, H. Shen, K. Mesaki, A.  Ferguson, O. Destaing, G. Ko, J. Takasaki, O. Cremona, et al.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"18:332) http://dx.doi.org/10   .1016/j.devcel.2009.11.00 5 Fiala, J.C., M. Feinberg, V. Popov, and K.M.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/   10.1016/S0896-6273(00)80467- 5 Fogel, A.I., M.R.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/nn.238 6 Xie, Z., H. Photowala, M.E.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1170-08.200 8 Yuste, R. 2011.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.07.02 4 Yuste, R., and T. Bonhoeffer.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1016/j.neuron.2004.09.02 2 Ziv, N.E., and S.J.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
http://dx.doi   .org/10.1016/S0896-6273(00)80283- 4of focal adhesion kinase and RhoA activation.,OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"281:1587– 1598. http://dx.doi.org/10.1074/jbc.M51175620 0 Nakamura, T., K. Aoki, and M. Matsuda.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/j.ymeth.2005.05.02 1 Nakayama, A.Y., M.B.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/   S0896-6273(02)01168- 6 Penzes, P., M.E.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/nn.274 1 Regalado, M.P., R.T. Terry-Lorenzo, C.L.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.5247-05.200 6 Robbins, E.M., A.J.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/   j.neuron.2010.11.00 3 Shilov, I.V., S.L.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi   .org/10.1074/mcp.T600050-MCP20 0 Shu, X., V. Lev-Ram, T.J. Deerinck, Y. Qi, E.B.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1371/journal   .pbio.100104 1 Stagi, M., A.I.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1073/   pnas.091179810 7 Stoppini, L., P.A.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/   nature0745 6 Sugita, S., and T.C.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1021/bi992098 4 Tada, T., and M. Sheng.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1016/   j.conb.2005.12.00 1 Tagliaferro, P., and M. Morales.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1002/cne.2157 6 Tashiro, A., A. Minden, and R. Yuste.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10   .1093/cercor/10.10.92 7 Thomas, L.A., M.R.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1002/cne.2177 3 Tolias, K.F., J.B. Bikoff, C.G.",Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"http://dx.doi.org/10.1038/emboj.2011.5 9 Tran, T.S., M.E.",OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
http://dx.doi.org/10.1038/nature0862 8,Non-OADS,/arxiv_data1/oa_pdf/44/09/JCB_201205041.PMC3518221.pdf
"Recent work has shed light on the mecha - nisms that link abnormal mitosis with the development of  DNA damage, how cells respond to such affronts, and the  potential impact on tumorigenesis.Linking abnormal mitosis to the acquisition   of DNA damage Neil J. Ganem and David Pellman Howard Hughes Medical Institute, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children’s Hospital, Department of Cell Biology, Harvard Medical  School, Boston, MA 02115 © 2012 Ganem and Pellman  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/   j.tcb.2004.03.00 2 Alberts, B.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.113.4.80 5 Andreassen, P.R., O.D.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.4161/cc.9.9.1131 4 Baker, D.J., F. Jin, K.B.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.05.03 2 Davoli, T., and T. de Lange.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-092910-15423 4 Davoli, T., and T. de Lange.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.03.04 4 Dong, Y., K.J.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1038/ncb157 6 Dotiwala, F., J.C. Harrison, S. Jain, N. Sugawara, and J.E.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.20050706 9 Duesberg, P., C. Rausch, D. Rasnick, and R. Hehlmann.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10   .1038/3411 2 Fackenthal, J.D., and O.I.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"7:937– 948. http://dx.doi.org/10.1038/nrc205 4 Forment, J.V., A. Kaidi, and S.P.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nrc335 2 Fujiwara, T., M. Bandi, M. Nitta, E.V.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1038/nature0421 7 Ganem, N.J., and D. Pellman.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.cell.2007.10.02 4 Ganem, N.J., Z. Storchova, and D. Pellman.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1016/j.gde.2007.02.01 1 Ganem, N.J., S.A. Godinho, and D. Pellman.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2008.07.00 2 Gerace, L., A. Blum, and G. Blobel.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.4161/cc.10.8.1533 4 Giunta, S., R. Belotserkovskaya, and S.P.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"190:197– 207. http://dx.doi.org/10.1083/jcb.20091115 6 Goldstein, J.C., N.J. Waterhouse, P. Juin, G.I.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1038/3500402 9 Gollin, S.M., W. Wray, S.K.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1007/s00412-007-0109- 5 Grandbois, M., M. Beyer, M. Rief, H. Clausen-Schaumann, and H.E.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
http://dx.doi.org/10.1016/j.tcb.2011.01.00 3through tumor suppressor gene loss of heterozygosity.,OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.10.02 3 Baumann, C., R. Körner, K. Hofmann, and E.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1016/j.cell.2006.11.04 1 Baxter, J., and J.F.X.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.04.01 9 Beroukhim, R., C.H.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nature0882 2 Blagosklonny, M.V.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1007/s00412-007-0138- 0 Bonneau, A.M., and N. Sonenberg.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10   .1038/nrm285 2 Chan, K.L., and I.D.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.semcdb.2011.07.00 1 Chan, K.-L., P.S.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10   .1038/sj.emboj.760177 7 Chan, K.L., T. Palmai-Pallag, S. Ying, and I.D.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/ncb188 2 Chen, L., K. Trujillo, W. Ramos, P. Sung, and A.E.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1016/S1097-2765(01)00388- 4 Ciccia, A., and S.J.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/   j.molcel.2010.09.01 9 Cimini, D. 2008.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1093/mutage/14.6.56 3 Cimini, D., B. Howell, P. Maddox, A. Khodjakov, F. Degrassi, and E.D.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.153.3.51 7 Cimini, D., D. Fioravanti, E.D.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1242/jcs.0071 6 Cimini, D., L.A. Cameron, and E.D.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.cub.2004.11.02 9 Compton, D.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"23:109– 113. http://dx.doi.org/10.1016/j.ceb.2010.08.00 7 Coschi, C.H., A.L.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1101/gad.191761 0 Crasta, K., N.J. Ganem, R. Dagher, A.B.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nature1080 2 Dalton, W.B., M.O.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-516 2 Daum, J.R., T.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/cdd.2010.16 5 Lanni, J.S., and T. Jacks.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.gde.2012.02.01 2 Loncarek, J., O. Kisurina-Evgenieva, T. Vinogradova, P. Hergert, S. La Terra,  T.M.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nature0634 4 Longworth, M.S., A. Herr, J.-Y.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1101/gad.163150 8 Manning, A.L., M.S.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1101/gad.191731 0 McClintock, B.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/ncb185 5 Mikhailov, A., R.W.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10   .1016/S0960-9822(02)01226- 5 Millman, S.E., and M. Pagano.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/embor.2011.6 2 Minn, A.J., L.H.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1101/gad.10.20.262 1 Moldovan, G.-L., and A.D. D’Andrea.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1146/annurev-genet-102108-13422 2 Mullins, J.M., and J.J. Biesele.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.73.3.67 2 Negrini, S., V.G.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nrm285 8 Nelson, G., M. Buhmann, and T. von Zglinicki.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.4161/cc.8.20.985 7 Nicklas, R.B.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/sj.onc.120787 3 Norden, C., M. Mendoza, J. Dobbelaere, C.V. Kotwaliwale, S. Biggins, and  Y. Barral.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"125:85– 98. http://dx.doi.org/10.1016/j.cell.2006.01.04 5 Orth, J.D., A. Loewer, G. Lahav, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1091/ mbc.E11-09-078 1Guerrero, A.A., M.C.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.01 3 Hanks, S.K., S.M.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1007/BF0028585 6 Harley, M.E., L.A. Allan, H.S.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1038/emboj.2010.11 2 Hauf, S., I.C.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"293:1320– 1323. http://dx.doi.org/10.1126/science.106137 6 Hayashi, M.T., A.J.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nsmb.224 5 Hetzer, M.W.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1101/cshperspect.a00053 9 Hirano, T., S. Funahashi, T. Uemura, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1056/NEJMra080461 5 Hoffelder, D.R., L. Luo, N.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1007/s00412-004-0284- 6 Holland, A.J., and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1038/embor.2012.5 5 Holliday, R. 1989.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/0168-9525(89)90020- 6 Hopfner, K.-P., L. Craig, G. Moncalian, R.A. Zinkel, T. Usui, B.A.L.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1038/nature0092 2 Houchmandzadeh, B., J.F.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.08.02 0 Inuzuka, H., S. Shaik, I. Onoyama, D. Gao, A. Tseng, R.S.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nature0973 2 Janssen, A., M. van der Burg, K. Szuhai, G.J.P.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"226:717– 722. http://dx.doi.org/10.1038/226717a 0 Jullien, D., P. Vagnarelli, W.C. Earnshaw, and Y. Adachi.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/emboj.2011.22 6 Khodjakov, A., C. Rieder, C.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1016/j.mito.2003.10.00 2 Krzywicka-Racka, A., and G. Sluder.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.20110107 3 Kunda, P., and B. Baum.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
http://dx.doi.org/   10.1016/j.tcb.2009.01.00 6,OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1016/j.cell.2008.12.02 0 Stephens, P.J., C.D.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.11.05 5 Stingele, S., G. Stoehr, K. Peplowska, J. Cox, M. Mann, and Z. Storchova.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"8:608. http://dx.doi   .org/10.1038/msb.2012.4 0 Tan, N., M. Malek, J. Zha, P. Yue, R. Kassees, L. Berry, W.J.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"17:1394– 1404. http://dx.doi.org/10.1158/1078-0432.CCR-10-235 3 Tang, Y.-C., B.R.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.cell.2011.01.01 7 Taylor, J.H.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
http://dx.doi.org/10.1111/j.1749- 6632.1960.tb23259.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.mrrev.2010.03.00 4 Thompson, S.L., and D.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"180:665– 672. http://dx.doi.org/10.1083/jcb.20071202 9 Thompson, S.L., and D.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"188:369– 381. http://dx.doi.org/10.1083/jcb.20090505 7 Thompson, S.L., and D.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"20:1666– 1671. http://dx.doi.org/10.1016/j.cub.2010.08.01 8 van Vugt, M.A.T.M., A.K.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1371/journal.pbio.100028 7 Varley, J.M., D.G.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1038/bjc.1997.32 8 Vaughan, A.T.M., C.J.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1023/A:101437471777 3 Wang, L.H.-C., T. Schwarzbraun, M.R.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1007/s00412-007-0131- 7 Wang, L.H.-C., B. Mayer, O. Stemmann, and E.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1242/jcs.05825 5 Weaver, B.A.A., A.D.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2006.12.00 3 Williams, B.R., V.R.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1126/science.116005 8 Yang, Z., J. Loncarek, A. Khodjakov, and C.L.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/ncb173 8 Zeng, X., F. Sigoillot, S. Gaur, S. Choi, K.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2010.08.01 0Prescott, D.M., and M.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/0014-4827(62)90176- 3 Quignon, F., L. Rozier, A.-M. Lachages, A. Bieth, M. Simili, and M. Debatisse.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/sj.onc.120978 7 Raab, M.S., I. Breitkreutz, S. Anderhub, M.H.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-12-202 6 Rebacz, B., T.O.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"67:6342– 6350. http://dx.doi.org/10.1158/0008-5472.CAN-07-066 3 Rieder, C.L., and R.W.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.142.4.101 3 Rieder, C.L., and H. Maiato.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.devcel.2004.09.00 2 Rieder, C.L., and R.H. Medema.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.09.02 1 Rieder, C.L., and R.E.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1083/jcb.21.3.42 9 Rogakou, E.P., D.R.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1074/   jbc.273.10.585 8 Sager, P.R., P.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1016/0092-8674(84)90005- 9 Sakahira, H., M. Enari, and S. Nagata.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/3421 4 Salmon, E.D., D. Cimini, L.A. Cameron, and J.G.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1098/rstb.2004.161 0 Samoshkin, A., A. Arnaoutov, L.E.T.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1371/journal.pone.000683 1 Sánchez-Pérez, T., G. Ortiz-Ferrón, and A. López-Rivas.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1038/cdd.2009.17 6 Saxton, W.M., D.L.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1083/jcb.99.6.217 5 Schvartzman, J.-M., R. Sotillo, and R. Benezra.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1038/nrc278 1 Sheltzer, J.M., H.M. Blank, S.J.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/   10.1126/science.120641 2 Shi, J., Y. Zhou, H.-C. Huang, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-10-433 6 Spence, J.M., H.H.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"http://dx.doi   .org/10.1242/jcs.01373 0 Spry, M., T. Scott, H. Pierce, and J.A.",OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
"12:4191– 4207. http://dx.doi.org/10.2741/238 0 Steigemann, P., C. Wurzenberger, M.H.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/JCB_201210040.PMC3518222.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"The telomeric subset of reads were extracted using  a custom script (motif_counter) incorporating functions from SAMtools   (Li et al., 2009) and standard Linux pattern-matching programs   (http://sourceforge.net/projects/motifcounter/).",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201207189/DC1.,Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1093/nar/17.12.461 1 Anderson, M.J., G. Casey, C.L.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1002/gcc   .287009040 7 Baird, D.M., A.J.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1086/30272 1 Bechard, L.H., B.D.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1128/MCB.00423-0 8 Bechter, O.E., Y. Zou, W. Walker, W.E.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/   10.1158/0008-5472.CAN-04-032 3 Brault, M.E., and C. Autexier.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/   10.1091/mbc.E10-02-017 3 Bryan, T.M., A. Englezou, J. Gupta, S. Bacchetti, and R.R.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btp32 4 Li, S., J.E.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-095 3 Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G.  Abecasis, and R. Durbin; 1000 Genome Project Data Processing Subgroup.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1093/bioinformatics/btp35 2 Londoño-Vallejo, J.A., H. Der-Sarkissian, L. Cazes, S. Bacchetti, and R.R.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1371/journal.pgen.100277 2 Marusíc, L., M. Anton, A.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi   .org/10.1073/pnas.85.18.662 2 Muntoni, A., A.A. Neumann, M. Hills, and R.R.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1093/hmg/ddn43 6 Nabetani, A., and F. Ishikawa.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1146/annurev.genet   .41.110306.13035 0 Perrem, K., T.M.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi   .org/10.1038/sj.onc.120275 2 Perrem, K., L.M.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/   emboj.2009.4 2 Sandelin, A., and W.W. Wasserman.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/   10.1210/me.2004-010 1 Schwartzentruber, J., A. Korshunov, X.Y.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi   .org/10.1038/nature1083 3 Sfeir, A., S. Kabir, M. van Overbeek, G.B.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1126/   science.118510 0 Shay, J.W., and S. Bacchetti.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1016/ S0959-   8049(97)00062- 2 Stern, J.L., K.G.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1128/MCB.00379-1 2Bryan, T.M., A. Englezou, L. Dalla-Pozza, M.A.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"3:1271– 1274. http://dx.doi.org/10.1038/nm1197-127 1 Celli, G.B., E.L. Denchi, and T. de Lange.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/   ncb144 4 Cesare, A.J., and J.D.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1128/MCB.24.22.9948-9957.200 4 Cesare, A.J., and R.R.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/   10.1016/j.mad.2007.11.00 6 Cesare, A.J., Z. Kaul, S.B.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/nsmb.172 5 Coleman, J., D.M.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1093/hmg/8.9.163 7 Cui, S., K.E.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/nature0211 8 Déjardin, J.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1002/bies.20110012 2 Déjardin, J., and R.E.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1016/   j.cell.2008.11.04 5 Dunham, M.A., A.A. Neumann, C.L.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/8258 6 Fasching, C.L., K. Bower, and R.R.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-288 1 Griffith, J.D., L. Comeau, S. Rosenfield, R.M.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80760- 6 Guiducci, C., M.A.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/sj.onc.120414 5 Hanaoka, S., A. Nagadoi, and Y. Nishimura.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1110/ps.0498370 5 Harley, C.B., A.B.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/   10.1038/345458a 0 Heaphy, C.M., R.F.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"333:425. http://dx.doi.org/10.1126/science.120731 3 Henson, J.D., and R.R.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1016/j.febslet.2010.06.00 9 Henson, J.D., Y. Cao, L.I.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1038/nbt.158 7 Hockemeyer, D., A.J.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
http://dx.doi.org/10.1128/MCB.25.7   .2708-2721.200 5,Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-08-050 4 Sullivan, B.A.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1007/   978-1-60761-789-1_ 7 Tokutake, Y., T. Matsumoto, T. Watanabe, S. Maeda, H. Tahara, S. Sakamoto,  H. Niida, M. Sugimoto, T. Ide, and Y. Furuichi.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/   10.1006/bbrc.1998.887 6 van Steensel, B., A. Smogorzewska, and T. de Lange.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10   .1038/ng83 4 Wang, R.C., A. Smogorzewska, and T. de Lange.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1016/j.cell.2004.10.01 1 Wong, J.M., and K. Collins.",OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
"http://dx.doi.org/10.1101/gad.147620 6 Yeager, T.R., A.A. Neumann, A. Englezou, L.I.",Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
http://dx.doi.org/10.1074/ jbc.M70141320 0,Non-OADS,/arxiv_data1/oa_pdf/be/17/JCB_201207189.PMC3518223.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/S1534-5807(02)00168- 5 Audhya, A., M. Foti, and S.D.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1083/   jcb.20080400 3 Balla, A., and T. Balla.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1016/j.tcb.2006.05.00 3 Balla, A., G. Tuymetova, A. Tsiomenko, P. Várnai, and T. Balla.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1091/mbc.E04-07-057 8 Balla, A., Y.J.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1091/mbc   .E07-07-071 3 Berger, K.L., J.D.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1073/pnas.090269310 6 Bianco, A., V. Reghellin, L. Donnici, S. Fenu, R. Alvarez, C. Baruffa, F. Peri,  M. Pagani, S. Abrignani, P. Neddermann, and R. De Francesco.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100257 6 Borawski, J., P. Troke, X. Puyang, V. Gibaja, S. Zhao, C. Mickanin, J. Leighton- Davies, C.J.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1038/nature0878 7 Calloway, N., T. Owens, K. Corwith, W. Rodgers, D. Holowka, and B. Baird.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1242/jcs.08417 8 D’Angelo, G., M. Vicinanza, A.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1242/jcs.02363 0 de Saint-Jean, M., V. Delfosse, D. Douguet, G. Chicanne, B. Payrastre, W.  Bourguet, B. Antonny, and G. Drin.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1083/jcb.20110406 2 Di Paolo, G., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1038/   nature0518 5 Doughman, R.L., A.J.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1007/s00232-003-2027- 7 Fairn, G.D., K. Ogata, R.J. Botelho, P.D.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1083/   jcb.20090902 5 Ferguson, S.M., A. Raimondi, S. Paradise, H. Shen, K. Mesaki, A.  Ferguson, O. Destaing, G. Ko, J. Takasaki, O. Cremona, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1016/j.devcel.2009.11.00 5 Foster, L.J., C.L.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201206095/DC1.,Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/j.tibs.2012.03.00 4 Alvisi, G., V. Madan, and R. Bartenschlager.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
http://dx.doi   .org/10.4161/rna.8.2.1501 1,Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1096/fj.09-13192 0 Vicinanza, M., G. D’Angelo, A.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1007/   s00018-008-8353- 2 Walsh, C.M., M. Chvanov, L.P. Haynes, O.H.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1042/BJ2009088 4 Wang, Y.J., J. Wang, H.Q.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00603- 2 Wess, J., R.M.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1038/nrd237 9 Wong, K., Meyers R., and L.C.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"187:967– 975. http://dx.doi.org/10.1083/jcb.20090906 3 Yount, J.S., M.M.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
http://dx.doi.org/   10.1016/j.bbamem.2007.03.02 6lipid determinants of membrane identity.,OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1021/ar200063 v Huang, F.-D., H.J.G.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/   j.cell.2011.10.00 2 Kaiser, S.E., J.H.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/j.str.2005.04.01 0 Korzeniowski, M.K., M.A.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"284:21027– 21035. http://dx.doi.org/10.1074/jbc.M109.01225 2 Kunz, J., A. Fuelling, L. Kolbe, and R.A. Anderson.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1074/jbc.M11077520 0 Lee, E., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1038/nrm232 8 McCrea, H.J., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1152/physiol.00035.200 8 Milosevic, I., J.B. Sørensen, T. Lang, M. Krauss, G. Nagy, V. Haucke, R.  Jahn, and E. Neher.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.3761-04.200 5 Nakagawa, T., K. Goto, and H. Kondo.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"271:12088– 12094. http://dx.doi.org/10.1074/jbc.271.20.1208 8 Nakatsu, F., R.M.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1083/jcb.20100501 8 Raychaudhuri, S., and W.A.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1146/annurev.cellbio.042308.11333 4 Rodgers, W. 2002.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)00384- 5 Shui, G., W.F.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi.org/10.1016/j.chroma.2011.05.01 1 Stefan, C.J., A.G. Manford, D. Baird, J. Yamada-Hanff, Y. Mao, and S.D.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.12.03 4 Tabuchi, M., A. Audhya, A.B.",OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
"26:5861– 5875. http://dx.doi.org/10.1128/MCB.02403-0 5 Tai, A.W., Y. Benita, L.F. Peng, S.-S. Kim, N. Sakamoto, R.J. Xavier, and R.T.  Chung.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
http://dx.doi   .org/10.1016/j.chom.2009.02.00 1,OADS,/arxiv_data1/oa_pdf/23/9e/JCB_201206095.PMC3518224.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10   .1016/j.sbi.2010.10.00 3 Cheng, Z., and R. Gilmore.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/   10.1038/nsmb114 6 Cheng, Z., Y. Jiang, E.C.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/   10.1083/jcb.20040818 8 Cock, P.J., T. Antao, J.T.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btp16 3 Deshaies, R.J., S.L.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1038/349806a 0 du Plessis, D.J., G. Berrelkamp, N. Nouwen, and A.J.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1074/jbc.M90185520 0 Egea, P.F., and R.M.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10   .1073/pnas.101255610 7 Emr, S.D., S. Hanley-Way, and T.J. Silhavy.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1016/0092-8674(81)90272- 5 Engelman, D.M., T.A.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi   .org/10.1146/annurev.bb.15.060186.00154 1 Finke, K., K. Plath, S. Panzner, S. Prehn, T.A.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1038/nature0638 7 Jiang, Y., Z. Cheng, E.C.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90313- 5 Junne, T., T. Schwede, V. Goder, and M. Spiess.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1074/jbc   .M70721920 0 Ng, D.T.W., J.D.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1083/jcb.134.2.26 9 Nishikawa, S.-I., S.W.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1083/jcb.153.5.106 1 Ogg, S.C., W.P.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/   10.1083/jcb.142.2.34 1 Panzner, S., L. Dreier, E. Hartmann, S. Kostka, and T.A.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi   .org/10.1016/0092-8674(95)90077- 2 Park, E., and T.A.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1038/nature1001 4 Petersen, T.N., S. Brunak, G. von Heijne, and H. Nielsen.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1038/nmeth.170 1performed as described previously (Rothblatt and Schekman, 1989).",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"The hydrophobicity of the signal sequence of CPY and derivatives  thereof was estimated using an in vivo hydrophobicity scale (Hessa et al.,  2007) as implemented using the G server (http://dgpred.cbr.su.se/).",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi   .org/10.1126/science.117853 5 Bondar, A.N., C. del Val, J.A.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
http://dx.doi.org/10.1016/j.str.2010.04.01 0,OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)81738- 9 Potter, M.D., and C.V. Nicchitta.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1074/jbc.M00529420 0 Rees, D.C., L. DeAntonio, and D. Eisenberg.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10   .1126/science.266713 8 Rothblatt, J., and R. Schekman.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi   .org/10.1016/S0091-679X(08)61165- 6 Sherman, F. 1991.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94023- 6 Silberstein, S., P.G.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10   .1083/jcb.131.2.37 1 Smith, M.A., W.M.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1128/JB.187   .18.6454-6465.200 5 Trueman, S.F., E.C.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi   .org/10.1091/mbc.E11-01-007 0 Tsukazaki, T., H. Mori, S. Fukai, R. Ishitani, T. Mori, N. Dohmae, A. Perederina,  Y. Sugita, D.G.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1038/nature0742 1 Van den Berg, B., W.M.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"http://dx.doi.org/10.1038/   nature0221 8 Wilkinson, B.M., A.J.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
"271:25590– 25597. http://dx.doi.org/10.1074/jbc.271.41.2559 0 Zimmer, J., Y. Nam, and T.A.",OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
455:936– 943. http://dx.doi.org/10.1038/nature0733 5,Non-OADS,/arxiv_data1/oa_pdf/60/dd/JCB_201207163.PMC3518225.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/d0/04/S0021859612000330a.PMC3518273.pdf
Available online at: http://epp.eurostat.ec.,Non-OADS,/arxiv_data1/oa_pdf/d0/04/S0021859612000330a.PMC3518273.pdf
Analysis of the subgroup of patients with aMCI also showed no effect of WML group on time to conversion to dementia (HR 1.36; CI 0.48 – 3.87; p=0.56) (see Figure S1 published as supplement-ary material online attached to the electronic version of this paper at http://journals.cambridge.org/ipg).,Non-OADS,/arxiv_data1/oa_pdf/09/80/S1041610212000932a.PMC3518278.pdf
(Email: K.S.Howe@exeter.ac.uk) The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/96/ae/S095026881200060Xa.PMC3518279.pdf
(Email: karina.olsen@unn.no) The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/87/20/S0950268812000465a.PMC3518280.pdf
"Labour Market (http://www.ssbno), 2009, pp.",Non-OADS,/arxiv_data1/oa_pdf/87/20/S0950268812000465a.PMC3518280.pdf
"Statistics Norway (http://www.ssbno/),2011.",OADS,/arxiv_data1/oa_pdf/87/20/S0950268812000465a.PMC3518280.pdf
"Increase in health workers – 2010 (http://www.ssbno/english/ subjects/06/0 1/hesospers_ en/), 2011.",Non-OADS,/arxiv_data1/oa_pdf/87/20/S0950268812000465a.PMC3518280.pdf
Education (http://www.ssbno) 2009; pp.,Non-OADS,/arxiv_data1/oa_pdf/87/20/S0950268812000465a.PMC3518280.pdf
"ICF Online version   http://apps.who.int/classiﬁ  cations/icd10/ 3.  browse/2010/en          Gradinger   F ,  Cieza   A ,  Stucki   A ,  Michel   F ,  Bentley   A , 4.",Non-OADS,/arxiv_data1/oa_pdf/22/d4/PHY-14-146.PMC3518292.pdf
PLoS Negl Trop Dis 2010;4(10):e709 10. http://www.dndi.org/diseases/vl.html11.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://dndi.org/diseases/vl/target- product-profile.html 12.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/ 050740a_081797-1.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
ClinicalTrials.gov.Available from: http://clinicaltrials.gov/ ct2/show/NCT01310738?,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT00832208?term=ambisome+AND+visceral+leishmaniasis&rank=10 45.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
2002.Available from: http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/ Guidances/ucm070570.pdf 49.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM199635.pdf 50.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
2011.Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from:http://www.bnf.org/bnf/index.htm 59.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://www.mpr.gov.za/ PublishedDocuments.aspx#DocCatId=21 60.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://www.gilead.com/AR2011/ GileadSciences_10K_20120223.pdf 61.,Non-OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2000/50-740S001_AmBisome_prntlbl.pdf 62.,OADS,/arxiv_data1/oa_pdf/40/32/EMD-17-493.PMC3518293.pdf
"Materials and methods    Oligonucleotides and TFO labeling   TFO and biotinylated oligonucleotides were designed employing TFO Target Sequence Search (http://spi.mdanderson.org/tfo/about.php) and synthesized by Met- abion (Martinsried, Germany) in standard quality and are displayed in Table I. Th  e sequences of the I-125-labeled TFO  (I-125-TFO-GAPDH, I-125-TFO-QRT and I-125-TFO-MBS) and the templates used for the primer extension are shown  in Figure 1.",OADS,/arxiv_data1/oa_pdf/2f/d3/RAB-88-972.PMC3518296.pdf
"Discussion   Th e sequence of all investigated TFO, except the two multi- binding site TFO, was determined with the help of the TFO target sequence search tool provided by http://spi.mdander-son.org/tfo/about.php.",OADS,/arxiv_data1/oa_pdf/2f/d3/RAB-88-972.PMC3518296.pdf
"This is an open access article, published under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5) .",Non-OADS,/arxiv_data1/oa_pdf/2d/68/JVR-03-015.PMC3518302.pdf
"This is an open access article, published under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5) .",Non-OADS,/arxiv_data1/oa_pdf/b1/36/JVR-03-007.PMC3518322.pdf
"4,5 The PD-1/PD-L1 interaction  inhibits T lymphocyte proliferation, sur - vival and effector functions (cytotoxicity, Targeting PD-1/PD-L1 interactions   for cancer immunotherapy Laurence Zitvogel1,2,3,4,* and Guido Kroemer5,6,7,8,9 1INsErM; U1015; Institut Gustave r oussy; Villejuif, France; 2Center of Clinical Investigations CB t507; Institut Gustave r oussy; Villejuif, France; 3Institut Gustave r oussy; Villejuif,  France; 4University of Paris s ud; Villejuif, France; 5INsErM; U848; Villejuif, France; 6Metabolomics Platform; Institut Gustave r oussy; Villejuif, France; 7Centre de r echerche   des Cordeliers; Paris, France; 8Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; 9Université Paris d escartes; Faculté de Médecine; Paris, France *Correspondence to: Laurence Zitvogel; Email: zitvogel@igr.fr Submitted: 06/28/12; Accepted: 06/28/12http://dx.doi.org/10.4161/onci.21335cytokine release),6 induces apoptosis of  tumor-specific T cells,7 promotes the dif - ferentiation of CD4+ T cells into Foxp3+  regulatory T cells,8 as well as the resis - tance of tumor cells to CTL attack.9,10  The extent of PD-1 inhibition depends  on the strength of the TCR stimulation, with more inhibitory effects at low levels of TCR engagement, preventing the induc - tion of the survival factor Bcl-X L and the  transcription factors GATA-3, EOMES and T-BET.",Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
"There are currently six agents block - ing the PD-1/PD-L1 pathway in clinical evaluation: MDX-1106/BMS-936558/ONO-4538 (fully human IgG4 anti-PD1 mAb from BMS), CT-011 (humanized IgG1 anti-PD1 mAb from CureTech/Teva), MK-3475 (human IgG4 anti-PD1 mAb from Merck), MPDL3280A/RG7446 (anti-PD-L1 from Genentech), BMS-936559 (fully humanized PD-L1 IgG4 mAb inhibiting ligation to both PD-1 and B7.1) and AMP-224 (a B7-DC/IgG1 fusion protein licensed to GSK) (http://www.clinical trials.gov).",Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Clin Cancer Res 2007; 13:2151-7; PMID:17404099;  http://dx.doi.org/10.1158/1078-0432.CCR-06-2746.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Cancer 2010; 116:1757- 66; PMID:20143437; http://dx.doi.org/10.1002/ cncr.24899.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Eur J Haematol 2012; 88:465-75;  PMID:22372959; http://dx.doi.org/10.1111/j.1600- 0609.2012.01766.x.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Cancer Res 2006; 66:3381-5; PMID:16585157; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Sci T ransl Med 2012; 4:27ra37;  PMID:22461641; http://dx.doi.org/10.1126/scitrans- lmed.3003689.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Immunity 2007; 27:111-22;  PMID:17629517; http://dx.doi.org/10.1016/j.immu- ni.2007.05.016.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Curr Opin Immunol 2012; 24:207-12;  PMID:22236695; http://dx.doi.org/10.1016/j.coi.2011.12.009.13.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Nat Immunol 2005; 6:280-6; PMID:15685176;  http://dx.doi.org/10.1038/ni1165.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Exp Med 2003; 198:63- 9; PMID:12847137; http://dx.doi.org/10.1084/ jem.20022125.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Clin  Invest 2010; 120:3878-90; PMID:20972331; http://dx.doi.org/10.1172/JCI43271.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Nat Immunol  2010; 11:535-42; PMID:20453843; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Exp Med 2009; 206:3015-29;  PMID:20008522; http://dx.doi.org/10.1084/ jem.20090847.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Exp Med 2008; 205:565-74; PMID:18283119;  http://dx.doi.org/10.1084/jem.20071477.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Nat Med 2007; 13:84-8; PMID:17159987;  http://dx.doi.org/10.1038/nm1517.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Cancer Res  2011; 71:5393-9; PMID:21724589; http://dx.doi.org/10.1158/0008-5472.CAN-11-0993.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Cancer Res 2012; 72:2757-67;  PMID:22427351; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3379.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Int Immunol 2007; 19:813-24; PMID:17606980; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
T rends Immunol 2006;  27:195-201; PMID:16500147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Exp Med  2006; 203:883-95; PMID:16606670; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Exp Med  2001; 193:839-46; PMID:11283156; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Proc Natl Acad Sci U S  A 2002; 99:12293-7; PMID:12218188; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Blood  2007; 110:180-5; PMID:17289811; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
Mol Cell Biol 2005; 25:9543- 53; PMID:16227604; http://dx.doi.org/10.1128/ MCB.25.21.9543-9553.2005.,OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
J Exp Med  2000; 191:891-8; PMID:10704469; http://dx.doi.org/10.1084/jem.191.5.891.if suitable biomarkers allowed to predict  which fraction of the patient popula - tion may profit from these treatments.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/onci-1-1223.PMC3518493.pdf
"Highlight from this issue http://dx.doi.org/10.4161/onci.22839; Correspondence to: Andriy Nemchenko; www.info2visual.comOncoImmunology 1:8, 1226–1226; November 2012; © 2012 Landes Bioscience INfOgraphIc Infographic from: J.I.",Non-OADS,/arxiv_data1/oa_pdf/eb/79/onci-1-1226.PMC3518494.pdf
"www.landesbioscience.com OncoImmunology 1227OncoImmunology 1:8, 1227–1238; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Sonsoles Hortelano; Email: shortelano@isciii.es Submitted: 06/20/12; Accepted: 06/21/12http://dx.doi.org/10.4161/onci.21207Introduction The immune system constitutes one of the first-line defenses to  prevent tumor development, owing to its ability to identify and destroy tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
"Gene expression was compared with the web-based software package for the PCR Array System (http://www.superarray.com/pcr/arrayanalysis.php), which automatically performs all ΔΔ Ct  based fold-change calculations from the specific uploaded raw threshold cycle data.",OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
T rends Immunol 2002; 23:549-55;  PMID:12401408; http://dx.doi.org/10.1016/S1471-4906(02)02302-5.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Nat Rev Immunol 2003; 3:23-35; PMID:12511873;  http://dx.doi.org/10.1038/nri978.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Annu Rev Immunol 2009; 27:451-83;  PMID:19105661; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Front Biosci  2008; 13:453-61; PMID:17981560; http://dx.doi.org/10.2741/2692.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Immunol  Lett 2003; 85:173-80; PMID:12527225; http://dx.doi.org/10.1016/S0165-2478(02)00225-0.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
J Immunol 2011; 187:6527-38; PMID:22095712; http://dx.doi.org/10.4049/jimmu- nol.1004070.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Mutat Res 2005; 576:22-38;  PMID:15878778; http://dx.doi.org/10.1016/j.mrfm- mm.2004.08.021.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Cell 1997; 91:649-59;  PMID:9393858; http://dx.doi.org/10.1016/S0092- 8674(00)80452-3.11.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
EMBO J 2006; 25:4284- 92; PMID:16957780; http://dx.doi.org/10.1038/ sj.emboj.7601302.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Immunol Rev 2008; 222:180-91; PMID:18364002;  http://dx.doi.org/10.1111/j.1600-065X.2008.00608.x.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Clin Cancer Res 2009; 15:4391-400; PMID:19549768; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Toxicol Appl Pharmacol  2012; 258:109-17; PMID:22036724; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
J Immunol 2012; 188:2464-71; PMID:22287720;  http://dx.doi.org/10.4049/jimmunol.1101101.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Oncogene  2012; PMID:22310289; http://dx.doi.org/10.1038/onc.2012.23.22.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
J Biol Chem  2001; 276:28421-9; PMID:11382768; http://dx.doi.org/10.1074/jbc.M102847200.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
J Clin Invest 2012; 122:1283- 95; PMID:22378045; http://dx.doi.org/10.1172/ JCI38596.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Clin Cancer Res  2007; 13:721s-6s; PMID:17255300; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Am J Pathol 2004; 164:1315-26;  PMID:15039219; http://dx.doi.org/10.1016/S0002- 9440(10)63218-X.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
J Biol Chem  2001; 276:41969-76; PMID:11553626; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Cancer Cell 2002; 2:289-300; PMID:12398893; http://dx.doi.org/10.1016/S1535- 6108(02)00153-8.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
Cancer Res 2010; 70:4749-58;  PMID:20501856; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0368.,Non-OADS,/arxiv_data1/oa_pdf/cc/91/onci-1-1227.PMC3518495.pdf
"www.landesbioscience.com OncoImmunology 1239OncoImmunology 1:8, 1239–1247; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Linda A. Sherman; Email: lsherman@scripps.edu Submitted: 06/07/12; Revised: 06/26/12; Accepted: 06/27/12http://dx.doi.org/10.4161/onci.21285Introduction The T-cell repertoire available for immunotherapy of cancer  is constrained by central and/or peripheral tolerance mecha - nisms.1−3 The majority of T cells with high avidity for self/tumor  antigens are deleted in the thymus resulting in a T-cell repertoire in the periphery specific for self/tumor antigens that display a relatively low affinity.",Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Annu Rev Immunol 2006; 24:571-606;  PMID:16551260; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Immunol Rev 2002; 185:126-35;  PMID:12190927; http://dx.doi.org/10.1034/j.1600- 065X.2002.18512.x.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Immunol  Rev 1998; 165:267-77; PMID:9850866; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Immunity 2000; 13:829-40; PMID:11163198;  http://dx.doi.org/10.1016/S1074-7613(00)00080-7.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Annu Rev Immunol 2003; 21:807-39;  PMID:12615893; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Immunol  Rev 2011; 239:27-44; PMID:21198663; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Nat Med  2004; 10:909-15; PMID:15340416; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Cancer Res 2010;  70:8368-77; PMID:20940398; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Semin Cancer Biol 2012; 22:14-22; PMID:22210183;  http://dx.doi.org/10.1016/j.semcancer.2011.12.006.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Blood 2007; 110:3564-72;  PMID:17660381; http://dx.doi.org/10.1182/blood- 2007-02-075010.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Science 2006; 314:126-9; PMID:16946036;  http://dx.doi.org/10.1126/science.1129003.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Proc Natl Acad Sci U S A 1996; 93:4102- 7; PMID:8633023; http://dx.doi.org/10.1073/ pnas.93.9.4102.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Nat Rev Immunol 2007; 7:678- 89; PMID:17717539; http://dx.doi.org/10.1038/ nri2156.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
J Pathol  2008; 214:179-89; PMID:18161751; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Nature  2009; 458:211-4; PMID:19182777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
J Exp Med 2003; 197:643- 56; PMID:12615905; http://dx.doi.org/10.1084/ jem.20021378.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
J Exp Med 2002; 196:999- 1005; PMID:12370261; http://dx.doi.org/10.1084/ jem.20020666.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Science 2000; 290:1354-8;  PMID:11082062; http://dx.doi.org/10.1126/sci-ence.290.5495.1354.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
J Exp Med 2000; 192:117- 22; PMID:10880532; http://dx.doi.org/10.1084/ jem.192.1.117.29.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Nat Immunol 2011; 12:908- 13; PMID:21804558; http://dx.doi.org/10.1038/ ni.2079.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
J Clin Invest  2007; 117:3383-92; PMID:17932562; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Cancer  Res 2012; 72:917-27; PMID:22186141; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Cancer  Res 2005; 65:2921-9; PMID:15805295; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Proc Natl Acad Sci U S A 2005; 102:7934- 9; PMID:15908507; http://dx.doi.org/10.1073/ pnas.0500357102.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
Immunity 2005; 22:117-29; PMID:15664164;  http://dx.doi.org/10.1016/j.immuni.2004.12.005.,OADS,/arxiv_data1/oa_pdf/3a/53/onci-1-1239.PMC3518496.pdf
"OncoImmunology 1:8, 1248–1257; November 2012; © 2012 Landes Bioscience ReseaR ch papeR 1248 OncoImmunology Volume 1 Issue 8*Correspondence to: Steven W. Dow; Email: sdow@colostate.edu Submitted: 05/09/12; Revised: 06/29/12; Accepted: 06/30/12 http://dx.doi.org/10.4161/onci.21317Introduction Liposomal clodronate (LC) has been used for years as a research  tool to rapidly and efficiently deplete splenic and non-splenic macrophages.",Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Exp Hematol  2006; 34:1393-402; PMID:16982332; http://dx.doi.org/10.1016/j.exphem.2006.05.014.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Immunol Methods  1994; 174:83-93; PMID:8083541; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Br J Cancer  2006; 95:272-81; PMID:16832418; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Immunol Immunother  2010; 59:441-52; PMID:19760220; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Invest Dermatol 2007; 127:2031- 41; PMID:17460736; http://dx.doi.org/10.1038/sj.jid.5700827.8.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Mol Cancer Ther 2008; 7:788-99; PMID:18375821; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Sci  2008; 99:1595-602; PMID:18754872; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Clin Cancer Res  2009; 15:4391-400; PMID:19549768; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Exp Med 1990; 172:1025- 33; PMID:2145387; http://dx.doi.org/10.1084/ jem.172.4.1025.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Immunol Cell Biol 2010; 88:107- 16; PMID:19949422; http://dx.doi.org/10.1038/ icb.2009.94.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Nature 1981;  291:334-5; PMID:7231554; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J  Immunol 2009; 182:6160-7; PMID:19414769; http://dx.doi.org/10.4049/jimmunol.0802664.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Blood 2009; 113:6120-7; PMID:19202127;  http://dx.doi.org/10.1182/blood-2008-11-190421.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Exp Med  2009; 206:1717-25; PMID:19581407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Blood 2004; 103:2677-82; PMID:14630824;  http://dx.doi.org/10.1182/blood-2003-06-2070.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer  Gene Ther 2006; 13:306-17; PMID:16138118; http://dx.doi.org/10.1038/sj.cgt.7700895.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Immunol 2009; 183:937-44;  PMID:19553533; http://dx.doi.org/10.4049/jimmu- nol.0804253.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Immunol 2010; 184:3106- 16; PMID:20142361; http://dx.doi.org/10.4049/jim- munol.0902661.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Res 2010; 70:68-77; PMID:20028852;  http://dx.doi.org/10.1158/0008-5472.CAN-09-2587.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Immunobiology  2006; 211:609-18; PMID:16920499; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer  Res 2008; 68:2561-3; PMID:18413722; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Immunol Immunother 2009; 58:49-59;  PMID:18446337; http://dx.doi.org/10.1007/s00262- 008-0523-4.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Clin Invest 2006;  116:2587-90; PMID:17016554; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Clin Invest 2006; 116:2777-90; PMID:17016559; http://dx.doi.org/10.1172/ JCI28828.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Res 2006; 66:1123-31; PMID:16424049;  http://dx.doi.org/10.1158/0008-5472.CAN-05-1299.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Clin Cancer Res 2005; 11:6713-21; PMID:16166452;  http://dx.doi.org/10.1158/1078-0432.CCR-05-0883.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Res  2009; 69:5514-21; PMID:19549903; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Cell 2008; 13:23- 35; PMID:18167337; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J  Genet Genomics 2010; 37:423-30; PMID:20659706;  http://dx.doi.org/10.1016/S1673-8527(09)60061-8.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Dermatol Sci 2010; 59:1-6; PMID:20570112;  http://dx.doi.org/10.1016/j.jdermsci.2010.05.001.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Immunol Rev  2008; 222:162-79; PMID:18364001; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Pathol 2005; 207:147-55; PMID:16104052;  http://dx.doi.org/10.1002/path.1830.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Res 2007; 67:5708-16;  PMID:17575137; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4375.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Clin Cancer Res 2010; 16:3420-30; PMID:20570927; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2904.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Invest Ophthalmol Vis Sci 2010; 51:2671-7;  PMID:20053982; http://dx.doi.org/10.1167/iovs.09- 4255.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Immunol 2010; 185:3481-8;  PMID:20713886; http://dx.doi.org/10.4049/jimmu- nol.0903479.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Immunol  Immunother 2009; 58:2011-23; PMID:19365632;  http://dx.doi.org/10.1007/s00262-009-0708-5.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Clin  Invest 2005; 115:2979-91; PMID:16239969; http://dx.doi.org/10.1172/JCI23298.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Cancer Sci 2007; 98:2009- 18; PMID:17924976; http://dx.doi.org/10.1111/ j.1349-7006.2007.00633.x.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Semin Cancer  Biol 2006; 16:53-65; PMID:16168663; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Angiogenesis 2010; 13:251-8; PMID:20734228;  http://dx.doi.org/10.1007/s10456-010-9182-0.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Immunol  2010; 185:7165-73; PMID:21078911; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Blood  2008; 112:362-73; PMID:18354038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Exp Med 2005; 202:1477-82; PMID:16314433; http://dx.doi.org/10.1084/ jem.20050240.54.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Exp Med 2010; 207:2439- 53; PMID:20876310; http://dx.doi.org/10.1084/ jem.20100587.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
Int Immunopharmacol  2003; 3:553-70; PMID:12689660; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Exp Med 2006; 203:2691-702; PMID:17101732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
J Immunol 2010; 185:203-10; PMID:20525890;  http://dx.doi.org/10.4049/jimmunol.0903573.,Non-OADS,/arxiv_data1/oa_pdf/98/49/onci-1-1248.PMC3518497.pdf
"OncoImmunology 1:8, 1258–1270; November 2012; © 2012 Landes Bioscience ReseaR ch papeR 1258 OncoImmunology Volume 1 Issue 8*Correspondence to: Luigi Aurisicchio; Email: luigi_aurisicchio@libero.it Submitted: 05/25/12; Revised: 06/27/12; Accepted: 07/04/12http://dx.doi.org/10.4161/onci.21355Introduction Cytotoxic T lymphocytes (CTLs) represent a key component  of the immune system and play a crucial role in tumor surveil - lance.",Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Science  1994; 265:528-30; PMID:7518614; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Science 2006; 314:126-9; PMID:16946036;  http://dx.doi.org/10.1126/science.1129003.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Cancer Immunol Immunother  2010; 59:1295-312; PMID:20532501; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Immunity 1999; 10:673-9;  PMID:10403642; http://dx.doi.org/10.1016/S1074- 7613(00)80066-7.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
J Exp Med 2000; 191:795- 804; PMID:10704461; http://dx.doi.org/10.1084/ jem.191.5.795.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
J Exp Med  1997; 185:833-41; PMID:9120389; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
J Clin Oncol  2008; 26:4418-25; PMID:18802154; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Br J Cancer 2001; 84:94- 9; PMID:11139320; http://dx.doi.org/10.1054/ bjoc.2000.1547.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Methods Mol Biol  2009; 524:361-7; PMID:19377958; http://dx.doi.org/10.1007/978-1-59745-450-6_26.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Eur J Immunol  2000; 30:3411-21; PMID:11093159; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Immunome Res 2008; 4:2; PMID:18221540;  http://dx.doi.org/10.1186/1745-7580-4-2.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
T rends  Biochem Sci 2000; 25:147-50; PMID:10694887;  http://dx.doi.org/10.1016/S0968-0004(99)01540-6.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Cell 1993; 74:929-37; PMID:8104103; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Immunogenetics  1995; 41:178-228; PMID:7890324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Eur J Immunol 1999; 29:3112- 21; PMID:10540322; http://dx.doi.org/10.1002/(SICI)1521-4141(199910)29:10<3112::AID- IMMU3112>3.0.CO;2-Q.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Mol Ther 2009; 17:1804-13; PMID:19623161; http://dx.doi.org/10.1038/ mt.2009.165.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Int J Cancer 2005; 113:67-77; PMID:15386429;  http://dx.doi.org/10.1002/ijc.20536.41.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
J Exp Med 2004; 199:905- 15; PMID:15067030; http://dx.doi.org/10.1084/ jem.20031982.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Eur J Immunol  2001; 31:3261-70; PMID:11745343; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Br J Cancer  2005; 92:72-9; PMID:15583693; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Immunogenetics  1999; 50:213-9; PMID:10602881; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Proc Natl Acad Sci U  S A 1994; 91:2105-9; PMID:7510885; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Protein Sci 2003; 12:1007- 17; PMID:12717023; http://dx.doi.org/10.1110/ ps.0239403.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
PLoS Comput Biol 2006; 2:e65; PMID:16789818; http://dx.doi.org/10.1371/journal.pcbi.0020065.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Methods 2003; 29:260- 9; PMID:12725791; http://dx.doi.org/10.1016/S1046-2023(02)00348-1.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Eur J Immunol  2002; 32:213-22; PMID:11782012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Immunogenetics 2003; 55:172- 6; PMID:12750860; http://dx.doi.org/10.1007/ s00251-003-0570-0.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Immunogenetics 2001; 53:87-94; PMID:11345595;  http://dx.doi.org/10.1007/s002510100300.,Non-OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
Int Immunol  2006; 18:1707-18; PMID:17077179; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/91/onci-1-1258.PMC3518498.pdf
"www.landesbioscience.com OncoImmunology 1271OncoImmunology 1:8, 1271–1280; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Hélène Haegel; Email: haegel@transgene.fr Submitted: 07/10/12; Accepted: 07/13/12http://dx.doi.org/10.4161/onci.21479Introduction Effector cellular and humoral immune responses to tumor anti - gens can be detected in cancer patients1,2 but are unable to control  cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Immunol Rev 2002; 188:51-64; PMID:12445281;  http://dx.doi.org/10.1034/j.1600-065X.2002.18806.x.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Cancer Immunol Immunother 2011; 60:319-26;  PMID:21267721; http://dx.doi.org/10.1007/s00262- 010-0968-0.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Cancer Immunol Immunother  2006; 55:1064-71; PMID:16328385; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Immunol Res 2010; 46:79-93;  PMID:19763889; http://dx.doi.org/10.1007/s12026-009-8124-7.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Immunity 2009; 30:636- 45; PMID:19464986; http://dx.doi.org/10.1016/j.immuni.2009.04.010.8.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Blood  2008; 112:2340-52; PMID:18617638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Eur J  Immunol 2008; 38:3274-81; PMID:19039774; http://dx.doi.org/10.1002/eji.200838950.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol 2011; 187:2278-90;  PMID:21775683; http://dx.doi.org/10.4049/jimmu- nol.1003715.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Nat Immunol 2007; 8:967-74;  PMID:17581537; http://dx.doi.org/10.1038/ni1488.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Immunity 2006; 25:455- 71; PMID:16973386; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Exp Med  2007; 204:1849-61; PMID:17635957; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Expert Rev Vaccines  2008; 7:889-93; PMID:18767940; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Clin Infect Dis 2004; 38:1749-53;  PMID:15227622; http://dx.doi.org/10.1086/421266.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Cancer Biol Ther 2007;  6:481-6; PMID:18027437; http://dx.doi.org/10.4161/ cbt.6.4.4201.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
PLoS Pathog 2009; 5:e1000480;  PMID:19543380; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Science 2005; 309:1380- 4; PMID:16123302; http://dx.doi.org/10.1126/sci- ence.1113401.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Clin Cancer Res 2007; 13:6947-58; PMID:18056169; http://dx.doi.org/10.1158/1078-0432.CCR-07-0842.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol  2011; 186:4388-95; PMID:21357259; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol  2010; 185:4063-71; PMID:20805420; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Blood  2008; 112:362-73; PMID:18354038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Immunity 2010; 32:692-702; PMID:20434372;  http://dx.doi.org/10.1016/j.immuni.2010.04.010.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Eur J Biochem  1990; 189:463-73; PMID:2351132; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Int J Cancer 1996; 65:664-70; PMID:8598319;  http://dx.doi.org/10.1002/(SICI)1097- 0215(19960301)65:5<664::AID-IJC17>3.0.CO;2-7.30.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Curr Opin Immunol  2007; 19:39-45; PMID:17129718; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Cancer  J 2010; 16:342-7; PMID:20693845; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Clin Invest 2005; 115:3623- 33; PMID:16308572; http://dx.doi.org/10.1172/ JCI25947.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Ann N Y Acad Sci 2009; 1174:99-106;  PMID:19769742; http://dx.doi.org/10.1111/j.1749- 6632.2009.04939.x.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J  Immunol 2009; 183:3170-6; PMID:19648274; http://dx.doi.org/10.4049/jimmunol.0803721.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol 2009; 183:155-63; PMID:19535633; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Nature 2006; 441:235-8; PMID:16648838;  http://dx.doi.org/10.1038/nature04753.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Cell  2006; 126:1121-33; PMID:16990136; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Cell  2007; 130:1071-82; PMID:17889651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Clin Invest 2006; 116:485-94; PMID:16424940;  http://dx.doi.org/10.1172/JCI25439.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Proc Natl Acad Sci U S A  2006; 103:7048-53; PMID:16632602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol 2009; 183:4458-66;  PMID:19748987; http://dx.doi.org/10.4049/jimmu-nol.0901465.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol 2010; 184:4733-40;  PMID:20363971; http://dx.doi.org/10.4049/jimmu- nol.0804279.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
J Immunol 2011; 186:1963-9; PMID:21217015;  http://dx.doi.org/10.4049/jimmunol.1002320.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Eur J Immunol  2006; 36:1684-93; PMID:16761317; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
Proc Natl Acad Sci U S A  2004; 101:3029-34; PMID:14981245; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
FASEB J 2008; 22:3628-37; PMID:18587008; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/77/onci-1-1271.PMC3518499.pdf
"www.landesbioscience.com OncoImmunology 1281OncoImmunology 1:8, 1281–1289; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Jahan S. Khalili; Email: jahkhalili@mdanderson.org Submitted: 06/18/12; Accepted: 07/17/12http://dx.doi.org/10.4161/onci.21511Introduction Missense mutations in cancer cells can generate unique T cell epi - topes.1 Natural antigen-specific T-cell responses against missense  mutant epitopes in acute myeloid leukemia (AML), melanoma,  renal and lung cancer have been discovered using traditional dis - covery methods based on CD8+ tumor infiltrating lymphocytes  (TILs).2–6 Such foreign epitopes have been shown is to facilitate  immunosurveillance and cancer control in chemically-induced murine models of carcinogens.",Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer Immunol Immunother  1996; 43:135-41; PMID:9001566; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer Res 2011; 71:1253-62; PMID:21216894;  http://dx.doi.org/10.1158/0008-5472.CAN-10-2693.5.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
J Exp Med 1996;  183:1185-92; PMID:8642260; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Blood 2012;  Epub ahead of print; PMID:22592607; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Nature 2012; 482:400-4; PMID:22318521;  http://dx.doi.org/10.1038/nature10755.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer Res 2012; 72:1081-91;  PMID:22237626; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3722.9.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer Immunol  Immunother 2008; 57:1413-20; PMID:18297281;  http://dx.doi.org/10.1007/s00262-008-0477-6.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Lung Cancer 2007; 58:88- 94; PMID:17599645; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
J  Natl Cancer Inst 1995; 87:1853-61; PMID:7494229;  http://dx.doi.org/10.1093/jnci/87.24.1853.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer Res 2009; 69:7499-502;  PMID:19752088; http://dx.doi.org/10.1158/0008- 5472.CAN-09-1354.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer  Res 2008; 68:6360-7; PMID:18676861; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
J Immunol  2009; 182:6328-41; PMID:19414786; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Immunome Res 2010; 6(Suppl 2):S3;  PMID:21067545; http://dx.doi.org/10.1186/1745- 7580-6-S2-S3.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
J  Immunol Methods 2011; 374:1-4; PMID:21986107;  http://dx.doi.org/10.1016/j.jim.2011.09.010.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Nucleic Acids Res 2011; 39(Database  issue):D945-50; PMID:20952405; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
J Clin Oncol  2005; 23:741-50; PMID:15613700; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Proc Natl Acad Sci U S A 2006; 103:57- 62; PMID:16371460; http://dx.doi.org/10.1073/ pnas.0609973103.,OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Blood 2011;  118:499-509; PMID:21531979; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Int J Cancer 1996;  65:450-3; PMID:8621226; http://dx.doi.org/10.1002/ (SICI)1097-0215(19960208)65:4<450::AID- IJC10>3.0.CO;2-E. 13.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Lancet 1995; 346:1399-400;  PMID:7475823; http://dx.doi.org/10.1016/S0140-6736(95)92408-6.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Br J Cancer 1996; 74:1828-33; PMID:8956801;  http://dx.doi.org/10.1038/bjc.1996.638.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
Cancer Res 2008; 68:889-92;  PMID:18245491; http://dx.doi.org/10.1158/0008- 5472.CAN-07-3095.,Non-OADS,/arxiv_data1/oa_pdf/27/a2/onci-1-1281.PMC3518500.pdf
"OncoImmunology 1:8, 1290–1296; November 2012; © 2012 Landes Bioscience ReseaR ch papeR 1290 OncoImmunology Volume 1 Issue 8*Correspondence to: Mads Hald Andersen; Email: mads.hald.andersen@regionh.dk Submitted: 06/14/12; Accepted: 07/25/12http://dx.doi.org/10.4161/onci.21625Introduction Nuclear factor κ light chain enhancer of activated B cells (NF κB)  contributes to cell proliferation, immunity, inflammation and - apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Hum Pathol 2009; 40:795- 806; PMID:19157506; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Cell 2011; 144:646-74;  PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Oncogene 2011; 30:1615- 30; PMID:21170083; http://dx.doi.org/10.1038/ onc.2010.566.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Nat Rev Immunol 2002; 2:725-34;  PMID:12360211; http://dx.doi.org/10.1038/nri910.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
PLoS ONE  2012; 7:e34568; PMID:22539948; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
J Clin Invest 2009; 119:2245- 56; PMID:19662679; http://dx.doi.org/10.1172/ JCI38739.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Curr Opin Immunol  1993; 5:35-44; PMID:7680871; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Nat Med 2006; 12:246-51;  PMID:16462803; http://dx.doi.org/10.1038/nm1360.,OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Nat Protoc 2006; 1:1120-32;  PMID:17406393; http://dx.doi.org/10.1038/ nprot.2006.121.15.,OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Clin Cancer Res  2007; 13:1076-82; PMID:17317814; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Br J Haematol 2011; Epub Ahead of Print;  PMID:21732930; http://dx.doi.org/10.1111/j.1365- 2141.2011.08791.x.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
J T ransl Med 2003; 1:14; PMID:14697097; http://dx.doi.org/10.1186/1479- 5876-1-14.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
J Clin Invest  2010; 120:3869-77; PMID:20978348; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Carcinogenesis 2000; 21:871-9;  PMID:10783306; http://dx.doi.org/10.1093/car- cin/21.5.871.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Annu Rev Immunol  1998; 16:323-58; PMID:9597133; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
J Cell Physiol 2000; 182:323- 31; PMID:10653598; http://dx.doi.org/10.1002/ (SICI)1097-4652(200003)182:3<323::AID- JCP2>3.0.CO;2-#.,OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
Tissue Antigens 2000; 55:519-31; PMID:10902608; http://dx.doi.org/10.1034/j.1399- 0039.2000.550603.x.,Non-OADS,/arxiv_data1/oa_pdf/4e/5e/onci-1-1290.PMC3518501.pdf
"www.landesbioscience.com OncoImmunology 1297OncoImmunology 1:8, 1297–1304; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Inge Marie Svane; Email: inge.marie.svane@regionh.dk Submitted: 07/18/12; Accepted: 07/28/12http://dx.doi.org/10.4161/onci.21659Introduction Two major subsets of T cells carrying the γδ  T-cell receptor  (TCR) have been described.",Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Annu Rev Immunol 2000; 18:975-1026; PMID:10837080; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Cancer Res  2007; 67:5-8; PMID:17210676; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Int Immunol 2010; 22:329-40;  PMID:20185432; http://dx.doi.org/10.1093/intimm/ dxq014.4.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Proc Natl Acad Sci U S A  1999; 96:6879-84; PMID:10359807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Science 1998; 279:1737- 40; PMID:9497295; http://dx.doi.org/10.1126/sci- ence.279.5357.1737.,OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Biochem Biophys Res Commun 2006; 339:232-40; PMID:16297874;  http://dx.doi.org/10.1016/j.bbrc.2005.10.198.,OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Nat Rev Immunol 2010; 10:467-78; PMID:20539306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
BMC Immunol 2009; 10:50; PMID:19772585;  http://dx.doi.org/10.1186/1471-2172-10-50.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Cancer Immunol Immunother 2005; 54:1162-71;  PMID:15889254; http://dx.doi.org/10.1007/s00262- 005-0682-5.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Semin Immunol 1993;  5:41-6; PMID:8467094; http://dx.doi.org/10.1006/ smim.1993.1006.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Clin Cancer Res  2008; 14:4232-40; PMID:18594005; http://dx.doi.org/10.1158/1078-0432.CCR-07-4912.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0116.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
J Immunother 2010; 33:547-56; PMID:20463593;  http://dx.doi.org/10.1097/CJI.0b013e3181d367bd.11.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Eur J Clin Invest 2012; 42:575-6; PMID:22050593; http://dx.doi.org/10.1111/j.1365- 2362.2011.02612.x.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Cytometry A 2005; 68:71-80; PMID:16228974; http://dx.doi.org/10.1002/ cyto.a.20189.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Immunology 2000; 101:185-90; PMID:11012771;  http://dx.doi.org/10.1046/j.1365-2567.2000.00088.x.,Non-OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
Int Immunol  1994; 6:199-211; PMID:8155597; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/01/onci-1-1297.PMC3518502.pdf
"www.landesbioscience.com OncoImmunology 1305OncoImmunology 1:8, 1305–1312; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Isabel Poschke; Email: i.poschke@dkfz.de Submitted: 07/09/12; Revised: 07/27/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21678Introduction Arginase (ARG) is an enzyme catalyzing the conversion of the  amino acid L -arginine ( L-Arg) to ornithine and urea.",Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Blood 2005; 105:2549-56;  PMID:15546957; http://dx.doi.org/10.1182/blood- 2004-07-2521.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Nat Rev  Immunol 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
J Clin Invest 2006; 116:2777- 90; PMID:17016559; http://dx.doi.org/10.1172/ JCI28828.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
J Immunol 2010; 185:203-10; PMID:20525890; http://dx.doi.org/10.4049/jimmunol.0903573.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Hum Immunol  2009; 70:325-30; PMID:19236898; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Clin Biochem 2009; 42:353-7;  PMID:19101531; http://dx.doi.org/10.1016/j.clinbio- chem.2008.11.018.,OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Surg Today 2003; 33:655-61;  PMID:12928840; http://dx.doi.org/10.1007/s00595- 002-2563-2.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Int J Cancer 2012; 131:129- 39; PMID:21823123; http://dx.doi.org/10.1002/ ijc.26355.14.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Int J Cancer 2012; 131:1611-20;  PMID:22190148; http://dx.doi.org/10.1002/ ijc.27410.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Neuro Oncol 2011; 13:591-9;  PMID:21636707; http://dx.doi.org/10.1093/neuonc/ nor042.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Surgery 2000; 127:419- 26; PMID:10776433; http://dx.doi.org/10.1067/ msy.2000.104745.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
J Exp Med  2006; 203:2691-702; PMID:17101732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Int J Cancer 2012; 131:129- 39; PMID:21823123; http://dx.doi.org/10.1002/ ijc.26355.23.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
J Infect Dis 2006; 194:1385-93;  PMID:17054067; http://dx.doi.org/10.1086/508200.,OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
Crit Care Med 2011; 39:380- 5; PMID:21150584; http://dx.doi.org/10.1097/ CCM.0b013e3181ffd9f7.,Non-OADS,/arxiv_data1/oa_pdf/60/7d/onci-1-1305.PMC3518503.pdf
"www.landesbioscience.com OncoImmunology 1313OncoImmunology 1:8, 1313–1322; November 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Mark J. Smyth; Email: mark.smyth@petermac.org Submitted: 07/22/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21680Introduction Hedgehog (Hh) signaling regulates multiple genes that are  important for both cellular growth and differentiation during embryonic development across multiple species.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
"Ann Surg  2011; 254:818-23, discussion 823; PMID:22042473;  http://dx.doi.org/10.1097/SLA.0b013e318236bc0f.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Cancer Res 2012; 72:897-907;  PMID:22186138; http://dx.doi.org/10.1158/0008-5472.CAN-11-2681.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Annu Rev Immunol 2007; 25:267-96; PMID:17134371; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
PLoS One 2011; 6:e16798;  PMID:21304817; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Nat Rev Immunol 2007; 7:726-35;  PMID:17690714; http://dx.doi.org/10.1038/nri2151.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Cancer Res 2011; 71:3540-51;  PMID:21430066; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0096.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
J Exp Med 2004; 199:437-48; PMID:14769851; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Science 2004; 304:1755- 9; PMID:15205520; http://dx.doi.org/10.1126/sci- ence.1098020.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Nat Med 2010; 16:1429- 33; PMID:21076395; http://dx.doi.org/10.1038/ nm.2251.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Carcinogenesis 2011; 32:445-51;  PMID:21186299; http://dx.doi.org/10.1093/carcin/ bgq280.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Onco Targets  Ther 2012; 5:47-58; PMID:22500124; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Cancer Lett 2009; 283:119-24; PMID:19232458;  http://dx.doi.org/10.1016/j.canlet.2009.01.014.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
J Invest  Dermatol 2011; 131:1735-44; PMID:21430703; http://dx.doi.org/10.1038/jid.2011.48.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
N Engl J Med 2012; 366:2180-8; PMID:22670904;  http://dx.doi.org/10.1056/NEJMoa1113538.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Science 2009; 326:572-4; PMID:19726788;  http://dx.doi.org/10.1126/science.1179386.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev-immunol-031210-101324.13.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Nat Med 2009; 15:1170- 8; PMID:19767732; http://dx.doi.org/10.1038/ nm.2028.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
J Exp Med 2011; 208:491-503;  PMID:21383056; http://dx.doi.org/10.1084/ jem.20100269.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Proc Natl Acad Sci U S A  2011; 108:7142-7; PMID:21482773; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
PLoS One 2011; 6:e27306; PMID:22087285; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
J Pathol 2011; 224:169- 79; PMID:21506130; http://dx.doi.org/10.1002/ path.2880.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Mol  Cancer 2010; 9:5; PMID:20067614; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
PLoS One 2011; 6:e18330;  PMID:21483830; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Cancer Res 2011; 71:5904-14; PMID:21747117; http://dx.doi.org/10.1158/0008-5472.CAN-10-4173.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b9/02/onci-1-1313.PMC3518504.pdf
"www.landesbioscience.com OncoImmunology 1323OncoImmunology 1:8, 1323–1343; November 2012; © 2012 Landes BioscienceREVIEW  REVIEW *Correspondence to: Lorenzo Galluzzi and Guido Kroemer;   Email: deadoc@vodafone.it and kroemer@orange.frSubmitted: 08/28/12; Accepted: 08/29/12http://dx.doi.org/10.4161/onci.22009Solid tumors are constituted of a variety of cellular  components, including bona fide malignant cells as well as endothelial, structural and immune cells.",Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Front  Oncol 2011; 1:1; PMID:22655224; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nature  2001; 414:105-11; PMID:11689955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell 2011; 144:646-74;  PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Cancer  2007; 7:139-47; PMID:17218951; http://dx.doi.org/10.1038/nrc2067.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Drug Discov 2010;  9:360-1; PMID:20431564; http://dx.doi.org/10.1038/nrd3163.7.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat  Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nature 2011; 473:298- 307; PMID:21593862; http://dx.doi.org/10.1038/nature10144.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Histopathology 2008; 53:30-8; PMID:18510570;  http://dx.doi.org/10.1111/j.1365-2559.2008.03058.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2011; 29:1949-55; PMID:21483002;  http://dx.doi.org/10.1200/JCO.2010.30.5037.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin  Endocrinol (Oxf) 2012; In press; PMID:22738343; http://dx.doi.org/10.1111/j.1365-2265.2012.04482.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2001; 91:2136-47;  PMID:11391595; http://dx.doi.org/10.1002/1097- 0142(20010601)91:11<2136::AID- CNCR1242>3.0.CO;2-Q.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2011; 17:1603-15; PMID:21135147;  http://dx.doi.org/10.1158/1078-0432.CCR-10-2563.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2008; 113:1387-95; PMID:18671239;  http://dx.doi.org/10.1002/cncr.23712.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J  Natl Cancer Inst 1989; 81:1893-904; PMID:2593166;  http://dx.doi.org/10.1093/jnci/81.24.1893.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 1996; 77:1303- 10; PMID:8608507; http://dx.doi.org/10.1002/ (SICI)1097-0142(19960401)77:7<1303::AID- CNCR12>3.0.CO;2-5.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Cancer Res Clin Oncol  2006; 132:293-301; PMID:16421755; http://dx.doi.org/10.1007/s00432-006-0075-y.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2011; 29:1539- 46; PMID:21422430; http://dx.doi.org/10.1200/ JCO.2010.30.6308.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2003; 52:423-8;  PMID:12695859; http://dx.doi.org/10.1007/s00262- 003-0388-5.26.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2003; 3:383-91; PMID:12766760; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2002; 2:487-98; PMID:12094223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2010; 10:467-78; PMID:20539306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2008; 8:788- 801; PMID:18802443; http://dx.doi.org/10.1038/ nri2416.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2005; 5:251-60;  PMID:15738955; http://dx.doi.org/10.1038/nri1569.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2010; 10:248-56; PMID:20336152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2011; 208:491-503;  PMID:21383056; http://dx.doi.org/10.1084/jem.20100269.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2010; 10:490-500;  PMID:20559327; http://dx.doi.org/10.1038/nri2785.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2006; 211:93- 103; PMID:16824120; http://dx.doi.org/10.1111/ j.0105-2896.2006.00393.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
T rends Immunol 2002; 23:226-8; PMID:12102732;  http://dx.doi.org/10.1016/S1471-4906(02)02190-7.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 1996; 14:233-58; PMID:8717514; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
BMC  Cancer 2001; 1:7; PMID:11481031; http://dx.doi.org/10.1186/1471-2407-1-7.10.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell 2011; 146:873- 87; PMID:21925313; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell Cycle 2012; 11:1059;  PMID:22343921; http://dx.doi.org/10.4161/ cc.11.6.19746.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell Cycle  2012; 11:1108-17; PMID:22313602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Exp Cell Res 2010; 316:2713-22;  PMID:20451516; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2007; 25:267-96;  PMID:17134371; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141609.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Clin Oncol 2011; 8:151-60; PMID:21364688; http://dx.doi.org/10.1038/nrclinonc.2010.223.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Res 2011; 71:5601-5; PMID:21846822;  http://dx.doi.org/10.1158/0008-5472.CAN-11-1316.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncogene 2010; 29:1093- 102; PMID:19946335; http://dx.doi.org/10.1038/ onc.2009.416.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncoimmunology  2012; 1:306-15; PMID:22737606; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/onci.20696.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncoimmunology 2012; 1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
OncoImmunology 2012; 1: In press; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2006; 12:3355-60;  PMID:16740757; http://dx.doi.org/10.1158/1078- 0432.CCR-05-2434.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res  2006; 12:5423-34; PMID:17000676; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science  2006; 313:1960-4; PMID:17008531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Sci 2003; 94:1003-9; PMID:14611679; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2008; 57:97-106;  PMID:17602225; http://dx.doi.org/10.1007/s00262- 007-0353-9.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2006; 12:465-72;  PMID:16428488; http://dx.doi.org/10.1158/1078- 0432.CCR-05-1886.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2011; 29:610-8; PMID:21245428; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2009; 27:5944- 51; PMID:19858404; http://dx.doi.org/10.1200/ JCO.2008.19.6147.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2010; 116:5188- 99; PMID:20665489; http://dx.doi.org/10.1002/ cncr.25293.68.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
PLoS One 2011; 6:e18219;  PMID:21483813; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2008; 14:5220-7;  PMID:18698040; http://dx.doi.org/10.1158/1078-0432.CCR-08-0133.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Invest Dermatol  1991; 97:197-202; PMID:1712819; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hepatology  1998; 27:407-14; PMID:9462638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Pancreas  2004; 28:e26-31; PMID:14707745; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Br J Cancer  2003; 89:1736-42; PMID:14583778; http://dx.doi.org/10.1038/sj.bjc.6601331.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Br J Cancer 2010; 102:1129- 36; PMID:20234368; http://dx.doi.org/10.1038/ sj.bjc.6605611.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Surgery  2009; 145:286-93; PMID:19231581; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother  2010; 59:909-19; PMID:20087581; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Pathol 1986; 39:585-9; PMID:3722412;  http://dx.doi.org/10.1136/jcp.39.6.585.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Br J Cancer  2009; 101:1382-92; PMID:19755986; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Lab Invest  2004; 84:493-501; PMID:14968119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hum Pathol 2004; 35:808-16; PMID:15257543; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Pathol 1997; 182:318-24;  PMID:9349235; http://dx.doi.org/10.1002/ (SICI)1096-9896(199707)182:3<318::AID- PATH862>3.0.CO;2-6.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Gastroenterology  2009; 137:1270-9; PMID:19577568; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Eur J Cancer 1994; 30A:1797-803; PMID:7880609;  http://dx.doi.org/10.1016/0959-8049(94)E0159-2.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Proc Natl Acad Sci U S A 2007; 104:3967- 72; PMID:17360461; http://dx.doi.org/10.1073/ pnas.0611618104.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int Immunopharmacol 2003; 3:1073-81; PMID:12860164; http://dx.doi.org/10.1016/S1567- 5769(03)00029-8.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol  Immunother 2012; 61:771-82; PMID:22057678;  http://dx.doi.org/10.1007/s00262-011-1134-z.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Br J Cancer 2008; 98:148- 53; PMID:18087278; http://dx.doi.org/10.1038/ sj.bjc.6604149.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Lung Cancer 2012; 75:95-101; PMID:21719142; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Ann Surg Oncol 2010; 17:718- 30; PMID:19915919; http://dx.doi.org/10.1245/s10434-009-0809-6.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin  Cancer Res 2009; 15:1052-8; PMID:19188179;  http://dx.doi.org/10.1158/1078-0432.CCR-08-1296.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Med 2004; 10:942-9;  PMID:15322536; http://dx.doi.org/10.1038/nm1093.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Laryngoscope  2012; 122:121-7; PMID:22183632; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Blood 2006; 108:2957-64; PMID:16825494; http://dx.doi.org/10.1182/blood- 2006-04-018218.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Haematologica 2008; 93:193-200;  PMID:18223287; http://dx.doi.org/10.3324/haema- tol.11702.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2009; 27:186- 92; PMID:19064967; http://dx.doi.org/10.1200/JCO.2008.18.7229.106.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hematol Oncol 2009;  27:31-9; PMID:18924115; http://dx.doi.org/10.1002/ hon.878.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2011; 208:469- 78; PMID:21339327; http://dx.doi.org/10.1084/jem.20101876.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int J Biol  Sci 2011; 7:53-60; PMID:21234303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Blood 2009; 114:1141-9;  PMID:19470694; http://dx.doi.org/10.1182/blood- 2009-03-208249.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Lung Cancer 2010; 69:348-54; PMID:20022135;  http://dx.doi.org/10.1016/j.lungcan.2009.11.013.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Hepatol 2009; 50:980-9; PMID:19329213; http://dx.doi.org/10.1016/j.jhep.2008.12.033.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Biochem Biophys  Res Commun 2011; 407:348-54; PMID:21396350;  http://dx.doi.org/10.1016/j.bbrc.2011.03.021.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2008; 14:5166-72; PMID:18698034;  http://dx.doi.org/10.1158/1078-0432.CCR-08-0320.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Neuroimmunol 2010; 225:195-9; PMID:20537408;  http://dx.doi.org/10.1016/j.jneuroim.2010.05.020.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Pathol Oncol Res 2010; 16:303- 9; PMID:20306313; http://dx.doi.org/10.1007/ s12253-010-9254-x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2006; 24:5373-80; PMID:17135638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Breast Cancer Res T reat 2011; 127:99-108;  PMID:20556505; http://dx.doi.org/10.1007/s10549- 010-0987-8.93.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Pathol  2010; 222:350-66; PMID:20927778; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol  2008; 26:4410-7; PMID:18802153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Metastasis  Rev 2011; 30:13-25; PMID:21271351; http://dx.doi.org/10.1007/s10555-011-9279-y.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Cancer Res Clin Oncol 2009; 135:439-49;  PMID:18781326; http://dx.doi.org/10.1007/s00432- 008-0469-0.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int Immunol  2006; 18:1591-602; PMID:16987935; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
BMC Cancer 2010; 10:604; PMID:21050467;  http://dx.doi.org/10.1186/1471-2407-10-604.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2011; 60:693-703; PMID:21327638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol  Immunother 2003; 52:617-24; PMID:12802519;  http://dx.doi.org/10.1007/s00262-003-0406-7.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Surg  Oncol 2010; 102:742-7; PMID:20872813; http://dx.doi.org/10.1002/jso.21725.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Res 2009; 69:2685-93; PMID:19258510;  http://dx.doi.org/10.1158/0008-5472.CAN-08-2654.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Res 2011; 71:1263-71; PMID:21303976;  http://dx.doi.org/10.1158/0008-5472.CAN-10-2907.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Am J Obstet Gynecol 2004; 191:1598- 605; PMID:15547530; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2000; 88:577- 83; PMID:10649250; http://dx.doi.org/10.1002/ (SICI)1097-0142(20000201)88:3<577::AID- CNCR13>3.0.CO;2-V. 161.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Lett 2000; 159:103-8;  PMID:10974412; http://dx.doi.org/10.1016/S0304- 3835(00)00542-5.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Ai Zheng 2009; 28:1198- 202; PMID:19895742; http://dx.doi.org/10.5732/cjc.009.10284.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 1997; 79:2320- 8; PMID:9191519; http://dx.doi.org/10.1002/ (SICI)1097-0142(19970615)79:12<2320::AID- CNCR5>3.0.CO;2-P .,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Med 2011; 17:700-7; PMID:21552268;  http://dx.doi.org/10.1038/nm.2366.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Res 2009; 69:3563-9; PMID:19351841;  http://dx.doi.org/10.1158/0008-5472.CAN-08-3807.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2007; 25:297-336;  PMID:17150027; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science 1997; 278:1623- 6; PMID:9374462; http://dx.doi.org/10.1126/sci-ence.278.5343.1623.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev  Immunol 2004; 4:231-7; PMID:15039760; http://dx.doi.org/10.1038/nri1309.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2003; 21:483-513; PMID:12543936; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science 1999; 283:225- 9; PMID:9880256; http://dx.doi.org/10.1126/sci- ence.283.5399.225.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Invest 2009; 119:1524- 36; PMID:19411762; http://dx.doi.org/10.1172/ JCI37869.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Blood 2009; 114:4823-31; PMID:19805616;  http://dx.doi.org/10.1182/blood-2009-04-216374.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunology  2005; 116:354-61; PMID:16236125; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2002; 2:957-64; PMID:12461568; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol  Rev 2006; 214:219-28; PMID:17100887; http://dx.doi.org/10.1111/j.1600-065X.2006.00450.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Med 2001; 7:94-100; PMID:11135622;  http://dx.doi.org/10.1038/83416.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med  2000; 191:661-8; PMID:10684858; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2005; 202:583- 8; PMID:16129707; http://dx.doi.org/10.1084/ jem.20050994.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2004; 200:1325- 35; PMID:15545356; http://dx.doi.org/10.1084/ jem.20041522.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
PLoS One 2012; 7:e39170; PMID:22723958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2005; 11:1899-909;  PMID:15756016; http://dx.doi.org/10.1158/1078- 0432.CCR-04-1524.132.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Immunother  2010; 33:435-41; PMID:20386463; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2012; 18:850-7; PMID:22142823; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
BJU Int 2011; 108:1672-8;  PMID:21244603; http://dx.doi.org/10.1111/j.1464- 410X.2010.10020.x.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol  Immunother 2011; 60:909-18; PMID:21644034;  http://dx.doi.org/10.1007/s00262-011-1046-y.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res  2008; 14:2413-20; PMID:18413832; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Pathol 2011; 224:389-400; PMID:21437909; http://dx.doi.org/10.1002/path.2866.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2006; 107:2866-72; PMID:17099880; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2007; 25:2586- 93; PMID:17577038; http://dx.doi.org/10.1200/ JCO.2006.09.4565.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2009; 58:449-59;  PMID:18791714; http://dx.doi.org/10.1007/s00262- 008-0583-5.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Proc Natl Acad Sci U S A 2005; 102:18538- 43; PMID:16344461; http://dx.doi.org/10.1073/ pnas.0509182102.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science  2011; 331:44-9; PMID:21212348; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell Immunol  2002; 218:74-86; PMID:12470615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hum Immunol 2002; 63:1126-32;  PMID:12480256; http://dx.doi.org/10.1016/S0198- 8859(02)00751-6.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat  Immunol 2000; 1:305-10; PMID:11017101; http://dx.doi.org/10.1038/79747.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2002; 195:953- 8; PMID:11927638; http://dx.doi.org/10.1084/ jem.20020045.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Pathology 2011; 43:239- 47; PMID:21436634; http://dx.doi.org/10.1097/ PAT.0b013e328344e266.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Pathol 2010; 63:497- 503; PMID:20439325; http://dx.doi.org/10.1136/ jcp.2009.067819.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2010; 234:5-17;  PMID:20193008; http://dx.doi.org/10.1111/j.0105- 2896.2009.00888.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Laryngoscope  1991; 101:487-93; PMID:2030628; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Surg Oncol 1993; 52:207- 12; PMID:8468980; http://dx.doi.org/10.1002/ jso.2930520402.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncology 1998; 55:65-9; PMID:9428378; http://dx.doi.org/10.1159/000011837.189.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2012; 30:1- 22; PMID:22136168; http://dx.doi.org/10.1146/ annurev-immunol-100311-102839.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol  2003; 21:685-711; PMID:12615891; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Proc Natl Acad Sci U S A 1999; 96:1036- 41; PMID:9927689; http://dx.doi.org/10.1073/ pnas.96.3.1036.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science 2007; 315:107-11; PMID:17204652; http://dx.doi.org/10.1126/science.1136080.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunity 2008; 29:497-510;  PMID:18789730; http://dx.doi.org/10.1016/j.immu- ni.2008.07.013.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2007; 219:118-42;  PMID:17850486; http://dx.doi.org/10.1111/j.1600- 065X.2007.00551.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2010; 207:1273-81; PMID:20479115;  http://dx.doi.org/10.1084/jem.20100348.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med  2010; 207:1283-92; PMID:20479118; http://dx.doi.org/10.1084/jem.20100223.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med  2010; 207:1261-71; PMID:20479117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev  2010; 234:142-62; PMID:20193017; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2011; 11:558-65; PMID:21779033; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Exp Med 2001; 194:863-9; PMID:11561001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Leuk Res 2005; 29:147-52;  PMID:15607362; http://dx.doi.org/10.1016/j.leu- kres.2004.06.005.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
APMIS 2009; 117:870-9;  PMID:20078551; http://dx.doi.org/10.1111/j.1600-0463.2009.02547.x.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Med Oncol 2012; In press;  PMID:22669567; http://dx.doi.org/10.1007/s12032- 012-0262-4.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Immunol 2011; 140:167- 76; PMID:21349771; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Immunol  2011; 138:255-65; PMID:21185787; http://dx.doi.org/10.1016/j.clim.2010.11.014.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
PLoS One 2012; 7:e32493;  PMID:22396772; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int J Clin Oncol 2008; 13:528- 35; PMID:19093181; http://dx.doi.org/10.1007/ s10147-008-0789-8.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Immunol 2011; 186:4490- 9; PMID:21357532; http://dx.doi.org/10.4049/jim-munol.1003748.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nature 2007; 449:419-26; PMID:17898760;  http://dx.doi.org/10.1038/nature06175.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Cancer 2012; 12:265-77;  PMID:22437871; http://dx.doi.org/10.1038/nrc3258.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2011; 117:5234- 44; PMID:21523763; http://dx.doi.org/10.1002/ cncr.26143.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Mod Pathol  2012; 25:493-504; PMID:22080065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Urol  2009; 181:1894-900; PMID:19237175; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
BJU Int 2011; 107:1918-22;  PMID:21044246; http://dx.doi.org/10.1111/j.1464-410X.2010.09804.x.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol  2005; 23:8959-67; PMID:16219934; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer  1981; 48:1353-62; PMID:7023654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2007; 13:1472-9; PMID:17332291; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2073.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2012; 118:2476- 85; PMID:21953023; http://dx.doi.org/10.1002/ cncr.26511.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2005; 5:953-64;  PMID:16322748; http://dx.doi.org/10.1038/nri1733.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2008; 8:958-69; PMID:19029990; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol  2005; 23:901-44; PMID:15771589; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Immunol 2012; 13:343-51;  PMID:22430787; http://dx.doi.org/10.1038/ni.2224.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2009; 27:451-83;  PMID:19105661; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Acta Otolaryngol  1991; 111:444-8; PMID:2068934; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Br J Cancer  2012; 106:702-10; PMID:22240784; http://dx.doi.org/10.1038/bjc.2011.610.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Am J Gastroenterol  2004; 99:1667-74; PMID:15330899; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hum Pathol 2009; 40:381-9;  PMID:18992916; http://dx.doi.org/10.1016/j.hump- ath.2008.08.011.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 1998; 82:1468- 75; PMID:9554522; http://dx.doi.org/10.1002/ (SICI)1097-0142(19980415)82:8<1468::AID- CNCR6>3.0.CO;2-5.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol  2008; 26:3235-41; PMID:18591558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin  Cancer Res 2007; 13:6666-72; PMID:18006767;  http://dx.doi.org/10.1158/1078-0432.CCR-07-0504.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Tohoku J Exp Med 1993; 169:187- 95; PMID:8248911; http://dx.doi.org/10.1620/tjem.169.187.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int J Cancer 2003; 104:92- 7; PMID:12532424; http://dx.doi.org/10.1002/ ijc.10915.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol  Immunother 2007; 56:1459-69; PMID:17279413;  http://dx.doi.org/10.1007/s00262-007-0286-3.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2004; 10:7466-74; PMID:15569976;  http://dx.doi.org/10.1158/1078-0432.CCR-04-0684.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2010; 59:389-95; PMID:19760221; http://dx.doi.org/10.1007/s00262- 009-0758-8.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2005; 11:2576-82; PMID:15814636;  http://dx.doi.org/10.1158/1078-0432.CCR-04-1448.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Cancer  Res Clin Oncol 2010; 136:35-45; PMID:19572148;  http://dx.doi.org/10.1007/s00432-009-0634-0.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2009; 15:2148-57;  PMID:19276286; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2011; 60:1419- 30; PMID:21644036; http://dx.doi.org/10.1007/ s00262-011-1028-0.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
T umour  Biol 2012; 33:121-9; PMID:22081309; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J T ransl Med 2011; 9:170; PMID:21978632;  http://dx.doi.org/10.1186/1479-5876-9-170.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Appl Immunohistochem Mol Morphol 2001;  9:97-106; PMID:11396639; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2006; 211:280-94; PMID:16824135;  http://dx.doi.org/10.1111/j.0105-2896.2006.00398.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol  2007; 7:144-54; PMID:17259970; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Immunol 2011; 187:3931-41; PMID:21918187; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Curr Dir Autoimmun 2004; 7:4-32; PMID:14719373; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Invest 2010; 120:214- 22; PMID:20038800; http://dx.doi.org/10.1172/ JCI40231.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol  1990; 8:717-35; PMID:2188677; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2003; 21:205-30;  PMID:12524387; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunology 2012; 136:176-83; PMID:22304731; http://dx.doi.org/10.1111/j.1365-2567.2012.03566.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2007; 13:5243-8; PMID:17875751;  http://dx.doi.org/10.1158/1078-0432.CCR-07-0182.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Gastroenterology 2008; 135:234-43;  PMID:18485901; http://dx.doi.org/10.1053/j.gas- tro.2008.03.020.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hepatology 2009; 50:799-807; PMID:19551844; http://dx.doi.org/10.1002/hep.23054.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Invest 2008; 118:3367-77; PMID:18776941; http://dx.doi.org/10.1172/ JCI35213.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nephrol Dial T ransplant  2012; 27:402-10; PMID:21617199; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2012; 61:1373-85; PMID:22215137; http://dx.doi.org/10.1007/s00262- 011-1178-0.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2009; 58:49-59;  PMID:18446337; http://dx.doi.org/10.1007/s00262- 008-0523-4.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hematol  Oncol 2012; In press; PMID:22714941; http://dx.doi.org/10.1002/hon.2019.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Breast Cancer Res T reat  2012; 132:215-23; PMID:22138748; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Med Oncol  2011; 28:1447-52; PMID:20676804; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Sci  2011; 102:1424-31; PMID:21453387; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2008; 14:1423-30; PMID:18316565;  http://dx.doi.org/10.1158/1078-0432.CCR-07-1712.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Haematologica 2011; 96:269-76; PMID:21071500; http://dx.doi.org/10.3324/haematol.2010.031542.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2008; 222:162-79; PMID:18364001; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Leukoc Biol 2011; 89:311- 7; PMID:21106641; http://dx.doi.org/10.1189/ jlb.0310162.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Blood  2011; 118:2254-65; PMID:21734236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Immunol Methods 2012; 381:14- 22; PMID:22522114; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2011; 60:1269-79; PMID:21604071;  http://dx.doi.org/10.1007/s00262-011-1029-z.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer J 2005; 11:217-25; PMID:16053665;  http://dx.doi.org/10.1097/00130404-200505000- 00008.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Surg  Oncol 1993; 53:92-6; PMID:8501912; http://dx.doi.org/10.1002/jso.2930530209.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Auris Nasus Larynx 2002; 29:175-81;  PMID:11893453; http://dx.doi.org/10.1016/S0385- 8146(01)00135-3.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Br J Cancer 2002; 86:674-9;  PMID:11875724; http://dx.doi.org/10.1038/ sj.bjc.6600161.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 1986; 58:1321-7; PMID:3742457; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Crit Rev  Oncol Hematol 2001; 39:31-42; PMID:11418300; http://dx.doi.org/10.1016/S1040-8428(01)00122-6.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2000; 88:1544-8;  PMID:10738211; http://dx.doi.org/10.1002/ (SICI)1097-0142(20000401)88:7<1544::AID- CNCR7>3.0.CO;2-S. 339.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Gynecol Oncol  1983; 16:19-30; PMID:6884827; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Adv Immunol 2009; 101:123-61;  PMID:19231594; http://dx.doi.org/10.1016/S0065- 2776(08)01004-3.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Curr  Pharm Des 2011; 17:3753-71; PMID:22103846;  http://dx.doi.org/10.2174/138161211798357881.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2011; 29:45-69;  PMID:21166539; http://dx.doi.org/10.1146/annurev- immunol-031210-101257.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2009;  9:9-13; PMID:19039320; http://dx.doi.org/10.1038/ nri2458.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nature  1993; 365:340-3; PMID:7690905; http://dx.doi.org/10.1038/365340a0.315.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Cell 2009; 16:183-94; PMID:19732719;  http://dx.doi.org/10.1016/j.ccr.2009.06.017.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Eur J Immunol  2011; 41:2535-8; PMID:21952813; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Hepatol 2011; 54:948- 55; PMID:21145847; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
PLoS  One 2012; 7:e33655; PMID:22442706; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Mod Pathol 2002; 15:831-7; PMID:12181268; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2011; 242:161-77; PMID:21682744; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu  Rev Immunol 2006; 24:147-74; PMID:16551246; http://dx.doi.org/10.1146/annurev.immu- nol.24.021605.090720.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2001; 179:5-15;  PMID:11292027; http://dx.doi.org/10.1034/j.1600- 065X.2001.790101.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Cancer 2008; 8:618-31;  PMID:18633355; http://dx.doi.org/10.1038/nrc2444.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Laryngoscope 1995; 105:413-6; PMID:7715387; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Craniofac Surg 2009; 20:287- 9; PMID:19218858; http://dx.doi.org/10.1097/ SCS.0b013e318199219b.299.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev 2010; 237:104-16;  PMID:20727032; http://dx.doi.org/10.1111/j.1600- 065X.2010.00939.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Curr Opin Immunol 2010; 22:566- 74; PMID:20829011; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Ann  N Y Acad Sci 2011; 1217:96-121; PMID:21251012;  http://dx.doi.org/10.1111/j.1749-6632.2010.05877.x.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Annu Rev Immunol 2012; 30:221-41;  PMID:22224776; http://dx.doi.org/10.1146/annurev- immunol-020711-074934.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell Death Differ 2012; 19:107-20; PMID:21760595;  http://dx.doi.org/10.1038/cdd.2011.96.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Physiol  Rev 2007; 87:99-163; PMID:17237344; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cell Death Differ  2009; 16:3-11; PMID:18846107; http://dx.doi.org/10.1038/cdd.2008.150.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Immunol Immunother 2011; 60:1729-38; PMID:21779876; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2006; 6:173-82;  PMID:16498448; http://dx.doi.org/10.1038/nri1785.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Lab Invest  2000; 80:617-53; PMID:10830774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Science 2004; 303:1532-5;  PMID:15001782; http://dx.doi.org/10.1126/sci- ence.1092385.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Carcinogenesis 2012; 33:949-55;  PMID:22425643; http://dx.doi.org/10.1093/carcin/ bgs123.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Proc Natl Acad Sci U S A 2009; 106:1903- 8; PMID:19174509; http://dx.doi.org/10.1073/ pnas.0811556106.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Eur J Immunol  2009; 39:1088-97; PMID:19283780; http://dx.doi.org/10.1002/eji.200838904.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
N Engl J Med 2005; 353:1224-35; PMID:16177248; http://dx.doi.org/10.1056/ NEJMoa051931.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Clin Oncol 2011; 29:1612-9; PMID:21422439;  http://dx.doi.org/10.1200/JCO.2010.31.1704.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol Rev  2007; 220:47-59; PMID:17979839; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Med 2009; 15:1170- 8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Lancet 2002; 360:1935-9;  PMID:12493261; http://dx.doi.org/10.1016/S0140- 6736(02)11917-9.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Oncoimmunology 2012;  1:271-8; PMID:22737602; http://dx.doi.org/10.4161/ onci.18684.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Lancet  2002; 359:1114-9; PMID:11943260; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int J Cancer 2012; 130:1109-19; PMID:21480223; http://dx.doi.org/10.1002/ ijc.26123.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Gastric Cancer 1999; 2:26-32;  PMID:11957067; http://dx.doi.org/10.1007/ s101200050017.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer 2000; 88:2686-92;  PMID:10870050; http://dx.doi.org/10.1002/1097- 0142(20000615)88:12<2686::AID- CNCR6>3.0.CO;2-6.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res 2011; 17:7015-23; PMID:21976550; http://dx.doi.org/10.1158/1078-0432.CCR-11-0607.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Clin Cancer Res  2010; 16:2257-65; PMID:20371681; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Eur Urol 2006; 50:530-4;  PMID:16426730; http://dx.doi.org/10.1016/j.euru - ro.2005.12.040.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Breast Cancer Res T reat  2008; 107:249-57; PMID:17431762; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Gynecol Oncol 2005; 99:20-5; PMID:16055178; http://dx.doi.org/10.1016/j.ygyno.2005.05.042.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J T ransl Med 2012; 10:1; PMID:22214470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nature 2008; 454:436-44; PMID:18650914; http://dx.doi.org/10.1038/ nature07205.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Int  J Colorectal Dis 2012; 27:159-69; PMID:22065108;  http://dx.doi.org/10.1007/s00384-011-1334-1.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Res 2011; 71:5670-7; PMID:21846824;  http://dx.doi.org/10.1158/0008-5472.CAN-11-0268.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Immunol  Rev 2009; 232:7-21; PMID:19909352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Intern Med 2011; 50:501-2; PMID:21372467;  http://dx.doi.org/10.2169/internalmedicine.50.4695.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Blood 2011; 118:686-92;  PMID:21536864; http://dx.doi.org/10.1182/blood- 2010-12-319038.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Blood 2003; 101:3386-90; PMID:12506028; http://dx.doi.org/10.1182/blood- 2002-03-0947.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
J Allergy Clin Immunol 2003; 111(Suppl):S486-94; PMID:12592295; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2008; 8:478-86;  PMID:18483499; http://dx.doi.org/10.1038/nri2327.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Nat Rev Immunol 2007; 7:93-104;  PMID:17259966; http://dx.doi.org/10.1038/nri2018.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Parasite Immunol 2009; 31:267-73; PMID:19388947;  http://dx.doi.org/10.1111/j.1365-3024.2009.01104.x.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
PLoS  One 2010; 5:e8922; PMID:20111717; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Biochim Biophys Acta 2012; 1822:2- 8; PMID:21130163; http://dx.doi.org/10.1016/j.bba- dis.2010.11.010.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Cancer Metastasis Rev 2011; 30:45-60;  PMID:21287360; http://dx.doi.org/10.1007/s10555- 011-9286-z.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Exp Hematol 2002; 30:1211-8;  PMID:12384153; http://dx.doi.org/10.1016/S0301- 472X(02)00890-1.,OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
Hum Pathol 1998; 29:498-504; PMID:9596274;  http://dx.doi.org/10.1016/S0046-8177(98)90066-1.,Non-OADS,/arxiv_data1/oa_pdf/b1/ef/onci-1-1323.PMC3518505.pdf
"5,6 Vv displays broad tissue tropism and is  known to take advantage of several membrane fusion pathways  *Correspondence to: Ignacio Melero and Phillip K. Darcy;   Email: imelero@unav.es and phil.darcy@petermac.orgSubmitted: 06/28/12; Revised: 07/30/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21679Malignant cells are susceptible to viral infection and  consequent cell death.",Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Expert Rev Vaccines 2011; 10:1221-40;  PMID:21854314; http://dx.doi.org/10.1586/ erv.11.79.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2010; 18:233-4; PMID:20125160;  http://dx.doi.org/10.1038/mt.2009.314.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nat Rev Cancer 2009; 9:64-71;  PMID:19104515; http://dx.doi.org/10.1038/nrc2545.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Immunol Res 2011; 50:286-93;  PMID:21717084; http://dx.doi.org/10.1007/s12026- 011-8211-4.8.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res 2009; 69:8516-25; PMID:19843856;  http://dx.doi.org/10.1158/0008-5472.CAN-09-2522.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
PLoS One 2010; 5:e8603; PMID:20066051;  http://dx.doi.org/10.1371/journal.pone.0008603.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Virus Res 2010; 153:179-96;  PMID:20692305; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2005; 11:4553-60; PMID:15958641;  http://dx.doi.org/10.1158/1078-0432.CCR-04-2610.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res 2006; 66:7185-94; PMID:16849565; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2214.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Gene Ther 2000; 7:1477- 82; PMID:11001367; http://dx.doi.org/10.1038/ sj.gt.3301263.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nat Biotechnol 2004;  22:70-7; PMID:14647305; http://dx.doi.org/10.1038/ nbt917.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature  1993; 361:739-42; PMID:8441470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Curr Opin Microbiol 2002; 5:395-402;  PMID:12160859; http://dx.doi.org/10.1016/S1369- 5274(02)00340-5.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res  2005; 65:9991-8; PMID:16267024; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Annu Rev Immunol 1994; 12:991-1045;  PMID:8011301; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Expert Rev Anticancer Ther  2008; 8:1581-8; PMID:18925850; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Natl Cancer Inst 1995;  87:581-6; PMID:7538593; http://dx.doi.org/10.1093/ jnci/87.8.581.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Hepatology 2001; 33:52- 61; PMID:11124820; http://dx.doi.org/10.1053/jhep.2001.20796.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2005; 12:153- 63; PMID:15963931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2012; PMID:22735380; http://dx.doi.org/10.1038/mt.2012.56.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Virol  2009; 83:12266-78; PMID:19740992; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Clin Oncol 2004; 22:1389-97;  PMID:15084613; http://dx.doi.org/10.1200/ JCO.2004.04.059.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2005; 11:4168-75; PMID:15930353; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature 2011; 477:99-102; PMID:21886163;  http://dx.doi.org/10.1038/nature10358.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Lancet Oncol 2008; 9:533-42;  PMID:18495536; http://dx.doi.org/10.1016/S1470- 2045(08)70107-4.37.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cytotherapy  2011; 13:739-52; PMID:21250864; http://dx.doi.org /10.3109/14653249.2010.549123.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Hum Gene Ther 2005; 16:348- 60; PMID:15812230; http://dx.doi.org/10.1089/ hum.2005.16.348.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Clin Invest  2012; 122:1628-43; PMID:22505455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cold Spring Harb  Symp Quant Biol 1989; 54:1-13; PMID:2700931;  http://dx.doi.org/10.1101/SQB.1989.054.01.003.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Virology  1996; 219:339-49; PMID:8638399; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature 1969; 222:940-4;  PMID:5789322; http://dx.doi.org/10.1038/222940a0.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature 1965; 206:532;  PMID:5831854; http://dx.doi.org/10.1038/206532a0.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Immunity 2007; 27:370-83; PMID:17892846;  http://dx.doi.org/10.1016/j.immuni.2007.08.012.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Vaccine  2006; 24:5110-8; PMID:16725231; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Virol 2006; 80:7100-10; PMID:16809315; http://dx.doi.org/10.1128/ JVI.02579-05.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Blood 2007; 109:619-25; PMID:16973959; http://dx.doi.org/10.1182/blood-2006-06-027136.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
T rends Immunol 2007; 28:429- 36; PMID:17845865; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Oncogene 2011; 30:1-20; PMID:20935674;  http://dx.doi.org/10.1038/onc.2010.460.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Ann N Y Acad Sci  2010; 1209:99-108; PMID:20958322; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature 2009; 458:899-903; PMID:19219027;  http://dx.doi.org/10.1038/nature07750.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Immunity 2012; 36:646-57; PMID:22483802;  http://dx.doi.org/10.1016/j.immuni.2012.03.009.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Science 2002; 296:301-5; PMID:11951032; http://dx.doi.org/10.1126/science.1071059.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cell Cycle 2009; 8:3723-8; PMID:19855167; http://dx.doi.org/10.4161/ cc.8.22.10026.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2011; 17:2619-27; PMID:21372217;  http://dx.doi.org/10.1158/1078-0432.CCR-10-1114.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Exp Med 2010; 207:1261-71; PMID:20479117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nat Med 1999; 5:823-7;  PMID:10395329; http://dx.doi.org/10.1038/10548.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Natl Cancer  Inst 2000; 92:931-6; PMID:10841829; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Int J Cancer 2004; 110:51- 60; PMID:15054868; http://dx.doi.org/10.1002/ ijc.20093.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Gene Ther  2012; PMID:22476202; http://dx.doi.org/10.1038/ gt.2012.31.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2011; 19:1737- 46; PMID:21673660; http://dx.doi.org/10.1038/ mt.2011.113.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature 2011; 480:480-9;  PMID:22193102; http://dx.doi.org/10.1038/ nature10673.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nat Rev Cancer 2012; 12:252- 64; PMID:22437870; http://dx.doi.org/10.1038/ nrc3239.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Proc Natl Acad Sci U S A 2008; 105:3005- 10; PMID:18287062; http://dx.doi.org/10.1073/ pnas.0712237105.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Exp Med  2009; 206:1717-25; PMID:19581407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Immunol 2009; 183:7898-908; PMID:20007574; http://dx.doi.org/10.4049/jimmu- nol.0901060.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Exp Med 2010; 207:2187- 94; PMID:20819927; http://dx.doi.org/10.1084/ jem.20100643.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nature 1992; 356:607-9; PMID:1313950;  http://dx.doi.org/10.1038/356607a0.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2005; 11:2416-26;  PMID:15788693; http://dx.doi.org/10.1158/1078- 0432.CCR-04-1380.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Hum  Gene Ther 2006; 17:239-44; PMID:16454657; http://dx.doi.org/10.1089/hum.2006.17.239.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Clin Oncol  2010; 28:1099-105; PMID:20100959; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Gene Ther 2006; 13:1010-20; PMID:16525479;  http://dx.doi.org/10.1038/sj.gt.3302759.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Br  J Cancer 2003; 89:385-90; PMID:12865933; http://dx.doi.org/10.1038/sj.bjc.6601099.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res  2006; 12:5859-68; PMID:17020994; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2000; 2:195- 203; PMID:10985949; http://dx.doi.org/10.1006/ mthe.2000.0114.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res 2006; 66:2442-50;  PMID:16489051; http://dx.doi.org/10.1158/0008- 5472.CAN-05-1681.66.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2009; 15:7029-35;  PMID:19903777; http://dx.doi.org/10.1158/1078- 0432.CCR-09-1540.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2009; 15:7036-44; PMID:19903780; http://dx.doi.org/10.1158/1078-0432.CCR-09-1544.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res 2004; 64:6337-43;  PMID:15342423; http://dx.doi.org/10.1158/0008- 5472.CAN-04-0757.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cell Mol Life Sci 2001; 58:4-43;  PMID:11229815; http://dx.doi.org/10.1007/ PL00000776.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Hepatology 2001; 34:72-81; PMID:11431736;  http://dx.doi.org/10.1053/jhep.2001.25757.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2010; 16:3279-87;  PMID:20448220; http://dx.doi.org/10.1158/1078-0432.CCR-10-0385.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Science 2011; 331:1612- 6; PMID:21436454; http://dx.doi.org/10.1126/sci- ence.1198443.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Eur J Immunol 1993; 23:2631- 41; PMID:8405064; http://dx.doi.org/10.1002/ eji.1830231037.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Immunol Today  1994; 15:321-31; PMID:7522010; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Nat Med 1997; 3:682-5;  PMID:9176498; http://dx.doi.org/10.1038/nm0697-682.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Immunity  1995; 2:507-21; PMID:7749983; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res 2004; 64:3281-7; PMID:15126371;  http://dx.doi.org/10.1158/0008-5472.CAN-03-3911.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2008; 14:6505-14;  PMID:18927290; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0200.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Proc Natl Acad Sci U S A  2009; 106:12915-20; PMID:19617539; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Gene Ther 2010; 17:922-9; PMID:20508601;  http://dx.doi.org/10.1038/gt.2010.82.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2012; 20:37-45; PMID:21915104; http://dx.doi.org/10.1038/mt.2011.187.116.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Immunotherapy 2009; 1:845- 53; PMID:20636027; http://dx.doi.org/10.2217/ imt.09.51.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2010; 18:233-4; PMID:20125160;  http://dx.doi.org/10.1038/mt.2009.314.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Proc Natl Acad Sci U S A  2011; 108:7142-7; PMID:21482773; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J T ransl Med 2010; 8:42; PMID:20426873; http://dx.doi.org/10.1186/1479- 5876-8-42.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol  Ther 2000; 2:39-46; PMID:10899826; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Gene Ther 2002; 9:786- 92; PMID:12040460; http://dx.doi.org/10.1038/ sj.gt.3301687.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2002; 6:528-36; PMID:12377195; http://dx.doi.org/10.1006/ mthe.2002.0699.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Mol Ther 2011; 19:490-9; PMID:21081903;  http://dx.doi.org/10.1038/mt.2010.247.105.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Exp Med 2011; 208:395-407; PMID:21300912;  http://dx.doi.org/10.1084/jem.20100466.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Clin Oncol  2010; 28:3167-75; PMID:20516446; http://dx.doi.org/10.1200/JCO.2009.26.7609.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Clin Cancer Res 2008; 14:3044-51;  PMID:18483370; http://dx.doi.org/10.1158/1078- 0432.CCR-07-4079.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Semin Oncol 2010; 37:508-16;  PMID:21074066; http://dx.doi.org/10.1053/j.semi - noncol.2010.09.008.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
Cancer Res  2012; 72:1651-60; PMID:22315352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J Exp Med 1999; 190:1535-40; PMID:10562327;  http://dx.doi.org/10.1084/jem.190.10.1535.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
J T ransl  Med 2012; 10:108; PMID:22640522; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/b9/onci-1-1344.PMC3518506.pdf
"Although selected for a low inci - dence of breast cancer, these mice display a low frequency of all  Correspondence to: George Klein; Email: georg.klein@ki.se Submitted: 08/24/12; Accepted: 09/11/12http://dx.doi.org/10.4161/onci.22194It is suggested that evolution has equipped humans and  other species with powerful and, largely non-immunological resistance mechanisms that can nip pre-neoplastic cells, as well  as cells disseminating from established tumors in the bud.",Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Carcinogenesis 1992; 13:2145-51;  PMID:1423887; http://dx.doi.org/10.1093/car- cin/13.11.2145.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Cancer Cell 2010; 17:135-47; PMID:20138012; http://dx.doi.org/10.1016/j.ccr.2009.12.041.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Int J Cancer 2012; 131:2274- 83; PMID:22396138; http://dx.doi.org/10.1002/ ijc.27521.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Int J Cancer 2011; 128:2793- 802; PMID:20715102; http://dx.doi.org/10.1002/ ijc.25612.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Cancer Res 2008; 68:4465-78;  PMID:18519710; http://dx.doi.org/10.1158/0008- 5472.CAN-07-1670.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
T rends Ecol Evol  2011; 26:175-82; PMID:21296451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Semin Cancer Biol 2005; 15:84-96; PMID:15652453; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
J Natl Cancer Inst  2002; 94:1494-503; PMID:12359858; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Semin Cancer Biol 2005; 15:75-83; PMID:15652452;  http://dx.doi.org/10.1016/j.semcancer.2004.08.008.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Science 1985; 230:676-8; PMID:2996144;  http://dx.doi.org/10.1126/science.2996144.,OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
J Cell Sci 2004;  117:1495-502; PMID:14996910; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Aging Cell 2008; 7:813-23; PMID:18778411;  http://dx.doi.org/10.1111/j.1474-9726.2008.00431.x 3.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Proc Natl Acad Sci USA 2009; 106:19352- 7; PMID:19858485; http://dx.doi.org/10.1073/ pnas.0905252106.,OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Curr Top  Microbiol Immunol 1996; 213:1-18; PMID:8814999;  http://dx.doi.org/10.1007/978-3-642-80071-9_1.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Br J Cancer 1982;  46:313-22; PMID:6982056; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Nat Med 2011; 17:320- 9; PMID:21383745; http://dx.doi.org/10.1038/ nm.2328.,OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
Cancer Res 2004; 64:1347-58; PMID:14973064; http://dx.doi.org/10.1158/0008-5472.CAN-03-2558.,Non-OADS,/arxiv_data1/oa_pdf/8e/a4/onci-1-1355.PMC3518507.pdf
"Neutrophils, eosinophils, dendritic cells (DC) and mast cells are known to play some part in the different phases of metastasis, but in recent years it is the tumor-associated  *Correspondence to: Benjamin Toh;   Email: benjamin_toh@immunol.a-star.edu.sgSubmitted: 09/09/12; Accepted: 09/11/12http://dx.doi.org/10.4161/onci.22196Metastasis is a key step in cancer progression, and was  traditionally attributed to the accumulation of genetic and epigenetic changes within individual cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
FEBS Lett 2006; 580:3042-50;  PMID:16678166; http://dx.doi.org/10.1016/j.febs- let.2006.04.049.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
BMC Cancer 2012; 12:35; PMID:22273460;  http://dx.doi.org/10.1186/1471-2407-12-35.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
EMBO  Rep 2010; 11:97-105; PMID:20075988; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Biochem 2012; 151:205-16; PMID:22161143; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Immunol 2012; 189:444-53;  PMID:22664874; http://dx.doi.org/10.4049/jimmu-nol.1103248.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat Rev Cancer 2011; 11:573-87;  PMID:21779009; http://dx.doi.org/10.1038/nrc3078.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
"Clin Cancer Res  2010; 16:2257-65; PMID:20371681; http://dx.doi.org/10.1158/1078-0432.CCR-09-1230.Anti-VEGF therapy, in addition to its anti-angiogenic effects,  may also help in reducing the numbers of myeloid cells.78  Interestingly, in mouse models, refractoriness to anti-VEGF ther - apy has been shown to be dependent on MDSCs.79 Furthermore, in  a tumor xenograft model in zebrafish, inhibition of VEGF signal - ing effectively suppresses localized tumor growth but accelerates  tumor invasiveness and micrometastasis through the recruitment of neutrophils.",Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Science 2011; 331:1559-64;  PMID:21436443; http://dx.doi.org/10.1126/sci- ence.1203543.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Lett  2008; 267:204-15; PMID:18448242; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Clin Invest 2012; 122:787- 95; PMID:22378047; http://dx.doi.org/10.1172/ JCI59643.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Blood 2008; 111:4233-44; PMID:18272812;  http://dx.doi.org/10.1182/blood-2007-07-099226.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Immunol Immunother 2011; 60:1419-30; PMID:21644036; http://dx.doi.org/10.1007/ s00262-011-1028-0.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Int Immunopharmacol 2011; 11:802-7; PMID:21237299; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
EMBO Mol Med 2009; 1:303- 14; PMID:20049734; http://dx.doi.org/10.1002/ emmm.200900043.10.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cell 2009; 139:871-90; PMID:19945376;  http://dx.doi.org/10.1016/j.cell.2009.11.007.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Biol Chem 2008; 283:13834- 41; PMID:18343818; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Int J Dev Biol 2004; 48:365-75; PMID:15349812;  http://dx.doi.org/10.1387/ijdb.041794hp.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J  Mammary Gland Biol Neoplasia 2010; 15:117-34;  PMID:20490631; http://dx.doi.org/10.1007/s10911- 010-9178-9.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
PLoS Biol  2011; 9:e1001162; PMID:21980263; http://dx.doi.org/10.1371/journal.pbio.1001162.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Melanoma Res 2010; 20:126- 32; PMID:20061986; http://dx.doi.org/10.1097/ CMR.0b013e328335a916.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Biol Chem 2006; 281:10365-73;  PMID:16455654; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Res  2009; 69:7969-77; PMID:19826052; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Virchows Arch  2000; 436:243-8; PMID:10782883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Int Arch Allergy Immunol  1998; 115:47-54; PMID:9430495; http://dx.doi.org/10.1159/000023829.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat Med 2004; 10:950-8;  PMID:15334073; http://dx.doi.org/10.1038/nm1097.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat  Med 2001; 7:192-8; PMID:11175850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat  Med 2001; 7:186-91; PMID:11175849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Am J Pathol  2002; 161:947-56; PMID:12213723; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Am J Pathol 1998; 153:865-73;  PMID:9736035; http://dx.doi.org/10.1016/S0002- 9440(10)65628-3.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat Rev Cancer 2009; 9:285-93;  PMID:19308068; http://dx.doi.org/10.1038/nrc2621.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Clin  Dev Immunol 2011; 2011:430394; PMID:22110524;  http://dx.doi.org/10.1155/2011/430394.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat Cell Biol 2006; 8:1369- 75; PMID:17128264; http://dx.doi.org/10.1038/ ncb1507.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Mol Cancer Res 2011; 9:133-48;  PMID:21228116; http://dx.doi.org/10.1158/1541- 7786.MCR-10-0394.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Res 2010; 70:6139-49;  PMID:20631080; http://dx.doi.org/10.1158/0008-5472.CAN-10-0706.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Cell 2002; 2:289-300;  PMID:12398893; http://dx.doi.org/10.1016/S1535- 6108(02)00153-8.43.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Oncology 2011;  81:199-205; PMID:22067898; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nature 2007; 450:825-31; PMID:18064003;  http://dx.doi.org/10.1038/nature06348.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Pathol 2000; 190:430-6;  PMID:10699991; http://dx.doi.org/10.1002/(SICI)1096-9896(200003)190:4<430::AID- PATH538>3.0.CO;2-6.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer  Lett 1998; 128:55-63; PMID:9652793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Oncol Rep 2010; 24:405-15; PMID:20596627;  http://dx.doi.org/10.3892/or_00000873.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Res  2006; 66:11238-46; PMID:17114237; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Res  2010; 70:5270-80; PMID:20530679; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Cell 2005; 8:211- 26; PMID:16169466; http://dx.doi.org/10.1016/j.ccr.2005.08.002.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Gastric Cancer 1999; 2:26-32;  PMID:11957067; http://dx.doi.org/10.1007/ s101200050017.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Oncogene  2010; 29:6203-15; PMID:20729915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer J 2005; 11:217-25; PMID:16053665;  http://dx.doi.org/10.1097/00130404-200505000- 00008.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cell 2010; 141:39- 51; PMID:20371344; http://dx.doi.org/10.1016/j.cell.2010.03.014.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.org/10.1016/j.cell.2010.03.015.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cell 2000; 103:481-90; PMID:11081634; http://dx.doi.org/10.1016/S0092- 8674(00)00139-2.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Genes Dev 2010; 24:241- 55; PMID:20080943; http://dx.doi.org/10.1101/ gad.1874010.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
T rends Immunol 2012; 33:119-26; PMID:22277903;  http://dx.doi.org/10.1016/j.it.2011.12.001.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Cell 2008; 13:23- 35; PMID:18167337; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat Genet 2007; 39:467-75;  PMID:17369830; http://dx.doi.org/10.1038/ng1997.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Int J Cancer 2012; 131:E329-36; PMID:21901747;  http://dx.doi.org/10.1002/ijc.26417.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Genes Dev 1999; 13:1382- 97; PMID:10364156; http://dx.doi.org/10.1101/ gad.13.11.1382.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Am J Pathol 2003; 162:1951- 60; PMID:12759251; http://dx.doi.org/10.1016/ S0002-9440(10)64328-3.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Pathol 2012; 227:431- 45; PMID:22374800; http://dx.doi.org/10.1002/ path.4013.76.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Curr Mol Med 2010;  10:369-73; PMID:20455855; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Clin Cancer Res 2009; 15:2148-57;  PMID:19276286; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Nat Biotechnol 2007; 25:911-20; PMID:17664940; http://dx.doi.org/10.1038/nbt1323.71.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
PLoS  One 2009; 4:e6525; PMID:19763275; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cancer Res 2012;  72:3919-27; PMID:22751466; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
PLoS One 2009; 4:e6562; PMID:19668347; http://dx.doi.org/10.1371/journal.pone.0006562.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
Cell 1990; 61:759-67; PMID:2188735;  http://dx.doi.org/10.1016/0092-8674(90)90186-I.,OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
J Clin Invest 2010; 120:2030-9; PMID:20501944; http://dx.doi.org/10.1172/ JCI42002.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/onci-1-1360.PMC3518508.pdf
"IL-21  *Correspondence to: Bernd Jahrsdörfer; Email: bernd.jahrsdoerfer@uni-ulm.de Submitted: 09/14/12; Accepted: 09/24/12http://dx.doi.org/10.4161/onci.22354B cells are generally believed to operate as producers of high  affinity antibodies to defend the body against microorganisms, whereas cellular cytotoxicity is considered as an exclusive  prerogative of natural killer (NK) cells and cytotoxic T  lymphocytes (CTLs).",Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood  2002; 100:3295-303; PMID:12384430; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood  2006; 108:2290-9; PMID:16794249; http://dx.doi.org/10.1182/blood-2006-03-010348.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood 2004; 103:1099-104; PMID:14512315;  http://dx.doi.org/10.1182/blood-2003-04-1069.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Br J Cancer  2003; 89:135-9; PMID:12838314; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood 2006; 108:2712-9;  PMID:16809616; http://dx.doi.org/10.1182/blood- 2006-03-014001.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Cytokine 2006; 33:41- 5; PMID:16406655; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Eur J Immunol 2003; 33:3284- 92; PMID:14635036; http://dx.doi.org/10.1002/ eji.200324376.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Autoimmun Rev 2004; 3:516-23;  PMID:15546800; http://dx.doi.org/10.1016/j.aut- rev.2004.07.035.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Science 1987; 236:77-81; PMID:3105056; http://dx.doi.org/10.1126/science.3105056.17.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Biol Chem 2005; 280:23549- 58; PMID:15843372; http://dx.doi.org/10.1074/jbc.M412001200.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Biol Chem 2006; 281:28326-35; PMID:16798735; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunity  2006; 25:237-47; PMID:16901729; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Biol Chem 2008; 283:22498- 504; PMID:18577516; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Arthritis Rheum 2007; 56:3448-58; PMID:17907150; http://dx.doi.org/10.1002/ art.22861.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Biol Chem 2006; 387:827-37; PMID:16913832; http://dx.doi.org/10.1515/ BC.2006.106.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Mol Hum Reprod  2001; 7:1133-42; PMID:11719590; http://dx.doi.org/10.1093/molehr/7.12.1133.References 1.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Exp Med  1984; 160:1102-13; PMID:6207262; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Nature 1985; 314:537-9; PMID:3157869;  http://dx.doi.org/10.1038/314537a0.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Nature  2000; 408:57-63; PMID:11081504; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Leukoc Biol 2008; 84:348-56; PMID:18467657;  http://dx.doi.org/10.1189/jlb.0308149.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Annu  Rev Immunol 2008; 26:57-79; PMID:17953510;  http://dx.doi.org/10.1146/annurev.immu-nol.26.021607.090316.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Curr Opin  Immunol 2008; 20:295-301; PMID:18554883; http://dx.doi.org/10.1016/j.coi.2008.02.004.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Immunol  2009; 183:1838-45; PMID:19592644; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Cell Death Differ 2012; 19:28- 35; PMID:22052191; http://dx.doi.org/10.1038/ cdd.2011.153.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Exp Med 1991; 173:1099- 109; PMID:2022921; http://dx.doi.org/10.1084/ jem.173.5.1099.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Curr Opin Immunol 2007; 19:339- 47; PMID:17442557; http://dx.doi.org/10.1016/j.coi.2007.04.007.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
T rends Immunol 2009; 30:117-23; PMID:19217825; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Biol Chem  2007; 282:4545-52; PMID:17179148; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Cell Biol 2007; 176:435- 44; PMID:17283187; http://dx.doi.org/10.1083/ jcb.200612025.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Tissue Antigens  2007; 70:198-204; PMID:17661907; http://dx.doi.org/10.1111/j.1399-0039.2007.00872.x.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Biochemistry  1991; 30:2217-27; PMID:1998680; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Exp Med 1992; 175:553- 66; PMID:1732416; http://dx.doi.org/10.1084/ jem.175.2.553.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Cell 1994; 76:977- 87; PMID:8137431; http://dx.doi.org/10.1016/0092- 8674(94)90376-X.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Cell Biol 2004; 167:457-68; PMID:15534000; http://dx.doi.org/10.1083/ jcb.200406115.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunity 2003; 18:319-29;  PMID:12648450; http://dx.doi.org/10.1016/S1074- 7613(03)00050-5.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Nat Rev Immunol 2008; 8:523-32; PMID:18566595; http://dx.doi.org/10.1038/nri2343.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Autoimmun Rev 2006; 5:403-8; PMID:16890894;  http://dx.doi.org/10.1016/j.autrev.2005.10.007.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunol Rev 2008; 223:60-86; PMID:18613830;  http://dx.doi.org/10.1111/j.1600-065X.2008.00631.x.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Ann Rheum  Dis 2008; 67(Suppl 3):iii83-6; PMID:19022821;  http://dx.doi.org/10.1136/ard.2008.098400.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood  2005; 105:4390-8; PMID:15701725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunol Rev 2008; 224:201-14; PMID:18759928;  http://dx.doi.org/10.1111/j.1600-065X.2008.00661.x.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunol Rev  2010; 233:146-61; PMID:20192998; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Immunol 2009; 182:7459- 72; PMID:19494269; http://dx.doi.org/10.4049/jim- munol.0900270.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunity 2008; 28:639-50;  PMID:18482568; http://dx.doi.org/10.1016/j.immu-ni.2008.03.017.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Immunol 2010; 185:4977-82;  PMID:20962266; http://dx.doi.org/10.4049/jimmu- nol.1001323.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Cancer Immunol  Immunother 2003; 52:715-38; PMID:12920480;  http://dx.doi.org/10.1007/s00262-003-0409-4.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
PLoS One 2008; 3:e3409;  PMID:18923710; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Activated mouse B cells lack  expression of granzyme B. J Immunol 2012; 188:3886- 92; PMID:22427643; http://dx.doi.org/10.4049/jim- munol.1103285.45.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Immunol  2011; 187:6301-9; PMID:22084442; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
FEBS Lett 2004; 562:87-92; PMID:15044006; http://dx.doi.org/10.1016/S0014-5793(04)00187-5.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Biochem Biophys Res Commun 1994; 205:1318-24; PMID:7802664; http://dx.doi.org/10.1006/ bbrc.1994.2809.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
"Gross C, Koelch W, DeMaio A, Arispe N, Multhoff  G. Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific  binding and uptake of granzyme B. J Biol Chem  2003; 278:41173-81; PMID:12874291; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J T ransl Med 2007; 5:46;  PMID:17894866; http://dx.doi.org/10.1186/1479- 5876-5-46.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood 2012; 119:1407-17; PMID:22184405; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Direct proteasome-independent cross-presentation of viral antigen by  plasmacytoid dendritic cells on major histocompat- ibility complex class I. Nat Immunol 2008; 9:551-7;  PMID:18376401; http://dx.doi.org/10.1038/ni.1602.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Nat Med 2006; 12:207-13; PMID:16444266;  http://dx.doi.org/10.1038/nm1352.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Nat Med  2006; 12:214-9; PMID:16444265; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Biochim Biophys Acta  2004; 1659:178-89; PMID:15576050; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Tissue Antigens 2008; 71:409-16;  PMID:18331532; http://dx.doi.org/10.1111/j.1399- 0039.2008.01013.x.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Immunol Lett 2007; 111:57- 65; PMID:17604848; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Blood 2004; 104:2840- 8; PMID:15238416; http://dx.doi.org/10.1182/blood- 2004-03-0859.90.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Science  2008; 322:268-71; PMID:18845757; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
J Exp Med 1999; 190:815- 26; PMID:10499920; http://dx.doi.org/10.1084/ jem.190.6.815.,Non-OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
Mol Cell 2011; 44:265-78; PMID:22017873; http://dx.doi.org/10.1016/j.molcel.2011.07.037.,OADS,/arxiv_data1/oa_pdf/9b/8e/onci-1-1368.PMC3518509.pdf
"The  DBD forms a helix-turn-helix structure and recognizes a DNA sequence known as IFN-stimulated response element (ISRE) 13  which is characterized by the consensus sequence, 5'-AAN NGA  *Correspondence to: Tadatsugu Taniguchi; Email: tada@m.u-tokyo.ac.jp Submitted: 10/06/12; Accepted: 10/06/12http://dx.doi.org/10.4161/onci.22475Members of the interferon-regulatory factor ( irF) proteins  family were originally identified as transcriptional regulators  of the Type i interferon system.",OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cell 1988; 54:903-13; PMID:3409321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Natl Acad Sci U S A 1990; 87:3743- 7; PMID:2111015; http://dx.doi.org/10.1073/ pnas.87.10.3743.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Genes Dev 1995; 9:1377- 87; PMID:7797077; http://dx.doi.org/10.1101/ gad.9.11.1377.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Genes Dev 1989; 3:1362-71; PMID:2606351; http://dx.doi.org/10.1101/gad.3.9.1362.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nucleic Acids  Res 1995; 23:2127-36; PMID:7541907; http://dx.doi.org/10.1093/nar/23.12.2127.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Science 1996; 274:1739- 44; PMID:8939871; http://dx.doi.org/10.1126/sci- ence.274.5293.1739.10.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Annu Rev Immunol 2008; 26:535-84;  PMID:18303999; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Annu Rev Immunol 2001; 19:623-55;  PMID:11244049; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Science  1994; 264:1415-21; PMID:8197455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
EMBO J 1999; 18:5028-41; PMID:10487755; http://dx.doi.org/10.1093/emboj/18.18.5028.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Gene 1999; 237:1-14;  PMID:10524230; http://dx.doi.org/10.1016/S0378- 1119(99)00262-0.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Eur J Immunol 2007; 37:306- 9; PMID:17273997; http://dx.doi.org/10.1002/ eji.200637009.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nat Rev Immunol 2006; 6:644-58;  PMID:16932750; http://dx.doi.org/10.1038/nri1900.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cytokine Growth Factor  Rev 1997; 8:293-312; PMID:9620643; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem 2007; 282:20065-9; PMID:17502370;  http://dx.doi.org/10.1074/jbc.R700003200.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Biochimie 2007; 89:744-53; PMID:17399883; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer Immunol Immunother  2010; 59:489-510; PMID:20049431; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer Sci 2008; 99:467-78;  PMID:18190617; http://dx.doi.org/10.1111/j.1349- 7006.2007.00720.x.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nature 1996; 382:816-8; PMID:8752276;  http://dx.doi.org/10.1038/382816a0.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Oncogene  2002; 21:7776-85; PMID:12420214; http://dx.doi.org/10.1038/sj.onc.1205981.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cell  1994; 77:829-39; PMID:8004672; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nature 1995; 376:596-9; PMID:7637809;  http://dx.doi.org/10.1038/376596a0.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
EMBO  Rep 2002; 3:153-8; PMID:11818340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Biochem Biophys Res Commun 1999; 257:672- 7; PMID:10208842; http://dx.doi.org/10.1006/bbrc.1999.0276.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Immunity 2000; 13:539-48;  PMID:11070172; http://dx.doi.org/10.1016/S1074- 7613(00)00053-4.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Biochem Biophys  Res Commun 2010; 397:202-7; PMID:20501320;  http://dx.doi.org/10.1016/j.bbrc.2010.05.085.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Virol  2000; 74:3781-92; PMID:10729153; http://dx.doi.org/10.1128/JVI.74.8.3781-3792.2000.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
FASEB J 2001; 15:501-15;  PMID:11156966; http://dx.doi.org/10.1096/fj.00- 0222com.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Virol 2005; 79:9320- 4; PMID:15994827; http://dx.doi.org/10.1128/ JVI.79.14.9320-9324.2005.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Natl Acad Sci U S A 2007; 104:3402- 7; PMID:17360658; http://dx.doi.org/10.1073/ pnas.0611559104.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nature 2004; 428:341-5; PMID:15029200;  http://dx.doi.org/10.1038/nature02405.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem  1999; 274:30686-9; PMID:10521456; http://dx.doi.org/10.1074/jbc.274.43.30686.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Natl Acad Sci U S A 2002; 99:2818-23; PMID:11867762; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem  2003; 278:15272-8; PMID:12582166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Clin Cancer Res  2009; 15:2954-61; PMID:19383829; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Oncogene 2002; 21:6751-65; PMID:12360402;  http://dx.doi.org/10.1038/sj.onc.1205843.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Interferon Cytokine  Res 2005; 25:43-51; PMID:15684621; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Int J Cancer 1998;  77:522-7; PMID:9679752; http://dx.doi.org/10.1002/ (SICI)1097-0215(19980812)77:4<522::AID- IJC8>3.0.CO;2-W. 48.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Genes Chromosomes  Cancer 1998; 21:177-84; PMID:9523192; http://dx.doi.org/10.1002/(SICI)1098- 2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Ann Surg 2001; 233:623-9; PMID:11323500;  http://dx.doi.org/10.1097/00000658-200105000- 00005.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Breast  Cancer Res T reat 2010; 121:227-31; PMID:19697121;  http://dx.doi.org/10.1007/s10549-009-0509-8.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
T umour Biol 2012; 33:247-55; PMID:22119988;  http://dx.doi.org/10.1007/s13277-011-0273-3.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Oncogene 2005; 24:7327-36; PMID:16007130;  http://dx.doi.org/10.1038/sj.onc.1208877.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nature 1995; 377:362-5; PMID:7566094; http://dx.doi.org/10.1038/377362a0.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem 1998; 273:194- 9; PMID:9417064; http://dx.doi.org/10.1074/ jbc.273.1.194.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem  2003; 278:25401-7; PMID:12738767; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Biochem J 2009; 418:575-85; PMID:19032150;  http://dx.doi.org/10.1042/BJ20082087.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Cell Biochem 2002; 85:369-80; PMID:11948692;  http://dx.doi.org/10.1002/jcb.10142.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Int J Cancer 2003; 104:400-8; PMID:12584735;  http://dx.doi.org/10.1002/ijc.10956.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Lysyl oxidase inhibits ras-mediated transformation  by preventing activation of NF-κ B. Mol Cell Biol  2003; 23:2251-63; PMID:12640111; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer Lett 1994; 83:191- 6; PMID:8062214; http://dx.doi.org/10.1016/0304-3835(94)90318-2.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Genes Dev  1999; 13:1240-5; PMID:10346812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Natl Acad Sci U S A 2007; 104:17028- 33; PMID:17942705; http://dx.doi.org/10.1073/ pnas.0609852104.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Br J Haematol 2002; 119:46-53; PMID:12358902; http://dx.doi.org/10.1046/j.1365- 2141.2002.03829.x.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Oncogene  1997; 15:1275-81; PMID:9315094; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J  Biol Chem 2011; 286:14291-303; PMID:21245151;  http://dx.doi.org/10.1074/jbc.M110.204602.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Science 1993; 259:968-71; PMID:8438156; http://dx.doi.org/10.1126/sci- ence.8438156.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Gastroenterology 1996; 110:52-7;  PMID:8536888; http://dx.doi.org/10.1053/gast.1996.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Blood 2001; 97:3648-50; PMID:11369663;  http://dx.doi.org/10.1182/blood.V97.11.3648.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nucleic Acids Res 2005; 33:6895-905; PMID:16396836; http://dx.doi.org/10.1093/nar/ gki1001.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Blood  2001; 97:3491-7; PMID:11369642; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Immunity 2007; 27:228-39;  PMID:17702615; http://dx.doi.org/10.1016/j.immu- ni.2007.06.009.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer Res 2011; 71:2882-91; PMID:21487040;  http://dx.doi.org/10.1158/0008-5472.CAN-10-2493.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem  2008; 283:7921-35; PMID:18195016; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer  Res 2007; 67:3301-9; PMID:17409439; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Oncogene 2008; 27:5267-76; PMID:18469857; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Genes Dev 1990; 4:1753-65; PMID:2249773;  http://dx.doi.org/10.1101/gad.4.10.1753.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nature 2003; 424:516- 23; PMID:12872134; http://dx.doi.org/10.1038/ nature01850.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Natl Acad Sci U  S A 1997; 94:7227-32; PMID:9207073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nat Genet 2006; 38:1329-34;  PMID:17041603; http://dx.doi.org/10.1038/ng1894.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Clin Invest  2010; 120:1570-7; PMID:20424325; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
EMBO J 2011; 30:4571- 85; PMID:21909072; http://dx.doi.org/10.1038/emboj.2011.325.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cell Cycle 2008; 7:1925-30; PMID:18604160; http://dx.doi.org/10.4161/cc.7.13.6221.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Mol Cell Biol  2008; 28:2235-43; PMID:18212048; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nat Med 2012; In Press; PMID:22820642;  http://dx.doi.org/10.1038/nm.2830.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
PLoS One 2011; 6:e28683;  PMID:22194884; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cell  1996; 87:307-17; PMID:8861914; http://dx.doi.org/10.1016/S0092-8674(00)81348-3.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Blood  2004; 103:3480-9; PMID:14656881; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem 2007; 282:5633-40; PMID:17189268;  http://dx.doi.org/10.1074/jbc.M607825200.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Blood 2003; 102:4547-54;  PMID:12933588; http://dx.doi.org/10.1182/blood- 2003-01-0291.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Mol Cell Biol 2000; 20:1149-61; PMID:10648600;  http://dx.doi.org/10.1128/MCB.20.4.1149- 1161.2000.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Leukemia 2009; 23:574- 80; PMID:18987657; http://dx.doi.org/10.1038/ leu.2008.320.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Leukemia 2008; 22:441- 5; PMID:17690696; http://dx.doi.org/10.1038/sj.leu.2404895.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nature 2008; 454:226-31; PMID:18568025; http://dx.doi.org/10.1038/nature07064.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Biochem Biophys Res Commun 1999; 260:329-31; PMID:10403770;  http://dx.doi.org/10.1006/bbrc.1999.0911.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer Cell 2012; 21:723-37; PMID:22698399;  http://dx.doi.org/10.1016/j.ccr.2012.05.024.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
PLoS One 2011; 6:e22628; PMID:21818355;  http://dx.doi.org/10.1371/journal.pone.0022628.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
PLoS  One 2009; 4:e5500; PMID:19430534; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cancer Res 2005; 65:7403-12; PMID:16103093; http://dx.doi.org/10.1158/0008-5472.CAN-05-0583.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Natl Acad Sci U S A 2008; 105:2556- 61; PMID:18268344; http://dx.doi.org/10.1073/ pnas.0712295105.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nat Genet 2006; 38:1335-40;  PMID:17041601; http://dx.doi.org/10.1038/ng1903.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nat Rev Cancer  2002; 2:342-50; PMID:12044010; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem  2000; 275:6764-9; PMID:10702232; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Genes Dev 1998; 12:2061-72; PMID:9649509;  http://dx.doi.org/10.1101/gad.12.13.2061.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Mol Biol Evol  2009; 26:2539-50; PMID:19638535; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Nat Immunol  2011; 12:715-23; PMID:21772280; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Mol Cell Biol  2000; 20:8254-63; PMID:11027294; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Virol 2007; 81:8282-92; PMID:17522209;  http://dx.doi.org/10.1128/JVI.00235-07.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem 2009; 284:8525-38; PMID:19129183;  http://dx.doi.org/10.1074/jbc.M809252200.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Proc Assoc Am Physicians  1999; 111:573-80; PMID:10591086; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Mol Cell Biol  2008; 28:6536-46; PMID:18710948; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Biol Chem 2004; 279:36570- 8; PMID:15215253; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
EMBO J  2008; 27:2147-57; PMID:18636090; http://dx.doi.org/10.1038/emboj.2008.143.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Cell Res 2006; 16:141-7; PMID:16474426;  http://dx.doi.org/10.1038/sj.cr.7310019.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
J Virol 2002; 76:9545- 50; PMID:12186937; http://dx.doi.org/10.1128/ JVI.76.18.9545-9550.2002.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Immunity 2005; 22:59-70;  PMID:15664159; http://dx.doi.org/10.1016/j.immu- ni.2004.11.011.,OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
Curr Top Microbiol  Immunol 2007; 312:185-209; PMID:17089798;  http://dx.doi.org/10.1007/978-3-540-34344-8_7.,Non-OADS,/arxiv_data1/oa_pdf/ef/fa/onci-1-1376.PMC3518510.pdf
"www.landesbioscience.com OncoImmunology 1387OncoImmunology 1:8, 1387–1389; November 2012; © 2012 Landes Bioscience POINt-Of-VIew POINt-Of-VIew Keywords:  adoptive cell therapy, cancer  stem cell, chimeric antigen receptor,   pancreas adenocarcinoma, T cell Abbreviations:  ACT, adoptive cell  therapy; CAR, chimeric antigen receptor;  CEA, carcinoembryonic antigen Submitted: 08/30/12Revised: 09/07/12Accepted: 09/11/12http://dx.doi.org/10.4161/onci.22195 *Correspondence to: Hinrich Abken;   Email: hinrich.abken@uk-koeln.deDespite intensive treatment, pancre - atic adenocarcinoma still has the  worst prognosis among all malignan - cies.",Non-OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
Handb Exp Pharmacol  2008; 181:329-42; PMID:18071952; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849.,OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
Trends Mol Med  2012; 18:377-84; PMID:22613370; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
"Gastroenterology 2012;  143:1095-107, e2; PMID:22750462; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
Mol Ther 2011; 19:620-6; PMID:21157437;  http://dx.doi.org/10.1038/mt.2010.272.8.,OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
Gene Ther  1999; 6:300-4; PMID:10435115; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
Gene Ther 2012; In  Press; PMID:22378346; http://dx.doi.org/10.1038/ gt.2012.21.,OADS,/arxiv_data1/oa_pdf/75/74/onci-1-1387.PMC3518511.pdf
"Dimitrov Protein Interactions Group; FNLC r; NIh; Frederick, MD us A Keywords:  cancer target, therapeutic antibodies, chimeric antibody receptor, germline antibodies *Correspondence to: Yang Feng; Email: fengya@mail.nih.gov Submitted: 05/21/12; Accepted: 05/30/12http://dx.doi.org/10.4161/onci.20925IR and HR.",Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Ann Oncol 2012; PMID:22234739; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Mol Cancer Ther 2012; 11:649-59;  PMID:22188815; http://dx.doi.org/10.1158/1535-7163.MCT-11-0575.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Clin  Cancer Res 2012; 18:2625-31; PMID:22465830;  http://dx.doi.org/10.1158/1078-0432.CCR-12-0061.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
J Clin Oncol 2011; 29:4541-7; PMID:22025149; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Mol Cancer Ther 2006; 5:114-20; PMID:16432169;  http://dx.doi.org/10.1158/1535-7163.MCT-05-0252.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Mol Cancer Ther 2010; 9:1809-19;  PMID:20515953; http://dx.doi.org/10.1158/1535- 7163.MCT-09-1134.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Cancer Res  2011; 71:1029-40; PMID:21245093; http://dx.doi.org/10.1158/0008-5472.CAN-10-2274.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Mol Cancer Ther 2011; 10:1677-85; PMID:21750218;  http://dx.doi.org/10.1158/1535-7163.MCT-11-0281.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
Ann Hematol 1998; 76:231-48; PMID:9692811; http://dx.doi.org/10.1007/ s002770050396.,Non-OADS,/arxiv_data1/oa_pdf/e3/45/onci-1-1390.PMC3518512.pdf
"The use of DCs loaded with full-length tumor antigens (TAs) overcomes the first Overcoming HLA restriction in clinical trials Immune monitoring of mRNA-loaded DC therapy An M. t. Van Nuffel,1 sofie w ilgenhof,2 Kris t hielemans1,2 and Aude Bonehill1,* 1Laboratory of Molecular and Cellular t herapy; Department of Immunology-Physiology; Medical s chool of the Vrije u niversiteit Brussel (V uB); Brussels, Belgium;   2Department of Medical Oncology; u niversitair Ziekenhuis Brussel; Brussels, Belgium Keywords:  dendritic cells, immune monitoring, DC-therapy, skin infiltrating lymphocytes, HLA restriction *Correspondence to: Aude Bonehill; Email: aude.bonehill@vub.ac.be Submitted: 05/22/12; Accepted: 05/30/12http://dx.doi.org/10.4161/onci.20926issue.1,2 We addressed the second issue and  we explored the immunologic potential  of mRNA-modified DC therapy in mela - noma patients.",Non-OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
Cancer Res 2012; 72:1661-71; PMID:22337996;  http://dx.doi.org/10.1158/0008-5472.CAN-11-2957.5.,Non-OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
J Immunol Methods  2012; 377:23-36; PMID:22269772; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
J Clin Oncol 2005; 23:5779-87; PMID:16110035; http://dx.doi.org/10.1200/ JCO.2005.06.478.,Non-OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
Mol Ther 2012; 20:1063-74;  PMID:22371843; http://dx.doi.org/10.1038/ mt.2012.11.References 1.,OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
Proc Natl Acad Sci USA  2010; 107:13824-9; PMID:20631300; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
J  Immunother 2011; 34:448-56; PMID:21577140; http://dx.doi.org/10.1097/CJI.0b013e31821dcb31.,Non-OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
Science 2003; 299:1033-6; PMID:12532024; http://dx.doi.org/10.1126/sci- ence.1078231.,OADS,/arxiv_data1/oa_pdf/87/96/onci-1-1392.PMC3518513.pdf
"5 Synergism between intratumoral  TNFα and chemotherapy has been attrib - uted to increased vascular permeability, Intratumoral TNFα improves immunotherapy Anna Johansson,1 Juliana h amzah2 and r uth Ganss1,* 1western Australian Institute for Medical r esearch; u niversity of w estern Australia Centre for Medical r esearch; Laboratory for Cancer Medicine; Perth, w A Australia;   2Burnham Institute for Medical r esearch; u niversity of California; Department of Molecular, Cellular and Developmental Biology; s anta Barbara, CA us A Keywords:  immune therapy, stroma reprogramming, vessel remodeling Abbreviations:  Ang2, angiopoietin 2; HGR, histidine-rich glycoprotein; IFN γ, interferon γ; IL-6, interleukin 6; iNOS, inducible  nitric oxide; MCP1, monocyte chemotactic protein 1; Tag, SV40 large T antigen; RIP, rat insulin gene promoter; TNF α, tumor  necrosis factor α; VCAM, vascular cell adhesion molecule *Correspondence to: Ruth Ganss; Email: ganss@waimr.uwa.edu.au Submitted: 05/31/12; Accepted: 06/02/12http://dx.doi.org/10.4161/onci.20981but analyses of stromal effects in vivo have  so far been limited.6 Moreover, the role of  TNFα as an adjuvant to immunotherapy  has not been explored until recently.7 Our work demonstrated that tumor- targeted TNF α has profound effects on  the tumor microenvironment by stabiliz - ing blood vessels and potentiating immu - notherapy.8 TNF α was conjugated to a  vascular homing peptide which specifi - cally binds to angiogenic tumor vessels in a murine model of pancreatic endocrine tumors (RIPTag, expression of the SV40 Large T antigen by the rat insulin gene promoter).",Non-OADS,/arxiv_data1/oa_pdf/29/07/onci-1-1395.PMC3518514.pdf
Cancers 2012; 4:340-53;  http://dx.doi.org/10.3390/cancers4020340.,Non-OADS,/arxiv_data1/oa_pdf/29/07/onci-1-1395.PMC3518514.pdf
J Immunol 2012; 188:2687-94; PMID:22323546;  http://dx.doi.org/10.4049/jimmunol.1101877.,Non-OADS,/arxiv_data1/oa_pdf/29/07/onci-1-1395.PMC3518514.pdf
Proc Natl Acad Sci USA  2012; 109:7841-6; PMID:22547817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/07/onci-1-1395.PMC3518514.pdf
Cancer Res 2010; 70:6171-80;  PMID:20631075; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0153.10.,Non-OADS,/arxiv_data1/oa_pdf/29/07/onci-1-1395.PMC3518514.pdf
Immunol Cell Biol 2006; 84:383-9;  PMID:16834573; http://dx.doi.org/10.1111/j.1440- 1711.2006.01448.x.,Non-OADS,/arxiv_data1/oa_pdf/29/07/onci-1-1395.PMC3518514.pdf
"In addition, because vac - cine-induced immunity is durable, strong and distinct in its mechanism, vaccines are Targeting dendritic cells in situ for breast cancer  immunotherapy Bei wang Laboratory of Cellular Physiology and Immunology and Chris Browne Center of Immunology and Immune Disease; t he r ockefeller u niversity; New York, NY us A Keywords:  dendritic cell targeting, DEC205, protein vaccine, breast cancer, HER2 Correspondence to: Bei Wang; Email: bwang@rockefeller.edu Submitted: 05/31/12; Accepted: 06/02/12http://dx.doi.org/10.4161/onci.20982a logical way to improve resistance to the  development of (micro)metastasis.",Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
Nat Rev Cancer  2009; 9:463-75; PMID:19536107; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
Nat Rev Immunol 2007; 7:790-802;  PMID:17853902; http://dx.doi.org/10.1038/nri2173.3.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
Nature  1995; 375:151-5; PMID:7753172; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
J Intern Med 2012; 271:183-92;  PMID:22126373; http://dx.doi.org/10.1111/j.1365- 2796.2011.02496.x.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
J Immunol 2012; 188:1147-55; PMID:22210914;  http://dx.doi.org/10.4049/jimmunol.1102541.8.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
Breast Cancer Res 2012; 14:39;  PMID:22397502; http://dx.doi.org/10.1186/bcr3135.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
Semin Immunol  2009; 21:185-93; PMID:19502082; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/71/onci-1-1398.PMC3518515.pdf
"Chang2 and Qiao Li2,* 1Department of Internal Medicine; u niversity of Michigan; Ann Arbor, MI us A; 2Department of s urgery; u niversity of Michigan; Ann Arbor, MI us A Keywords:  cancer stem cells, dendritic-cell vaccines, immunotherapy Abbreviations:  CSC, cancer stem cell; DC, dendritic cell; ALDH, aldehyde dehydrogenase *Correspondence to: Qiao Li; Email: qiaoli@umich.edu Submitted: 05/31/12; Accepted: 06/06/12http://dx.doi.org/10.4161/onci.21026immunocompetent mice: the D5 mela - noma growing in C57BL/6 mice and the  SCC7 squamous cell carcinoma growing in C3H mice.",Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Nature 2008; 451:345- 9; PMID:18202660; http://dx.doi.org/10.1038/ nature06489.2.,OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Nature 2010; 466:133-7; PMID:20596026;  http://dx.doi.org/10.1038/nature09161.3.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Head Neck  2010; 32:1195-201; PMID:20073073; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Clin Cancer Res 2011; 17:6174-84;  PMID:21856769; http://dx.doi.org/10.1158/1078- 0432.CCR-11-1111.7.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Cancer Res  2012; 72:1853-64; PMID:22473314; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Cell Stem  Cell 2007; 1:555-67; PMID:18371393; http://dx.doi.org/10.1016/j.stem.2007.08.014.4.,OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Nat Rev Cancer 2008; 8:755-68;  PMID:18784658; http://dx.doi.org/10.1038/nrc2499.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
Cancer Res 2008; 68:3243-50;  PMID:18451150; http://dx.doi.org/10.1158/0008- 5472.CAN-07-5480.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
J Clin Invest 2010; 120:485-97; PMID:20051626; http://dx.doi.org/10.1172/ JCI39397.,Non-OADS,/arxiv_data1/oa_pdf/4c/35/onci-1-1401.PMC3518516.pdf
"6 In  our hands, TRAMP mice developed pal - pable tumors between weeks 20 and 30 of life, which was significantly delayed in both the S100A9 −/− and TLR4−/− background.7  When we investigated S100A9 expression in prostate tumors, we noted that while S100A9 was barely absent in nonmalignant prostate tissue, it was readily detectable in S100A9 and tumor growth tomas Leanderson* and Fredrik Ivars Immunology Group; Lund u niversity; Lund, s weden Keywords:  S100A9, TLR4, cancer, TGF, myeloid cells *Correspondence to: Tomas Leanderson; Email: tomas.leanderson@med.lu.se Submitted: 06/01/12; Accepted: 06/06/12http://dx.doi.org/10.4161/onci.21027prostate tumors and, interestingly, often  associated with myeloid rather than tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Proc Natl Acad Sci U S  A 1995; 92:3439-43; PMID:7724580; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
PLoS One 2012; 7:34207;  PMID:22470535; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Cell 2008; 134:215-30; PMID:18662538; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Carcinogenesis 2008; 29:2035-43;  PMID:18689872; http://dx.doi.org/10.1093/carcin/ bgn188.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Immunology 2012; 137(2):172-82; PMID:22804476;  http://dx.doi.org/10.1111/j.1365-2567.2012.03619.x.3.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Clin Cancer Res  2005; 11:5146-52; PMID:16033829; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Mol Cancer 2010; 9:107; PMID:20470445; http://dx.doi.org/10.1186/1476-4598-9-107.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
J Clin Oncol 2011; 29:4022-8; PMID:21931019;  http://dx.doi.org/10.1200/JCO.2011.35.6295.constitute a new appraoch to anticancer  therapy ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
PLoS Biol 2009;  7:97; PMID:19402754; http://dx.doi.org/10.1371/ journal.pbio.1000097.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
Arthritis Rheum  2004; 50:3762-71; PMID:15593206; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/onci-1-1404.PMC3518517.pdf
"Mitsiades* Department of Medical Oncology; Dana-Farber Cancer Institute; Boston, MA us A; Department of Medicine; h arvard Medical s chool; Boston, MA us A Keywords:  pharmacological immunomodulators, high-throughput screening, cancer, immune effector cells, tumor heterogeneity *Correspondence to: Constantine S. Mitsiades; Email: Constantine_Mitsiades@dfci.harvard.edu Submitted: 05/17/12; Accepted: 06/08/12http://dx.doi.org/10.4161/onci.21058target but enhancing it against others.",Non-OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Genes Dev 2011; 25:2559-72;  PMID:22190457; http://dx.doi.org/10.1101/ gad.169029.111.,OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Nat Rev Clin Oncol 2011; 8:151-60; PMID:21364688;  http://dx.doi.org/10.1038/nrclinonc.2010.223.4.,Non-OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Blood  2008; 112:4364-5; PMID:19029450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Expert Rev Anticancer Ther 2006; 6:1165-73; PMID:16925483;  http://dx.doi.org/10.1586/14737140.6.8.1165.,Non-OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Expert Opin Investig Drugs 2006;  15:171-9; PMID:16433596; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Nat Med 2010; 16:483- 9; PMID:20228816; http://dx.doi.org/10.1038/ nm.2112.,OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
Blood 2012; 119:131-8; PMID:22289890;  http://dx.doi.org/10.1182/blood-2011-04-348490.,Non-OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
J Clin Invest 2008;  118:1991-2001; PMID:18523649; http://dx.doi.org/10.1172/JCI35180.,Non-OADS,/arxiv_data1/oa_pdf/db/60/onci-1-1406.PMC3518518.pdf
"Lee* Laboratory of Pathology; National Cancer Institute; NI h; Bethesda, MD us A Keywords:  NY-ESO-1, immunotherapy, sarcomas, synovial sarcoma, melanoma, cancer-testis antigen, diagnostic marker,  clinical trial, therapeutic target, T-cell receptor *Correspondence to: Chyi-Chia R. Lee; Email: leechy@mail.nih.gov Submitted: 06/04/12; Accepted: 06/08/12http://dx.doi.org/10.4161/onci.21059patients with malignant melanoma  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/55/be/onci-1-1409.PMC3518519.pdf
Br J Cancer 2001; 85:713- 20; PMID:11531257; http://dx.doi.org/10.1054/ bjoc.2001.1974.,Non-OADS,/arxiv_data1/oa_pdf/55/be/onci-1-1409.PMC3518519.pdf
J Clin Oncol 2011; 29:917- 24; PMID:21282551; http://dx.doi.org/10.1200/ JCO.2010.32.2537.,Non-OADS,/arxiv_data1/oa_pdf/55/be/onci-1-1409.PMC3518519.pdf
Mod Pathol 2012; 25:854- 8; PMID:22388761; http://dx.doi.org/10.1038/mod- pathol.2012.31.,Non-OADS,/arxiv_data1/oa_pdf/55/be/onci-1-1409.PMC3518519.pdf
Proc Natl Acad Sci USA 1997; 94:1914- 8; PMID:9050879; http://dx.doi.org/10.1073/ pnas.94.5.1914.,OADS,/arxiv_data1/oa_pdf/55/be/onci-1-1409.PMC3518519.pdf
Cancer Chemother Pharmacol  2000; 46:46-51; PMID:10950148; http://dx.doi.org/10.1007/PL00014050.,Non-OADS,/arxiv_data1/oa_pdf/55/be/onci-1-1409.PMC3518519.pdf
"This apparent inefficacy may be attributed to the fact that the pro-tumorigenic effects Hedgehog-targeted therapeutics uncouple   the vicious cycle of bone metastasis Michelle A. h urchla and Katherine N. w eilbaecher Department of Medicine; Division of Oncology; w ashington u niversity s chool of Medicine; s t. Louis, MO us A Keywords:  bone metastasis, hedgehog, osteoclast, SMO antagonist, sonic hedgehog, tumor microenvironment Correspondence to: Michelle A. Hurchla and Katherine N. Weilbaecher; Email: mhurchla@dom.wustl.edu and kweilbae@dom.wustl.edu Submitted: 06/04/12; Accepted: 06/08/12http://dx.doi.org/10.4161/onci.21060of Hh signaling in many settings is a result  of enhanced paracrine stimulation of host components, rather than of direct effects on malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Nat  Rev Drug Discov 2012; 11:437-8; PMID:22653209; http://dx.doi.org/10.1038/nrd3753.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Cancer Res 2009; 69:6007-10;  PMID:19638582; http://dx.doi.org/10.1158/0008-5472.CAN-09-0756.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Cancer Res 2012; 72:897-907;  PMID:22186138; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2681.5.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
J Biol Chem  2012; 287:20037-46; PMID:22532569; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Cancer Res 2006; 66:7548-53;  PMID:16885353; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0452.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Mol Cancer 2012; 11:30; PMID:22559324;  http://dx.doi.org/10.1186/1476-4598-11-30.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Nat Rev Cancer 2011; 11:411- 25; PMID:21593787; http://dx.doi.org/10.1038/ nrc3055.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
Clin Cancer Res 2010;  16:3130-40; PMID:20530699; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/e0/onci-1-1411.PMC3518520.pdf
"5 Using only 54 of the patients, we  identified a panel of 26 genes that could The peripheral immune response   and lung cancer prognosis Michael K. s howe, Andrew V. Kossenkov and Louise C. s howe* the w istar Institute; Philadelphia, PA us A Keywords:  lung cancer, prognosis, survival, gene expression, PBMC, T cell, myeloid, NSCLC Abbreviations:  NSCLC, non-small cell lung cancer; PBMC, peripheral blood mononuclear cells; miRNA, microRNA;   HR, hazard ratio *Correspondence to: Louise C. Showe; Email: lshowe@wistar.org Submitted: 06/05/12; Accepted: 06/11/12http://dx.doi.org/10.4161/onci.21096be used to predict survival.",Non-OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
Clin Cancer Res 2009; 15:284-90;  PMID:19118056; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1258.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
Semin Cancer  Biol 2006; 16:53-65; PMID:16168663; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
PLoS One 2012; 7:e34392;  PMID:22479623; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
Oncogene 2004; 23:6621- 9; PMID:15208666; http://dx.doi.org/10.1038/ sj.onc.1207861.References 1.,OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
Pharmacogenomics 2006;  7:187-202; PMID:16515398; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
J  Natl Cancer Inst 2010; 102:464-74; PMID:20233996;  http://dx.doi.org/10.1093/jnci/djq025.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/onci-1-1414.PMC3518521.pdf
"Grekova,* Jean r ommelaere and Zahari r aykov Programme Infection and Cancer; t umour Virology Division F010 and Institut National de la s anté et de la r echerche Médicale (IN serM; u nit 701;   German Cancer r esearch Center (DKFZ); h eidelberg, Germany Keywords:  oncolytic viruses, parvoviruses, immune response Abbreviations:  DC, dendritic cell; DLN, draining lymph nodes; hpi, hours post infection; IS, immune system;   ICD, immunogenic cell death; MVMp, minute virus of mice; OVs, oncolytic viruses; PDAC, pancreatic ductal adenocarcinoma;   PBMC, peripheral blood mononuclear cell; PVs, parvoviruses *Correspondence to: Svitlana Grekova; Email: s.grekova@dkfz.de Submitted: 06/08/12; Accepted: 06/11/12http://dx.doi.org/10.4161/onci.21097late secreion of interferon γ  (IFN γ) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Cytokine Growth Factor Rev  2010; 21:185-95; PMID:20211577; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Int J Cancer 2011; 128:908- 19; PMID:20473905; http://dx.doi.org/10.1002/ ijc.25415.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Int J Cancer  2008; 122:2880-4; PMID:18360875; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
J Virol 2005; 79:3517- 24; PMID:15731246; http://dx.doi.org/10.1128/ JVI.79.6.3517-3524.2005.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Hum  Gene Ther 2005; 16:996-1005; PMID:16076257;  http://dx.doi.org/10.1089/hum.2005.16.996.3.,OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Cancer Gene Ther 2012; PMID:22539062;  http://dx.doi.org/10.1038/cgt.2012.20.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Cancer Gene Ther 2002; 9:432-42; PMID:11961666;  http://dx.doi.org/10.1038/sj.cgt.7700457.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
Clin Cancer  Res 2009; 15:511-9; PMID:19147756; http://dx.doi.org/10.1158/1078-0432.CCR-08-1088.,Non-OADS,/arxiv_data1/oa_pdf/85/d5/onci-1-1417.PMC3518522.pdf
"MCPyV DNA is clonally integrated into the genome of MCC cells, yet contains mutations that Tumor-infiltrating lymphocytes and outcome in  Merkel cell carcinoma, a virus-associated cancer harri s ihto1 and h eikki Joensuu1,2,* 1Laboratory of Molecular Oncology and Molecular Cancer Biology Program; u niversity of h elsinki; h elsinki, Finland;   2Department of Oncology; h elsinki u niversity Central h ospital; h elsinki, Finland Keywords:  cytotoxic T cells, Merkel cell carcinoma, Merkel cell polyomavirus, survival, tumor-infiltrating lymphocytes Abbreviations:  CTLA-4, cytotoxic T-lymphocyte-associated protein 4; MCC, Merkel cell carcinoma; MCPyV, Merkel cell  polyomavirus; PD-1, programmed death-1; VP, viral capsid protein *Correspondence to: Heikki Joensuu; Email: heikki.joensuu@hus.fi Submitted: 05/29/12; Accepted: 06/13/12http://dx.doi.org/10.4161/onci.21120prevent viral replication, possibly reduc - ing the lethality of MCPyV infection  to host cells.2,3 The circulating levels of  anti-MCPyV IgG antibodies recogniz - ing the MCPyV viral capsid proteins VP1 and VP2 are higher in MCC patients as compared with the unaffected individu - als, and MCC tissues contain more viral DNA than tissues from healthy individu - als or patients with other types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Science 2008; 319:1096-100; PMID:18202256;  http://dx.doi.org/10.1126/science.1152586.,OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Curr Oncol  Rep 2011; 13:488-97; PMID:21953511; http://dx.doi.org/10.1007/s11912-011-0197-5.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Clin Cancer Res 2011; 17:4806-13;  PMID:21642382; http://dx.doi.org/10.1158/1078-0432.CCR-10-3363.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
J Virol 2010; 84:7064-72; PMID:20444890;  http://dx.doi.org/10.1128/JVI.02400-09.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
J Invest Dermatol 2009; 129:1547- 55; PMID:19020549; http://dx.doi.org/10.1038/ jid.2008.365.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Clin Cancer Res  2012; 18:1227-36; PMID:22261808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Cancer Res  2010; 70:8388-97; PMID:20959478; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Clin Cancer Res 2012; 18:2872-81;  PMID:22467679; http://dx.doi.org/10.1158/1078-0432.CCR-11-3020.,Non-OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
Nature 2006; 439:682-7; PMID:16382236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/61/onci-1-1420.PMC3518523.pdf
"wurz,1 Audrey Gutierrez1 and Michael w olf2 1Department of Internal Medicine; Division of h ematology and Oncology; u niversity of California, Davis; s acramento, CA us A; 2Department of ImmunoOncology;   Merck- serono; Darmstadt, Germany Keywords:  L-BLP25, Letrozole, breast cancer, MMT model, Tamoxifen *Correspondence to: Michael DeGregorio; Email: mwdegregorio@ucdavis.edu Submitted: 05/31/12; Revised: 06/08/12; Accepted: 06/13/12http://dx.doi.org/10.4161/onci.21129hyperplasia, adenoma, early carcinoma  and late carcinoma.2 These stages are com - parable to those observed in human benign or in situ proliferative and invasive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
Cancer Immunol Immunother 1989;  29:17-22; PMID:2706637; http://dx.doi.org/10.1007/ BF00199911.,Non-OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
J Natl Cancer Inst 2012;  104:599-613; PMID:22395641; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
Curr Med Chem 2009;  16:3076-80; PMID:19689284; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
Exp Gerontol 2009; 44:398-405; PMID:19298850;  http://dx.doi.org/10.1016/j.exger.2009.03.003.,OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
Clin Cancer Res 2012; 18:2861- 71; http://dx.doi.org/10.1158/1078-0432.CCR-12- 0168; PMID:22434666.,Non-OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
Am J Pathol  2003; 163:2113-26; PMID:14578209; http://dx.doi.org/10.1016/S0002-9440(10)63568-7.,Non-OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
Sci Signal 2008; 1:pe35; PMID:18612140;  http://dx.doi.org/10.1126/scisignal.127pe35.,OADS,/arxiv_data1/oa_pdf/41/c3/onci-1-1422.PMC3518524.pdf
"The HSP90 HSP90 inhibitor antagonizing MIF The specifics of pleiotropic cancer drug candidates ramona s chulz, Matthias Dobbelstein and u te M. Moll* Department of Molecular Oncology; Göttingen Center of Molecular Biosciences; u niversity of Göttingen; Göttingen, Germany Keywords:  MIF, HSP90 inhibitors, breast cancer, client, CHIP *Correspondence to: Ute M. Moll; Email: utemarthamoll@gmail.com Submitted: 05/29/12; Accepted: 06/19/12http://dx.doi.org/10.4161/onci.21173complex drives the correct folding of  nascent client proteins, normally protect - ing them from aggregation or assisting their proteasome-mediated degradation if they become irreversibly damaged.",Non-OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
Nat Rev Mol Cell Biol 2010; 11:515- 28; PMID:20531426; http://dx.doi.org/10.1038/ nrm2918.,OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
Nat Rev Cancer 2010; 10:537-49; PMID:20651736; http://dx.doi.org/10.1038/nrc2887.,Non-OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
Mol Cancer Res 2011; 9:577-88; PMID:21478269;  http://dx.doi.org/10.1158/1541-7786.MCR-10-0534.4.,Non-OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
Clin Cancer Res 2011; 17:5132-9; PMID:21558407;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0072.,Non-OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
J Exp Med 2012; 209:275-89; PMID:22271573; http://dx.doi.org/10.1084/ jem.20111117.7.,Non-OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
Cell Cycle  2007; 6:1030-4; PMID:17426455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
Immunity 2007; 26:281-5; PMID:17376392;  http://dx.doi.org/10.1016/j.immuni.2007.03.005.,OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
J Biol Chem 2003; 278:11078-85; PMID:12538581;  http://dx.doi.org/10.1074/jbc.M211985200.,OADS,/arxiv_data1/oa_pdf/3a/05/onci-1-1425.PMC3518525.pdf
"1 Such  a differential expression/function in the tumor microenvironment makes RTKs Shock block for improved immunotherapy Aparna r ao, Devin B. Lowe and w alter J. s torkus* Department of Immunology; u niversity of Pittsburgh s chool of Medicine; Pittsburgh, PA us A; Department of Dermatology; u niversity of Pittsburgh s chool of Medicine;  Pittsburgh, PA us A Keywords:  heat shock protein, adoptive immunotherapy, antigen presentation, tumor microenvironment, vaccine *Correspondence to: Walter J. Storkus; Email: storkuswj@upmc.edu Submitted: 06/13/12; Accepted: 06/19/12http://dx.doi.org/10.4161/onci.21174attractive targets for anticancer therapeu - tic interventions.",Non-OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
Clin Cancer Res 2011; 17:1561-70;  PMID:21278242; http://dx.doi.org/10.1158/1078- 0432.CCR-10-1927.,Non-OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
J Natl Cancer  Inst 2004; 96:980-1; PMID:15240773; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
Nat Rev Cancer 2005; 5:761-72;  PMID:16175177; http://dx.doi.org/10.1038/nrc1716.References 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
Curr Pharm Des 2002; 8:1959-72; PMID:12171522;  http://dx.doi.org/10.2174/1381612023393530.,Non-OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
Biochem Biophys Res Commun 2002; 296:214-20;  PMID:12147253; http://dx.doi.org/10.1016/S0006- 291X(02)00806-9.,OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
J Clin Oncol 2003;  21(Suppl):175s-86s; PMID:12743132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/2f/onci-1-1427.PMC3518526.pdf
"2 However, this model has been  challenged by the observation that effi - cient memory CTL responses require CD40 expression on CD8 + T cells but not A new dynamic model of three cell interactions  for CTL responses Khawaja Ashfaque Ahmed, Lu w ang and Jim Xiang* research u nit; s askatchewan Cancer Agency; s askatoon, s K Canada; Department of Oncology; u niversity of s askatchewan; s askatoon, s K Canada Keywords:  CD4 help, CD40-CD40L, CTL response, dendritic cells, two-photon *Correspondence to: Jim Xiang; Email: jim.xiang@saskcancer.ca Submitted: 06/16/12; Accepted: 06/19/12http://dx.doi.org/10.4161/onci.21175on DCs,3 highlighting the importance of  direct CD4+-CD8+ T-cell interactions in  the development of memory CTLs.",Non-OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
Eur J Immunol  1987; 17:1579-83; PMID:2445585; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
Nature 1998; 393:474-8;  PMID:9624003; http://dx.doi.org/10.1038/30989.,Non-OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
Science 2002; 297:2060-3;  PMID:12242444; http://dx.doi.org/10.1126/sci- ence.1072615.,OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
Science  1999; 286:952-4; PMID:10542149; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
Eur J Immunol  2010; 40:3450-7; PMID:21080375; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
J Leukoc Biol 2012; PMID:22544940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
Immunity 2009; 31:859- 71; PMID:20064446; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/59/onci-1-1430.PMC3518527.pdf
"1 Thus, at late Crosstalk between regulatory T cells (Tregs)   and myeloid derived suppressor cells (MDSCs)  during melanoma growth taku Fujimura,* Yumi Kambayashi and s etsuya Aiba Department of Dermatology; t ohoku u niversity Graduate s chool of Medicine; s endai, Japan Keywords:  B7-H1, IL-10, melanoma, MDSC, Tregs *Correspondence to: Taku Fujimura; Email: tfujimura1@mac.com Submitted: 06/19/12; Accepted: 06/19/12http://dx.doi.org/10.4161/onci.21176stages of tumor growth, the ret transplant - able melanoma maintains a suppressive  tissue microenvironment by driving an increased expression of B7-H1 in CD11b +  MDSCs.",Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
J  Invest Dermatol 2012; 132:1239-46; PMID:22189788;  http://dx.doi.org/10.1038/jid.2011.416.,Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
J Dermatol Sci 2010; 59:1-6; PMID:20570112;  http://dx.doi.org/10.1016/j.jdermsci.2010.05.001.,OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
Cancer 2010; 116:1757-66; PMID:20143437; http://dx.doi.org/10.1002/ cncr.24899.,Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
Cancer Res 2004; 64:5535-8; PMID:15313886;  http://dx.doi.org/10.1158/0008-5472.CAN-04-1272.,Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
J Allergy Clin Immunol 2010; 125(Suppl 2):S272- 83; PMID:20061007; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
Eur J Immunol  2010; 40:321-9; PMID:19950173; http://dx.doi.org/10.1002/eji.200939527.,Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
J Immunol  2010; 184:7144-53; PMID:20483737; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
Case Rep Dermatol  2012; 4:5-9; PMID:22308113; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
Proc Natl Acad Sci U S A  2007; 104:19446-51; PMID:18042719; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/72/onci-1-1433.PMC3518528.pdf
"Dudley* surgery Branch; National Cancer Institute; National Institutes of h ealth; Bethesda, MD us A Keywords:  adoptive cell transfer, bioreactors, immunotherapy, tumor infiltrating lymphocytes, cancer *Correspondence to: Mark E. Dudley; Email: med@nih.gov Submitted: 06/19/12; Accepted: 06/21/12http://dx.doi.org/10.4161/onci.21206clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
Blood  2012; 119:2709-20; PMID:22160384; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849.5.,OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
J Immunother 2012; 35:283-92; PMID:22421946;  http://dx.doi.org/10.1097/CJI.0b013e31824e801f.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
Clin Cancer Res 2010; 16:2646-55;  PMID:20406835; http://dx.doi.org/10.1158/1078-0432.CCR-10-0041.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
J ClinOncol 2011; 29:917- 24; PMID:21282551; http://dx.doi.org/10.1200/ JCO.2010.32.2537.References 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0116.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
Nat Rev Immunol 2012; 12:269-81;  PMID:22437939; http://dx.doi.org/10.1038/nri3191.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
J Immunol Methods  2011; 364:94-100; PMID:21111743; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
J T ransl Med 2012; 10:69;  PMID:22475724; http://dx.doi.org/10.1186/1479-5876-10-69.,Non-OADS,/arxiv_data1/oa_pdf/b8/98/onci-1-1435.PMC3518529.pdf
"tim F. Greten,* Fei Zhao, Jaba Gamrekelashvili and Firouzeh Korangy Gastrointestinal Malignancy s ection; Medical Oncology Branch; National Cancer Institute; Bethesda, MD us A Keywords:  IL-17, CCR4, CCR6, liver, cancer *Correspondence to: Tim F. Greten; Email: tim.greten@nih.gov Submitted: 06/22/12; Accepted: 06/22/12http://dx.doi.org/10.4161/onci.21245these results and on data published by others  demonstrating that the number of tumor-infiltrating Th17 cells inversely correlates with disease outcome, 7 we have decided to  examine Th17 cells in more detail.",Non-OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
Annu Rev Immunol 2009; 27:485-517;  PMID:19132915; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
Cancer Immunol Immunother 2010; 59:979- 87; PMID:20352428; http://dx.doi.org/10.1007/ s00262-010-0849-6.accumulation of this cell type needs to  be further investigated.,Non-OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
Cancer Immunol Immunother 2012;  61:1-7; PMID:22086162; http://dx.doi.org/10.1007/ s00262-011-1151-y.,Non-OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
Gastroenterology 2008; 135:234-43; PMID:18485901; http://dx.doi.org/10.1053/j.gas- tro.2008.03.020.,Non-OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
Blood  2011; 117:6532-41; PMID:21493801; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
Nat Immunol  2007; 8:639-46; PMID:17486092; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/43/onci-1-1438.PMC3518530.pdf
"Immunotherapy based on autologous EBV-specific T cells has recently emerged as an effec - tive tool for the treatment of EBV-associated malignancies and its efficacy in lymphoid malignancies such as A new approach for cellular immunotherapy   of nasopharyngeal carcinoma Corey s mith and r ajiv Khanna* Australian Centre for Vaccine Development and t umour Immunology Laboratory; Department of Immunology; Queensland Institute of Medical r esearch; Brisbane, Australia Keywords:  T cells, HLA, immunotherapy, EBV, adenovirus, epitope, nasopharyngeal carcinoma *Correspondence to: Rajiv Khanna; Email: rajiv.khanna@qimr.edu.au Submitted: 06/26/12; Accepted: 06/27/12http://dx.doi.org/10.4161/onci.21286post-transplantation lymphomas (PTLs)  has been convincingly demonstrated.",Non-OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
Expert Rev Anticancer Ther  2006; 6:383-94; PMID:16503855; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
J Clin Oncol  2005; 23:8942-9; PMID:16204009; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
J Immunother 2010; 33:983-90; PMID:20948438;  http://dx.doi.org/10.1097/CJI.0b013e3181f3cbf4.,Non-OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
Blood 2005; 105:1898-904; PMID:15542583; http://dx.doi.org/10.1182/blood-2004-07-2975.,Non-OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
Cancer Res 2012; 72:1116-25; PMID:22282657;  http://dx.doi.org/10.1158/0008-5472.CAN-11-3399.8.,Non-OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
J Virol 2009; 83:6192- 8; PMID:19357166; http://dx.doi.org/10.1128/ JVI.00239-09.,Non-OADS,/arxiv_data1/oa_pdf/8f/0e/onci-1-1440.PMC3518531.pdf
"These protocols utilize different combinations of clinical grade recombinant cytokines such as interferon (IFN) IFN α and γ or  tumor necrosis factor α (TNF α) and/or  toll-like receptor (TLR) agonists includ - ing monophosphoryl lipid A (MPLA), polyinosinic:polycytidylic acid (poly-I:C) and the imidazoquinoline resiquimod (R-848), in order to induce mature type-1 polarized DCs (DC1s) with a high capac - ity to produce biologically active inter - leukin-12 (IL-12p70), a critical factor for Lymphocyte-polarized DC1s Effective inducers of tumor-specific CTLs erik Berk1 and Pawel Kalinski1,2,3,4,* 1Department of s ugery; u niversity of Pittsburgh; Pittsburgh, PA us A; 2Department of Infectious Diseases and Microbiology; u niversity of Pittsburgh; Pittsburgh, PA us A;  3Department of Immunology; u niversity of Pittsburgh; Pittsburgh, PA us A; 4university of Pittsburgh Cancer Institute; Pittsburgh, PA us A Keywords:  dendritic cells, effector CD8+ T cells, IL-12p70, polarization Abbreviations:  APCs, antigen presenting cells; DCs, dendritic cells; PGE2, prostaglandin E2; TCR, T cell receptor;   TLR, toll-like receptor *Correspondence to: Pawel Kalinski; Email: kalinskip@upmc.edu Submitted: 06/26/12; Accepted: 06/27/12http://dx.doi.org/10.4161/onci.21295the immunologic and clinical efficacy of  cancer vaccines and for the induction of Type-1 immunity.",Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
Annu Rev Immunol 1991; 9:271-96;  PMID:1910679; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
Nat Rev Immunol  2003; 3:984-93; PMID:14647480; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
J Immunother  2008; 31:89-100; PMID:18157016; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
J Immunother 2011; 34:45-57; PMID:21150712;  http://dx.doi.org/10.1097/CJI.0b013e3181fb651a.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
J Clin Oncol  2011; 29:330-6; PMID:21149657; http://dx.doi.org/10.1200/JCO.2010.30.7744.9.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
Vaccine 2012; •••: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
Cancer Res  2009; 69:1587-95; PMID:19190335; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/onci-1-1443.PMC3518532.pdf
"3 DCs that secrete  high levels of biologically active interleu - kin-12 (IL-12p70) induce optimal antitu - mor immunity, as they have an increased capacity to enhance natural killer (NK) cell activity, skew the immune response to a Th1 profile and prime tumor antigen-specific CD8 + T cells.4,5 DCs also express Dendritic cell inhibition correlates   with survival of colorectal cancer patients   on bevacizumab treatment Adriana J. Michielsen,1 elizabeth J. r yan2 and Jacintha N. O’ sullivan1,* 1Department of s urgery; Institute of Molecular Medicine; t rinity Centre for h ealth s ciences; s t. James’s h ospital; Dublin, Ireland; 2Centre for Colorectal Disease;   education and r esearch Centre; s t. Vincent’s u niversity h ospital; Dublin, Ireland Keywords:  bevacizumab, colorectal cancer, dendritic cells, tumor microenvironment Abbreviations:  BCM, bevacizumab-conditioned media; DC, dendritic cell; TCM, tumor-conditioned media *Correspondence to: Jacintha N. O’Sullivan; Email: osullij4@tcd.ie Submitted: 06/29/12; Accepted: 06/30/12http://dx.doi.org/10.4161/onci.21318CD1d, which presents lipid antigens  and specifically activates natural killer T (NKT) cells, including invariant NKT (iNKT) cells.",Non-OADS,/arxiv_data1/oa_pdf/7c/1f/onci-1-1445.PMC3518533.pdf
Recent Pat Endocr Metab  Immune Drug Discov 2010; 4:146-52; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/1f/onci-1-1445.PMC3518533.pdf
Cancer Res 2008; 68:9441-50;  PMID:19010919; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0900.5.,Non-OADS,/arxiv_data1/oa_pdf/7c/1f/onci-1-1445.PMC3518533.pdf
Nat Immunol 2010; 11:197-206;  PMID:20139988; http://dx.doi.org/10.1038/ni.1841.,Non-OADS,/arxiv_data1/oa_pdf/7c/1f/onci-1-1445.PMC3518533.pdf
Mol Cancer Ther 2012;  PMID:22675042; http://dx.doi.org/10.1158/1535- 7163.MCT-12-0162.8.,Non-OADS,/arxiv_data1/oa_pdf/7c/1f/onci-1-1445.PMC3518533.pdf
PLoS One 2011; 6:e27944; PMID:22125641;  http://dx.doi.org/10.1371/journal.pone.0027944.,Non-OADS,/arxiv_data1/oa_pdf/7c/1f/onci-1-1445.PMC3518533.pdf
"We then conducted a preclinical A glypican-3-derived peptide vaccine   against hepatocellular carcinoma Yu s awada, Mayuko s akai, t oshiaki Yoshikawa, Kazuya Ofuji and t etsuya Nakatsura* Division of Cancer Immunotherapy; r esearch Center for Innovative Oncology; National Cancer Center h ospital e ast; Kashiwa, Japan Keywords:  clinical trial, cytotoxic T lymphocyte, glypican-3, hepatocellular carcinoma, peptide vaccine *Correspondence to: Tetsuya Nakatsura; Email: tnakatsu@east.ncc.go.jp Submitted: 06/30/12; Accepted: 07/03/12http://dx.doi.org/10.4161/onci.21351study in mice to design an optimal sched - ule for a clinical trial with the GPC3- derived peptide vaccine ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Cancer Sci  2011; 102:918-25; PMID:21281401; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Cancer Sci  2011; 102:1622-9; PMID:21668581; http://dx.doi.org/10.1111/j.1349-7006.2011.02003.x.,Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Curr  Opin Immunol 2009; 21:233-40; PMID:19304471; http://dx.doi.org/10.1016/j.coi.2009.03.002.5.,OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Clin Cancer Res 2006; 12:2689-97;  PMID:16675560; http://dx.doi.org/10.1158/1078- 0432.CCR-05-2267.,Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Clin Cancer  Res 2012; •••: http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Biochem Biophys Res Commun  2003; 306:16-25; PMID:12788060; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Clin Cancer Res 2004; 10:8630-40; PMID:15623647;  http://dx.doi.org/10.1158/1078-0432.CCR-04-1177.,Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
Cancer Sci 2009; 100:1403-7;  PMID:19496787; http://dx.doi.org/10.1111/j.1349- 7006.2009.01206.x.,Non-OADS,/arxiv_data1/oa_pdf/79/9b/onci-1-1448.PMC3518534.pdf
"Prinz Institute of Molecular Immunology; h elmholtz Center Munich; German r esearch Center for e nvironmental h ealth; Munich, Germany Keywords:  dendritic cells, immune escape, renal cell carcinoma, tumor-infiltrating lymphocytes, tumor milieu *Correspondence to: Elfriede Noessner; Email: noessner@helmholtz-muenchen.de Submitted: 06/29/12; Accepted: 07/04/12http://dx.doi.org/10.4161/onci.21356response toward immunosuppression.",Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
J Immunol 2012;  188:5990-6000; http://dx.doi.org/10.4049/jimmu- nol.1103028; PMID:22573804.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
Clin Cancer Res  2010; 16:2333-43; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2897; PMID:20371691.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
J Mol Med (Berl)  2012; 90:55-66; http://dx.doi.org/10.1007/s00109- 011-0806-7; PMID:21870102.4.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
Am J  Pathol 2011; 179:436-51; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
Nat Rev Cancer 2012; 12:298-306;  http://dx.doi.org/10.1038/nrc3245; PMID:22419253.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
Clin Cancer  Res 2006; 12:718-25; http://dx.doi.org/10.1158/1078- 0432.CCR-05-0857; PMID:16467081.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
Int J Cancer 2012; 131:633-40; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
Int Immunopharmacol 2010; 10:1220-8;  http://dx.doi.org/10.1016/j.intimp.2010.07.002;  PMID:20637838.,OADS,/arxiv_data1/oa_pdf/d8/bf/onci-1-1451.PMC3518535.pdf
"were the first  to describe a small subpopulation of Immunotargeting of tumor subpopulations   in melanoma patients A paradigm shift in therapy approaches Margarita Maurer,1 rajasekharan s omasundaram,2 Meenhard h erlyn2 and s tephan N. w agner1,* 1Division of Immunology, Allergy and Infectious Diseases; Department of Dermatology; Vienna, Austria; 2the w istar Institute; Philadelphia, PA us A Keywords:  adjuvant immunotherapy, CD20, melanoma, rituximab, tumor-infiltrating B cells, tumor-initiating subpopulations Abbreviations:  NED, no evidence of disease; OS, overall survival; RF, recurrence-free; TIBC, tumor- infiltrating B cell; TME,  tumor microenvironment *Correspondence to: Stephan N. Wagner; Email: stephan.wagner@meduniwien.ac.at Submitted: 07/02/12; Accepted: 07/04/12http://dx.doi.org/10.4161/onci.21357melanoma cells expressing the B-cell sur - face marker CD20 when they were grown  as tumor spheroids.2 Such a CD20+ popu - lation was indicated as “cancer stem cell-like” or “tumor-initiating” as these cells fulfilled the criteria of “tumor stemness” by their ability to differentiate into mul - tiple different cell lineages and being more tumorigenic than the CD20-negative population in a preclinical xenotransplan - tation model.",Non-OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
J  Invest Dermatol 2011; 131:1600-4; PMID:21654838;  http://dx.doi.org/10.1038/jid.2011.159.,Non-OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
Cancer Res  2005; 65:9328-37; PMID:16230395; http://dx.doi.org/10.1158/0008-5472.CAN-05-1343.,Non-OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
Cancer Cell 2010; 17:121-34; PMID:20138013;  http://dx.doi.org/10.1016/j.ccr.2009.12.019.,Non-OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
Nature 2010; 464:302- 5; PMID:20220849; http://dx.doi.org/10.1038/ nature08782.9.,Non-OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
Nature 2008; 451:345-9; PMID:18202660; http://dx.doi.org/10.1038/ nature06489.,OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
Cancer Immunol Immunother 2011; 60:1597-608;  PMID:21691723; http://dx.doi.org/10.1007/s00262- 011-1063-x.,Non-OADS,/arxiv_data1/oa_pdf/e9/f1/onci-1-1454.PMC3518536.pdf
"3)4) In between the parietal and vis - ceral pericardium, there is a pericardial cavity filled with 10-50 cc of fluid, an ultrafiltrate of plasma that is produced by the visceral pe-Review http://dx.doi.org/10.4070/kcj.2012.42.1 1.725 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Pericardial Effusion and Pericardiocentesis: Role of Echocardiography Hae-Ok Jung, MD Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea Pericardial effusion can develop from any pericardial disease, including pericarditis and several systemic disorders, such as malignancies,  pulmonary tuberculosis, chronic renal failure, thyroid diseases, and autoimmune diseases.",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ricardium.",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
726 Pericardial Effusion and Pericardiocentesis http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org cardiocentesis between countries or centers.,Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
"727 Hae-Ok Jung http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org sion is detected by echocardiography, the next step is to assess the  size of the effusion, its location, hemodynamic importance, and as - sociated diseases.4)17) A pericardial effusion is not always uniformly  distributed around the heart.",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
"728 Pericardial Effusion and Pericardiocentesis http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org Cardiac Tamponade Cardiac tamponade is a life-threatening, slow or rapid compres - sion of the heart due to the pericardial accumulation of fluid, pus,  blood, clots, or gas as a result of effusion, trauma, or rupture of the heart.",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
"729 Hae-Ok Jung http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org stood that small acute pericardial effusions (occurring most com - monly post-intervention or traumatically) can lead to dramatic tam- ponade physiology when fluid accumulates rapidly; whereas, mo-derate-sized or even large pericardial effusions that accumulate slowly can be well tolerated, hemodynamically (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
"730 Pericardial Effusion and Pericardiocentesis http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org matic pericardial effusion or cardiac tamponade, and it continues to  be used as a diagnostic procedure in some patients with asymptom - atic pericardial effusion, such as chronic idiopathic effusion.7)17)36)37)  Before, during, and after the percutaneous pericardiocentesis, trans - thoracic echocardiography guidance is essential.36)38) If the pericar - diocentesis is performed at bedside without echocardiographic guid-ance, the risk of threatening complications like bleeding or shock have been reported to be as high as 20%.",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
731 Hae-Ok Jung http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org whether to perform pericardiocentesis.,Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
732 Pericardial Effusion and Pericardiocentesis http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org  phy.,Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
733 Hae-Ok Jung http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org cil Medicine .,OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
734 Pericardial Effusion and Pericardiocentesis http://dx.doi.org/10.4070/kcj.2012.42.11.725 www.e-kcj.org Pericardiocentesis: a clinical anatomy review.,Non-OADS,/arxiv_data1/oa_pdf/fe/aa/kcj-42-725.PMC3518705.pdf
"735 Copyright © 2012 The Korean Society of CardiologyKorean Circulation Journal Introduction Radiofrequency catheter ablation (RFCA) is widely applied as a  curative treatment for many types of pediatric cardiac arrhythmias.1)  The first pediatric RFCA was performed in a child with supraven -Original Article http://dx.doi.org/10.4070/kcj.2012.42.1 1.735 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Pediatric Tachyarrhythmia and Radiofrequency Catheter Ablation:   Results From 1993 to 2011 Yeo Hyang Kim, MD1, Hyoung-Seob Park, MD2, Myung Chul Hyun, MD3, and Yoon-Nyun Kim, MD2 1Department of Pediatrics, 2Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, 3Department of Pediatrics, Kyungpook National University Hospital, Daegu, Korea Background and Objectives:  We performed a retrospective study to elucidate the frequency of tachycardia mechanisms and the char - acteristics of accessory pathways (APs), confirmed by radiofrequency catheter ablation (RFCA) in pediatric tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tricular tachycardia (SVT) in 1989.2)  We have used RFCA as a treatment for pediatric tachyarrhyth - mias in Daegu since 1993.",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
"736 Pediatric Radiofrequency Catheter Ablation http://dx.doi.org/10.4070/kcj.2012.42.11.735 www.e-kcj.org Subjects and Methods Patient selection Pediatric EPS and RFCA were performed in Keimyung University  Dongsan Medical Center and Kyungpook National University Hospi - tal according to the pediatric RFCA guidelines of the NASPE Expert  Consensus Conference6) or by the choice of the patients and their  parents, when patients had recurrent symptomatic tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.735 www.e-kcj.org termined by the ablation site and are illustrated in Figs.,OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
738 Pediatric Radiofrequency Catheter Ablation http://dx.doi.org/10.4070/kcj.2012.42.11.735 www.e-kcj.org Atrioventricular nodal reentry tachycardia AVNRT was detected in 83 patients.,Non-OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.735 www.e-kcj.org mented.,OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
740 Pediatric Radiofrequency Catheter Ablation http://dx.doi.org/10.4070/kcj.2012.42.11.735 www.e-kcj.org recurrent cases was 95%.,Non-OADS,/arxiv_data1/oa_pdf/0d/9c/kcj-42-735.PMC3518706.pdf
"741 Copyright © 2012 The Korean Society of CardiologyKorean Circulation Journal Introduction Fibrate is a peroxisome proliferator-activated receptor α agonist Original Article http://dx.doi.org/10.4070/kcj.2012.42.1 1.741 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Fenofibrate Reduces C-Reactive Protein Levels in Hypertriglyceridemic   Patients With High Risks for Cardiovascular Diseases Yun Joo Min, MD, Young Hwan Choi, MD, Cheol Won Hyeon, MD, Jun Hwan Cho, MD,   Kyung Joon Kim, MD, Jee Eun Kwon, MD, Eun Young Kim, MD, Wang-Soo Lee, MD,   Kwang Je Lee, MD, Sang-Wook Kim, MD, Tae Ho Kim, MD, and Chee Jeong Kim, MD Division of Cardiology, Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea Background and Objectives:  The effects of fenofibrate on C-reactive protein (CRP) are under debate.",Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and is widely used to decrease triglyceride and to increase high den - sity lipoprotein-cholesterol (HDL-C).1) Several large-scale studies  have investigated the effect of fibrate in the prevention of cardio - vascular events.2-6) However, the results are contentious.",Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
742 Fenofibrate and C-Reactive Protein http://dx.doi.org/10.4070/kcj.2012.42.11.741 www.e-kcj.org ing CRP levels in a relatively large number of patients.,Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.741 www.e-kcj.org also similar (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
"744 Fenofibrate and C-Reactive Protein http://dx.doi.org/10.4070/kcj.2012.42.11.741 www.e-kcj.org In all patients (n=280), baseline CRP levels were higher in patients  with a BMI >26 kg/m2 than in those with a BMI ≤26 kg/m2 (1.63 ±  1.54 mg/L vs. 1.47 ±1.71 mg/L, p=0.014).",Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.741 www.e-kcj.org vels.9-25) However, most studies did not have a comparison group9-1 1)  or a comparison of fibrate with statins.12-16) In several studies with a  comparison group, there were differences in the clinical characteris- tics and baseline CRP levels.17-19) In the present study, CRP levels de- creased not only in the fenofibrate group but also in the compari - son group.",Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
746 Fenofibrate and C-Reactive Protein http://dx.doi.org/10.4070/kcj.2012.42.11.741 www.e-kcj.org 7.,Non-OADS,/arxiv_data1/oa_pdf/a3/94/kcj-42-741.PMC3518707.pdf
"Patho - logic study confirmed that plaque growth with PR did not affect the lumen area until the atherosclerotic plaque reached 40% of Original Article http://dx.doi.org/10.4070/kcj.2012.42.1 1.747 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Positive Vascular Remodeling in Culprit Coronary   Lesion is Associated With Plaque Composition:   An Intravascular Ultrasound-Virtual Histology Study Chung Seop Lee, MD1, Young Hoon Seo, MD1, Dong Ju Yang, MD1, Ki Hong Kim, MD1, Hyun Woong Park, MD1,  Hyung Bin Yuk, MD1, Moo-Sik Lee, MD2, Wan-Ho Kim, MD1, Taek-Geun Kwon, MD1, and Jang-Ho Bae, MD1 1Departments of Cardiology and  2Preventive Medicine, Konyang University College of Medicine, Daejeon, Korea Background and Objectives:  The relationship between the positive remodeling (PR) of a coronary artery and plaque composition has  been studied only in a relatively small number of study population or non-culprit lesion.",Non-OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.the internal elastic lamina areas.1) However, in vivo  intravascular  ultrasound (IVUS) studies showed that NR is also observed in 15- 50% of stenotic lesions in a human coronary artery2)3) and that the  target lesions in patients with acute coronary syndrome (ACS) more frequently exhibited PR and a large plaque area, whereas patients with stable angina more frequently showed intermediate or NR and a smaller plaque area.",Non-OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
"748 Positive Vascular Remodeling and Plaque Composition http://dx.doi.org/10.4070/kcj.2012.42.11.747 www.e-kcj.org Varnava  et al.6) have reported that a PR lesion has higher lipid con- tents and a macrophage count, both markers of plaque vulnerabili- ty in a necropsy study.",Non-OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.747 www.e-kcj.org Sciences (SPSS) (version 18.0; SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
"750 Positive Vascular Remodeling and Plaque Composition http://dx.doi.org/10.4070/kcj.2012.42.11.747 www.e-kcj.org higher corrected fibrous volume (3.85 ±2.12 mm3/mm vs. 3.04 ±1.79  mm3/mm, p=0.003) and corrected necrotic core volume than those  with NR (Table 2, Fig.",Non-OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.747 www.e-kcj.org the minimal luminal diameter site and no differences of plaque com- positions in the entire culprit lesion.,Non-OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
752 Positive Vascular Remodeling and Plaque Composition http://dx.doi.org/10.4070/kcj.2012.42.11.747 www.e-kcj.org secutively enrolled and a relatively large population that divided  into the PR and NR group.,Non-OADS,/arxiv_data1/oa_pdf/ce/20/kcj-42-747.PMC3518708.pdf
"Angiographic recognition of coronary Original Article http://dx.doi.org/10.4070/kcj.2012.42.1 1.753 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Incidence and Pattern of Coronary Artery Anomalies   in the North-West of Iran: A Coronary Arteriographic Study Bahram Sohrabi, MD, Afshin Habibzadeh, MD, and Eyvaz Abbasov, MD Department of Cardiology, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Background and Objectives:  Coronary artery anomalies are found in approximately 1% of patients undergoing diagnostic coronary angi - ography (CAG).",Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.anomalies is of great importance.",Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
"754 Incidence and Pattern of Coronary Artery Anomalies http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org terial anatomy (congenital stenosis of ostium, congenital aneurysms,  and myocardial bridging), and 3) anomalies of coronary termination (fistulae).",Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org Anomalous circumflex artery from the right coronary sinus/ right coronary artery The second common anomaly was anomalous circumflex artery  (CX) from RCS/right coronary artery (RCA), observed in 17 patients (1 1 from RCS and 6 from RCA), accounting for 21.51% of our anoma - lies with angiographic incidence of 0.28%.",Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
756 Incidence and Pattern of Coronary Artery Anomalies http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org All 3 coronary arteries arising from right coronary sinus   with separate ostia This anomaly was present in one (1.27%) patient with angiogra- phic incidence of 0.02%.,Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org to our knowledge, had not been reported before.",OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
758 Incidence and Pattern of Coronary Artery Anomalies http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org terminated immediately after that bifurcation.,Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org cardiac surgeon should be informed concerning this anomaly in or - der to avoid accidental compression of the vessel during a valve re - placement.,Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
"760 Incidence and Pattern of Coronary Artery Anomalies http://dx.doi.org/10.4070/kcj.2012.42.11.753 www.e-kcj.org In conclusion, anomalous coronary arteries are a rare group of pa- thologies, with a variety of clinical manifestations related to their  course.",Non-OADS,/arxiv_data1/oa_pdf/86/46/kcj-42-753.PMC3518709.pdf
"The renin-angiotensin-aldosterone sys -Original Article http://dx.doi.org/10.4070/kcj.2012.42.1 1.761 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Changes of Gene Expressions in Spontaneously Hypertensive   Rat Model After Losartan Treatment Ji Hei Cha, MD1, Hye Ryon Lee, MD1, Kwan Chang Kim, MD2, Min-Sun Cho, MD3, and Young Mi Hong, MD1 1Departments of Pediatrics, 2Thoracic and Cardiovascular Surgery and 3Pathology, Ewha Womans University School of Medicine, Seoul, Korea Background and Objectives:  The renin angiotensin system seems to play an important role in the development of cardiac and vascular  hypertrophy in hypertension.",Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tem (RAAS) seems to play a key role in the development of hyper - tension.2) The principle mediator regarding the physiological ac- tions of the RAAS is the octapeptide angiotensin (QAT).3) There is  considerable evidence supporting the involvement for the inappro- priately elevated levels of angiotensin (AT) II in many forms of hy - pertension.4) Angiotensin II is intimately involved in many regulatory mechani- sms in the cardiovascular system beside blood pressure.",Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
762 Gene Expressions in Hypertension After Losartan Treatment http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org strain were developed by the selective breeding of Wistar-Kyoto  stock for higher blood pressure.1 1) SHRs spontaneously and consis - tently develop moderate-to-severe hypertension between 7 and 15 weeks of age and have served as models of genetic hypertension in humans.,Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org Biosystems, Foster City, CA, USA), which included the HotStarTaqt  DNA-Polymerase in an optimized buffer, the dNTP mix (with dUTP ad-ditive), the SYBRs Green I fluorescent dye, and ROX dye as a passive reference.",OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
"764 Gene Expressions in Hypertension After Losartan Treatment http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org Pathologic finding in heart tissues Under light microscopy, collagen was observed to penetrate be - tween the LV myocardiocytes, staining blue as noted in Fig.",Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org Serum angiotensin converting enzyme levels after losartan  treatment Serum ACE level did not significantly differ among the three gr- oups (Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
766 Gene Expressions in Hypertension After Losartan Treatment http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org Angiotensin converting enzyme protein content was significantly  higher in the H group compared with that in the C group in weeks  3 and 5 (p<0.05) and significantly lower in the L group compared with the H group in week 5 (p<0.05) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org SHR model including left ventricular hypertrophy and LH/BW ratio  in week 3, increased BNP and troponin I protein content by western blot analysis in week 5, and increased collagen content by histology.",Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
768 Gene Expressions in Hypertension After Losartan Treatment http://dx.doi.org/10.4070/kcj.2012.42.11.761 www.e-kcj.org One 201 1;6:e16013.,Non-OADS,/arxiv_data1/oa_pdf/74/26/kcj-42-761.PMC3518710.pdf
"1)2) For reduction of the annulus or STJ, a  commercially available sizing device, strip or ring and template (Sci - enCity Co, Seoul, Korea) are used.3) CARVAR procedure and devices,  named and designed by Dr. MG Song, are under evaluation for list up process as new health technology by the Health Insurance Review Brief Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.769 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Safety of Comprehensive Aortic Root and Valve Repair Surgery:   A Retrospective Outcomes Research by National Evidence-Based Health Care Collaborating Agency, Korea Jong-Myon Bae, MD1,2, Eunhee Shin, PhD1, and Dae Seog Heo, MD1,3 1National Evidence-Based Healthcare Collaborating Agency (NECA), Seoul, 2Department of Preventive Medicine, Jeju National University School of Medicine, Jeju,  3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Comprehensive aortic root and valve repair (CARVAR) is a recently introduced surgical technique for aortic valve disease.",Non-OADS,/arxiv_data1/oa_pdf/3b/b7/kcj-42-769.PMC3518711.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and Assessment Service (HIRA) from 2007.",Non-OADS,/arxiv_data1/oa_pdf/3b/b7/kcj-42-769.PMC3518711.pdf
"770 Safety of CARVAR Surgery http://dx.doi.org/10.4070/kcj.2012.42.11.769 www.e-kcj.org To obtain more complete information, a follow up was performed  via 2 tracks including medical records of the out patient department  and claim data of medical service in HIRA.",OADS,/arxiv_data1/oa_pdf/3b/b7/kcj-42-769.PMC3518711.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.769 www.e-kcj.org valve replacement strategy.,Non-OADS,/arxiv_data1/oa_pdf/3b/b7/kcj-42-769.PMC3518711.pdf
"ScienCity Co., Ltd, Available from: http://www.sciencity.net/sub01_1.html.",Non-OADS,/arxiv_data1/oa_pdf/3b/b7/kcj-42-769.PMC3518711.pdf
Avail - able from: http://www.neca.re.kr/ktic/publication/disease_view.jsp?runMode=boardView &seq=41 &t=20121030143322046 &boardNo=GA &cpage=1 &range=10 &block=10 &searchCol= &searchVal= &condition =MIDDLE_2%3D%2770%27+ &menuName=%C1%DF%C0%E7%BA %B0&named=%C1%DF%C0%E7%BA%B0+%26gt%3B+%C4%A1% B7%E1+%26gt%3B+%BD%C3%BC%F.,Non-OADS,/arxiv_data1/oa_pdf/3b/b7/kcj-42-769.PMC3518711.pdf
"However, pulmonary thrombosis can be secondary to other condi -Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.772 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Pulmonary Arterial Thrombosis in a Patient With an Atrial   Septal Defect and Eisenmenger Syndrome Ching-Wei Lee, MD, Shao-Sung Huang, MD, and Po-Hsun Huang, MD Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan Pulmonary hypertension is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure.",Non-OADS,/arxiv_data1/oa_pdf/8b/96/kcj-42-772.PMC3518712.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tions such as primary pulmonary hypertension,1) hypercoagulation  status, deep venous thrombosis, or Eisenmenger syndrome.",Non-OADS,/arxiv_data1/oa_pdf/8b/96/kcj-42-772.PMC3518712.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.772 www.e-kcj.org vealed grade III systolic murmurs over the left lower sternal border  and a wide fixed splitting S2.,Non-OADS,/arxiv_data1/oa_pdf/8b/96/kcj-42-772.PMC3518712.pdf
774 Pulmonary Thrombosis in Eisenmenger Syndrome http://dx.doi.org/10.4070/kcj.2012.42.11.772 www.e-kcj.org Insidious and prolonged symptoms may imply the slowly progres - sive nature of the disease.,Non-OADS,/arxiv_data1/oa_pdf/8b/96/kcj-42-772.PMC3518712.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.772 www.e-kcj.org nel blockers on survival in primary pulmonary hypertension.,Non-OADS,/arxiv_data1/oa_pdf/8b/96/kcj-42-772.PMC3518712.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.776 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Primary Cardiac Lymphoma Mimicking   Acute Coronary and Aortic Syndrome Sung Woo Cho, MD1,2, Byung Kyu Kim, MD2, Jin Tae Hwang, MD2, Jeong Hoon Kim, MD2, Byung Ok Kim, MD2,  Choong Won Goh, MD2, Kun Joo Rhee, MD2, Hyo Seung Ahn, MD2, Hyun Jung Kim, MD3, and Young Sup Byun, MD2 1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon,  2Division of Cardiology, Departments of Internal Medicine and 3Pathology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea Primary cardiac lymphoma (PCL) is a rare disorder, but the incidence is increasing and its clinical manifestations are various.",Non-OADS,/arxiv_data1/oa_pdf/f6/61/kcj-42-776.PMC3518713.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 51-year-old female with end stage renal disease on hemodial - ysis and a history of diabetes along with hypertension was pre - sented to the emergency room (ER).",Non-OADS,/arxiv_data1/oa_pdf/f6/61/kcj-42-776.PMC3518713.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.776 www.e-kcj.org to the previous ECG at the ER.,Non-OADS,/arxiv_data1/oa_pdf/f6/61/kcj-42-776.PMC3518713.pdf
778 PCL Mimicking ACS and AAS http://dx.doi.org/10.4070/kcj.2012.42.11.776 www.e-kcj.org One ample of atropine bolus was injected intravenously and car - diopulmonary resuscitation was immediately performed.,Non-OADS,/arxiv_data1/oa_pdf/f6/61/kcj-42-776.PMC3518713.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.776 www.e-kcj.org ther than ACS, due to stenosis of the distal LCX.",Non-OADS,/arxiv_data1/oa_pdf/f6/61/kcj-42-776.PMC3518713.pdf
780 PCL Mimicking ACS and AAS http://dx.doi.org/10.4070/kcj.2012.42.11.776 www.e-kcj.org survival case.,Non-OADS,/arxiv_data1/oa_pdf/f6/61/kcj-42-776.PMC3518713.pdf
"We report a rare complication of silent and late device embolization of the ASD occluder device into the right pulmonary artery, three months after implantation.Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.781 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Silent and Late Embolization of Atrial Septal Defect Occluder   Device Into the Right Pulmonary Artery: A Case Report Durmu s¸ Yıldıray S¸ahin, MD1, Mevlüt Ko c¸, MD1, Habib C¸akır, MD2,  Osman Ziya Arık, MD1, Zafer Elbasan, MD1, and Murat C¸aylı, MD1 1Departments of Cardiology and 2Cardiovascular Surgery, Adana Numune Education and Research Hospital, Adana, Turkey Percutaneous device closure of atrial septal defect (ASD) is an alternative treatment to surgery.",Non-OADS,/arxiv_data1/oa_pdf/13/a9/kcj-42-781.PMC3518714.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 16 year-old patient presented with dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/13/a9/kcj-42-781.PMC3518714.pdf
"782 Embolization of Atrial Septal Defect   http://dx.doi.org/10.4070/kcj.2012.42.1 1.781 www.e-kcj.org the third month physical examination, a fixed split second heart  sound and a systolic ejection murmur was heard within the pulmo-nary area.",Non-OADS,/arxiv_data1/oa_pdf/13/a9/kcj-42-781.PMC3518714.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.1 1.781 www.e-kcj.org Percutaneous transcatheter closure of ASD is an established altern- ative treatment to surgical closure as it has lesser morbidity, short - er hospital stay, lack of a scar, and comparable rates of complica - tions.4-6) However, percutaneous device closure is associated with  rare early and late complications such as migration or embolization of the device, pericardial effusion, arrhythmias, thrombus formation on the device, and mitral regurgitation and vascular injury.",Non-OADS,/arxiv_data1/oa_pdf/13/a9/kcj-42-781.PMC3518714.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.784 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Recurrence of Coronary-Subclavian Steal Syndrome After Successful Angioplasty of Malfunctioning Arteriovenous Fistula Hyun-Jeong Han, MD, Byung-Soo Kang, MD, and Yun-Hyeong Cho, MD Department of Cardiology, Cardiovascular Center, Myongji Hospital, Kwandong University College of Medicine, Goyang, Korea We report a case of coronary-subclavian steal syndrome, which had been masked by a malfunctioning hemodialysis access vessel and then  reappeared after a successful angioplasty of multiple stenoses in the arteriovenous fistula of the left arm in a 61-year-old man.",Non-OADS,/arxiv_data1/oa_pdf/7f/b7/kcj-42-784.PMC3518715.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Seven years ago, the patient had been diagnosed with three-vessel  coronary artery disease and underwent coronary artery bypass gr-afting, during which his left internal mammary artery was sequen - tially anastomosed to the mid portion of the left anterior descend - ing artery, ramus intermedius, and the posterior descending branch of the right coronary artery.",Non-OADS,/arxiv_data1/oa_pdf/7f/b7/kcj-42-784.PMC3518715.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.784 www.e-kcj.org ography showed no significant changes compared to what was re- ported a year ago.,OADS,/arxiv_data1/oa_pdf/7f/b7/kcj-42-784.PMC3518715.pdf
"786 Coronary-Subclavian Steal Syndrome After Hemodialysis Access Intervention   http://dx.doi.org/10.4070/kcj.2012.42.11.784 www.e-kcj.org tion, during which the left internal mammary artery conduit is used,  a great vessel disease, in particular subclavian artery stenosis, sh-ould be suspected.",Non-OADS,/arxiv_data1/oa_pdf/7f/b7/kcj-42-784.PMC3518715.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.784 www.e-kcj.org 5.,Non-OADS,/arxiv_data1/oa_pdf/7f/b7/kcj-42-784.PMC3518715.pdf
"About one third of pa - tients with severe AS and older than 75 years are not referred to a Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.788 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The First Case of Successful Transcatheter Aortic   Valve Implantation Using CoreValve in Korea In-Soo Kim, MD1, Young-Guk Ko, MD1, Sanghoon Shin, MD1, Ji-Young Shim, MD1, Sak Lee, MD2,  Byung-Chul Chang, MD2, Jae-Kwang Shim, MD3, Young-Ran Kwak, MD3, and Myeong-Ki Hong, MD1 1Division of Cardiology, 2Departments of Thoracic and Cardiovascular Surgery and 3Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital,  Yonsei University Health System, Seoul, Korea Surgical replacement of the aortic valve is the standard therapy for severe aortic valve stenosis.",Non-OADS,/arxiv_data1/oa_pdf/1d/95/kcj-42-788.PMC3518716.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.surgeon because of the high surgical risk associated with comor - bidities.1) The development of a catheter-based therapy for heart valve dise- ase, in particular AS, is rapidly evolving.",Non-OADS,/arxiv_data1/oa_pdf/1d/95/kcj-42-788.PMC3518716.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.788 www.e-kcj.org with strain signs on lateral leads.,Non-OADS,/arxiv_data1/oa_pdf/1d/95/kcj-42-788.PMC3518716.pdf
790  http://dx.doi.org/10.4070/kcj.2012.42.11.788 www.e-kcj.org Transcatheter Aortic Valve Implantation   diate post-procedural aortogram showed good position of the Co - reValve with mild aortic regurgitation (Fig.,Non-OADS,/arxiv_data1/oa_pdf/1d/95/kcj-42-788.PMC3518716.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.788 www.e-kcj.org complications.1 1) In this case, the diameters of the iliac and common  femoral arteries were larger than 6 mm and there was no problem  with engaging the catheter through the iliofemoral artery to aorta.",Non-OADS,/arxiv_data1/oa_pdf/1d/95/kcj-42-788.PMC3518716.pdf
"2-7) But choosing an appropriate method  of CAVF treatment still remains a controversial issue.8) We report a Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.792 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Congenital Giant Right Coronary Artery Aneurysm With Fistula   to the Coronary Sinus and Persistent Left   Superior Vena Cava in an Old Woman Soo-Yong Lee, MD, Yong Hyun Park, MD, Hye-Ju Yeo, MD, Chang-Bae Sohn, MD, Dong-Cheul Han, MD,   Jeong Su Kim, MD, Jun Kim, MD, June-Hong Kim, MD, and Kook-Jin Chun, MD Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea The combination of coronary arteriovenous fistula to the coronary sinus (CS), dilatation of the entire length of coronary artery, coronary  aneurysm and persistent left superior vena cava (PLSVC) is very rare.",Non-OADS,/arxiv_data1/oa_pdf/f9/57/kcj-42-792.PMC3518717.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.case of congenital giant right coronary artery which had a fistulous  connection to the coronary sinus (CS) and left persistent superior vena cava treated with medical therapy.",Non-OADS,/arxiv_data1/oa_pdf/f9/57/kcj-42-792.PMC3518717.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.792 www.e-kcj.org A   B   C   Fig.,Non-OADS,/arxiv_data1/oa_pdf/f9/57/kcj-42-792.PMC3518717.pdf
"794 Right Coronary Artery Aneurysm Fistula to the Coronary Sinus http://dx.doi.org/10.4070/kcj.2012.42.11.792 www.e-kcj.org CT revealed a right coronary artery to CS fistula with persistent left  superior vena cava (PLSVC), low lying left innominate vein, and right atrial enlargement possibly due to a left to right shunt.",Non-OADS,/arxiv_data1/oa_pdf/f9/57/kcj-42-792.PMC3518717.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.792 www.e-kcj.org nary sinus.,Non-OADS,/arxiv_data1/oa_pdf/f9/57/kcj-42-792.PMC3518717.pdf
"The most common approach for Case Report http://dx.doi.org/10.4070/kcj.2012.42.1 1.796 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The First Korean Patient With Severe Aortic Stenosis and Bilateral   Iliofemoral Artery Disease Treated With Transcatheter Aortic Valve Implantation by Transsubclavian Approach Seung-Jun Lee, MD1, Young-Guk Ko, MD1, Ji-Young Shim, MD1, Sak Lee, MD2, Byung-Chul Chang, MD2, Jae-Kwang Shim, MD3, Young-Ran Kwak, MD3, and Myeong-Ki Hong, MD1 1Division of Cardiology, 2Departments of Thoracic and Cardiovascular Surgery and 3Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital,  Yonsei University Health System, Seoul, Korea Transcatheter aortic valve implantation (TAVI) is indicated as an alternative treatment modality to surgical aortic valve replacement for high  risk patients.",Non-OADS,/arxiv_data1/oa_pdf/53/7f/kcj-42-796.PMC3518718.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.TAVI is the transfemoral approach because the relatively large pro - file (18 Fr) of the delivery catheter requires an access route with a dia- meter larger than 6 mm.",Non-OADS,/arxiv_data1/oa_pdf/53/7f/kcj-42-796.PMC3518718.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.796 www.e-kcj.org At that time he also underwent percutaneous transluminal angio - plasty with implantation of self-expandable nitinol stents at the bi - lateral iliac arteries.,Non-OADS,/arxiv_data1/oa_pdf/53/7f/kcj-42-796.PMC3518718.pdf
798 Transsubclavian Approach TAVI in Severe AS Patient With PAD http://dx.doi.org/10.4070/kcj.2012.42.11.796 www.e-kcj.org under general anesthesia.,Non-OADS,/arxiv_data1/oa_pdf/53/7f/kcj-42-796.PMC3518718.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.11.796 www.e-kcj.org alve 1 1%, p=0.99) and one year (Edwards 18% vs. CoreValve 21%) for  both systems.",OADS,/arxiv_data1/oa_pdf/53/7f/kcj-42-796.PMC3518718.pdf
"It may be associated with complex cardiac congenital malformations, can cause the left ventricle out -Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2012.42.1 1.800 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Asymptomatic Accessory Mitral Valve Tissue Diagnosed   by Echocardiography Onur Kadir Uysal, MD1, Mustafa Duran, MD1, Bugra Ozkan, MD2, Kamuran Tekin, MD2, and Zafer Elbasan, MD2 1Department of Cardiology, Kayseri Education and Research Hospital, Kayseri,  2Department of Cardiology, Adana Numune Education and Research Hospital, Adana, Turkey Received:  March 6, 2012 / Revision Received: May 2, 2012 / Accepted: May 7, 2012 Correspondence: Onur Kadir Uysal, MD, Department of Cardiology, Kayseri Education and Research Hospital, Kocasinan, Kayseri, Turkey 38000 Tel: 00905640010, Fax: 009035223321 10, E-mail: onurkadir@gmail.com • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/b3/97/kcj-42-800.PMC3518719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.flow tract obstruction and valve insufficiency.1)2) In patients with ac - cessory mitral valve tissue, surgery is mandatory if there is significant  obstruction in the left ventricular outflow tract, severe valvular regur-gitation or any complication associated with this accessory tissue.",Non-OADS,/arxiv_data1/oa_pdf/b3/97/kcj-42-800.PMC3518719.pdf
http://dx.doi.org/10.4070/kcj.2012.42.11.800  www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/b3/97/kcj-42-800.PMC3518719.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/4a/srep00957.PMC3518810.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kang, S., Huynh, T. & Zhou, R. Non-destructive Inhibition of Metallofullerenol Gd@C 82(OH) 22on WW domain: Implication on Signal Transduction Pathway.",Non-OADS,/arxiv_data1/oa_pdf/6b/4a/srep00957.PMC3518810.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/09/srep00961.PMC3518811.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Serna, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/09/srep00961.PMC3518811.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/c3/srep00952.PMC3518812.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fan, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/c3/srep00952.PMC3518812.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/48/56/srep00960.PMC3518813.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Reddy, A.L.M.",Non-OADS,/arxiv_data1/oa_pdf/48/56/srep00960.PMC3518813.pdf
Resulting multiple protein alignments were manually verified and edited using Se-Al 2.0 (http://tree.bio.ed.ac.uk/software/seal/).,OADS,/arxiv_data1/oa_pdf/4c/ab/srep00955.PMC3518814.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 2 : 955 | DOI: 10.1038/srep00955 11,Non-OADS,/arxiv_data1/oa_pdf/4c/ab/srep00955.PMC3518814.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Reyes-Prieto, A.",Non-OADS,/arxiv_data1/oa_pdf/4c/ab/srep00955.PMC3518814.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0f/25/srep00959.PMC3518815.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yun, K., Watanabe, K. & Shimojo, S. Interpersonal body and neural synchronization as a marker of implicit social interaction.",Non-OADS,/arxiv_data1/oa_pdf/0f/25/srep00959.PMC3518815.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Jiang, W.X., Luo, C.Y., Ma, H.F., Mei, Z.L.",Non-OADS,/arxiv_data1/oa_pdf/11/ef/srep00956.PMC3518816.pdf
Multiple identifications were refined by mat- ching with reference 2-DE maps available in the SWISS-2DPAGE database (http://world-2dpage.expasy.,OADS,/arxiv_data1/oa_pdf/65/22/srep00953.PMC3518817.pdf
Protein identification was manually performed by searching the National Center for Biotechnology Information non-redundant data- base using the Mascot 2.3 MS/MS Ion Search program (http://www.matrixscience.com).,OADS,/arxiv_data1/oa_pdf/65/22/srep00953.PMC3518817.pdf
Photographic films were scanned with a Epson Perfection V750 Pro transmission scanner (Epson) and images (16 bit grayscale) were analyzed using the ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/65/22/srep00953.PMC3518817.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: TA, MF and LL are listed as inventors in the patent application IT/TO2011A001241 entitled ‘‘Method for the in vitro diagnosis of Parkinson’sdisease’’.",Non-OADS,/arxiv_data1/oa_pdf/65/22/srep00953.PMC3518817.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Alberio, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/65/22/srep00953.PMC3518817.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d2/1a/srep00958.PMC3518818.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Chen, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/1a/srep00958.PMC3518818.pdf
"Drug Discovery Today (2012), in press : http://dx.doi.org/10.1016/j.drudis.2012.09.001 25.",Non-OADS,/arxiv_data1/oa_pdf/7d/61/srep00954.PMC3518819.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/61/srep00954.PMC3518819.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Lin, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/61/srep00954.PMC3518819.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published electronically 23 August 2012 Adult macronutrient intake and physical capability in the MRC National Survey of Health and Development U.",Non-OADS,/arxiv_data1/oa_pdf/bd/ec/afs101.PMC3518903.pdf
Signal peptides were identiﬁed using SignalP ( http://www.cbs.dtu.dk/services /SignalP/ ) and transmembrane regions predicted by TMpred ( http://www .ch.embnet.org/software/TMPRED_form.html ).,OADS,/arxiv_data1/oa_pdf/6c/17/mBio.00303-12.PMC3518915.pdf
Biofuels 4:32. http://dx.doi.org/10.1186/1754-6834 -4-32 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
http://dx.doi.org/10.1093/nar/gkq1027 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
6:378. http://dx.doi.org/10.1038/msb.2010.33 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
http://dx.doi.org/10.1371/journal.pone.0017678 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
5:277. http://dx.doi.org/10.1038/msb.2009.34 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
7:32.http://dx.doi.org/10 .1186/1472-6750-7-32 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
7:487. http://dx.doi.org/10 .1038/msb.2011.21 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
12:18.http://dx.doi.org/10.1186/1471-2199-12-18 .,Non-OADS,/arxiv_data1/oa_pdf/9e/fb/mBio.00308-12.PMC3518916.pdf
http://dx.doi.org/10.1371 /journal.pone.0010734 .,Non-OADS,/arxiv_data1/oa_pdf/d7/73/mBio.00312-12.PMC3518917.pdf
http://dx.doi.org/10.1016/S0196-6553(09)00135-7 .,OADS,/arxiv_data1/oa_pdf/d7/73/mBio.00312-12.PMC3518917.pdf
http://dx.doi.org/10.1371/journal.pone.0029446 .,Non-OADS,/arxiv_data1/oa_pdf/d7/73/mBio.00312-12.PMC3518917.pdf
http://dx.doi.org/10.1371 /journal.pone.0030673 .,Non-OADS,/arxiv_data1/oa_pdf/d7/73/mBio.00312-12.PMC3518917.pdf
http://dx.doi.org/10.1371/journal.ppat .1000703 .,Non-OADS,/arxiv_data1/oa_pdf/d7/73/mBio.00312-12.PMC3518917.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/S0305000912000086a.PMC3518974.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/35/101794 Copyright: © 2012 Ho J.,Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/35BACKGROUND The pathologist’s workflow in the practice of anatomic  pathology (AP) has traditionally been a complicated  manual process where pathologists microscopically  examine stained slices of formalin-fixed, paraffin- embedded tissue affixed to glass slides.",Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/35inquiry models in AP workflow.",OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/3524 second-level categories, and finally into five main  categories.",Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/35Figure 1: Consolidated flow model.",OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/35for the day’s workload (trigger: arrival of case packages  to pathologist); 2.",Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/3560×) were used to confirm findings obtained at the low and  medium magnifications and to examine in detail cellular  morphological features.",OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/35misidentification errors.",Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/35about the overall quality of their final reports and carefully  crafted their reports.",Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
"J Pathol Inform 2012, 3:35  http://www.jpathinformatics.org/content/3/1/353.",Non-OADS,/arxiv_data1/oa_pdf/40/12/JPI-3-35.PMC3519008.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/34/101786 Copyright: © 2012 Horn AJ.,Non-OADS,/arxiv_data1/oa_pdf/8b/23/JPI-3-34.PMC3519009.pdf
"J Pathol Inform 2012, 3:34  http://www.jpathinformatics.org/content/3/1/34to histology by American Allopathic and Osteopathic  medical schools has dropped from 134 hours in 1967 to  81 hours in 2001.",Non-OADS,/arxiv_data1/oa_pdf/8b/23/JPI-3-34.PMC3519009.pdf
"J Pathol Inform 2012, 3:34  http://www.jpathinformatics.org/content/3/1/34consisting of ten true or false style questions covering  content from the vignettes and were unaware of the  answers until after the post-test.",Non-OADS,/arxiv_data1/oa_pdf/8b/23/JPI-3-34.PMC3519009.pdf
"J Pathol Inform 2012, 3:34  http://www.jpathinformatics.org/content/3/1/34Figures 4: Results of the satisfaction survey taken after completing  the vignettes traditional lecture/laboratory setting.",Non-OADS,/arxiv_data1/oa_pdf/8b/23/JPI-3-34.PMC3519009.pdf
"J Pathol Inform 2012, 3:34  http://www.jpathinformatics.org/content/3/1/34REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/23/JPI-3-34.PMC3519009.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/36/101803 Copyright: © 2012 Khurana KK.,Non-OADS,/arxiv_data1/oa_pdf/64/83/JPI-3-36.PMC3519010.pdf
"J Pathol Inform 2012, 3:36  http://www.jpathinformatics.org/content/3/1/36INTRODUCTION Locoregional axillary lymph node status has long been  the gold standard in determining the management  and prognosis of breast carcinoma patients.",Non-OADS,/arxiv_data1/oa_pdf/64/83/JPI-3-36.PMC3519010.pdf
"J Pathol Inform 2012, 3:36  http://www.jpathinformatics.org/content/3/1/36Figure 1: The telecytopathology digital system comprises an  Olympus camera and a monitor with a microscope Figure 2: Reactive lymph node in ultrasound-guided fine needle  aspiration (USG-FNA) of axillary lymph node specimen viewed  remotely on a computer screen using telecytopathology digital  system (Diff-Quik) the telecytopathology cases were performed by the  cytopathologist.",Non-OADS,/arxiv_data1/oa_pdf/64/83/JPI-3-36.PMC3519010.pdf
"J Pathol Inform 2012, 3:36  http://www.jpathinformatics.org/content/3/1/36breast parenchyma with ductal ectasia was identified in  the cell block [Figure 4] and the atypical epithelial cells  identified on the smears correlated with those lining the  ectatic duct in the cell block material.",Non-OADS,/arxiv_data1/oa_pdf/64/83/JPI-3-36.PMC3519010.pdf
"J Pathol Inform 2012, 3:36  http://www.jpathinformatics.org/content/3/1/36(35%) required more than two passes to obtain adequate  material for cytologic diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/64/83/JPI-3-36.PMC3519010.pdf
"J Pathol Inform 2012, 3:36  http://www.jpathinformatics.org/content/3/1/36services as long as they participate in the preliminary  evaluation of these passes and assess the need for  additional passes to obtain material for cytologic diagnosis  and ancillary studies.",Non-OADS,/arxiv_data1/oa_pdf/64/83/JPI-3-36.PMC3519010.pdf
Accessed  through https://docs.google.com 4.,Non-OADS,/arxiv_data1/oa_pdf/8a/ce/LI-29-319.PMC3519015.pdf
Accessed through https://docs.google.com/ viewer 9.,Non-OADS,/arxiv_data1/oa_pdf/8a/ce/LI-29-319.PMC3519015.pdf
Accessed through http://www.indmedica.com /journals 11.,Non-OADS,/arxiv_data1/oa_pdf/8a/ce/LI-29-319.PMC3519015.pdf
[Accessed through http://www.nepjol.info/index.,Non-OADS,/arxiv_data1/oa_pdf/8a/ce/LI-29-319.PMC3519015.pdf
"Each of seven components of PSQI was scored from 0 to  3, and global score of PSQI was calculated using PSQI  scoring database (http://www.sleep.pitt.edu).",OADS,/arxiv_data1/oa_pdf/3c/4a/LI-29-332.PMC3519018.pdf
Available from: http://www.who.int/ csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_4/en/.,OADS,/arxiv_data1/oa_pdf/45/11/LI-29-341.PMC3519020.pdf
"Department of Pulmonary Medicine,   CHRISTIAN MEDICAL COLLEGE (CMC), VELLORE, TN (in collaboration with) INTERNATIONAL ASTHMA SERVICES (IAS) ,   COLORADO, USA Invite application for 1 year distance education program (Diploma in Allergy & Asthma) with 4 one week contact sessions at Vellore (Tamilnadu) The training will be imparted by both International & National facultyEligibility:M.D / DNB in TB & Chest / Respiratory medicine / General Medicine/ PaediatricsDTCD / DCH / M.S (E.N.T)MBBS (with proven track record in the field of allergy & asthma) The course is likely to start in January 2013 Completed application should be received before: 15 th October 2012 To download application forms, logon to: http://www.cm ch‑vellore.edu/DAA/main.html     E‑Mail:  daacmc@gmail.comAnnouncementHow to cite this article: Sharma R, Kaur S, Sodhi A.",Non-OADS,/arxiv_data1/oa_pdf/45/11/LI-29-341.PMC3519020.pdf
Available from:  http://www.archive.org/details/ hippocrates02hippuoft.,Non-OADS,/arxiv_data1/oa_pdf/a9/6e/LI-29-354.PMC3519022.pdf
Email: raghupathy.a@iiphh.org and nandu.k@iiphh.org   Website: http://ceu.phpc.cam.ac.uk/staff/raghupathy ‑anchala/ Announcement,Non-OADS,/arxiv_data1/oa_pdf/a9/6e/LI-29-354.PMC3519022.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/12/LI-29-370.PMC3519025.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/6b/12/LI-29-370.PMC3519025.pdf
Available from: http://www.pediatricurologybook.com/kidney_fusion.html [Last accessed on 2011 Dec 8].,Non-OADS,/arxiv_data1/oa_pdf/12/a1/LI-29-373.PMC3519026.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/12/a1/LI-29-373.PMC3519026.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/32/ed/LI-29-378.PMC3519028.pdf
Available from: http://www.who-umc.org/graphics/4409.,Non-OADS,/arxiv_data1/oa_pdf/30/75/LI-29-395.PMC3519036.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/33/101782 Copyright: © 2012 Qi X.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33to represent image texture: statistical methods, structural  methods and model based methods.",OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33different imaging conditions.",Non-OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33Region distortion is implemented using a B-splines  transformation, which deforms a specific region in the  image by manipulating an underlying mesh of control  points.",OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33calculated using a multi-resolution approach to gray- scale and rotation invariant texture extraction based  LBP .",OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33and 40 ×) with even illumination under focal plane.",Non-OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33At different illumination levels, TFCM has the highest  generative power; Texton has the lowest generative  power; CSAC, COOC and LBP have the medium  generative power.",OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33T able 1: The performance evaluation ranking results T ype I COOC CSAC LBP T exton TFCM T ype II COOC CSAC LBP T exton TFCM M 2 4 3 1 5 M 2 3 4 5 1 O 1 4 2 3 5 O 2 5 3 4 1 I 3 4 2 1 5 I 2 4 5 3 1 N 1 5 3 2 4 N 3 5 4 1 2 C 3 5 2 1 4 C 2 4 3 5 1 D 3 5 1 2 4 D 2 5 3 4 1 R 3 5 2 1 4 R 2 5 3 4 1 5 denotes the highest score (the smallest D value) and 1 denotes the lowest score (the largest D value) for both generative (type I) and discriminative (type II) powers.",Non-OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33At different distortion levels, CSAC has the highest  generative power; COOC, TFCM and texton have the  medium level generative power; and LBP has the lowest  generative power.",OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33average runtime for each feature extraction method to  execute an image on a single worker.",OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
"J Pathol Inform 2012, 3:33  http://www.jpathinformatics.org/content/3/1/33Research Resources, UL1RR033173, and the National Centre  for Advancing Translational Sciences, UL1TR000117.",Non-OADS,/arxiv_data1/oa_pdf/eb/c1/JPI-3-33.PMC3519094.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/41/103995 Copyright: © 2012 Lee RE.,Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41FELLOWSHIP TRAINING IN PATHOLOGY  INFORMATICS Pathologists analyze blood, fluids, and tissue.",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41in formal Pathology Informatics fellowship programs  across the nation.",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41The goals and concerns of our fellows are not unique.",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41faculty members are asked to create and facilitate cases  from their area(s) of expertise, ideally calling upon their own work experiences.",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41T able 2: Schedule of a typical one-day long retreat Session Session schedule and description Morning session 8:00 – 8:30 AM: Meet and greet with breakfast, introduction of today’s instructors 8:30 – 9:00 AM: Discuss the goals of the event, recap of the events from the prior retreat 9:00 – 10:00 AM: Short Case #1 10:00 – 11:00 AM: Short Case #2 11:00 – 12:00 AM: Short Case #3 Lunch 12:00 – 1:00 PM: Lunch in retreat conference room Afternoon session 1 1:00 – 1:45 PM: Quick Hits, session 1 (Three 15-minutes cases each)1:45 – 2:30 PM: Quick Hits, session 2 (Three 15-minutes cases each) Afternoon session 2 2:30 – 3:45 PM: Long case, presentation and workup3:45 – 4:30 PM: Long case, group discussion Retreat recap 4:30 – 5:00 PM: Recap, thoughts, discussion, and feedback of the day’s events Adjourn 5:00 PM The schedule of a typical 1-day Pathology Informatics Fellow Retreat (adapted from the “Instructor’s Manual” from the 2012 Spring Retreat).",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41Figure 1: Pathology informatics faculty and fellows at the summer 2011 retreat concentrating on a wide range of leadership and  management issues.",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"J Pathol Inform 2012, 3:41  http://www.jpathinformatics.org/content/3/1/41of the active pathology informatics fellows in the country  a chance to meet on a quarterly basis (three informatics retreats and the Pathology Informatics 2011 meeting).",Non-OADS,/arxiv_data1/oa_pdf/b1/f4/JPI-3-41.PMC3519095.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/38/103008 Pantanowitz L, T uthill JM,  Balis UGJ (Editors).",Non-OADS,/arxiv_data1/oa_pdf/61/9c/JPI-3-38.PMC3519096.pdf
"J Pathol Inform 2012, 3:38  http://www.jpathinformatics.org/content/3/1/38practical purposes.",Non-OADS,/arxiv_data1/oa_pdf/61/9c/JPI-3-38.PMC3519096.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/40/103013,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40HGP was expected to provide mankind with a dramatic  advance in our understanding of human health and spawn  a revolution in personalized healthcare approaches.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"The major commercial entities which came  into existence after the success of the HGP include[6]  454 sequencing (http://www.my454.com/), Solexa/ Illumina (http://www.illumina.com), SOLiD (http://www.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"Beyond the 2nd generation and benchtop sequencing  instrumentation, the “third generation” sequencers Helicos  Heliscope (http://www.helicosbio.com), Pacific Biosciences  SMRT (http://www.pacificbiosciences.com) and Oxford  Nanopore (http://www.nanoporetech.com) are being  actively developed.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40using engineered protein polymerases.",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40informational integration.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
These panels are used to assess risk for recurrence of  cancer and make treatment decisions whether to deliver adjunct chemotherapy in breast cancer patients or not  (http://www.agendia.com/pages/mammaprint/21.,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
The latest version (GRCh37) of the human reference  genome is provided by the Genome Reference  Consortium (see http://www.ncbi.nlm.nih.gov/projects/ genome/assembly/grc/index.shtml for details).,OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40desired.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
see http://seqanswers.com/ wiki/Software/list).,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"These include software  such as Velvet,[43,44] EULER-SR,[45] EDENA,[46] QSRA,[47]  AbYSS,[48] AllPathsLG (http://www.broadinstitute.org/ software/allpaths-lg), Ray and SoapDeNovo (http://soap.",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40the implementing clinical lab to ensure adequate quality of  the DNA sequence that is produced and analysed.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"Examples of such software include SNVmix,[51]  VarScan[52] and SomaticSniper (http://gmt.genome.wustl.",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40at understanding these multiple layers of biologic  complexity.",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"For a comprehensive listing of  noncoding RNAs, the reader is referred to online database  of NONCODE (http://www.noncode.org/NONCODERv3/).",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40and dedicated and shared nodes for research.",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
Data source – http://www.genome.gov/sequencingcosts/ Figure  3: Storage and computational processor trends over time.,OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40data formats.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40statistics to create an environment that encourages  collaboration of ideas for data analysis.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40comprehensive, molecular scale view of the human genome.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40limited only to diseases and subsets for which the  patient presents for evaluation and management?",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40APPENDIX A Appendix A: List of drugs currently approved by the  Food and Drug Administration (FDA) with associated pharmacogenomic information.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"Clinical specialty Drugs used Associated genes Allergy Desloratadine and Pseudoephedrine CYP2D6 Analgesics Celecoxib, Codeine CYP2C9, CYP2D6 Tramadol and Acetaminophen CYP2D6 Antiarrhythmics Quinidine CYP2D6 Antifungals Terbinafine, 	Voriconazole CYP2D6, CYP2C19 Anti-infectives Chloroquine, Rifampin, Isoniazid, and  PyrazinamideG6PD, NAT1; NAT2 Antivirals Abacavir,	Boceprevir, 	Maraviroc	Nelfinavir, 	 Peginterferon alfa-2b, T elaprevirHLA-B*5701, IL28B, CCR5, CYP2C19, IL28B  IL28B Cardiovascular Carvedilol, Clopidogrel, Isosorbide and  Hydralazine, Metoprolol, Prasugrel, Pravastatin,  Propafenone, Propranolol, TicagrelorCYP2D6, CYP2C19, NAT1; NAT2, CYP2D6 CYP2C19 , Genotype E2/ E2 and Fredrickson Type III  dysbetalipoproteinemia, CYP2D6 CYP2D6, CYP2C19 Dermatology and Dental Cevimeline, Dapsone, Fluorouracil, Tretinoin CYP2D6, G6PD, DPD PML/RARa Gastroenterology Dexlansoprazole (1)‡, Dexlansoprazole (2),  Esomeprazole, Pantoprazole, Rabeprazole Sodium Phenylacetate and Sodium Benzoate,  Sodium PhenylbutyrateCYP2C19, CYP1A2, CYP2C19, CYP2C19,  CYP2C19, UCD (NAGS; CPS; ASS; OTC; ASL;  ARG), UCD (NAGS; CPS; ASS; OTC; ASL; ARG) Hematology Lenalidomide, Warfarin (1), Warfarin (2) 5q Chromosome, CYP2C9, VKORC1 Metabolic and  EndocrinologyAtorvastatin LDL receptor Musculoskeletal Carisoprodol, Mivacurium CYP2C9 , Cholinesterase gene Neurology Carbamazepine, Dextromethorphan and  Quinidine, Galantamine, T etrabenazineHLA-B*1502, CYP2D6, CYP2D6, CYP2D6 Oncology Arsenic Trioxide, Brentuximab Vedotin, Busulfan,  Capecitabine, Cetuximab (1), Cetuximab (2),  Crizotinib, Dasatinib, Erlotinib Fulvestrant, 	Gefitinib	(1), 	Gefitinib	(2), 	Imatinib	 (1), Imatinib (2), Imatinib (3), Imatinib (4) Irinotecan, Lapatinib, Mercaptopurine, Nilotinib  (1), Nilotinib (2), Panitumumab (1), Panitumumab  (2), Rasburicase, Tamoxifen, Thioguanine,  T ositumomab, Trastuzumab, VemurafenibPML/RARa , CD30, Ph Chromosome, DPD EGFR, KRAS, ALK , Ph Chromosome, EGFR ER receptor, CYP2D6, EGFR , C-Kit,  Ph Chromosome, PDGFR, FIP1L1- PDGFRa, UGT1A1, Her2/neu, TPMT , Ph  Chromosome, UGT1A1, EGFR, KRAS,  G6PD , ER receptor, TPMT , CD20 antigen,  Her2/neu, BRAF Opththalmology Timolol CYP2D6 Psychiatry Aripiprazole, Atomoxetine, Chlordiazepoxide and  Amitriptyline, Citalopram (1), Citalopram (2) Clomipramine, Clozapine, Desipramine,  Diazepam, Doxepin, Fluoxetine, Fluoxetine  and Olanzapine, Fluvoxamine (1), Fluvoxamine  (2), Fluvoxamine (3), Iloperidone, Imipramine,  Modafinil	(1), 	Modafinil	(2), 	Nefazodone, 	 Nortriptyline, Paroxetine, Perphenazine,  Pimozide, Protriptyline, Risperidone, Thioridazine,  Trimipramine, Valproic Acid, VenlafaxineCYP2D6, CYP2D6, CYP2D6, CYP2C19,  CYP2D6, CYP2D6, CYP2D6, CYP2D6,  CYP2C19, CYP2D6, CYP2D6, CYP2D6,  CYP2C9, CYP2C19, CYP2D6, CYP2D6,  CYP2D6, CYP2C19, CYP2D6, CYP2D6,  CYP2D6, CYP2D6, CYP2D6, CYP2D6,  CYP2D6, CYP2D6, CYP2D6, CYP2D6, UCD  (NAGS; CPS; ASS; OTC; ASL; ARG), CYP2D6 Pulmonary Tiotropium CYP2D6 Reproductive Drospirenone and Ethinyl Estradiol Clomiphene, T olterodineCYP2C19 , Rh genotype, CYP2D6 Rheumatology Azathioprine, Flurbiprofen TPMT, CYP2C9 §Data source - http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm, ‡Numbers in the brackets indicate that the drug is affected by  multiple genetic polymorphisms",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
"J Pathol Inform 2012, 3:40  http://www.jpathinformatics.org/content/3/1/40VarScan: Variant detection in massively parallel sequencing of individual and  pooled samples.",OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
Northfield: 	College	of	American	 Pathologists; Available from: http://www.cap.org/apps/cap.portal [Last  accessed on 2011 Oct 13].,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
Chicago: American Medical  Association; Available from: http://www.ama-assn.org/ama/pub/physician- resources/solutions-managing-your-practice/coding-billing-insurance/cpt/ applying-cpt-codes.page [Last accessed on 2009 Jul 29].,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/JPI-3-40.PMC3519097.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2012/3/1/39/103009 Access this article online Quick Response Code: Website:  www.jpathinformatics.org DOI: 10.4103/2153-3539.103009,Non-OADS,/arxiv_data1/oa_pdf/19/0a/JPI-3-39.PMC3519098.pdf
"J Pathol Inform 2012, 3:39  http://www.jpathinformatics.org/content/3/1/39(ASAP) from adenocarcinoma on prostate biopsy, and  the other was resolving the presence of Helicobacter pylori   on immunohistochemical staining of gastric biopsies.",Non-OADS,/arxiv_data1/oa_pdf/19/0a/JPI-3-39.PMC3519098.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d1/3e/UA-4-137.PMC3519103.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/73/ca/UA-4-162.PMC3519108.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/73/ca/UA-4-162.PMC3519108.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/66/25/UA-4-191.PMC3519115.pdf
Available from:  http://www.icjme.org.,Non-OADS,/arxiv_data1/oa_pdf/c1/fe/JOMFP-16-312.PMC3519199.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a5/8d/JOMFP-16-368.PMC3519212.pdf
Available from: https://www.nacoonline.,Non-OADS,/arxiv_data1/oa_pdf/5c/d0/JOMFP-16-388.PMC3519215.pdf
Available  from: http://www.unaids.org/epidemic‑update/  [Last accessed  on 2012 Jan].,OADS,/arxiv_data1/oa_pdf/5c/d0/JOMFP-16-388.PMC3519215.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.,Non-OADS,/arxiv_data1/oa_pdf/01/f2/JOMFP-16-435.PMC3519225.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ee/f4/JOMFP-16-438.PMC3519226.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/8e/e7/JOMFP-16-446.PMC3519229.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8e/e7/JOMFP-16-446.PMC3519229.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Altered neurochemical profile after TBI JL Harris et al 2134 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 2122–2134",Non-OADS,/arxiv_data1/oa_pdf/69/fc/jcbfm2012114a.PMC3519407.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NOTCH3 affects actin organization in CADASIL VSMCs S Tikka et al 2180 Journal of Cerebral Blood Flow & Metabolism (2012), 2171 – 2180 &2012 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/jcbfm2012123a.PMC3519411.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 10/01/12; Accepted: 10/01/12http://dx.doi.org/10.4161/fly.22463Development and Evolution   of Abdominal Segment Reduction   pp.,Non-OADS,/arxiv_data1/oa_pdf/bc/a8/fly-6-211.PMC3519654.pdf
"The process by which a Drosophila egg acquires its elongated shape provides an  *Correspondence to: Julie Gates; Email: julie.gates@bucknell.edu Submitted: 06/30/12; Revised: 08/22/12; Accepted: 08/24/12http://dx.doi.org/10.4161/fly.21969As tissues and organs are formed, they acquire a specific shape  that plays an integral role in their ability to function properly.",Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Science  2011; 331:1071-4; PMID:21212324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nat Cell Biol 2010; 12:1133- 42; PMID:21102441; http://dx.doi.org/10.1038/ ncb2124.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cold Spring Harb Perspect Biol 2009; 1:a001891; PMID:20066085; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol  1994; 165:336-51; PMID:7958404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Annu Rev Genet 2002; 36:455- 88; PMID:12429700; http://dx.doi.org/10.1146/ annurev.genet.36.052802.114101.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell Death Differ  2000; 7:1071-4; PMID:11139280; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 2004; 274:3-14; PMID:15355784;  http://dx.doi.org/10.1016/j.ydbio.2004.07.017.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 2007; 311:1-10; PMID:17884037; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Dyn  2006; 235:1455-68; PMID:16586443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 2009; 331:129-39; PMID:19409378;  http://dx.doi.org/10.1016/j.ydbio.2009.04.028.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 2010; 341:20-33; PMID:19914236; http://dx.doi.org/10.1016/j.ydbio.2009.11.014.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nat  Rev Mol Cell Biol 2003; 4:13-24; PMID:12511865;  http://dx.doi.org/10.1038/nrm1006.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
T rends Cell Biol 2002; 12:325-31; PMID:12185849; http://dx.doi.org/10.1016/S0962- 8924(02)02311-5.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Semin Cell Dev Biol  2008; 19:271-82; PMID:18304845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
J Cell Sci 2010; 123:1385-8; PMID:20410370;  http://dx.doi.org/10.1242/jcs.066183.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell 1992; 69:11-25; PMID:1555235; http://dx.doi.org/10.1016/0092- 8674(92)90115-S. 54.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Curr Opin Cell Biol  2003; 15:607-13; PMID:14519396; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Development 2003; 130:173- 84; PMID:12441301; http://dx.doi.org/10.1242/ dev.00199.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nat Rev Cancer 2003; 3:422-33; PMID:12778132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Proc Natl Acad Sci USA 1982; 79:1761- 5; PMID:6210912; http://dx.doi.org/10.1073/ pnas.79.6.1761.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Gene  1997; 198:17-25; PMID:9370260; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Neurobiol 2011; 71:1102- 30; PMID:21688401; http://dx.doi.org/10.1002/ dneu.20935.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Development 2009; 136:4123- 32; PMID:19906848; http://dx.doi.org/10.1242/ dev.039099.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
T rends Cell Biol 2011; 21:718-26; PMID:21924908; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell 2004; 116:167-79; PMID:14744429; http://dx.doi.org/10.1016/S0092-8674(04)00003-0.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cytoskeleton (Hoboken) 2010; 67:545- 54; PMID:20803696; http://dx.doi.org/10.1002/ cm.20472.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nature 2002; 416:438-42;  PMID:11919634; http://dx.doi.org/10.1038/416438a.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 2007; 305:470-82; PMID:17383630; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell 2000; 101:283-94; PMID:10847683;  http://dx.doi.org/10.1016/S0092-8674(00)80838-7.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
PLoS  One 2012; 7:e33737; PMID:22438988; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Genetics 2011; 187:501-12;  PMID:21098722; http://dx.doi.org/10.1534/genet - ics.110.120998.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Cell 2002; 3:569-79;  PMID:12408808; http://dx.doi.org/10.1016/S1534- 5807(02)00290-3.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nat Cell Biol 2005; 7:510-6;  PMID:15852002; http://dx.doi.org/10.1038/ ncb1253.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell 1996; 84:611-22; PMID:8598047;  http://dx.doi.org/10.1016/S0092-8674(00)81036-3.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Neuron 1999; 22:301-12; PMID:10069336; http://dx.doi.org/10.1016/S0896- 6273(00)81091-0.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
J Cell Sci  2009; 122:1947-53; PMID:19494122; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Tissue Eng Part A 2008; 14:1479-88; PMID:18707228;  http://dx.doi.org/10.1089/ten.tea.2008.0124.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Biol Cell 1990; 68:119-27; PMID:1694097; http://dx.doi.org/10.1016/0248-4900(90)90296-F .,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Tissue Cell  1991; 23:853-65; PMID:1796455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol  2010; 338:136-47; PMID:19962374; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell 2011;   145:1012-22; PMID:21703446; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
J Cell Sci 2009; 122:4363- 74; PMID:19903692; http://dx.doi.org/10.1242/ jcs.055996.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Mech Dev 2006; 123:801-18; PMID:17008069; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Curr Biol 2001; 11:1317-27; PMID:11553324;  http://dx.doi.org/10.1016/S0960-9822(01)00420-1.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Development 2006; 133:3805-15; PMID:16943280;  http://dx.doi.org/10.1242/dev.02549.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Development 2003; 130:5065-72; PMID:12975340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Mol Cell Endocrinol 2012; 353:10-20; PMID:22108439;  http://dx.doi.org/10.1016/j.mce.2011.11.005.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nature 2002; 420:629-35; PMID:12478284; http://dx.doi.org/10.1038/nature01148.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol  2010; 341:114-25; PMID:19874815; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Oncogene 2001; 20:6459-72; PMID:11607845; http://dx.doi.org/10.1038/ sj.onc.1204786.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
J Microsc  2008; 231:446-54; PMID:18755000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Curr Opin Cell Biol 2011; 23:531-9; PMID:21764278;  http://dx.doi.org/10.1016/j.ceb.2011.06.002.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Curr Biol 2011; 21:R231-3; PMID:21419992; http://dx.doi.org/10.1016/j.cub.2011.01.071.75.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Development 2003; 130:4001-10;  PMID:12874122; http://dx.doi.org/10.1242/ dev.00595.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 1977; 55:392-6; PMID:838125;  http://dx.doi.org/10.1016/0012-1606(77)90182-8.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Int J Insect Morphol 1978; 7:415-26;  http://dx.doi.org/10.1016/S0020-7322(78)80003-8.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Science 2003; 302:1704-9; PMID:14657486; http://dx.doi.org/10.1126/sci - ence.1092053.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Curr Biol 2007; 17:1349-55; PMID:17656094; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Biol 2010; 341:360- 74; PMID:20211163; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
BMC Dev Biol 2010; 10:40; PMID:20406475;  http://dx.doi.org/10.1186/1471-213X-10-40.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Dev Genes Evol 2002; 212:218-29; PMID:12070612; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Cell 2004; 119:245- 56; PMID:15479641; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
G3 (Bethesda) 2012; 2:371-8; PMID:22413091; http://dx.doi.org/10.1534/ g3.111.001677.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
Nat Rev Mol Cell Biol 2006; 7:253- 64; PMID:16607288; http://dx.doi.org/10.1038/ nrm1891.,OADS,/arxiv_data1/oa_pdf/1e/17/fly-6-213.PMC3519655.pdf
"Cell 2011; 147:690-703; PMID:22036573;  http://dx.doi.org/10.1016/j.cell.2011.08.047.Keywords:  mass spectrometry, pro - teomics, affinity purifications, protein  complex map, Drosophila proteome, interaction mapping, high-throughput techniques Submitted: 07/23/12Revised: 08/29/12Accepted: 09/07/12http://dx.doi.org/10.4161/fly.22108 *Correspondence to: Spyros Artavanis-Tsakonas;  Email: artavanis@hms.harvard.eduProteins perform essential cellular  functions as part of protein com - plexes, often in conjunction with RNA, DNA, metabolites and other small mole - cules.",OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
"The raw mass  spectrometry data that passed our quality  control regime have been regularly made  available, prior to publication, through  FlyBase (http://flybase.org/) where they  have been widely used by the commu - nity.",OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Cell 2011; 147:690- 703; PMID:22036573; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Genome Biol 2002; 3:RESEARCH0080;  PMID:12537569; http://dx.doi.org/10.1186/gb- 2002-3-12-research0080.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Methods Mol Biol 2011; 723:257-72;  PMID:21370071; http://dx.doi.org/10.1007/978-1- 61779-043-0_17.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Genome Res 2011; 21:301- 14; PMID:21177962; http://dx.doi.org/10.1101/ gr.112961.110.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Genome Res 2003; 13:2129-41; PMID:12952881;  http://dx.doi.org/10.1101/gr.772403.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
BMC Bioinformatics  2007; 8:236; PMID:17605818; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nucleic  Acids Res 2011; 39(Database issue):D736-43;  PMID:21036869; http://dx.doi.org/10.1093/nar/ gkq1092.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nucleic Acids Res 2002; 30:1575- 84; PMID:11917018; http://dx.doi.org/10.1093/ nar/30.7.1575.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nature  2011; 471:473-9; PMID:21179090; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nat Genet 2007; 39:715- 20; PMID:17534367; http://dx.doi.org/10.1038/ ng2049.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Science 2010; 330:1787-97; PMID:21177974; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nat Rev Genet  2012; 13:654-66; PMID:22868267; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Genome Biol 2012; 13:r28;  PMID:22531030; http://dx.doi.org/10.1186/gb- 2012-13-4-r28.References 1.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Science 2003; 302:1727- 36; PMID:14605208; http://dx.doi.org/10.1126/sci - ence.1090289.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Science 2004; 303:540- 3; PMID:14704431; http://dx.doi.org/10.1126/sci - ence.1091403.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Cell 2005; 122:957-68; PMID:16169070;  http://dx.doi.org/10.1016/j.cell.2005.08.029.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nature 2005; 437:1173-8; PMID:16189514; http://dx.doi.org/10.1038/nature04209.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Genome Biol 2004;  5:R96; PMID:15575970; http://dx.doi.org/10.1186/ gb-2004-5-12-r96.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nature 2010; 466:68-76; PMID:20562859;  http://dx.doi.org/10.1038/nature09204.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Mol Syst  Biol 2007; 3:89; PMID:17353931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Cell 2009; 138:389-403; PMID:19615732; http://dx.doi.org/10.1016/j.cell.2009.04.042.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nature 2002; 415:180-3; PMID:11805837; http://dx.doi.org/10.1038/415180a.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nature  2006; 440:631-6; PMID:16429126; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
These lines were generated at the Drosophila Transgenic Fly Facility   (http://www.ncbs.res.in/tff) and are listed on the DPiM website (https://interfly.med.harvard.edu/transgenic_info.php).,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Methods Mol Biol 2010; 658:187-204;  PMID:20839105; http://dx.doi.org/10.1007/978-1- 60761-780-8_11.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Anal Chem 2008; 80:2921- 31; PMID:18312001; http://dx.doi.org/10.1021/ ac702422x.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
J Cell Biol 2011; 192:481-95; PMID:21300852;  http://dx.doi.org/10.1083/jcb.201004016.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Proc Natl Acad Sci U S A  2005; 102:1974-9; PMID:15687504; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Bioinformatics  2009; 25:i253-8; PMID:19477996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Sci STKE 2005; 2005:pl2; PMID:15657263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Nucleic Acids Res 2009;  37(Database issue):D555-9; PMID:18948289;  http://dx.doi.org/10.1093/nar/gkn788.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Cell 2012; 150:1068- 81; PMID:22939629; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Genetics 2007; 177:2493-505;  PMID:18073442; http://dx.doi.org/10.1534/genet - ics.107.080994.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
Proc Natl Acad Sci U S A 2009;  106:2218-23; PMID:19171888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
PLoS One 2008; 3:e3209;  PMID:18791638; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/fly-6-246.PMC3519659.pdf
"Do not distribute.Fly 6:4, 254-260; October/November/December 2012; © 2012 Landes Bioscience EXTRA VIEW 254 F ly  V olume 6 Issue 4Keywords:  Drosophila larva, hemato - poiesis, microenvironment, hemocyte,  hematopoietic pocket, peripheral nervous system, sensory neuron, tissue macro - phage, hematopoietic stem cell, niche Submitted: 07/22/12Revised: 09/13/12Accepted: 09/17/12http://dx.doi.org/10.4161/fly.22267 *Correspondence to: Katja Brückner;   Email: katja.brueckner@ucsf.eduHematopoiesis is well-conserved  between Drosophila and verte - brates.",Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev 2011; 138:5379-91; PMID: 22071105; http://dx.doi.org/10.1242/dev.067322,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science 1999; 284:1991-4;  PMID:10373118; http://dx.doi.org/10.1126/sci - ence.284.5422.1991.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell 2005; 123:335-46;  PMID:16239149; http://dx.doi.org/10.1016/j.cell.2005.08.034.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell Cycle  2007; 6:1443-4; PMID:17582220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Rev  Mol Cell Biol 2007; 8:542-51; PMID:17565363;  http://dx.doi.org/10.1038/nrm2202.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell Mol  Life Sci 2009; 66:2643-50; PMID:19418022; http://dx.doi.org/10.1007/s00018-009-0036-0.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Cell 2003; 5:673-90;  PMID:14602069; http://dx.doi.org/10.1016/S1534- 5807(03)00335-6.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Growth Differ 1982; 24:65-82; http://dx.doi.org/10.1111/j.1440-169X.1982.00065.x.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Biol  2001; 230:243-57; PMID:11161576; http://dx.doi.org/10.1006/dbio.2000.0123.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Acta Biol Hung 2007; 58(Suppl):95-111; PMID:18297797;  http://dx.doi.org/10.1556/ABiol.58.2007.Suppl.8.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Annu Rev Cell Dev Biol  2006; 22:677-712; PMID:16824014; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Insect Physiol 2006; 52:417-29; PMID:16527302; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science 2000; 288:146-9; PMID:10753120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
"Dev  Comp Immunol 1992; 16:103-10; PMID:1499832;  http://dx.doi.org/10.1016/0145-305X(92)90011-Z.Much like Drosophila larval hemocytes,  vertebrate tissue macrophages expand  within local microenvironments.82,84,86,97,99  However, compared with the systemic  functions of Drosophila larval hemo - cytes,16,23,60 vertebrate tissue macrophages  may have evolved to adopt more restricted, tissue-specific roles.",Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Annu Rev Immunol  2007; 25:697-743; PMID:17201680; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Genes Evol 2011; 221:121-31;  PMID:21509534; http://dx.doi.org/10.1007/ s00427-011-0364-6.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Genet  2004; 36:1019-23; PMID:15286786; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Immunol 2008; 9:129-36; PMID:18204427;  http://dx.doi.org/10.1038/ni1560.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Semin Cell Dev Biol 2011; 22:1036-47;  PMID:22001113; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Genes Dev 2003; 17:348-53; PMID:12569125;  http://dx.doi.org/10.1101/gad.1052803.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Development 2011; 138:5379-91; PMID:22071105; http://dx.doi.org/10.1242/dev.067322.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Development 2003; 130:4955-62; PMID:12930778;  http://dx.doi.org/10.1242/dev.00702.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Biol Chem 2010;  285:11607-16; PMID:20139076; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Dyn 2012; 241:16- 26; PMID:21932321; http://dx.doi.org/10.1002/ dvdy.22737.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Proc Natl Acad Sci USA 2007; 104:5199-204; PMID:17360325; http://dx.doi.org/10.1073/ pnas.0700895104.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nature  2010; 468:921-6; PMID:21068723; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell 2003; 113:261-73; PMID:12705873; http://dx.doi.org/10.1016/S0092-8674(03)00272-1.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Neuron 1989; 3:21-32; PMID:2515889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Genes Dev 1999; 13:2549- 61; PMID:10521399; http://dx.doi.org/10.1101/gad.13.19.2549.38.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nature 2007; 446:320- 4; PMID:17361183; http://dx.doi.org/10.1038/ nature05585.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Biol 2007; 305:726-34; PMID:17418114; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Development 2007; 134:2387-96; PMID:17522156;  http://dx.doi.org/10.1242/dev.003616.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Genetics 2008; 180:253-67; PMID:18757933; http://dx.doi.org/10.1534/genet - ics.108.089094.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Genes Dev 2007;  21:3044-60; PMID:18056420; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev  Cell 2009; 16:756-63; PMID:19460351; http://dx.doi.org/10.1016/j.devcel.2009.03.003.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science  2011; 332:1210-3; PMID:21636775; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Biol  2011; 352:308-16; PMID:21295568; http://dx.doi.org/10.1016/j.ydbio.2011.01.035.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Cell Biol  2012; 14:394-400; PMID:22407365; http://dx.doi.org/10.1038/ncb2453.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Cell  Biol 2010; 12:605-10; PMID:20495554; http://dx.doi.org/10.1038/ncb2063.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Development 2005; 132:2521- 33; PMID:15857916; http://dx.doi.org/10.1242/ dev.01837.22.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nature 2007; 446:325-8; PMID:17361184; http://dx.doi.org/10.1038/nature05650.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Oncogene  1999; 18:6875-87; PMID:10602463; http://dx.doi.org/10.1038/sj.onc.1203223.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Differentiation 2001; 69:83-90;  PMID:11798069; http://dx.doi.org/10.1046/j.1432- 0436.2001.690202.x.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Biol  2002; 248:369-83; PMID:12167411; http://dx.doi.org/10.1006/dbio.2002.0740.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell  2002; 108:865-76; PMID:11955438; http://dx.doi.org/10.1016/S0092-8674(02)00676-1.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
EMBO Rep 2002; 3:1195- 200; PMID:12446570; http://dx.doi.org/10.1093/ embo-reports/kvf242.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Curr Biol  2002; 12:1923-7; PMID:12445385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Blood Cells Mol Dis  2003; 30:223-8; PMID:12732186; http://dx.doi.org/10.1016/S1079-9796(03)00028-7.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev  Cell 2004; 7:73-84; PMID:15239955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
EMBO J 2004; 23:3984-94; PMID:15457211; http://dx.doi.org/10.1038/sj.emboj.7600417.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Exp Med 2007; 204:2545-52; PMID:17938236; http://dx.doi.org/10.1084/ jem.20071401.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Immunol 2010; 185:3248-55; PMID:20713882;  http://dx.doi.org/10.4049/jimmunol.1000981.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Trends Mol Med 2007; 13:72-81; PMID:17197241;  http://dx.doi.org/10.1016/j.molmed.2006.12.003.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Immunol 2006; 7:333-7;  PMID:16550195; http://dx.doi.org/10.1038/ni1331.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell 2007; 131:994-1008; PMID:18045540;  http://dx.doi.org/10.1016/j.cell.2007.09.047.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat  Rev Immunol 2008; 8:290-301; PMID:18323850;  http://dx.doi.org/10.1038/nri2279.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Curr Opin Hematol 2009; 16:235- 42; PMID:19417648; http://dx.doi.org/10.1097/ MOH.0b013e32832bd0f5.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell Stem  Cell 2011; 8:72-83; PMID:21211783; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
"Leukemia Research Fund, UK 2012; 26:63-72;  http://dx.doi.org/10.1038/leu.2011.242.",Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell 2006; 124:407- 21; PMID:16439213; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nature 2008; 452:442- 7; PMID:18256599; http://dx.doi.org/10.1038/ nature06685.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Trends  Pharmacol Sci 2004; 25:640-6; PMID:15530642;  http://dx.doi.org/10.1016/j.tips.2004.10.007.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Digestion 2002; 66:79-88; PMID:12428066;  http://dx.doi.org/10.1159/000065594.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science  2008; 322:1250-4; PMID:19023081; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Neurobiol 2012;  PMID:22648905; http://dx.doi.org/10.1002/ dneu.22039.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science 2012; 336:86-90;  PMID:22442384; http://dx.doi.org/10.1126/sci - ence.1219179.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Annu Rev Immunol 2007; 25:745-85; PMID:17201678; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141538.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell 2008; 132:612-30; PMID:18295579;  http://dx.doi.org/10.1016/j.cell.2008.01.041.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Curr Opin Hematol 2009; 16:243-8; PMID:19491671; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Immunol  2006; 7:76-82; PMID:16341216; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Exp Med 2011; 208:421- 8; PMID:21402747; http://dx.doi.org/10.1084/ jem.20110132.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nature 2010; 466:829-34; PMID:20703299;  http://dx.doi.org/10.1038/nature09262.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell 2011; 147:1146- 58; PMID:22118468; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Curr Opin Hematol 2010; 17:281- 6; PMID:20473160; http://dx.doi.org/10.1097/ MOH.0b013e32833a25d8.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Neurosci 2007; 10:1538-43; PMID:18026097;  http://dx.doi.org/10.1038/nn2014.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Trends Immunol 2010; 31:438- 45; PMID:21030305; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Curr Biol 2003; 13:618-26; PMID:12699617;  http://dx.doi.org/10.1016/S0960-9822(03)00207-0.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
PLoS Biol  2009; 7:e1000135; PMID:19547742; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Development  2007; 134:55-64; PMID:17164414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nature 2007; 445:275-80; PMID:17136098; http://dx.doi.org/10.1038/ nature05382.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell  1993; 73:1307-21; PMID:8324823; http://dx.doi.org/10.1016/0092-8674(93)90358-W. 75.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Nat Rev Neurosci 2010; 11:316- 28; PMID:20404840; http://dx.doi.org/10.1038/ nrn2836.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
BMC Dev Biol 2005; 5:4; PMID:15717925;  http://dx.doi.org/10.1186/1471-213X-5-4.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Neurosci Res 2008;  86:1189-98; PMID:18041093; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Glia 2011; 59:1237- 52; PMID:21438012; http://dx.doi.org/10.1002/glia.21162.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Dev Cell 2003; 5:441-50; PMID:12967563; http://dx.doi.org/10.1016/S1534-5807(03)00244-2.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
J Cell  Biol 2006; 173:405-16; PMID:16651377; http://dx.doi.org/10.1083/jcb.200508161.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Brain Res Dev Brain Res  1999; 117:145-52; PMID:10567732; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science 2010; 327:656- 61; PMID:20133564; http://dx.doi.org/10.1126/sci - ence.1178331.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Annu Rev Immunol 2009; 27:119-45; PMID:19302036;  http://dx.doi.org/10.1146/annurev.immu - nol.021908.132528.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Brain Behav Immun 2007; 21:736- 45; PMID:17467231; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Science 2011; 332:729-32; PMID:21474712;  http://dx.doi.org/10.1126/science.1203411.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Cell Host Microbe  2009; 5:425-9; PMID:19454346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Viral Immunol 2005; 18:41-78; PMID:15802953;  http://dx.doi.org/10.1089/vim.2005.18.41.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Biochem Biophys Res Commun 2008; 370:531- 5; PMID:18413144; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Annu Rev Physiol 2010; 72:219-46; PMID:20148674; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Brain Res 2012;  PMID:22285436; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Immunology 2005; 116:145-63;  PMID:16162264; http://dx.doi.org/10.1111/j.1365- 2567.2005.02223.x.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
Auton Autacoid Pharmacol 2003; 23:1-25; PMID:14565534; http://dx.doi.org/10.1046/j.1474- 8673.2003.00280.x.,Non-OADS,/arxiv_data1/oa_pdf/e1/04/fly-6-254.PMC3519660.pdf
"Do not distribute.Fly 6:4, 284-289; October/November/December 2012; © 2012 Landes Bioscience RESEARCH PAPER 284 F ly  V olume 6 Issue 4 *Correspondence to: Stefanie Fischnaller; Email: stefanie.fischnaller@gmail.com Submitted: 03/26/12; Revised: 07/03/12; Accepted: 07/18/12http://dx.doi.org/10.4161/fly.21535Introduction Drosophila obscura  and D. subobscura  (Diptera: Drosophilidae)  are closely related species of the D. obscura  group,1 with a wide  distribution in the Palaearctic.",Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
"Such outliers were detected by visual examination of the spectra using spekwin32 (F. Menges “Spekwin32 – free software for optical spectroscopy”- Vers.1.71.5, 2010, http://www.effemm2.de/spekwin/) and by examination of the leverage and studentised residuals plots generated in GRAMS  (compare ref.",OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Med Vet Entomol  2010; 24:32-7; PMID:20377729; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
PLoS One 2010; 5:e9607;  PMID:20231905; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Proc Natl Acad Sci U S A 2011; 108:668- 73; PMID:21199954; http://dx.doi.org/10.1073/ pnas.1017393108.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Evol Biol  2002; 15:673-82; http://dx.doi.org/10.1046/j.1420-9101.2002.00405.x.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Evol Biol 2000; 13:9-19;  http://dx.doi.org/10.1046/j.1420-9101.2000.00116.x.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Insect Sci 2007; 7:1-7; PMID:20307237; http://dx.doi.org/10.1673/031.007.1801.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Ann Entomol Soc Am 2003; 96:865-9; http://dx.doi.org/10.1603/0013- 8746(2003)096[0865:NSMTIC]2.0.CO;2.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Chemometr Intell Lab 2001; 58:109-30; http://dx.doi.org/10.1016/S0169- 7439(01)00155-1.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Mol Genet Genomics 1953;  85:373-81; http://dx.doi.org/10.1007/BF00309674.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Oecologia 1998; 116:293-305; http://dx.doi.org/10.1007/s004420050591.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J  Braz Chem Soc 2003; 14:198-219; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Chem Ecol 2011; 37:549-52; PMID:21537901; http://dx.doi.org/10.1007/s10886-011-9956-x.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Am J T rop Med Hyg 2009; 81:622-30; PMID:19815877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Parasit Vectors 2010; 3:49; PMID:20525305; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
BMC Evol Biol 2008; 8:66-77; PMID:18302790; http://dx.doi.org/10.1186/1471-2148-8-66.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Evolution 1989; 43:468-73; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Naturwissenschaften 2000; 87:412-6;  PMID:11091966; http://dx.doi.org/10.1007/ s001140050752.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Evolution 2007; 61:223-31;  PMID:17300441; http://dx.doi.org/10.1111/j.1558-5646.2007.00019.x.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
BMC  Evol Biol 2007; 7:87; PMID:17555574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Evol Biol 2004; 17:841-55; PMID:15271084;  http://dx.doi.org/10.1111/j.1420-9101.2004.00721.x.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Evolution 2008; 62:1817-29. http://dx.doi.org/10.1111/j.1558-5646.2008.00423.x;  PMID:18489721 6.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
BMC Evol  Biol 2010; 10:363; PMID:21108788; http://dx.doi.org/10.1186/1471-2148-10-363.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Z Vgl Physiol 1967;  54:353-94; http://dx.doi.org/10.1007/BF00298224.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Insect Physiol 2000; 46:439-42; PMID:12770207; http://dx.doi.org/10.1016/S0022- 1910(99)00129-8.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Exp Zool 1982; 222:249- 53; http://dx.doi.org/10.1002/jez.1402220307.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Anim Behav 1990; 39:1058-67; http://dx.doi.org/10.1016/S0003-3472(05)80778-X.,Non-OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
J Chem Ecol 2005; 31:2747-52;  PMID:16132336; http://dx.doi.org/10.1007/s10886- 005-7570-5.,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
Insect Biochem 1991; 21:91-7; http://dx.doi.org/10.1016/0020-1790(91)90068-P .,OADS,/arxiv_data1/oa_pdf/80/27/fly-6-284.PMC3519663.pdf
"This implies that anagonist for clinical use should not pass the blood- -brain barrier.At present, there are no on-going clinical trials on LXR modulators, at least not reported in the US National Institutes of Health database (http://ww.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/ad/a8/ijo201221a.PMC3520012.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/LXR and fat cell metabolism J Laurencikiene and M Ryde ´n 1502 International Journal of Obesity (2012) 1494 - - 1502 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/ad/a8/ijo201221a.PMC3520012.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)Nanobody display technology C Goyvaerts et al 1140 Gene Therapy (2012) 1133 - - 1140 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/33/d3/gt2011206a.PMC3520013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/BMPs as an efﬁcient gene vaccine delivery system Y-S Tang et al 1195 Gene Therapy (2012) 1187 - - 1195 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/f1/d7/gt2011197a.PMC3520014.pdf
"2012, 9      http://www.medsci.org  909  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(10):909-915.  doi: 10.7150/ ijms.4733  Research Paper   The Diagnostic Value of D -dimer, Procalcitonin and  CRP in Acute Appendicitis   Bulent Kaya1, Baris Sana2, Cengiz Eris3, Koray Karabulut4, Orhan Bat5, Riza Kutanis6   1.",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9    http://www.medsci.org  910  (CRP) are the most commonly used laboratory tests.",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9    http://www.medsci.org  911  (p<0.05).",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9    http://www.medsci.org  912  Table 3 .",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9    http://www.medsci.org  913    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9    http://www.medsci.org  914  study, the sensitivity of D -dimer test in patients  needing urgent laparotomy was found as 95.7%.",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9    http://www.medsci.org  915  24.",Non-OADS,/arxiv_data1/oa_pdf/34/72/ijmsv09p0909.PMC3520016.pdf
"2012, 9      http://www.medsci.org  916  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(10):916-922.  doi: 10.7150/ ijms.4567  Research Paper   Hollow -Bone -Graft Dynamic Hip Screw  Can Fix and  Promote Bone Union  after Femoral Neck Fracture: an  Experimental Research   Jia-zuo SHEN, Jian- fei YAO , Da-sheng  LIN,  Ke-jian LIAN, Zhen- qi DING , Bin  LIN , Zhi -min GUO ,  Ming -hua ZHANG , Qiang  LI, Lin  LI, Peng QI  Department of Orthopaedic  Surgery, the Affiliated Dongnan Hospital of Xiamen University, Orthopaedic Trauma Center of the 175th Ho s- pital of PLA, Zhangzhou , Fujian, 363000 , PR China.",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9    http://www.medsci.org  917  fixation, over 100 other internal fixation devices have  been developed.",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9      http://www.medsci.org  918  Surgical Procedure and  Postoperative Care   The authors performed all surgeries under basic  anesthesia (xylazine 0.1 mL/kg compounded with  ketamine 0.1 mL/kg im).We used the classical Wa t- son- Jones approach, peeled back the connective and  muscular tissue,  exposed the greater trochanter and  hip joint capsule and opened the hip joint capsule to  expose the femoral neck.",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9    http://www.medsci.org  919  femoral head was still better in the Hb-DHS than th e  DHS group and also better than that in the Hb-DHS  grou p at week 8 (pink in the Hb-DHS at week 16  versus kermesinus  in the DHS group at week 16,  kermesinus  in the Hb-DHS group at week 8, Figure 5A/C) .",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9    http://www.medsci.org  920    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9    http://www.medsci.org  921  osteotomy[12-19]; these have  various  advantages and  disadvantages.",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9    http://www.medsci.org  922  [15] Kakar S, Little D, Einhorn TA.",Non-OADS,/arxiv_data1/oa_pdf/77/6b/ijmsv09p0916.PMC3520017.pdf
"2012, 9      http://www.medsci.org  923  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(10):923-932.  doi: 10.7150/ ijms.4878  Research Paper   Ischemic Postconditioning Protects Neuronal Death  Caused  by Cerebral Ischemia and Reperfusion via    Attenuating Protein Aggregation   Jianmin Liang1, Jihang Yao2, Guangming Wang3, Ying Wang4, Boyu Wang3, Pengfei Ge3   1.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9      http://www.medsci.org  924  1.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  925  ing both carotid arteries for 15 min.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  926  umes  of ice -cold homogenization buffer ( 1.5 mmol/L  Tris base -HCl pH 7.6, 1 mmol/L DTT, 0.25 mol/L  sucrose, 1 mmol/L MgCl 2, 1.25  µg/m L pepstatin A , 10  µg/m L leupeptin, 2.5  µg/m L aproptonin, 0.5 mmol/L  PMSF, 2.5 mmol/L EDTA, 1 mmol/L EGTA, 0.1  mol/L Na 3VO 4, 50 mmol/L NaF, and 2 mmol/L s o- dium pyrophosphate ).",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  927    Figure 2 .",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  928    Figure 4 .",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  929  In order to find out the mechanism underlying  the maintaining of proteasome activity after applic a- tion of ischemic postconditioning, we examined the  quantitative alteration of proteasome in the CA1  neurons by Western blotting (fig 7).",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  930  tioning is associated with attenuating protein aggr e- gation.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  931  results suggested that suppression of protein aggr e- gation by ischemic postconditioning might be related  to elevate the expression of inducible  chaperone  hsp70 and maintained the quantity of hsp40.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
"2012, 9    http://www.medsci.org  932  36.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijmsv09p0923.PMC3520018.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/fa/jcav03p0454.PMC3520020.pdf
http://www.leicester.gov.uk/your-council-services/ council-and-democracy/city-statistics/ (last accessed Dec 2009).,Non-OADS,/arxiv_data1/oa_pdf/0f/c1/srep00963.PMC3520025.pdf
http://www.metoffice.gov.uk/climate/uk/averages/ (last accessed Dec 2009).,Non-OADS,/arxiv_data1/oa_pdf/0f/c1/srep00963.PMC3520025.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0f/c1/srep00963.PMC3520025.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Edmondson, J.L., Davies, Z.G., McHugh, N., Gaston, K.J.",Non-OADS,/arxiv_data1/oa_pdf/0f/c1/srep00963.PMC3520025.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kachkanov, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/srep00969.PMC3520026.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/27/srep00966.PMC3520027.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zehtabi-Oskuie, A., Bergeron, J.G.",Non-OADS,/arxiv_data1/oa_pdf/8f/27/srep00966.PMC3520027.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/11/srep00968.PMC3520028.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Chiuri, A., Greganti, C., Mazzola, L., Paternostro, M. & Mataloni, P. Linear Optics Simulation of Quantum Non-Markovian Dynamics.",Non-OADS,/arxiv_data1/oa_pdf/b9/11/srep00968.PMC3520028.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports.,Non-OADS,/arxiv_data1/oa_pdf/15/90/srep00962.PMC3520029.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Jeon, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/15/90/srep00962.PMC3520029.pdf
"Other sources included a database for drug-drug interactions for Norwegian clinicians (http://www.interaksjoner.no), the on-line version of the monographs in the national drug formu-lary, Felleskatalogen database (http://www.felleskatalo-gen.no), and the online version of general recommendations for drug therapy for various diseases in Norway, Norsk legemiddelhåndbok (http://www.legemiddelhandboka.no).",OADS,/arxiv_data1/oa_pdf/25/f0/TODENTJ-6-182.PMC3520036.pdf
"[24] Jones RB, Maramba I, Boulos MNK, Alexander T. Use of Live Interactive Webcasting for an International Postgraduate Module in eHealth: Case Study Evaluation 2009; Retrieved from: http://www.jmir.org/2009/4/e46/ [cited 2011 6 September]  Received: July 19, 2012 Revised: September 06, 2012 Accepted: September 07, 2012 © Rosenbaum et al.",Non-OADS,/arxiv_data1/oa_pdf/25/f0/TODENTJ-6-182.PMC3520036.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/f0/TODENTJ-6-182.PMC3520036.pdf
"Pull -down ex peri- ments were performed according to the manufacturer’s  guidelines (http://www.promega.com/tbs/tm342/tm342.pdf)  with the exce ption of supplementing lysis, wash, and elution  buffers with 30 mM MgCl 2 and 40 units/ml of RNasin  (Promega).",Non-OADS,/arxiv_data1/oa_pdf/76/92/TOCHGENJ-6-55.PMC3520037.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licen - ses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduc tion in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/92/TOCHGENJ-6-55.PMC3520037.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Vazquez-Martin, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/89/srep00964.PMC3520055.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S370 SNI: Spine SNI: Spine, a supplement to , a supplement to Surgical Neurology International Surgical Neurology International INTRODUCTION Spinal epidural abscess (SEA), as a bacterial infection  of the spine resulting in accumulation of purulent fluid in the epidural space, has the potential to expand and compress the spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/SNI-3-370.PMC3520071.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/370/103871 Copyright: © 2012 Avilucea FR.,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/SNI-3-370.PMC3520071.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S329 SNI: Spine SNI: Spine , a supplement to , a supplement to Surgical Neurology InternationalSurgical Neurology International How much medicine do spine surgeons need to know to better select and care for patients?",Non-OADS,/arxiv_data1/oa_pdf/d2/b9/SNI-3-329.PMC3520072.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/329/103866 Copyright: © 2012 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/d2/b9/SNI-3-329.PMC3520072.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S377 SNI: Spine SNI: Spine , a supplement to , a supplement to Surgical Neurology InternationalSurgical Neurology International Morbidity and mortality conferences: Their educational role and why we should be there Nancy E. Epstein Clinical Professor of Neurological Surgery, Departments of Neurosurgery, The Albert Einstein College of Medicine, Bronx, NY , and Chief of Neurosurgical Spine  and Education Winthrop University Hospital, Mineola, NY , USA E-mail: Nancy E. Epstein - nancy.epsteinmd@gmail.com *Corresponding author Received: 16 September 2012 Accepted: 17 September 2012 Published: 26 November 12 This article may be cited as: Epstein NE.",Non-OADS,/arxiv_data1/oa_pdf/43/a8/SNI-3-377.PMC3520073.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/377/103872 Copyright: © 2012 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/43/a8/SNI-3-377.PMC3520073.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S366 SNI: Spine SNI: Spine , a supplement to , a supplement to Surgical Neurology InternationalSurgical Neurology International Negative effects of smoking, workers’ compensation, and litigation on pain/disability scores for spine patients Mark L. Prasarn, Mary B. Horodyski1, Caleb Behrend2, John Wright2, Glenn R. Rechtine2 Departments of Orthopaedics and Rehabilitation, University of T exas Health Science Center, Ironman Sports Medicine Institute, Houston, TX,  1University of Florida, Gainesville, FL, 2University of Rochester, Strong Memorial Hospital, Rochester, NY , USA E-mail: *Mark L. Prasarn - markprasarn@yahoo.com; Mary B. Horodyski - horodmb@ortho.ufl.edu; Caleb Behrend - caleb_behrend@urmc.rochester.edu;  John Wright - johnwright@medicalmavericks.com; Glenn R. Rechtine - grechtine@gmail.com*Corresponding author Received: 27 August 12 Accepted: 10 September 12 Published: 26 November 12 This article may be cited as: Prasarn ML, Horodyski MB, Behrend C, Wright J, Rechtine GR.",Non-OADS,/arxiv_data1/oa_pdf/dd/d0/SNI-3-366.PMC3520074.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/366/103870 Copyright: © 2012 Prasarn ML.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/SNI-3-366.PMC3520074.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S362 SNI: Spine SNI: Spine, a supplement to , a supplement to Surgical Neurology International Surgical Neurology International INTRODUCTION The posterior only approaches for anterior vertebral  pathology are being used more frequently due to advances in technique and instrumentation.",Non-OADS,/arxiv_data1/oa_pdf/c7/2e/SNI-3-362.PMC3520075.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/362/103869 Copyright: © 2012 Jandial R.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c7/2e/SNI-3-362.PMC3520075.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S350 SNI: Spine SNI: Spine , a supplement to , a supplement to Surgical Neurology InternationalSurgical Neurology International The value of “another” opinion for spinal surgery:  A prospective 14-month study of one surgeon’s experience Francis W .",Non-OADS,/arxiv_data1/oa_pdf/1d/c3/SNI-3-350.PMC3520076.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/350/103867 Copyright: © 2012 Gamache FW.,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/SNI-3-350.PMC3520076.pdf
Available from: http://www.sciencedaily.com/releases/2011/01/110127101315.,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/SNI-3-350.PMC3520076.pdf
Available from: http://www.washingtonpost.com/politics/improving-the-reliability-of-medical-imaging-technology/2012/07/15/gJQAZZzJnW_story.html.,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/SNI-3-350.PMC3520076.pdf
"Surgical Neurology InternationalSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University  Hospital, Mineola, NY , USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.com S355 SNI: Spine SNI: Spine , a supplement to , a supplement to Surgical Neurology InternationalSurgical Neurology International Extent of intraoperative muscle dissection does not affect long-term outcomes after minimally invasive surgery versus open-transforaminal lumbar interbody fusion surgery: A prospective longitudinal cohort study Owoicho Adogwa, Kwame Johnson, Elliot T .",Non-OADS,/arxiv_data1/oa_pdf/b4/00/SNI-3-355.PMC3520077.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/6/355/103868 Copyright: © 2012 Adogwa O.,Non-OADS,/arxiv_data1/oa_pdf/b4/00/SNI-3-355.PMC3520077.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/8c/gfs068.PMC3520080.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The effect of low glucose degradation product 4445",Non-OADS,/arxiv_data1/oa_pdf/b9/47/gfs314.PMC3520083.pdf
Data were analysed by Statistical Revelations Pty Ltd ( http://www.statisticalrevelations.com.au/ ).,OADS,/arxiv_data1/oa_pdf/b9/47/gfs314.PMC3520083.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/b8/gfs375.PMC3520085.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/gfs385.PMC3520086.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/03/gfs461.PMC3520087.pdf
BMC Genomics 11:10. http://dx.doi.org/10.1186 /1471-2164-11-S3-S10 .,OADS,/arxiv_data1/oa_pdf/b0/cf/mBio.00407-12.PMC3520106.pdf
http://dx.doi.org/10.1371/journal.pgen.1000875 .,Non-OADS,/arxiv_data1/oa_pdf/b0/cf/mBio.00407-12.PMC3520106.pdf
BMC Bioinformatics 11:395. http://dx.doi.org/10.1186/1471-2105-11-395 .,OADS,/arxiv_data1/oa_pdf/b0/cf/mBio.00407-12.PMC3520106.pdf
The list of C. albicans pro- teins identiﬁed is presented in Table S2 and submitted to thePRIDE (proteomics identiﬁcations database) proteomic data re-pository ( http://www.ebi.ac.uk/pride/ ) (accession numbers 3186 to 3192).,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.00495-12.PMC3520108.pdf
We screened for consensus ubiquitination target sites in Ca-Icl1 and ScIcl1 using UbPred (predictor of protein ubiquitinationsites) ( http://www.ubpred.org/index.html ) (56).,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.00495-12.PMC3520108.pdf
(A) Schematic representation illustrating the existence of high-conﬁdence ubiquitination sites in ScIcl1 and the lack ofsuch sites in CaIcl1 as predicted by UbPred ( http://www.ubpred.org/index .html ) (56).,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.00495-12.PMC3520108.pdf
The proteomic data set is available in the supplemental material (see Table S2 in the supplemental material) and atthe PRIDE proteomic data repository ( http://www.ebi.ac.uk/pride/ ) (ac- cession numbers 3186 to 3192).,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.00495-12.PMC3520108.pdf
The carbon source network was con-structed using Cytoscape version ( http://www.cytoscape.org/ ) (75).,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.00495-12.PMC3520108.pdf
Proteinconcentration was estimated from the absorbance at 280 nm based on theknown amino acid composition of the protein using the Protparam tool(http://www.expasy.org/tools/protparam.html ).,OADS,/arxiv_data1/oa_pdf/39/8e/mBio.00508-12.PMC3520109.pdf
]http://dx.doi.org/10.4161/bioe.21951 .,Non-OADS,/arxiv_data1/oa_pdf/39/8e/mBio.00508-12.PMC3520109.pdf
http://www.bp.com/liveassets/bp_internet/globalbp/STAGING/global_assets/downloads/B/Bio_biobutanol_fact_sheet_jun06.pdf .,OADS,/arxiv_data1/oa_pdf/ed/e4/mBio.00518-12.PMC3520111.pdf
"For Permissions, please email: journals.permissions@oup.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.†Dr Usichenko and Mrs Ro ¨ttenbacher made equal contributions in conducting the investigation and writing the manuscript.British Journal of Anaesthesia 110 (1): 87–95 (2013) Advance Access publication 9 October 2012 .doi:10.1093/bja/aes352",Non-OADS,/arxiv_data1/oa_pdf/cb/80/aes352.PMC3520148.pdf
"Br J Anaesth 2011; 107( Suppl 1): i27–40 9 http://www.postoppain.org/ (accessed 13 October 2011)10 Rawal N, Berggren.",Non-OADS,/arxiv_data1/oa_pdf/cb/80/aes352.PMC3520148.pdf
"Pain 1994; 57: 117–23 11 http://www.schmerzfreies-krankenhaus.de/ (accessed 13 October 2011) 12 http://www.tuv.com/de/deutschland/gk/managementsysteme/ medizin_gesundheitswesen/initiative_schmerzfreie_klinik/initiative_ schmerzfreie_klinik.jsp (accessed 13 October 2011) 13 Jaffe RA, ed.",Non-OADS,/arxiv_data1/oa_pdf/cb/80/aes352.PMC3520148.pdf
"J Pain 2003; 4: 361–71 17 http://www.awmf.org/uploads/tx_szleitlinien/041-001_S3_Behandlung_ akuter_perioperativer_und_posttraumatischer_Schmerzen_ aktualisierte_Fassung_04-2009_05-2011.pdf (accessed 3 October2011) 18 Gan TJ, Meyer TA, Apfel CC, et al.",Non-OADS,/arxiv_data1/oa_pdf/cb/80/aes352.PMC3520148.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e4216 | Page 1 of 8Video Article A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes Ryan D. Heselpoth1, Daniel C. Nelson1 1Institute for Bioscience and Biotechnology Research, University of Maryland Correspondence to: Daniel C. Nelson at nelsond@umd.edu URL: http://www.jove.com/video/4216 DOI: doi:10.3791/4216 Keywords: Immunology, Issue 69, Molecular Biology, Genetics, Microbiology, directed evolution, thermal behavior, thermostability, endolysin, enzybiotic, bacteriolytic, antimicrobial, therapeutic, PlyC Date Published: 11/7/2012 Citation: Heselpoth, R.D., Nelson, D.C. A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes.",Non-OADS,/arxiv_data1/oa_pdf/39/14/jove-69-4216.PMC3520584.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4216/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/39/14/jove-69-4216.PMC3520584.pdf
"Do not distribute.www.landesbioscience.com  Small GTP ases  199Small GTPases 3:4, 199–200; October/November/December 2012; © 2012 Landes Bioscience EDITOR’S CAORNER EDITOR’S PREVIEW In this issue of Small GTPases Elaine L. Ellerton Landes Bioscience; Austin, TX USA Correspondence to: Elaine L. Ellerton; Email: elaine@landesbioscience.com Submitted: 10/26/12; Accepted: 10/26/12http://dx.doi.org/10.4161/sgtp.22705Editor’s Corner   pg.",Non-OADS,/arxiv_data1/oa_pdf/2c/61/sgtp-3-199.PMC3520880.pdf
"Therefore, it is critical that responsible research is performed, studies are thoroughly executed using various model systems—with  a critical approach and doses that are more representative of environmental exposures—and we are sure of our results before going public.Scientific yellow journalism Anica Klockars* and Michael Williams Department of Neuroscience; Uppsala University; Uppsala, Sweden *Correspondence to: Anica Klockars; Email: anica.klockars@neuro.uu.se Submitted: 07/30/12; Accepted: 07/30/12http://dx.doi.org/10.4161/sgtp.22289",Non-OADS,/arxiv_data1/oa_pdf/08/51/sgtp-3-201.PMC3520881.pdf
"Experimental evidence points at PLD2 being able to complete both functions.Structure analysis between the SWAP-70   RHO-GEF and the newly described PLD2-GEF Julian Gomez-Cambronero Department of Biochemistry and Molecular Biology; Wright State University School of Medicine; Dayton, OH USA Keywords:  GEF, Rac2, chemotaxis, leukocyte, GTPases Correspondence to: Julian Gomez-Cambronero; Email: julian.cambronero@wright.edu Submitted: 02/10/12; Revised: 05/01/12; Accepted: 05/24/12http://dx.doi.org/10.4161/sgtp.20887Sites of Interaction   with the Small GTPase RAC2 The first indications that PLD2 has  a dual activity (lipase and GEF) were derived from the observation of a PLD2-Rac2 complex formation, both in vitro and in vivo (the latter demonstrated by FRET microscopy).",OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
"4,5using the structure viewer “Chimera” (http://www.cgl.ucsf.edu/chimera/down - load.html).",Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Alignments of 3D structures were visualized in “Chimera” http://www.cgl.ucsf.edu/chimera/download.html.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Proc Natl Acad Sci U S A 2011;  108:19617-22; PMID:22106281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Cell Signal 2011; 23:1885-95; PMID:21740967; http://dx.doi.org/10.1016/j.cell - sig.2011.06.017.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J  Biol Chem 2011; 286:16308-20; PMID:21378159;  http://dx.doi.org/10.1074/jbc.M110.206672.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Mol Cell Biol  2011; 31:2227-40; PMID:21444720; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Curr Opin Cell Biol 1996; 8:216-22; PMID:8791419; http://dx.doi.org/10.1016/S0955-0674(96)80068-8.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Nat Rev Mol Cell Biol 2005; 6:167- 80; PMID:15688002; http://dx.doi.org/10.1038/ nrm1587.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
T rends Cell Biol 2007; 17:36-43; PMID:17126549;  http://dx.doi.org/10.1016/j.tcb.2006.11.004.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Biochem Biophys Res Commun 2002; 296:716-20;  PMID:12176041; http://dx.doi.org/10.1016/S0006- 291X(02)00931-2.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Biol Chem  2003; 278:43541-9; PMID:12923183; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Immunity 2008; 29:704-19; PMID:18976935; http://dx.doi.org/10.1016/j.immuni.2008.08.015.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Eur J Immunol 1999; 29:1812-22;  PMID:10382743; http://dx.doi.org/10.1002/ (SICI)1521-4141(199906)29:06<1812::AID- IMMU1812>3.0.CO;2-J.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Mol Cell Biol 2007; 27:312- 23; PMID:17060455; http://dx.doi.org/10.1128/ MCB.00985-06.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
FEBS Lett 2003; 555:556-60;  PMID:14675773; http://dx.doi.org/10.1016/S0014- 5793(03)01351-6.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Cell  2002; 108:809-21; PMID:11955434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Blood 2006; 108:3564-72; PMID:16873675;  http://dx.doi.org/10.1182/blood-2006-02-005959.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Cell Signal  2006; 18:2283-91; PMID:16837165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Mol Biol 2011; 408:850-62; PMID:21414324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Cell Signal 2011; 23:969-79;  PMID:21044680; http://dx.doi.org/10.1016/j.cell - sig.2010.10.022.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Prog Lipid Res  2012; 51:71-81; PMID:22212660; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Nature 2002; 416:759-63; PMID:11961559; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Blood 2009; 113:1474- 82; PMID:18802007; http://dx.doi.org/10.1182/ blood-2008-04-152587.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Biol Chem 2001;  276:27145-51; PMID:11373293; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Immunol 2009; 182:3837-45; PMID:19265163;  http://dx.doi.org/10.4049/jimmunol.0803838.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Mol Cell Biol 2004; 24:10277-88; PMID:15542837; http://dx.doi.org/10.1128/ MCB.24.23.10277-10288.2004.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Mol Biol Cell 2003; 14:3242-53; PMID:12925760;  http://dx.doi.org/10.1091/mbc.E03-01-0043.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Blood 2011; 117:1574- 84; PMID:21123826; http://dx.doi.org/10.1182/ blood-2010-07-295659.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Hum Immunol 2003; 64:389-401;  PMID:12651066; http://dx.doi.org/10.1016/S0198- 8859(03)00024-7.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Br J Haematol  1999; 106:335-44; PMID:10460589; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Immunity 2003; 18:403- 14; PMID:12648457; http://dx.doi.org/10.1016/ S1074-7613(03)00054-2.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Immunol Rev 2009; 232:319-33; PMID:19909373; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Nat Cell Biol  2000; 2:899-905; PMID:11146654; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Cell Sci  2002; 115:4901-13; PMID:12432077; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Cell Sci 2005; 118:4937-46; PMID:16254241; http://dx.doi.org/10.1242/ jcs.02671.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Biol Chem 2008; 283:3088- 96; PMID:18056264; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Biol Chem 2010; 285:23075- 85; PMID:20457609; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Nature 2002; 415:541-4; PMID:11823862;  http://dx.doi.org/10.1038/415541a.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J Cell Sci 2004; 117:3785-95; PMID:15252117; http://dx.doi.org/10.1242/jcs.01220.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Biochem Biophys Res Commun 2005; 335:1280- 6; PMID:16112081; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Naunyn Schmiedebergs Arch Pharmacol  2006; 373:333-41; PMID:16896804; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
J  Immunol 2011; 186:5345-55; PMID:21421853;  http://dx.doi.org/10.4049/jimmunol.1003461.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
PLoS One 2010; 5:e14180; PMID:21152038; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
Nat Immunol 2006; 7:827-34; PMID:16845395;  http://dx.doi.org/10.1038/ni1365.,Non-OADS,/arxiv_data1/oa_pdf/68/e5/sgtp-3-202.PMC3520882.pdf
"Development 2012; 139:948-57; PMID:22278918; http://dx.doi.org/10.1242/dev.067579.Keywords:  Rho, ROCK, Shp2, Noonan  syndrome, cardiac morphogenesis Submitted: 03/28/12Revised: 05/24/12Accepted: 05/30/12http://dx.doi.org/10.4161/sgtp.20960 *Correspondence to: Joan Taylor;   Email: jmt3x@med.unc.eduDuring embryogenesis, the heart is  one of the first organs to develop.",Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Best Pract Res Clin Endocrinol Metab 2011; 25:161-79;  PMID:21396583; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Cell Signal 2008; 20:453-9; PMID:17993263; http://dx.doi.org/10.1016/j.cellsig.2007.10.002.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
J Clin Invest  2007; 117:2123-32; PMID:17641779; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Development 2007; 134:4119- 30; PMID:17928416; http://dx.doi.org/10.1242/ dev.009290.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Mol Cell Biol 2010; 30:2498- 507; PMID:20308328; http://dx.doi.org/10.1128/ MCB.00646-09.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Am  J Physiol Heart Circ Physiol 2011; 301:1531-9; PMID:21803945; http://dx.doi.org/10.1152/ajp - heart.00216.2011.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Am J Physiol Heart  Circ Physiol 2012; 302:231-43; PMID:22058153;  http://dx.doi.org/10.1152/ajpheart.00665.2011.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Mol Cell Biol  2000; 20:299-311; PMID:10594032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Development  2012; 139:948-57; PMID:22278918; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
J Cell Biol 2008; 181:999-1012; PMID:18559669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
J Neurol Sci  2005; 238:31-9; PMID:16005902; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
J Cell Biol 2005; 168:941- 53; PMID:15753128; http://dx.doi.org/10.1083/ jcb.200411179.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Mol Cell Biol  2003; 23:5043-55; PMID:12832488; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Proteins 2011; 79:1573- 88; PMID:21365683; http://dx.doi.org/10.1002/ prot.22984.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
FASEB J 2012; 26:469-79; PMID:22038046; http://dx.doi.org/10.1096/fj.11- 192252.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Circulation 2008; 117:1423- 35; PMID:18316486; http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.728865.15.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Am J Physiol Lung Cell  Mol Physiol 2010; 298:361-70; PMID:20023173;  http://dx.doi.org/10.1152/ajplung.00374.2009.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
J Biol Chem 2005; 280:18418-24;  PMID:15738000; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
PLoS Genet 2007;  3:e225; PMID:18159945; http://dx.doi.org/10.1371/ journal.pgen.0030225.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Circ Res  2009; 104:1066-75; PMID:19359598; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Am J Physiol  Cell Physiol 2009; 297:C1062-70; PMID:19692654;  http://dx.doi.org/10.1152/ajpcell.00174.2009.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
Mol Cell Biol 2004; 24:5340- 52; PMID:15169898; http://dx.doi.org/10.1128/ MCB.24.12.5340-52.2004.,Non-OADS,/arxiv_data1/oa_pdf/ff/1d/sgtp-3-209.PMC3520883.pdf
"Curr Biol 2012; 22:278–88; PMID:22305756; http://dx.doi.org/10.1016/j.cub.2012.01.014.Keywords:  collective cell migration,  myosin IXA, Rho GTPases, RhoGAP,  actin cytoskeleton, cell-cell contact Submitted: 04/09/12Accepted: 04/24/12http://dx.doi.org/10.4161/sgtp.20495 Correspondence to: Tatiana Omelchenko;   Email: omelchet@mskcc.orgCollective cell migration is a key  process during epithelial morpho - genesis, tissue regeneration and tumor dissemination.",OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Cell Sci 2012; PMID:22344263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Nat Cell Biol 2007; 9:92- 8; PMID:17159998; http://dx.doi.org/10.1038/ ncb1520.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Curr Biol 2010; 20:161-9; PMID:20079641;  http://dx.doi.org/10.1016/j.cub.2009.11.036.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Cell  Mol Life Sci 2012; PMID:22410739; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Annu Rev Cell  Biol 1994; 10:31-54; PMID:7888179; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Mol Membr Biol 2011; 28:427-44;  PMID:21781017; http://dx.doi.org/10.3109/096876 88.2011.603101.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Cell Biol 2011; 192:907- 17; PMID:21422226; http://dx.doi.org/10.1083/ jcb.201009141.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Nat Rev Mol Cell Biol 2005; 6:167- 80; PMID:15688002; http://dx.doi.org/10.1038/ nrm1587.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Cell 2007; 129:865-77; PMID:17540168;  http://dx.doi.org/10.1016/j.cell.2007.05.018.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Curr Biol  2012; 22:278-88; PMID:22305756; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Nat Cell Biol 2002; 4:408-15; PMID:11992112;  http://dx.doi.org/10.1038/ncb796.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Proc Natl Acad Sci USA  2010; 107:9944-9; PMID:20463286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Nat Rev  Mol Cell Biol 2009; 10:445-57; PMID:19546857;  http://dx.doi.org/10.1038/nrm2720.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Cell Sci 2005; 118:51-63; PMID:15585576; http://dx.doi.org/10.1242/jcs.01577.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Mol Cell Biol 2011; 31:342-50; PMID:20974808;  http://dx.doi.org/10.1128/MCB.00800-10.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Proc Natl Acad Sci USA 2007;  104:15988-93; PMID:17905871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Dev Cell 2011; 21:1026-37;  PMID:22118769; http://dx.doi.org/10.1016/j.dev - cel.2011.10.012.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Nat Cell Biol 2007; 9:893- 904; PMID:17618273; http://dx.doi.org/10.1038/ ncb1616.More detailed imaging analysis will be  required to understand how myosin IXA  is delivered to primordial cell-cell junc - tions.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Biol Chem 2010;  285:24933-42; PMID:20538589; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Biol Chem 2009; 284:3663-71;  PMID:19059909; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Mol Biol Cell 2009; 20:5074-85;  PMID:19828736; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Mol Biol Cell  2007; 18:1507-18; PMID:17314409; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Cell Biol 2007; 178:517-27; PMID:17646397; http://dx.doi.org/10.1083/ jcb.200701058.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Mol Biol Cell 2008; 19:3801-11; PMID:18596233;  http://dx.doi.org/10.1091/mbc.E08-04-0352.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Cell  2006; 127:1027-39; PMID:17129786; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Nat Cell Biol  2005; 7:954-60; PMID:16184169; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Exp Cell Res 2008; 314:939- 49; PMID:18241859; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Biochem Soc Trans 2011; 39:1166- 8; PMID:21936783; http://dx.doi.org/10.1042/ BST0391166.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Biol Chem 2002;  277:11679-83; PMID:11801597; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Cell Biol 2011;  194:643-56; PMID:21844208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Curr Opin Cell Biol 2011; 23:531- 9; PMID:21764278; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J Cell Sci 2005; 118:5549-62; PMID:16291727;  http://dx.doi.org/10.1242/jcs.02639.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Front Biosci  2008; 13:6662-81; PMID:18508686; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Mol Cell Biol 2011; 31:81- 91; PMID:20974804; http://dx.doi.org/10.1128/ MCB.01001-10.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
J R Soc Interface  2011; 8:305-11; PMID:20826475; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
Am  J Physiol Lung Cell Mol Physiol 2004; 287:1134- 44; PMID:15298851; http://dx.doi.org/10.1152/ ajplung.00022.2004.,Non-OADS,/arxiv_data1/oa_pdf/41/cd/sgtp-3-213.PMC3520884.pdf
"Do not distribute.www.landesbioscience.com  Small GTPases  219Small GTPases 3:4, 219-224; October/November/December 2012; © 2012 Landes Bioscience COMMENTARY COMMENTARY Keywords:  microvesicles, oncosomes,  cancer, cell communication, tissue trans - glutaminase, glutaminase, Rho, GTPase,  warburg effect, transformation Abbreviations:  BPTES, bis-2-(5-phen - ylacetamido-1,2,4-thiadiazol-2-yl)ethyl  sulfide; Dbl, diffuse B-lymphoma; EGF, epidermal growth factor; LIMK, LIM kinase; MV, microvesicle; ROCK, Rho-associated, coiled-coil containing protein kinase; tTG, tissue transglutaminase Submitted: 03/20/12Revised: 05/09/12Accepted: 05/14/12http://dx.doi.org/10.4161/sgtp.20755 *Correspondence to: Richard A. Cerione;   Email: rac1@cornell.eduA novel form of cell-to-cell communi - cation involving the formation and  shedding of large vesicular structures,  called microvesicles (MVs), from the surfaces of highly aggressive forms of human cancer cells has been attracting increasing amounts of attention.",Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Oncogene 2012; In press; PMID:22266864;  http://dx.doi.org/10.1038/onc.2011.636,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Cell 1995; 81:53-62; PMID:7536630;  http://dx.doi.org/10.1016/0092-8674(95)90370-4.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Nature 2000; 406:532-5; PMID:10952316;  http://dx.doi.org/10.1038/35020106.,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Curr Biol 1999; 9:136-45;  PMID:10021386; http://dx.doi.org/10.1016/S0960- 9822(99)80067-0.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Cell Mol Life Sci 2010; 67:171-7; PMID:19907920; http://dx.doi.org/10.1007/ s00018-009-0189-x.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Nat Rev Cancer 2011; 11:325- 37; PMID:21508971; http://dx.doi.org/10.1038/ nrc3038.,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Cancer Cell 2010; 18:207-19; PMID:20832749; http://dx.doi.org/10.1016/j.ccr.2010.08.009.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Biochem J 2007; 406:407- 14; PMID:17581113; http://dx.doi.org/10.1042/ BJ20070039.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Cell 2011;  145:1012-22; PMID:21703446; http://dx.doi.org/10.1016/j.cell.2011.06.010.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
J Cell Biol  2007; 178:23-30; PMID:17606864; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
J Cell Physiol 2009; 218:460-6; PMID:19006176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Int J Dev Biol 2011; 55:685-96;  PMID:22161825; http://dx.doi.org/10.1387/ ijdb.113396se.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Semin Oncol 2006; 33:369-85; PMID:16890793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Trends Cell Biol 2009; 19:43-51; PMID:19144520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
J Cell Sci 2010; 123:1603-11; PMID:20445011; http://dx.doi.org/10.1242/jcs.064386.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Oncogene  2012; In press; PMID:22266864; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Annu Rev Biochem  1980; 49:517-31; PMID:6105840; http://dx.doi.org/10.1146/annurev.bi.49.070180.002505.,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Cancer Res 2008; 68:5849-58; PMID:18632639; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6130.,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Proc Natl Acad Sci USA  2010; 107:1408-13; PMID:20080707; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Oncogene 2007; 26:2563- 73; PMID:17099729; http://dx.doi.org/10.1038/ sj.onc.1210048.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
J Biol Chem 2011; 286:37094-107;  PMID:21896482; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Nat Cell Biol 2008; 10:619- 24; PMID:18425114; http://dx.doi.org/10.1038/ ncb1725.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Proc Natl Acad Sci USA 2011; 108:4852- 7; PMID:21368175; http://dx.doi.org/10.1073/ pnas.1017667108.,OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
Semin Cancer Biol  2011; 21:139-46; PMID:21251983; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/94/sgtp-3-219.PMC3520885.pdf
"Do not distribute.www.landesbioscience.com  Small GTPases  225Small GTPases 3:4, 225-228; October/November/December 2012; © 2012 Landes Bioscience COMMENTARY COMMENTARY Keywords:  RhoA, RhoC, centrosome,  mitotic spindle, cell polarity, golgi,   epithelium Submitted: 04/25/12Accepted: 05/17/12http://dx.doi.org/10.4161/sgtp.20791 *Correspondence to: Bénédicte Lemmers and   Jean Marie Blanchard;   Email: benedicte.lemmers@igmm.cnrs.fr and   jean-marie.blanchard@igmm.cnrs.frCell cycle regulators, such as cyclins,  are often upregulated in many pro - liferative disorders and Cyclin A2 is gen - erally considered as a marker of aggressive cancers.",Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol 2012; 196:147-62; PMID: 22232705; http://dx.doi.org/10.1083/jcb.201102085,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol 2012; 196:147-62; PMID:22232705; http://dx.doi.org/10.1083/jcb.201102085.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cell Mol Life Sci 2002; 59:1317- 26; PMID:12363035; http://dx.doi.org/10.1007/ s00018-002-8510-y.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Mol Biol Cell  2007; 18:1861-73; PMID:17344473; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Oncogene 2008; 27:4261-8; PMID:18372919;  http://dx.doi.org/10.1038/onc.2008.74.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
"Cell 2009; 138:352-65; PMID:19592082;  http://dx.doi.org/10.1016/j.cell.2009.04.062.pancreas,42 along with hepatocellular,43  breast,44 ovarian,45 bladder and esophageal  cancers, has been observed and correlated  with progression and poor prognosis.46  Moreover, invasion by several cell types, such as breast, 47 colon carcinoma,48 or  prostate cancer cell lines,49 was shown to  be dependent on RhoC expression and activation.",OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cell Mol Life Sci 2009; 66:370-4;  PMID:19151919; http://dx.doi.org/10.1007/s00018- 008-8552-x.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Nature 2007; 449:682-8;  PMID:17898713; http://dx.doi.org/10.1038/ nature06174.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Nat Cell Biol  2005; 7:255-61; PMID:15723050; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Genes Dev 2005; 19:1974- 9; PMID:16107613; http://dx.doi.org/10.1101/ gad.1310805.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Exp Cell Res  2004; 301:43-9; PMID:15501444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Br J Cancer 1998; 77:147-52; PMID:9459160; http://dx.doi.org/10.1038/ bjc.1998.23.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Br J Cancer 2002; 87:635- 44; PMID:12237774; http://dx.doi.org/10.1038/ sj.bjc.6600510.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Ann Surg Oncol 2007; 14:3593-601;  PMID:17896152; http://dx.doi.org/10.1245/s10434- 007-9562-x.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cancer Res  2004; 64:8694-701; PMID:15574779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Oncogene 2006; 25:6959-67; PMID:16715134;  http://dx.doi.org/10.1038/sj.onc.1209682.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cancer Res 2008; 68:7613-20; PMID:18794150;  http://dx.doi.org/10.1158/0008-5472.CAN-07- 6700.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Hum Pathol 2002; 33:1006-15; PMID:12395374; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Int J Cancer 2008; 122:377-86; PMID:17918157; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Clin Invest 2011; 121:468-74; PMID:21370523; http://dx.doi.org/10.1172/ JCI44595.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Annu Rev Physiol  2011; 73:413-35; PMID:21054168; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Pathol Oncol Res  2011; 17:341-7; PMID:21104359; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Nat Cell Biol  2010; 12:982-92; PMID:20818389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Oncogene 2005; 24:5764-74; PMID:16123809; http://dx.doi.org/10.1038/ sj.onc.1208927.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cancer Res 2007; 67:9066-76; PMID:17909010;  http://dx.doi.org/10.1158/0008-5472.CAN-07- 0575.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cancer Cell  2007; 12:559-71; PMID:18068632; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Oncogene  2005; 24:7443-54; PMID:16288291; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Nat Genet 1997; 15:83-6;  PMID:8988174; http://dx.doi.org/10.1038/ng0197- 83.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cancer Res 2006; 66:9986-94;  PMID:17047061; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1596.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cell Cycle 2006; 5:2440-2; PMID:17106256; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Mol Cell Biol 2006; 26:4240- 56; PMID:16705174; http://dx.doi.org/10.1128/ MCB.02124-05.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol 2002; 158:321- 9; PMID:12119358; http://dx.doi.org/10.1083/ jcb.200202071.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Biol Chem 2003; 278:52919-23;  PMID:14530263; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol 2003; 160:255-65; PMID:12538643;  http://dx.doi.org/10.1083/jcb.200207130.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol 2005; 170:91-101; PMID:15998801; http://dx.doi.org/10.1083/ jcb.200501131.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Biol Chem 2009; 284:29015-23; PMID:19703905;  http://dx.doi.org/10.1074/jbc.M109.042820.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol  2010; 188:621-8; PMID:20212314; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Small Gtpases  2011; 2:247-58; PMID:22292127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
J Cell Biol 2009;  186:693-702; PMID:19720875; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
Cancer 2002; 94:973-9; PMID:11920465; http://dx.doi.org/10.1002/cncr.10338.,Non-OADS,/arxiv_data1/oa_pdf/6f/ad/sgtp-3-225.PMC3520886.pdf
"Do not distribute.www.landesbioscience.com  Small GTPases  229Small GTPases 3:4, 229-235; October/November/December 2012; © 2012 Landes Bioscience COMMENTARY COMMENTARY Keywords:  endocytosis, clathrin-inde - pendent, yeast, actin, Rho1 GTPase Abbreviations:  CIE, clathrin-indepen - dent endocytosis; CLIC/GEEC, clathrin-  and dynamin-independent carrier/glyco - sylphosphatidylinositol-anchored protein-enriched early endosomal compartment; CME, clathrin-mediated endocytosis; ENTH, epsin N-terminal homology; GAP, GTPase-activating protein; GEF, guanine nucleotide exchange factor; IL2R, interleukin-2 receptor; TORC2, target of rapamycin complex 2; WASp, Wiskott-Aldrich syndrome protein Submitted: 06/04/12Accepted: 07/26/12http://dx.doi.org/10.4161/sgtp.21631 *Correspondence to: Derek Prosser;   Email: dprosser@jhu.eduEukaryotic cells use numerous endo - cytic pathways for nutrient uptake,  protein turnover and response to the  extracellular environment.",Non-OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Cell Biol 2011; 195:657-71; PMID:22065638;  http://dx.doi.org/10.1083/jcb.201104045.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Curr Biol  2010; 20:538-43; PMID:20226669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Biol Chem 1996;  271:33123-30; PMID:8955161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Cell Biol 2011; 195:657- 71; PMID:22065638; http://dx.doi.org/10.1083/ jcb.201104045.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Mol Biol Cell  2008; 19:2936-48; PMID:18448668; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Proc Natl Acad Sci U S A 2006; 103:4116- 21; PMID:16537494; http://dx.doi.org/10.1073/ pnas.0510513103.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Traffic 2010; 11:1141-50;  PMID:20626707; http://dx.doi.org/10.1111/j.1600- 0854.2010.01088.x.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Mol Cell Biol 2001; 21:271-80;  PMID:11113201; http://dx.doi.org/10.1128/ MCB.21.1.271-280.2001.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Microbiol Mol Biol Rev 2005; 69:262-91; PMID:15944456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Mol Biol Cell 2003;  14:4676-84; PMID:14593073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Nature 2002; 415:141-7; PMID:11805826; http://dx.doi.org/10.1038/415141a.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Nat Cell Biol 2002; 4:260-9; PMID:11875440;  http://dx.doi.org/10.1038/ncb718.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Cell 2003; 115:475-87;  PMID:14622601; http://dx.doi.org/10.1016/S0092- 8674(03)00883-3.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Cell 2005; 123:305-20;  PMID:16239147; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
PLoS Biol  2011; 9:e1000604; PMID:21445324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Cell Sci  2011; 124:1613-22; PMID:21536832; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Nat Cell Biol 2011; 13:1124-31; PMID:21841790;  http://dx.doi.org/10.1038/ncb2307.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
PLoS Biol 2009; 7:e1000191;  PMID:19809571; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Annu Rev Cell Dev Biol 2003; 19:287-332; PMID:14570572;  http://dx.doi.org/10.1146/annurev.cell - bio.19.111401.093127.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Nat Cell Biol 2009; 11:1039-42; PMID:19597484; http://dx.doi.org/10.1038/ ncb1918.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Annu Rev Biochem 2009; 78:857-902; PMID:19317650; http://dx.doi.org/10.1146/ annurev.biochem.78.081307.110540.,Non-OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
Traffic 2001; 2:311-20;  PMID:11350627; http://dx.doi.org/10.1034/j.1600- 0854.2001.002005311.x.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
"Mol Biol Cell 2007; 18:4387-96; PMID:17761527;  http://dx.doi.org/10.1091/mbc.E07-05-0486.As opposed to differences in cargo  specificity for the CME and Rho1 path - ways, it is possible that the Rho1 pathway  becomes activated under specific growth  conditions or during specific stages of  the cell cycle.",Non-OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Cell Sci 2008; 121:1773-83; PMID:18492791;  http://dx.doi.org/10.1242/jcs.018036.30.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Exp Med 1999;  190:1849-56; PMID:10601359; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Cell Biol 2004; 166:273-82; PMID:15249579;  http://dx.doi.org/10.1083/jcb.200404166.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
J Cell Biol 2006; 174:701- 13; PMID:16943183; http://dx.doi.org/10.1083/ jcb.200605006.,OADS,/arxiv_data1/oa_pdf/1c/82/sgtp-3-229.PMC3520887.pdf
"Oncogene 2012; In press; PMID:22231449; http://dx.doi.org/10.1038/onc.2011.607.Keywords:  ubiquitination, trafficking,  desensitization, G-protein, signal trans - duction, post-translational modfication,  endocytosis, cancer, oncogene, tumori - genesis Submitted: 03/29/12Revised: 04/19/12Accepted: 04/23/12http://dx.doi.org/10.4161/sgtp.20460 *Correspondence to: Eric C. Chang;   Email: echang1@bcm.tmc.eduRas proteins are best known to func - tion on the plasma membrane  to mediate growth factor signaling.",Non-OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Mol Cell 2006; 21:481-93; PMID:16483930;  http://dx.doi.org/10.1016/j.molcel.2006.01.012.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Cell Res  2012; 22:399-412; PMID:21876558; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Cell 1994; 79:131-41; PMID:7923372; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Proc Natl Acad Sci USA 2006; 103:9045- 50; PMID:16754851; http://dx.doi.org/10.1073/ pnas.0603318103.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Cell Cycle 2006; 5:1936-9; PMID:16931912; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Oncogene 2012; In press; PMID:22231449; http://dx.doi.org/10.1038/ onc.2011.607.,Non-OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Methods Cell Biol 2008; 85:431-70;  PMID:18155474; http://dx.doi.org/10.1016/S0091- 679X(08)85019-4.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Nature 2009; 458:445-52; PMID:19325624; http://dx.doi.org/10.1038/nature07961.,Non-OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Biochemistry  2009; 48:9321-3; PMID:19673488; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
J Cell Biol 2009; 184:863- 79; PMID:19289794; http://dx.doi.org/10.1083/ jcb.200807186.,Non-OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Sci Signal 2011; 4:13;  PMID:21386094; http://dx.doi.org/10.1126/scisig - nal.2001518.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Science 2005; 307:1746-52; PMID:15705808; http://dx.doi.org/10.1126/science.1105654.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
J Biol Chem 2005; 280:34997-5010;  PMID:16079139; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Curr Opin Cell Biol 2011; 23:393-403; PMID:21474295; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Dev  Cell 2001; 1:73-82; PMID:11703925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Mol Cell 2006; 21:679-87; PMID:16507365;  http://dx.doi.org/10.1016/j.molcel.2006.02.011.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Curr Biol 2010; 20:1372-7;  PMID:20655225; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Curr Biol 2010; 20:1378-82; PMID:20655224; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Cell Signal 2009; 21:1672-9;  PMID:19616621; http://dx.doi.org/10.1016/j.cell - sig.2009.07.004.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Cell 1989; 57:1167-77;  PMID:2661017; http://dx.doi.org/10.1016/0092- 8674(89)90054-8.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
J Biol Chem  2005; 280:31141-8; PMID:16000296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Mol Cell Biol 2000; 20:2475-87; PMID:10713171;  http://dx.doi.org/10.1128/MCB.20.7.2475-87.2000.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
J Cell Biol  2010; 191:23-9; PMID:20876282; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
Nat Rev Mol Cell Biol 2012; 13:39-51; PMID:22189424; http://dx.doi.org/10.1038/ nrm3255.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
J Biol Chem  1998; 273:15830-7; PMID:9624183; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
J Cell Biol  2005; 170:261-72; PMID:16027222; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/db/sgtp-3-236.PMC3520888.pdf
"Dev Cell 2012; 22:799-810; PMID:22516198;  http://dx.doi.org/10.1016/j.devcel.2012.02.006.Keywords:  Arf1, Sec7, positive feedback,  Golgi, TGN, Arf-GEF, autoregulation,  GTPase Abbreviations:  GTP, guanosine triphos - phate; TGN, trans-Golgi network; GEF,  guanine nucleotide exchange factor; PH, pleckstrin homology Submitted: 06/29/12Accepted: 08/14/12http://dx.doi.org/10.4161/sgtp.21828 *Correspondence to: J. Christopher Fromme;   Email: jcf14@cornell.eduMembers of the highly conserved Arf  family of small GTPases serve as  master regulators of vesicular transport.",OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
BMC Genomics  2005; 6:20; PMID:15717927; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Nature 1996; 384:481-4; PMID:8945478;  http://dx.doi.org/10.1038/384481a0.,Non-OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
J Biol Chem 2011; 286:3873-83; PMID:21118813;  http://dx.doi.org/10.1074/jbc.M110.145532.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Cell 2003; 112:685- 95; PMID:12628188; http://dx.doi.org/10.1016/ S0092-8674(03)00149-1.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Nature  1985; 313:241-3; PMID:3918269; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Nat Cell Biol  2012; 14:239-48; PMID:22344030; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
J  Biol Chem 2008; 283:27717-23; PMID:18693248;  http://dx.doi.org/10.1074/jbc.M804528200.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Nature 2002; 417:187-93; PMID:12000962; http://dx.doi.org/10.1038/417187a.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Cell 2012; 148:530-42;  PMID:22304919; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Proc Natl Acad Sci U S A 1996; 93:12856- 60; PMID:8917509; http://dx.doi.org/10.1073/ pnas.93.23.12856.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Dev Cell 2012; 22:799-810;  PMID:22516198; http://dx.doi.org/10.1016/j.dev - cel.2012.02.006.proteins with overlapping roles20 may lead  to a greater dependence on Arl1 as a unique  TGN identifier and makes a full combi - natorial analysis of Arf depletion on Sec7  localization problematic.,Non-OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
EMBO J 2007; 26:1953- 62; PMID:17347647; http://dx.doi.org/10.1038/ sj.emboj.7601634.19.,Non-OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
J Biol Chem 1997; 272:30998-1005;  PMID:9388248; http://dx.doi.org/10.1074/ jbc.272.49.30998.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Mol  Biol Cell 2005; 16:4495-508; PMID:16030262;  http://dx.doi.org/10.1091/mbc.E04-12-1042.,Non-OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Eur J Cell Biol 2010; 89:575-83; PMID:20434792; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
J  Biol Chem 2008; 283:34188-96; PMID:18832381;  http://dx.doi.org/10.1074/jbc.M806023200.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
J Cell Biol  2012; 196:327-35; PMID:22291037; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Nat Cell Biol 2004; 6:414- 9; PMID:15077114; http://dx.doi.org/10.1038/ ncb1121.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Science 2004; 303:808-13;  PMID:14764870; http://dx.doi.org/10.1126/sci - ence.1091317.,OADS,/arxiv_data1/oa_pdf/b8/7b/sgtp-3-240.PMC3520889.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/25/bf/srep00942.PMC3521080.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Eltschka, C. & Siewert, J.",Non-OADS,/arxiv_data1/oa_pdf/25/bf/srep00942.PMC3521080.pdf
"Received: May 17, 2012    Revised: July 19, 2012 Accepted: August 5, 2012    Available online: November 14, 2012  Correspondence:  Sungwon Roh, MD, PhD Department of Mental Health Research, Seoul National Hospital, Ministry of  Health and Welfare, 398 Neungdong-ro, Gwangjin-gu, Seoul 143-711, Repub - lic of Korea Tel: +82-2-2204-0292, Fax: +82-2-2-2204-0280, E-mail:  swroh@korea.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.311ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/5c/62/pi-9-311.PMC3521105.pdf
Available at: http://www.who.int/features/factfiles/global_burden/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/5c/62/pi-9-311.PMC3521105.pdf
Available at:?http://info.stakes.fi/mindful/EN/frontpage.htm.,Non-OADS,/arxiv_data1/oa_pdf/5c/62/pi-9-311.PMC3521105.pdf
Available at: http://www.mhsip.org/report - card/.,Non-OADS,/arxiv_data1/oa_pdf/5c/62/pi-9-311.PMC3521105.pdf
Available at: http://www.chi.nhs.uk/Ratings/Trust/Overview/mht_overview.asp.,Non-OADS,/arxiv_data1/oa_pdf/5c/62/pi-9-311.PMC3521105.pdf
"Received: April 26, 2012    Revised: June 23, 2012 Accepted: July 17, 2012    Available online: November 12, 2012  Correspondence:  Y ong-Chon Park, MD, PhD Department of Psychiatry, Hanyang University Guri Hospital, 153 Gyeongchun- ro, Guri 471-701, Republic of Korea Tel: +82-31-560-2273, Fax: +82-31-554-2599, E-mail:  hypyc@hanyang.ac.kr  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.319ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/ac/4f/pi-9-319.PMC3521106.pdf
"Received:  February 12, 2012    Revised:  June 9, 2012   Accepted:  June 26, 2012    Available online:  November 14, 2012  Correspondence:  Seung Jae Lee, MD, PhD Department of Psychiatry, School of Medicine, Kyungpook National Univer - sity, 200 Dongdeok-ro, Jung-gu, Daegu 700-721, Republic of Korea Tel: +82-53-420-5747, Fax: +82-53-426-5361, E-mail:  jayleemd@knu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2012.9.4.325ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/8a/7a/pi-9-325.PMC3521107.pdf
"Received: July 4, 2012    Revised: July 23, 2012 Accepted: August 1, 2012    Available online: November 12, 2012  Correspondence:  Chang Uk Lee, MD, PhD  Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University  of Korea College of Medicine, 505 Banpo-dong, Seocho-gu, Seoul 137-701,  Republic of KoreaTel: +82-2-2258-6082, Fax: +82-2-594-3870, E-mail:  jihan@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.332ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/1b/87/pi-9-332.PMC3521108.pdf
"Received: September 16, 2012    Revised: October 7, 2012 Accepted: October 7, 2012    Available online: November 12, 2012  Correspondence:  Kyooseob Ha, MD, PhD  Department of Psychiatry, Seoul National University Bundang Hospital, 82  Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Republic of Korea Tel: +82-31-787-7431, Fax: +82-31-787-4058, E-mail:  kyooha@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.339ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/86/03/pi-9-339.PMC3521109.pdf
"Received: January 11, 2012    Revised: June 8, 2012 Accepted: July 12, 2012    Available online: November 12, 2012  Correspondence:  Y eon Ho Joo, MD, PhD  Department of Psychiatry, Asan Medical Center, University of Ulsan College  of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, Republic of  KoreaTel: +82-2-3010-3412, Fax: +82-2-485-8381, E-mail:  jooyh@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.347ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/e2/b0/pi-9-347.PMC3521110.pdf
"Received: March 28, 2012    Revised: June 1, 2012 Accepted: June 10, 2012    Available online: November 14, 2012  Correspondence:  Massimiliano Buoli, MD Department of Psychiatry, University of Milan, Fondazione IRCCS Ca’Granda  Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milan, Italy Tel: +39-02-55035934, Fax: +39-02-55033190 E-mail:  massimiliano.buoli@hotmail.it cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.354ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/b6/6a/pi-9-354.PMC3521111.pdf
"Received:  November 21, 2011    Revised:  March 5, 2012 Accepted:  March 27, 2012    Available online:  November 14, 2012  Correspondence:  Y ong-Ku Kim, MD, PhD Department of Psychiatry, Korea University College of Medicine, Ansan Hos - pital, 123 Jeokgeum-ro, Ansan 425-707, Republic of Korea Tel: +82-31-412-5140, Fax: +82-31-412-5144, E-mail:  yongku@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION A long history of psychiatry suggests that personality is a  trait that maintains itself despite experience.",Non-OADS,/arxiv_data1/oa_pdf/b7/63/pi-9-361.PMC3521112.pdf
"In previous  studies, severe depression reportedly strengthened the corre - lation between the harm avoidance (HA) and cooperativeness  (CO) dimensions of the Temperament and Character Inven - tory (TCI).8,9 Because the factor structures of those samples Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.361ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/b7/63/pi-9-361.PMC3521112.pdf
"Received: May 9, 2012    Revised: June 28, 2012 Accepted: July 31, 2012    Available online: November 12, 2012  Correspondence:  Changsu Han, MD, PhD, MHS  Department of Psychiatry, Korea University College of Medicine, Ansan Hos - pital, 516 Gojan-dong, Ansan 425-707, Republic of KoreaTel: +82-31-412-4931, Fax: +82-31-412-5144, E-mail:  hancs@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.368ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/19/25/pi-9-368.PMC3521113.pdf
"Received: October 21, 2011    Revised: December 6, 2011 Accepted: March 19, 2012    Available online: November 15, 2012  Correspondence:  Dai Jin Kim, MD, PhD  Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University  of Korea College of Medicine, 505 Banpo-dong, Seocho-gu, Seoul 137-040,  Republic of KoreaTel: +82-2-2258-6933, Fax: +82-2-594-3870, E-mail:  kdj922@chollian.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.373ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/98/9a/pi-9-373.PMC3521114.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.379   Copyright © 2012 Korean Neuropsychiatric Association   379ORIGINAL ARTICLE Effects of Antidepressant Treatment on Sexual Arousal   in Depressed Women: A Preliminary fMRI Study Jong-Chul Yang1,2, Jong-Il Park2, Gwang-Won Kim3, Sung-Jong Eun4, Moo-Suk Lee5,  Kyung-Lae Han6, Jeong-Ho Chae7 and Gwang-Woo Jeong3  1Department of Psychiatry, Chonbuk National University Medical School and Institute for Medical Sciences, Jeonju, Republic of Korea 2Department of Psychiatry, Chonbuk National University Hospital and Research Institute of Clinical Medicine, Jeonju, Republic of Korea 3Department of Radiology, Chonnam National University Medical School, Gwangju, Republic of Korea 4Department of Radiology, Hanlyo University, Gwangyang, Republic of Korea 5Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea 6Department of Psychiatry, Yesan Hospital, Yesan, Republic of Korea 7Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Objective aaThere was a recent study to explore the cerebral regions associated with sexual arousal in depressed women using function - al magnetic resonance imaging (fMRI).",Non-OADS,/arxiv_data1/oa_pdf/51/fc/pi-9-379.PMC3521115.pdf
"Received:  June 15, 2012    Revised:  August 3, 2012 Accepted:  August 5, 2012    Available online:  November 12, 2012  Correspondence:  Gwang-Woo Jeong, MPh, PhD Department of Radiology, Chonnam National University Medical School, 8  Hak-dong, Dong-gu, Gwangju 501-757, Republic of Korea Tel: +82-62-220-5881, Fax: +82-62-226-4380 E-mail:  gwjeong@chonnam.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Depressed patients often have difficulties in sexual function  including loss of sexual interest, and disturbance of sexual  arousal or orgasm.1-8 There have been very few studies, how -ever, of neural mechanisms of sexual dysfunction in de - pressed patients.",Non-OADS,/arxiv_data1/oa_pdf/51/fc/pi-9-379.PMC3521115.pdf
"Received: February 7, 2012    Revised: June 4, 2012 Accepted: August 20, 2012    Available online: November 12, 2012  Correspondence:  Wan Seok Seo, MD, PhD  Department of Neuropsychiatry, Y eungnam University College of Medicine,   7 Daemyung-dong, Daegu 705-717, Republic of Korea Tel: +82-53-620-3344, Fax: +82-53-629-0256, E-mail:  sws3901@ynu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.384ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/8f/3e/pi-9-384.PMC3521116.pdf
"Received: December 2, 2011    Revised: April 20, 2012 Accepted: July 17, 2012    Available online: November 14, 2012  Correspondence:  Joel Raskin, MD Global Medical Strategy Leader, Alzheimer’s Disease Team, Eli Lilly and Com - pany, 3650 Danforth Ave, Toronto, ON, Canada M1N 2E8Tel: +1 416 699 7260, Fax: +1 416 699 7352 E-mail:  RASKIN_JOEL@LILLY.COM cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.391ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/ac/3c/pi-9-391.PMC3521117.pdf
"Received:  October 8, 2011    Revised:  March 8, 2012   Accepted:  May 8, 2012    Available online:  November 14, 2012  Correspondence:  Byung Dae Lee, MD, PhD Department of Psychiatry, Pusan National University Hospital, 305 Gudeok- ro, Seo-gu, Busan 602-739, Republic of Korea Tel: +82-51-240-7304, Fax: +82-51-248-3648 E-mail:  psyleebd@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2012.9.4.400ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/c8/d7/pi-9-400.PMC3521118.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.408 408  Copyright © 2012 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Orbito-Frontal Cortex Volumes in Panic Disorder Murad Atmaca1 , Hanefi Yildirim2, M. Gurkan Gurok1 and Muammer Akyol2 1Department of Psychiatry, Firat University School of Medicine, Elazig, Turkey 2Department of Radiology, Firat University School of Medicine, Elazig, Turkey Objective aaGiven the association between the pathophysiology of panic disorder and prefrontal cortex function, we aimed to perform  a volumetric MRI study in patients with panic disorder and healthy controls focusing on the in vivo neuroanatomy of the OFC.",Non-OADS,/arxiv_data1/oa_pdf/0a/f7/pi-9-408.PMC3521119.pdf
"Received:  September 30, 2011    Revised:  January 22, 2012 Accepted:  March 26, 2012    Available online:  November 12, 2012  Correspondence:  Murad Atmaca, MD Firat (Euphrates) Universitesi, Firat Tip Merkezi, Psikiyatri Anabilim Dali,  23119 Elazig, Turkey Tel: +90-424-233-3555/2965, Fax: +90-424-238-7688 E-mail:  matmaca_p@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Panic disorder, as defined by the Diagnostic and Statistical  Manual of Mental Disorders, 4th ed.",Non-OADS,/arxiv_data1/oa_pdf/0a/f7/pi-9-408.PMC3521119.pdf
"Received: March 2, 2012    Revised: June 15, 2012 Accepted: July 25, 2012    Available online: November 12, 2012  Correspondence:  Doh Kwan Kim, MD  Department of Psychiatry, Samsung Medical Center, Sungkyunkwan Univer - sity School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Re-public of KoreaTel: +82-2-3410-3582, Fax: +82-2-3410-0941, E-mail:  paulkim@skku.edu  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.413ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/f6/ba/pi-9-413.PMC3521120.pdf
"Received: April 13, 2012    Revised: June 22, 2012 Accepted: July 4, 2012    Available online: November 14, 2012  Correspondence:  Tomoyuki Kawada Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Send - agi, Bunkyo-Ku, Tokyo 113-8602, JapanTel: +81-3-3822-2131, Fax: +81-3-5685-3065, E-mail:  kawada@nms.ac.jp cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.418BRIEF REPORT",Non-OADS,/arxiv_data1/oa_pdf/dc/4e/pi-9-418.PMC3521121.pdf
"Received: June 24, 2012    Revised: August 8, 2012 Accepted: August 9, 2012    Available online: November 12, 2012  Correspondence:  Y oung-Min Park, MD, PhD  Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medi- cine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, Republic of Korea Tel: +82-31-910-7260, Fax: +82-31-910-7268, E-mail:  medipark@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.422CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/pi-9-422.PMC3521122.pdf
"Rongwang Yang1 , Suhan Zhang1, Rong Li1 and Zhengyan Zhao2 1Department of Child Psychology, The Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China 2Department of Child Health Care, The Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China Received: May 12, 2012    Revised: July 3, 2012 Accepted: July 3, 2012    Available online: November 14, 2012  Correspondence:  Rongwang Yang, MD Department of Child Psychology, The Children’s Hospital, Zhejiang University  School of Medicine, No.57, Zhuganxiang Road, Hangzhou, Zhejiang Province,  ChinaTel: +86 571 88873304, Fax: +86 571 87033296 E-mail:  colortea@zuaa.zju.edu.cn cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2012.9.4.425LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/59/bf/pi-9-425.PMC3521123.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Guzzo, C., Jung, M., Graveline, A., Banfield, B.W.",Non-OADS,/arxiv_data1/oa_pdf/87/ae/srep00974.PMC3521153.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/4f/a3/srep00976.PMC3521154.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Niu, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/a3/srep00976.PMC3521154.pdf
"http://www.who.int/mediacentre/factsheets/ fs211/en/index.html (Accessed September 11, 2012).",Non-OADS,/arxiv_data1/oa_pdf/81/22/srep00972.PMC3521156.pdf
"http://www.who.int/influenza/ human_animal_interface/EN_GIP_20120412CumulativeNumberH5N1cases.pdf(Accessed September 11, 2012).",Non-OADS,/arxiv_data1/oa_pdf/81/22/srep00972.PMC3521156.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Long, J.P. et al.",Non-OADS,/arxiv_data1/oa_pdf/81/22/srep00972.PMC3521156.pdf
We used the 5.05 version of MEGA5 software for sequence alignment (http://www.megasoftware.net/) 37.,Non-OADS,/arxiv_data1/oa_pdf/aa/4d/srep00975.PMC3521167.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Yamamoto, M., Cid, E. & Yamamoto, F. Molecular genetic basis of the human Forssman glycolipid antigen negativity.",Non-OADS,/arxiv_data1/oa_pdf/aa/4d/srep00975.PMC3521167.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/6c/srep00971.PMC3521219.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Tang, D.M.",Non-OADS,/arxiv_data1/oa_pdf/20/6c/srep00971.PMC3521219.pdf
"In order to contribute to the understanding of the tectonic framework, we explored the area by a multichannel seismic reflection and multibeam survey (TIR10, cruise report available at http://www.ismar.cnr.it).",OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
"Red, blue and green dots are earthquake epicentres38, occurring at depths ,15 km, between 15 and 35 km, and .35 km, respectively (http://csi.rm.ingv.it).",OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
All the data were elaborated using Move 2011 (http://www.mve.com/).,OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
"Methods Multibeam bathymetry .Bathymetry was acquired during the 2010 R/V Urania (TIR10, http://www.ismar.cnr.it) cruise with an EM710 Kongsberg-Simrad multibeam, DGPS positioning, and SEAPTH MRU and gyrocompass.",Non-OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
"Topography of the Messina Strait was obtained from asynthesis of ISMAR and our own multibeam and single-beam and multibeam data of Italian Navy Hydrographic Institute, and elevation data from the Shuttle Radar Topography Mission database (http://srtm.usgs.gov).",OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
Seismic reflection .Multichannel reflection seismic lines were acquired during TIR10 in the frame of the Italian CROP Project (http://www.crop.cnr.it).,OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
Maps and Digital Terrain Models were produced with the GMT package (http://gmt.soest.hawaii.edu).,Non-OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Doglioni, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/d9/srep00970.PMC3521220.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 177Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.177 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):177-182, 2013 Molecular and Epidemiological Characterization   of Carbapenem-Resistant Acinetobacter baumannii   in Non-Tertiary Korean Hospitals Sunok Park, Hwa-Su Kim, Kyeong Min Lee, Jung Sik Yoo, Jae Il Yoo,   Yeong Seon Lee, and Gyung Tae Chung  Division of Antimicrobial Resistance, Center for Infectious Diseases, Korea National Institute of Health, Cheongwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The increasing prevalence and global spread of carbapenem-resistant  Acinetobacter baumannii  (A. baumannii ) has become a serious problem.",Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 178Repetitive-sequence-based PCR (Rep-PCR) Rep-PCR was performed by using the DiversiLab system  (bioMerieux SA, Grenoble, France) to investigate the clon - al relatedness of A. baumannii  isolates.",OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
"Identification of carbapenemase genes PCR was performed to detect the genes encoding MBLs  (IMP-1 variants and VIM-2 variants) and OXA carbapene - mase (OXA-23-like, OXA-24-like, OXA-51-like and  OXA-58-like) according to the method described previous - ly.13 The sequence analysis of PCR products was carried  out by request at Macrogen (http://macrogen.co.kr).",OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
"Carbapenem Resistant Acinetobacter baumannii Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 179isolates (ST92)], band pattern 7 [3 isolates (ST69)], and  band pattern 8 [1 isolate (ST69)] (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 180clonality of carbapenem-resistant A. baumannii  isolates in  non-tertiary hospitals throughout various regions of Korea.,Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
Our results corresponded well  with those of an earlier study which reported that ST92  (ST22 was redesignated ST92 after an update of allelic pro - files at the database website http://pubmist.org) may contrib - ute to the high carbapenem resistance rates of Acinetobacter  have been described in Europe and worldwide.,Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
Carbapenem Resistant Acinetobacter baumannii Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 181ACKNOWLEDGEMENTS This study was supported by an intramural research fund of  the Korea Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 18216.,Non-OADS,/arxiv_data1/oa_pdf/00/2b/ymj-54-177.PMC3521248.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 101Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.101 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):101-107, 2013 Epidermal Growth Factor Receptor Is Related to Poor Survival   in Glioblastomas: Single-Institution Experience Youngmin Choi,1 Young-Jin Song,2 Hyung-Sik Lee,1 Won-Joo Hur,1 Ki-Han Sung,1 Ki-Uk Kim,2  Sun-Seob Choi,3 Su-Jin Kim,4 and Dae-Cheol Kim4 Departments of 1Radiation Oncology, 2Neurosurgery, 3Radiology, and 4Pathology, Dong-A University School of Medicine, Busan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  There are conflicting results surrounding the prognostic significance of  epidermal growth factor receptor (EGFR) status in glioblastoma (GBM) patients.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 102Immunohistochemical staining Formalin-fixed and paraffin embedded tissue blocks were  cut serially into 4 μm thick sections.,Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
"Unfavorable Prognosis in EGFR Expressing GBM Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 103(p=0.000) and 17.5 months vs. 12.5 months ( p=0.013), re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 104survival according to immunohistochemical staining differed  among researchers (Table 4).,OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
Unfavorable Prognosis in EGFR Expressing GBM Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 105an EGFR study with data from more homogenously man - aged patients.,Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 106glioblastoma in a randomised phase III study: 5-year analysis of  the EORTC-NCIC trial.,Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
Unfavorable Prognosis in EGFR Expressing GBM Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 107Monogr 1988;(6):279-84.,Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ymj-54-101.PMC3521249.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 123Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.123 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):123-130, 2013 Correlations of Dynamic Contrast-Enhanced Magnetic  Resonance Imaging with Morphologic, Angiogenic, and  Molecular Prognostic Factors in Rectal Cancer Hye-Suk Hong,1 Se Hoon Kim,2 Hae-Jeong Park,3 Mi-Suk Park,3 Ki Whang Kim,3  Won Ho Kim,4 Nam Kyu Kim,5 Jae Mun Lee,6 and Hyeon Je Cho7 1Department of Medicine, Graduate School, Yonsei University, Seoul; Departments of 2Pathology, 3Radiology, 4Internal Medicine, and  5Surgery,  Severance Hospital, Yonsei University College of Medicine, Seoul; 6Department of Radiology, Yeouido St. Mary’ s Hospital,  The Catholic University of Korea College of Medicine, Seoul; 7Department of Radiology, Seoul Veterans Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To investigate the correlations between parameters of dynamic contrast-en - hanced magnetic resonance imaging (DCE-MRI) and prognostic factors in rectal can - cer.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 124derwent curative surgery.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
DCE-MRI in the Prognostication of Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 125the values of four hot spots.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 126solution contained 20 ng of purified PCR products, 1 µL of  Big Dye Terminator, and 0.1 µM the same PCR primers as  listed above.",OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
DCE-MRI in the Prognostication of Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 127The distribution of each morphologic factor and the val - ues of each angiogenic marker are provided in Table 1.,OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 128reflect functional status.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
DCE-MRI in the Prognostication of Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 129REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 13022.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/ymj-54-123.PMC3521250.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 92Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.92 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):92-100, 2013 Glioma Stem Cell-Targeted Dendritic Cells as a Tumor   Vaccine Against Malignant Glioma Baowei Ji, Qianxue Chen, Baohui Liu, Liquan Wu, Daofeng Tian, Zhentao Guo, and Wei Yi Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.",Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Cancer stem cells have recently been thought to be closely related to tu - mor development and reoccurrence.",Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
"Glioma Stem Cell-Targeted Dendritic Cell V accine Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 93isolated by fluorescence-activated cell sorting (FACS) (EP - ICS ALTRA II, Beckman, Fullerton, CA, USA) and pas - saged under the same conditions for up to 4 weeks.",Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 945, 1 : 10, 1 : 20, 1 : 40 and 1 : 80) in 96 well plates.",Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
Glioma Stem Cell-Targeted Dendritic Cell V accine Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 95colonies enlarged with additional culture (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 96Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
Glioma Stem Cell-Targeted Dendritic Cell V accine Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 97T-cell proliferation was the highest compared with other  DC : T-cell ratios (†p<0.01) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 98and are closely related to tumor occurrence, progression,  metastasis, recurrence, drug resistance and immune eva - sion.14-16 Therefore, tumor stem cell eradiation is essential  for complete cancer clearance.",Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
"Glioma Stem Cell-Targeted Dendritic Cell V accine Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 99LPS-DCs group, and was respectively (38.5±0.043%),  (48.8±0.028%), and (70.9±0.010%) in the BGS-DCs  group.",Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 100arise from pediatric brain tumors.,Non-OADS,/arxiv_data1/oa_pdf/5e/b3/ymj-54-92.PMC3521251.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 246Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.246 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):246-252, 2013 The Genetically Modified Polysialylated Form of Neural   Cell Adhesion Molecule-Positive Cells for Potential Treatment   of X-Linked Adrenoleukodystrophy Jiho Jang,1 Han-Soo Kim,2 Joon Won Kang,3 and Hoon-Chul Kang3 Departments of 1Physiology and 2Laboratory Medicine and Cell Therapy Center,  3Division of Pediatric Neurology, Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Cell transplantation of myelin-producing exogenous cells is being exten - sively explored as a means of remyelinating axons in X-linked adrenoleukodystro - phy.",Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
Genetically Modified PSA-NCAM+ Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 247Isolation and culture of PSA-NCAM+ pre-progenitors PSA-NCAM+ pre-progenitors were obtained by a Percoll  density gradient using a slight modification of the isolation  procedure described by Lubetzki and co-workers (Fig.,OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 248were cultured for 16 hours in growth media containing 10  µM BrdU and then fixed in 5% glacial acetic acid, 95%  ethanol for 5-10 minutes.",Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
"Genetically Modified PSA-NCAM+ Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 249the effect of T3 on PSA-NCAM+ cell proliferation in re - sponse to bFGF, BrdU incorporation assay was performed  between three and four days.",Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 250with FGF2 and T3.,Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
Genetically Modified PSA-NCAM+ Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 251of multiple sclerosis.,Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 252diologic manifestations of X-linked adrenoleukodystrophy by  bone marrow transplantation.,Non-OADS,/arxiv_data1/oa_pdf/bd/d6/ymj-54-246.PMC3521252.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 160Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.160 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):160-165, 2013 Prevalence and Risk Factors of Esophageal Candidiasis in  Healthy Individuals: A Single Center Experience in Korea Jae Hyeuk Choi,1* Chang Geun Lee,1* Yun Jeong Lim,1 Hyoun Woo Kang,1  Chi Yeon Lim,2 and Jong-Sun Choi3 Departments of 1Internal Medicine, 2Biostatistics, and 3Pathology, Dongguk University Ilsan Hospital,  Dongguk University-Seoul, Graduate School of Medicine, Goyang, Korea.",Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Esophageal candidiasis (EC) is the most frequent opportunistic fungal  infection in immunocompromised host.",Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
"Esophageal Candidiasis in Healthy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 161EGD was performed about one third of EC patients (83  cases, 29.5%) and EGD was performed annually for rou - tine health examination.",Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 162dred and a eighty-one cases (281/88125, 0.32%) were final - ly included with EC.",Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
"Esophageal Candidiasis in Healthy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 163Candida  are known to colonize the esophagus of 20% of  healthy adults.10,11 Once colonization has been established,  impaired cellular immunity permits invasion of the epitheli - al layer, such as HIV infection.10,11 Proton pump inhibitors,  H2-receptor antagonists, and prior vagotomy are thought to  increase the risk of EC, which elevated gastric pH and al - ters the colonization of the esophagus by oral cavity bacte - ria and yeast.3,4 Antibiotics may predispose immunocompe - tent patients to fungal infection by allowing overgrowth  and colonization of the candida species.2 Administered cor - ticosteroids predispose one to infection by suppressing both  lymphocyte and granulocyte function.7 EC is also seen in  the setting of functional or mechanical obstruction of the  esophagus, with stasis and excessive growth of the fungus.4,5  However, the exact mechanism of invasion in a healthy in - dividuals has not been fully elucidated.10,11 The main findings of our study was that the prevalence of  EC was less observed (0.32%, 281/88125) comparing with  the data reported other countries by Underwood, et al.12  (0.71%, 18/2527) and by Naito, et al.13 (1.17%, 41/3501).",Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 164of transmural invasive Candida  infection and esophageal  perfration.17,19 Esophageal perforation should be considered  in patients with pre-existing esophagitis, unexplained fever,  pleuritic chest pain and pleural effusion.19 Our study has limitations.",Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
Esophageal Candidiasis in Healthy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 165On a fatal case of Candida krusei pleural empyema in a pregnant  woman with spontaneous esophagus perforation.,Non-OADS,/arxiv_data1/oa_pdf/17/a2/ymj-54-160.PMC3521253.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 253Brief Communicationhttp://dx.doi.org/10.3349/ymj.2013.54.1.253 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):253-257, 2013 Patients with Arthritis Undergoing Surgery: How Should We  Manage Tumour Necrosis Factor Blocking Agents  Perioperatively?-A Systematic Literature Review Herwig Pieringer,1,2 Kathrin Danninger,1 Nikolay Tzaribachev,3 Nikolaus Böhler,4  Erich Pohanka,1,5 and Manfred Herold6 1Section of Rheumatology, 2nd Department of Medicine, General Hospital Linz, Linz; 2Paracelsus Medical University, Salzburg, Austria.",Non-OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.We systematically reviewed the literature on the infectious risk in patients treated  with tumour necrosis factor blocking agents (TNF-BA) undergoing surgery: we  searched the Medline (PubMed) and the online archive from the Annual European  Congress of Rheumatology and the Annual Scientific Meeting of the American  College of Rheumatology.",Non-OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 254There were 6 y/n studies, 3 c/disc studies, and 3 papers that  presented data both in a y/n and c/disc form.",OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
"      RA and Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 255“off” drug at time of surgery, “DMARD” (disease-modify - ing anti-rheumatic drug) group].",Non-OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 256a higher risk of postoperative infections than are patients not  receiving this treatment.,Non-OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
      RA and Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 257anti-TNF therapies.,Non-OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
http://dgrh.de/fileadmin/media/Praxis___ Klinik/Therapie-Empfehlungen/TNF-Blocker_06.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/7f/ymj-54-253.PMC3521254.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 21Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.21 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):21-27, 2013 Usefulness of Diffusion Tensor Tractography in Pediatric  Epilepsy Surgery Mi-Jung Lee,1 Heung Dong Kim,2 Joon Soo Lee,2 Dong-Seok Kim,3 and Seung-Koo Lee1 1Department of Radiology and Research Institute of Radiological Science, Severance Hospital; Departments of 2Pediatrics and 3Pediatric Neurosurgery, Severance Children’ s Hospital,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  This study was conducted to assess the clinical relevance of diffusion  tensor tractography (DTT) in pre- and post-operative evaluations of childhood epi - lepsy surgery.",Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 22duration of 4.9 years (range from one month to 20 years).,Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
DTT in Pediatric Epilepsy Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 23Preoperative DTT analysis Preoperative DTT was used for evaluating the relationship  between the lesion and major white matter tract in 52 pa - tients who underwent lesional resection.,Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 24Postoperative complications and seizure outcomes There were two complicated cases.,Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
"DTT in Pediatric Epilepsy Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 25though this study was not a well designed prospective study,  we insist that the results of this review could be proof of the  clinical usefulness of DTT in daily neuroimaging of epilep - sy patients.",Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 26and the fiber connections were well-demonstrated in all  cases, including the one case of incomplete resection.",Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
DTT in Pediatric Epilepsy Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 2711.,Non-OADS,/arxiv_data1/oa_pdf/2f/e3/ymj-54-21.PMC3521255.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 154Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.154 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):154-159, 2013 Clinical Implications and Risk Factors of Acute Pancreatitis   after Cardiac Valve Surgery Joo Won Chung,1 Sung Ho Ryu,1 Jung Hyun Jo,1 Jeong Youp Park,1 Sak Lee,2  Seung Woo Park,1 Si Young Song,1,3 and Jae Bock Chung1 1Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul; 2Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul; 3Brain Korea 21 Project for Medical Science, Severance Biomedical Science Institute, Seoul, Korea Received: December 16, 2011 Revised: February 10, 2012 Accepted: February 24, 2012 Corresponding author: Dr. Jeong Youp Park, Division of Gastroenterology,  Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Acute pancreatitis is one of the potentially lethal complications that oc - curs after cardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
"Acute Pancreatitis after Cardiac Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 155ylase and lipase concentrations on post-operative day 2, du - ration of CPB, presence of post-operative complications,  post-operative hospital stay, and in-hospital mortality.",Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 15612.9%) than those without post-operative pancreatitis  (60.6±12.2%), but the difference was not statistically signif - icant (p=0.116).",Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
"Acute Pancreatitis after Cardiac Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 157serum marker for diagnosing acute pancreatitis, it is neither  specific nor sensitive for detecting pancreatic cellular injury  because post-operative hyperamylasemia may result from  an increased production of either pancreatic or salivary type  amylase11,14,15 and decreased clearance of amylase.18 In con - trast, lipase is a more sensitive and specific biomarker that  is done as a single laboratory test for acute pancreatitis.16,19-21  Lipase increased earlier and to a greater extent than total  amylase, and the peak activities of lipase and pancreatic  type amylase in the serum have shown significant correla - tion.14 In addition, serum lipase remains elevated for a lon - ger period of time than serum amylase.22 When the serum  lipase level was elevated three times greater than the upper  limit of normal level, the diagnostic accuracy of acute pan - creatitis was improved.19 Compared to previous studies, we detected a slightly high - er incidence of acute pancreatitis after cardiac valve surgery  (5.9%).",Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 158level of amylase and lipase, which meant that the possibility  that patients already had hyperlipasemia before surgery could  not be excluded.",Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
Acute Pancreatitis after Cardiac Surgery Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 159acute pancreatitis.,Non-OADS,/arxiv_data1/oa_pdf/a0/a1/ymj-54-154.PMC3521256.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 145Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.145 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):145-153, 2013 Predictors of Refractory Ascites Development in Patients   with Hepatitis B Virus-Related Cirrhosis Hospitalized   to Control Ascitic Decompensation Ju Hee Seo,1* Seung Up Kim,1-3* Jun Yong Park,1-3 Do Young Kim,1-3 Kwang-Hyub Han,1-4  Chae Yoon Chon,1-3 and Sang Hoon Ahn1-4 1Department of Internal Medicine, 2Institute of Gastroenterology, Yonsei University College of Medicine, Seoul; 3Liver Cirrhosis Clinical Research Center, Seoul; 4Brain Korea 21 Project for Medical Science, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Refractory ascites (RA) is closely related to a high morbidity and mortali - ty.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 146hepatorenal syndrome (HRS) at the time of admission and  those with ascites caused by nephrogenic causes, tuberculo - sis, or malignancy.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
Predictors of Refractory Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 147RESULTS   Baseline characteristics Baseline characteristics of 199 patients hospitalized to con - trol ascitic decompensation are shown in Table 1.,OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 148our study population (4.1 mEq/L; sensitivity 68.7%, speci - ficity 54.6%, positive predictive value 11.6%, and negative  predictive value 95.3%) as a cutoff value, RA development related cirrhosis who were hospitalized to control ascitic de - compensation ( p=0.013; HR, 2.800; 95% CI, 1.166-6.722).",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Predictors of Refractory Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 149dence rates of RA were 81.8%, 100%, and 100%, respec - tively, in patients with serum potassium ≥4.1 mEq/L where - as they were 38.2%, 60.4%, and 100%, respectively, in was significantly higher in patients with serum potassium  ≥4.1 mEq/L than those with <4.1 mEq/L (log-rank test,  p=0.011) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 150line characteristic between survivors and non-survivors ex - cept poorer liver function in non-survivors than survivors  (Child-Pugh C class, 91.7 vs. 25.0%; p=0.027) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Predictors of Refractory Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 151with Child-Pugh C liver function,10,21 Child-Pugh class in  our study was not found to be a significant predictor of RA  development even in the univariate analysis.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 152between hyperkalemia and the use of spironolactone, we  failed to unravel the role of hyperkalemia independent of  spironolactone, because of heterogenous treatment period  and various total cumulative dose of spironolactone in our  study population.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Predictors of Refractory Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 153treatment of refractory ascites: effect on clinical, renal, humoral,  and hemodynamic parameters.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/ymj-54-145.PMC3521257.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 238Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.238 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):238-245, 2013 Effect of Human Parathyroid Hormone on Hematopoietic   Progenitor Cells in NOD/SCID Mice Co-Transplanted with Human  Cord Blood Mononuclear Cells and Mesenchymal Stem Cells Yeon-Jung Lim,1* Kyoujung Hwang,2* Miyeon Kim,3 Youl-Hee Cho,4 Jong-Hwa Lee,5  Young-Ho Lee,6 and Jong-Jin Seo7 1Department of Pediatrics, Chungnam National University Hospital, Daejeon;  2Department of Translational Medicine, Hanyang University Graduate School of Biomedical Science & Engineering, Seoul;  3Biomedical Research Institute, MEDIPOST , Co., Ltd., Seoul; 4Department of Genetics, Hanyang University College of Medicine, Seoul;  5Department of Pediatrics, Wonkwang University Sanbon Medical Center, Gunpo; 6Department of Pediatrics, Hanyang University Medical Center, Seoul; 7Department of Pediatrics, Ulsan University Asan Medical Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  We evaluated the effect of human parathyroid hormone (hPTH) on the  engraftment and/or in vivo  expansion of hematopoietic stem cells in an umbilical  cord blood (UCB)-xenotransplantation model.",Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
Effect of Human Parathyroid Hormone on Hematopoietic Progenitor Cells in NOD/SCID Mice Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 239expansion of early HSCs ex vivo .,OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 240for complete blood cell counts.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
"Effect of Human Parathyroid Hormone on Hematopoietic Progenitor Cells in NOD/SCID Mice Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 241ed by human CD13 and human CD33 cells, and lymphoid  lineage cells represented by human CD19 cells, were mark - edly higher in Group 3 (Fig.",OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 242 Fig.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
Effect of Human Parathyroid Hormone on Hematopoietic Progenitor Cells in NOD/SCID Mice Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 243cells from normal donor animals survived to 28 days.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 244plant 2005;11:389-98.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
Effect of Human Parathyroid Hormone on Hematopoietic Progenitor Cells in NOD/SCID Mice Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 245plantation for the treatment of hematologic malignancies.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ymj-54-238.PMC3521258.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 225Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.225 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):225-230, 2013 Cerebral Oxygenation during Laparoscopic Surgery:   Jugular Bulb versus Regional Cerebral Oxygen Saturation Seung Ho Choi,1 Soo Hwan Kim,2 Sung Jin Lee,1 Sa Rah Soh,1 and Young Jun Oh1 1Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul; 2Department of Anesthesiology and Pain Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  We hypothesized that regional cerebral oxygen saturation (rSO 2) could  replace jugular bulb oxygen saturation (SjvO 2) in the steep Trendelenburg position  under pneumoperitoneum.",Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 226For SjvO 2 measurement, a 4-F dual oximeter catheterTM  (Edwards Lifesciences, Irvine, CA, USA) was inserted into  the left internal jugular vein according to the modified Seld - inger technique.",Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
Cerebral Oxygen Saturation during Laparoscopy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 227SjvO 2 values ranged from 59.0 to 92.7% whereas the val - ues for rSO 2 ranged from 52 to 88% during study periods.,Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 228There are some studies investigating the correlation be - tween rSO 2 and SjvO 2 under specific clinical situations with  contrary results.,Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
Cerebral Oxygen Saturation during Laparoscopy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 229change of PaCO 2 more accurately than rSO 2 during laparo - scopic surgery.,Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 23014.,Non-OADS,/arxiv_data1/oa_pdf/b5/1a/ymj-54-225.PMC3521259.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 139Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.139 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):139-144, 2013 Selective Neck Dissection for Clinically Node-Positive   Oral Cavity Squamous Cell Carcinoma Yoo Seob Shin,1 Yoon Woo Koh,2 Se-Heon Kim,2 and Eun Chang Choi2 1Department of Otolaryngology, Ajou University School of Medicine, Suwon;  2Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The treatment of a clinically node-positive (cN+) neck is important in  the management of oral cavity squamous cell carcinoma (OSCC).",Non-OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 140gin of primary tumor, T stage, N stage based on the criteria  of the American Joint Committee on Cancer (2009), and  the type of surgery performed.",Non-OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
"Selective Neck Dissection for cN+ Oral Cavity Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 141lymph nodes, but none were detected pre-operatively.",Non-OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 142(p=0.025) (Table 5) and level V lymph node metastasis  (p=0.036).,Non-OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
"Selective Neck Dissection for cN+ Oral Cavity Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 143However, there are many widely known long-term morbid - ities caused by chemo-radiotherapy, such as xerostomia,  dysphagia or neck fibrosis.17,18 If we could accurately pre - dict the possibility of nodal metastasis with the patients’  clinical characteristics and remove the suspicious area ap - propriately, we could decrease the severity of adjuvant ther - apy.",Non-OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 144GL, et al.",OADS,/arxiv_data1/oa_pdf/06/07/ymj-54-139.PMC3521260.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 87Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.87 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):87-91, 2013 The Change of Prostate Cancer Treatment in Korea:   5 Year Analysis of a Single Institution Dong Hoon Lee, Ha Bum Jung, Mun Su Chung, Seung Hwan Lee, and Byung Ha Chung Department of Urology and Urological Science Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  We analyzed changes to the trends of prostate cancer management and  patient characteristics at a single institute during 5 years due to the significant in - crease of the prostate cancer incidence and the robotic equipment in Korea.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 88For this present analysis, patients were stratified into lo - calized prostate cancer (LPC), locally advanced prostate  cancer (LAPC), advanced prostate cancer (APC), and hor - mone refractory prostate cancer (HRPC) based on the  pathologic stage.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
Change of the Prostate Cancer Trend in Korea Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 89patients increased by 79% in 2010 compared to 67% in  2006.,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 90that the main treatment after diagnosis of prostate cancer is  radical prostatectomy including RRP and RALP .,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
Change of the Prostate Cancer Trend in Korea Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 91early stage disease: results from J-CaP and CaPSURE.,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
[http://www.nccn.org/professionals/physician_gls/ PDF/prostate-asia.pdf].,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
[http://kostat.go.kr/portal/english/index.action].,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
[http://www.neca.re.kr/eng].,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
[http://english.mw.go.kr/front_eng/index.jSP].,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/ymj-54-87.PMC3521261.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 220Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.220 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):220-224, 2013 Change in Electromyographic Activity of Wrist Extensor   by Cylindrical Brace Jung Joong Yoon and Hasuk Bae Department of Rehabilitation Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2a/57/ymj-54-220.PMC3521262.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To verify the effect of a newly-developed cylindrical type forearm  brace, which was designed to give focal counterforce perpendicularly on the mus - cle belly of the wrist extensor.",Non-OADS,/arxiv_data1/oa_pdf/2a/57/ymj-54-220.PMC3521262.pdf
New Cylindrical Type Forearm Brace Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 221This study aimed to verify the effect of this new cylindri - cal type brace compared to existing braces by measuring  quantitative electromyographic activity on the muscle belly  at before and after applying the braces.,Non-OADS,/arxiv_data1/oa_pdf/2a/57/ymj-54-220.PMC3521262.pdf
Jung Joong Y oon and Hasuk Bae Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 222minutes.,Non-OADS,/arxiv_data1/oa_pdf/2a/57/ymj-54-220.PMC3521262.pdf
New Cylindrical Type Forearm Brace Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 223sults showed that the cylindrical type brace decreased tensile  force to the muscle origin area more than did the pneumatic  type brace.,Non-OADS,/arxiv_data1/oa_pdf/2a/57/ymj-54-220.PMC3521262.pdf
Jung Joong Y oon and Hasuk Bae Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 22415.,Non-OADS,/arxiv_data1/oa_pdf/2a/57/ymj-54-220.PMC3521262.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 269Retractionhttp://dx.doi.org/10.3349/ymj.2013.54.1.269 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):269-269, 2013 Retraction: Prognostic and Predictive Value of Carcinoembryonic  Antigen and Cytokeratin-19 Fragments Levels in Advanced   Non-Small Cell Lung Cancer Patients Treated with Gefitinib   or Erlotinib.",Non-OADS,/arxiv_data1/oa_pdf/b4/2a/ymj-54-269.PMC3521263.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 15Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.15 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):15-20, 2013 Effects of Art Therapy Using Color on Purpose in Life   in Patients with Stroke and Their Caregivers Mi Kyoung Kim1 and Sung Don Kang2  1Art Institute, Sungshin Women’ s University, Seoul; 2Department of Neurosurgery, School of Medicine, Wonkwang University, Iksan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Patients with stroke suffer from physical disabilities, followed by mental  instability.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
Mi Kyoung Kim and Sung Don Kang  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 16of author’s Hospital.,Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
"Color Therapy in Patients with Stroke Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 17hours (13 sessions using color, 3 sessions for PIL question - naire).",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
Mi Kyoung Kim and Sung Don Kang  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 18two groups ( p>0.05) (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
Color Therapy in Patients with Stroke Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 19directing patients to restore their desire to pursue the posi - tive life value.,Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
Mi Kyoung Kim and Sung Don Kang  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 2012.,Non-OADS,/arxiv_data1/oa_pdf/4e/a2/ymj-54-15.PMC3521264.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 166Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.166 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):166-171, 2013 The Frequency of Reexpansion Pulmonary Edema after Trocar  and Hemostat Assisted Thoracostomy in Patients   with Spontaneous Pneumothorax Kyoung Chul Cha,1 Hyun Kim,1 Ho Jin Ji,2 Woo Cheol Kwon,3 Hyung Jin Shin,1 Yong Sung Cha,1  Kang Hyun Lee,1 Sung Oh Hwang,1 Christopher C. Lee,4 and Adam J. Singer4 Departments of 1Emergency Medicine and 3Radiology, Wonju College of Medicine, Yonsei University, Wonju; 2Department of Emergency Medicine, Andong Hospital, Andong, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Several risk factors for development of reexpansion pulmonary edema  (REPE) after drainage of pneumothoraces have been reported, but the association  between the method of thoracostomy and the development of REPE is unknown.",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
"Reexpansion Pulmonary Edema Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 167ing closed thoracostomy, the end of the thoracostomy tube  was connected to a single bottle system that was attached to  a negative pressure (20 cm H 2O using an Emerson post-op - erative suction pump model 55-JS, J. H. EMERSON Corp.,  Cambridge, MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 168pressure (20 cmH 2O using an Emerson post-operative suc - tion pump, model 55-JS, J. H. Emerson Corp., Cambridge,  MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
Reexpansion Pulmonary Edema Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 169when the intercostal muscle and the parietal pleura are dis - sected.,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 170ing to detect REPE.15 CT imaging of the chest was used in  this study, because of its higher accuracy and sensitivity in  diagnosing REPE.",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
Reexpansion Pulmonary Edema Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 1714.,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/ymj-54-166.PMC3521265.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 172Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.172 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):172-176, 2013 Rare Acute Kidney Injury Secondary   to Hypothyroidism-Induced Rhabdomyolysis Ying Cai and Lin Tang Department of Nephrology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ymj-54-172.PMC3521266.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Acute kidney injury (AKI) caused by hypothyroidism-induced rhabdo - myolysis is a rare and potentially life-threatening syndrome.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ymj-54-172.PMC3521266.pdf
Acute Kidney Injury on Rhabdomyolysis Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 173ma was present.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ymj-54-172.PMC3521266.pdf
"Ying Cai and Lin Tang Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 174chondrial oxidative metabolism has been proposed as a  possible explanation.7 In our cases, the diagnoses of rhabdomyolysis and AKI  were based on abnormal laboratory results of elevated se - rum CK and creatinine, as well as urinary and serum myo - globin.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ymj-54-172.PMC3521266.pdf
Acute Kidney Injury on Rhabdomyolysis Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 175primary hypothyroidism in iodine-sufficient areas.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ymj-54-172.PMC3521266.pdf
Ying Cai and Lin Tang Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 176Lab Med 2010;48:749-56.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ymj-54-172.PMC3521266.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 41Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.41 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):41-47, 2013 Relationship between Angiographic Late Loss and 5-Year   Clinical Outcome after Drug-Eluting Stent Implantation Young-June Yang,1* Sanghoon Shin,1* Byeong-Keuk Kim,1 Jung-Sun Kim,1 Dong-Ho Shin,1  Young-Guk Ko,1 Donghoon Choi,1 Yangsoo Jang,1,2 and Myeong-Ki Hong1,2 1Division of Cardiology, Severance Cardiovascular Hospital and 2Severance Biomedical Science Institute,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Currently, insufficient data exist to evaluate the relationship between an - giographic late loss (LL) and long-term clinical outcome after drug-eluting stent  (DES) implantation.",Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 42met both the inclusion and exclusion criteria were enrolled  and subsequently divided into three groups according to an - giographic LL-individuals with angiographic LL <0.3 mm  (group I; n=378), individuals with angiographic LL be - tween 0.3 and 0.6 mm (group II; n=124), and individuals  with angiographic LLs >0.6 mm (group III; n=134).",Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
Long-Term Outcomes Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 43cal events were chronic renal failure [odds ratio (OR)=3.29;  95% confidence interval (CI): 1.48-7.31; p=0.003] and long  lesion length (lesion length >28 mm; OR=1.88; 95% CI:  1.02-3.46; p=0.042) (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 44Table 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
Long-Term Outcomes Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 45Table 3.,Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 46sions with an angiographic LL >0.6 mm had significantly  fewer uncovered struts, a greater risk of restenosis, and were  more likely to require target-lesion revascularization; howev - er, they carried a lower risk of stent thrombosis.",Non-OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
